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SUMMARY
Virus discovery using current and novel methods
Barbara Franziska Mühlemann
Next Generation Sequencing (NGS) technology allows researchers to sequence ge-
netic material from a wide range of sources, including patient and environmental
samples, and ancient remains. The recovery of viruses from such datasets can pro-
vide insights into the diversity and evolution of both novel and already known viruses.
This thesis focuses on two aspects of virus discovery in NGS datasets.
In the first part of this thesis, I present ancient viral sequences from hepatitis B virus,
human parvovirus B19, and variola virus. The sequences were recovered from NGS
datasets from individuals living in Eurasia between ∼150 to ∼31,630 years ago, us-
ing standard sequence matching tools. The data show the past existence of viruses
similar to variants circulating today. The sequences reveal a complexity of virus
evolution that is not evident when considering modern sequences alone, including
revised substitution rates and most recent common ancestor dates, as well as geo-
graphic movement and extinction of strains.
The identification of viral sequences in NGS datasets relies heavily on sequence-
based matching of unknown sequences to a database of known sequences. Compar-
isons are usually done at the nucleotide or amino acid level. However, those methods
only work well on sequences closely related to those already present in the database.
With the aim of identifying more diverged viral sequences, in the second part of this
thesis, I present an algorithm to compare sequences based on predicted structural
features, such as secondary structures and conserved amino acids. The algorithm is
modelled after the music-matching algorithm ‘Shazam’. While initial results of the
algorithm are somewhat encouraging, problems remain, in particular with the identi-
fication of adequate structural features. Identifying highly diverged viral sequences
is thus still a challenging problem, hopefully to be solved in the future.
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INTRODUCTION
Viruses are ubiquitous and diverse. Virus particles have been found in all environ-
ments examined so far, outnumber cells by a factor of 10 – 100 in most well-studied
habitats [1], and infect all forms of life [2]. The diversity of viruses is illustrated by
the differences in the type and size of viral genomes, virion morphology and replica-
tion strategies: virus genomes consist of either RNA or DNA, can be single or double-
stranded, linear or circular, multi- or monopartite, and positive or negative sense [2].
Viral morphologies are also highly diverse, including icosahedral, spherical, bottle-
shaped, rod-shaped, filamentous, pleomorphic, turreted, and bacilliform [2]. Finally,
viruses employ at least seven different replication strategies, which provides the basis
for the Baltimore classification [2].
Viruses play an important role in ecosystem and evolutionary processes [1,3,4]. Up to
40% of the marine prokaryote community is killed by viruses every day [3]. Organic
molecules released from the viral lysis of those organisms in turn stimulate further
growth of phyto- and zooplankton [3]. Viruses also influence the evolution of their
hosts [1, 4]. Hosts have multiple lines of defence against infections by pathogens
(for example the adaptive and innate immune systems, and programmed cell death),
and viruses have evolved ways to evade those mechanisms (including inhibitors of
apoptosis or signalling pathways leading to the production of interferons, as well as
proteins directly inhibiting interferons, cytokines, and chemokines), suggesting that
viruses and their hosts may at least in part be driving each others evolution [1, 5–7].
Viruses are an important mechanism for the transfer of genes between organisms,
some of which may be beneficial to the recipient [4]. There are a number of examples
where a gene that originally stems from a virus is now fulfilling an important role in
a cellular organism [4, 8]. Probably the best-known is the case of syncytin, a protein
that originated from the envelope protein of the human endogenous retrovirus W, and
which is essential for placental morphogenesis in mammals [8].
Viruses are also the cause of great devastation in humans and other organisms. While
some viruses usually cause mild or self-limiting disease, such as viral gastroenteritis
caused by norovirus or common cold caused by rhinoviruses, others can cause severe
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disease or death, for example infections by ebola virus (with an average case fatal-
ity rate of 78% [9]), variola virus (where the case fatality rate varied between 1 –
30% [10]), and rabies viruses (which is almost always fatal after the onset of clinical
symptoms [11]). In animals, viruses have been the cause of die-offs, such as those
caused by highly pathogenic avian influenza virus in chickens and turkey [12, 13],
or highly virulent strains of African swine fever virus in wild and domestic pigs,
where case fatality rates are almost 100% [14]. Using a dataset of 335 disease emer-
gence events between 1940 and 20041, Jones et al., (2008) estimated that a quarter
of all emerging infectious diseases in humans are caused by viruses [15]. Disease
emergence is correlated with human population density, suggesting that it is driven
by anthropogenic and demographic changes such as human population growth, de-
forestation, increased mobility, and urbanisation [15]. These drivers are expected
to remain constant or increase in the future, possibly resulting in increased disease
emergence [16–19].
In the past, the discovery of novel viruses relied on techniques such as filtration, culti-
vation, and electron microscopy [20]. In particular, cultivation has been the gold stan-
dard for virus discovery [21]. However, many viruses cannot be grown in culture [22],
which limits the use of tissue culture for virus discovery. The development of Next
Generation Sequencing (NGS) technology has made the sequencing of genetic mate-
rial fast and cheap. Since 2008, when NGS technology first came in use, the cost to
sequence one megabase of DNA has decreased almost 105-fold [23]. Among other
applications, NGS technology allows the sequencing and subsequent analysis of all
genetic material present in a sample, a so-called ‘metagenomic study’ [24]. Screen-
ing datasets from metagenomic studies for viral sequences opens up new possibilities
for the identification of unknown viruses, especially those which cannot be detected
by traditional techniques such as cultivation [20]. Identification of viral sequences in
NGS datasets is achieved by comparing the sequences (which may stem from differ-
ent organisms) obtained from a sample against known sequences in a database using
sequence homology search tools such as BLAST [20, 25]. However, the algorithms
that are currently employed for sequence comparison only allow the identification of
sequences that are closely related to sequences that have already been deposited in
databases [20]. Furthermore, NGS technology generally produces a high number of
short reads (e.g., most Illumina sequencing platforms yield over 100 million reads,
each of between 50 to 600 base pairs in length). This large amount of data makes the
1Defined as the “first temporal emergence of a pathogen in a human population which was related
to the increase in distribution, increase in incidence, or increase in virulence, or other factor which led
to that pathogen being classified as an emerging disease” [15].
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analysis of such datasets more computationally expensive, in some cases dramatically
so [20, 26, 27].
While metagenomic studies have improved our understanding of virus diversity in a
wide range of hosts, the following evidence suggests that a large number of viruses
still have not been detected. First, conspicuous gaps exist in the known range of viral
diversity, such as the almost complete absence of RNA viruses from archaea, and the
fact that most known bacteriophages have DNA genomes. Biological explanations
for the limited virus diversity in these hosts include the peptidoglycan-containing
cell wall in bacteria or the extreme environments inhabited by archaea [28]. However,
given the ubiquity of viral types infecting other hosts, these gaps suggest to some that
current detection methods may be unable to detect such viruses [29]. Second, based
on the assumption that each of the 8.7 million eukaryotic species on earth carries
10 species-specific viruses, Geoghegan et al. (2017), suggest that over 99.9% of the
existing viral diversity has not yet been detected [30]. Finally, metagenomic studies
often yield a high percentage of sequences of unknown provenance [20], sometimes
up to 99% [31], some of which may belong to novel viruses.
Since the structure of a protein is more conserved than its sequence [32], being able
to detect viral sequences based on structural features may facilitate the identification
of highly diverged sequences.
Viruses have fast mutation rates and large population sizes [2]. This makes them
a good model system for the study of evolutionary processes, since researchers can
observe changes in real time, test hypotheses about virus evolution, such as the effect
of point mutations, and test phylogenetic models [2]. Also, since viruses can be
altered in the laboratory relatively easily, the effect of mutations can be studied in
detail (see for example, Koel et al., 2013 [33]).
However, the ability of viruses to change rapidly can also hinder the study of their
evolution, especially when considering evolutionary processes taking place over large
timescales: apart from viruses that have integrated into host germ lines, viruses do
not leave a fossil record, and the vast majority of viral genomic sequences avail-
able today are less than 50 years old. Thus, the study of virus evolution so far has
relied on a temporally very limited set of viral samples and sequences [34]. This,
together with the fast mutation rates of viruses [35], severely limits our understand-
ing of virus evolution and diversity over time. We do not know what most viruses
looked like genotypically even a hundred years ago [34], we know very little about
the timescales of virus evolution, as estimates of substitution rates and most recent
common ancestor dates often differ between studies (e.g., [36–38]), and we know al-
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most nothing about the geographic spread of viruses over time going back more than
a few decades.
This PhD thesis is organised into two parts.
Part one describes the application of commonly used sequence matching algorithms
to screen for viruses in NGS datasets from remains of individuals that lived thousands
of years ago. The viral sequences provide concrete information about the timescales
of virus evolution, and the geographic distribution and diversity of the viruses that
were recovered. After a brief chapter introducing the field of ancient DNA, the po-
tential of ancient viral sequences for the study of virus evolution, and the datasets
studied (Chapter 1), I present the results on three different viruses where ancient se-
quences could be found: hepatitis B virus (Chapter 2), human parvovirus B19 (Chap-
ter 3), and variola virus (Chapter 4). Chapter 5 discusses these overall findings, their
implications, and possible future avenues for research in this field.
Part two describes an algorithm to perform sequence matching based on predicted
structural features, in order to identify the origin of highly diverged sequences. The
part starts with an overview of the current thinking in the field of sequence compar-
ison and a justification of the approach chosen (Chapter 6). Chapter 7 provides an
overview of the matching algorithm. The part concludes with a discussion of the
current shortcomings of the algorithm, and future work (Chapter 8). The appendices
contain details of the implementation, parametrisation, and evaluation of the algo-
rithm, as well as some preliminary results.
4
PART I: USING ANCIENT DNA TO STUDY
VIRUS EVOLUTION
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1.1 AN INTRODUCTION TO THE FIELD OF ANCIENT
DNA RESEARCH
Over the last ten years, it has become possible to sequence genetic material from
archaeological and environmental samples that are thousands of years old, so-called
‘ancient DNA’ (aDNA)1. The ancient sequence data, combined with data from mod-
ern individuals, have revolutionised our understanding of human evolution and past
population dynamics [40], giving us more detailed insight into migration, admix-
ture and replacement of human populations over time (e.g., [41–48]), the interbreed-
ing of modern humans with extinct hominins, namely Neanderthals and Denisovans
[49, 50], and human adaptation to the environment [51], such as high altitude [52],
diet [41, 53, 54], and lifestyles [55]. The field of aDNA research is relatively young,
with the first aDNA sequences, from the quagga (an equid species that went extinct
in 1883), published in 1984 [56]. Since then, the development of Polymerase Chain
Reaction (PCR) in the mid 1980s, modified extraction techniques specifically tar-
geting DNA fragments as short as 35 base pairs, and Next Generation Sequencing
(NGS) technology, have improved the efficiency of sequencing of DNA from ancient
remains [57]. The first complete ancient human genome and the first draft Nean-
derthal and Denisovan genomes were all published in 2010 [40, 50, 58, 59]. The first
multi-individual study involving ancient humans was published in 2012, presenting
data from four approximately 5000 year old individuals from Scandinavia [60]. The
oldest aDNA sequences available to date are from Greenlandic ice cores (450–700
thousand years old) [61] and from a Middle Pleistocene horse (560–780 thousand
years old) [62].
A challenge when working with DNA recovered from ancient samples is post-mortem
fragmentation and chemical modification of the genetic material [63]. While an or-
ganism is alive, DNA damage that naturally arises from radiation, metabolic and
hydrolytic processes, or exposure to chemicals such as polycyclic aromatic hydrocar-
1The term ‘ancient DNA’ is somewhat loosely used to indicate DNA sequences retrieved from "mu-
seum specimens, archaeological finds, fossil remains, and other unusual sources of DNA" [39]. How-
ever, there is no fixed age from which a sequence or sample is considered ‘ancient’. For the purpose of
this chapter, I am using 1950 Current Era (CE) as a cut-off.
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bons, is constantly being repaired by the DNA damage repair system of the cell [64].
However, after death, DNA damage accumulates, stemming from non-enzymatic
processes such as spontaneous hydrolysis and oxidation, and enzymatic processes
including nucleases, and digestion by micro-organisms [63, 64]. Four types of dam-
age predominate in aDNA: fragmentation, abasic sites (missing bases), cross-linking
of DNA (with another DNA molecule, proteins, or sugars), and miscoding lesions
(most commonly changes from cytosine to uracil, increasing in frequency towards
the fragment termini) [57, 65–67]. Post-mortem damage and fragmentation affects
the preservation of DNA, whose long-term survival is favoured by constant low tem-
peratures [64, 68, 69]. Allentoft et al., (2012) showed that the kinetics of DNA frag-
mentation follow an exponential decay relationship: 30 base pair fragments are esti-
mated to have a half-life of 158,000 and 500 years, at –5 and +25 degrees Celsius,
respectively [68]. Furthermore, humidity negatively affects long-term DNA preser-
vation, due to increased depurination [64, 69].
Another major problem when working with ancient DNA is the high chance of con-
tamination and hence confusion with modern DNA, both from human and non-human
sources [63,67]. Especially up to the mid-2000s, aDNA researchers published a num-
ber of studies based on false-positive results [67]. Examples include reports of the
sequencing of ancient DNA from archaeal and bacterial 16S rDNA in rock salt 11 to
425 million years old [70], from 80 million year old dinosaur bones [71], and also
a study describing sequences from a 2,400 year old Egyptian mummy [72]. None
of these reports could be verified and all are now considered to involve contamina-
tion [63]. Reasons for this conclusion include the following. 1) The half-life predic-
tions in Allentoft et al., (2012) [68] suggest that the survival of sequence fragments
of the lengths found in the three studies [70–72] (700 – 1000 base pairs [70], 174
base pairs [71], and 3,400 base pairs [72]), is highly unlikely. 2) The supposed di-
nosaur sequences [71] were later found to be of mammalian origin, most likely from
a human [73, 74]. 3) The close sequence similarity of the archaeal and bacterial 16S
rDNA to modern sequences [70] is indicative of modern contamination, given the age
of the samples.
The aforementioned problems with contamination resulted in a set of best-practice
recommendations for sample handling and laboratory procedures (often referred to
as ‘authentication criteria’) [63,75,76]. Their aim is to reduce the chance of contam-
ination, and to give researchers a means to better ensure that recovered sequences are
from the ancient sample. The recommendations are: using physically isolated work
areas for work prior to the amplification stage; including negative controls for extrac-
tions and PCR; ensuring that amplified DNA fragments exhibit appropriate molec-
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ular behaviour (PCR amplification strength should be inversely related to the size
of the fragment); reproducing results from the same and different extracts from the
same sample; verify a number of PCR sequences by cloning of amplified products,
to assess contamination, damage, and to detect the presence of nuclear insertions; in-
dependently replicate results in a different laboratory; show the preservation of other
biomolecules that correlate with DNA survival; and quantify the copy number of the
DNA target by Real-Time PCR [63, 75, 76].
The advent of NGS technology has been crucial for the recent advances in research
on aDNA [57,77]. The ability of NGS technology to sequence short DNA fragments,
as well as the fact that it alleviates the need to clone PCR products (in contrast to
the earlier PCR based techniques and Sanger sequencing), increases the amount of
retrievable DNA from ancient samples [57]. When sequencing aDNA, one of two
approaches is used [57]. First, whole genome shotgun sequencing, which aims to
sequence all genetic material in a sample. Second, capture enrichment, which uses
probe sequences designed to bind to specific regions of the genome(s) of interest.
Capture methods are used to answer specific questions (by only targeting genomic
regions, or whole genomes of interest) and are cheaper than whole genome shotgun
sequencing. Whole genome shotgun sequencing can also be used to address specific
questions, but in addition makes it possible to analyse the genomes of all organisms
present in the sample, including those that were not the focus of the initial inves-
tigation. For example, the whole genome shotgun sequencing performed on 101
individuals in Allentoft et al.’s (2015) paper on the population genomics of Bronze
Age Eurasia [41] made it possible to later screen the datasets for microorganisms.
This resulted in the identification of Yersinia pestis [78], as well as the hepatitis B
virus and human parvovirus B19 sequences presented in this thesis [79, 80].
Widespread adoption of NGS technology for aDNA sequencing resulted in modi-
fications to the original recommendations for ancient DNA authentication outlined
above [63,75,76], which were developed before the advent of NGS technology [77].
While the recommendations for physically isolated work areas and the inclusion of
negative controls remain important, others, such as the appropriate molecular be-
haviour and cloning of PCR products are no longer relevant [77]. Independent repli-
cations in different laboratories are also not done routinely [81]. New recommen-
dations specifically for the use of NGS technologies include the identification of
typical aDNA damage patterns on the sequences (in particular the accumulation of
cytosine→ thymine and guanine→ adenine changes towards the read termini [67])
and, for human sequences, the internal consistency of the data (e.g., haploid human
sequences should not show any evidence of polymorphic positions) [77].
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Most research on aDNA has been and still is focused on humans. By the end of
2017, aDNA sequences from 711 humans had been published. This is only a small
fraction of the ancient individuals that have already been sequenced [82]. For an
overview on what has been learned about human evolution using aDNA, see e.g.,
[40, 82, 83]. Ancient DNA has now also been sequenced from a wide variety of non-
human sources, including bone and teeth of horses [62], goats [84], wolves [85],
environmental samples [86], and even parchment [87].
1.2 APPLYING ANCIENT DNA TECHNIQUES TO THE
STUDY OF MICROORGANISMS
Physicians and scholars have long documented occurrences of disease epidemics af-
fecting humans. A depiction of an individual with one leg shorter than the other and
using a walking stick on a 3,500 year old stele in ancient Egypt has been interpreted
as representing a polio victim [88]. There are descriptions of a smallpox-like disease,
for example in the Vedic text Sushruta Samhita ∼100 Before Current Era (BCE), by
Ahrun of Alexandria in 622 CE, and by the physician Al-Rhazi in Baghdad in 910
CE [10]. The scholars Thucydides and Galen described the plague of Athens (430 –
426 BCE) and the Antonine plague (165 – 180 CE), respectively. Both of these have
been attributed as due to a variety of diseases, including smallpox, measles, bubonic
plague, and lassa fever [89]. Although these observations show that humans have
long suffered from infectious diseases, descriptions of diseases in early historical
records are often ambiguous, as are conclusions drawn based on skeletal pathologies,
which can often be caused by multiple pathogens and require long-lasting infections
to manifest [90]. Direct evidence of the pathogens involved in past epidemics has
mostly been lacking. Given the historical impact of major human epidemics, the un-
certainty about their causes, and the potential for future outbreaks due to the same or
related pathogens, the application of aDNA techniques to the study of microorgan-
isms, in particular human pathogens, was a logical next step in aDNA research.
As with other research on aDNA performed up to the mid-2000s, the majority of the
early attempts to sequence microorganisms from ancient remains did not follow the
recommendations for aDNA authentication, or were later judged as probable contam-
inations [91]. For example, Tsangaras and Greenwood (2012) found that of 43 studies
on ancient microorganisms published before 2006, only 15 used physically isolated
work areas specifically for the work on aDNA [91]. Similar to studies focusing on the
human genome, the advent of NGS technology and development of recommendations
12
1.2. APPLYING ANCIENT DNA TECHNIQUES TO THE STUDY OF MICROORGANISMS
for the sequencing and authentication of aDNA, now allows researchers to establish
the authenticity of the ancient sequences with higher confidence [34].
To date, the majority of studies on ancient microorganisms have focused on bac-
teria, and in particular those causing disease in humans [92, 93]. Unlike in aDNA
studies that target the host genome, in which every sample will yield important in-
formation (given sufficient DNA preservation), a high number of individuals may
need to be screened to detect a pathogen. The number of positive individuals de-
tected will most likely be lower than the number of infected individuals, due to the
imperfect diagnostic test, the need for long-term preservation of the pathogen, and
whether individuals died during the viraemic or bacteraemic phase of the infection
(if any). Thus, a focus has been on bacteria causing chronic and long-term infec-
tions (such as Myobacterium tuberculosis and Myobacterium leprae), since there is
a higher possibility that skeletal lesions develop, making it easier to identify samples
for sequencing [90, 94]. The first complete sequence of an ancient human pathogen,
Yersinia pestis, was published in 2011 [95], and further publications on the same
bacterium followed [78, 96–98]. The work on ancient Yersinia pestis showed that
the bacterium has been causing human infections at least since the Neolithic, and
that the neolithic and bronze age strains may have been unable to transmit efficiently
via the flea vector [78, 92, 96–98]. Since then, ancient sequences for at least twelve
human bacterial pathogens have been published [92], including Helicobacter pylori
(leading to stomach ulcers or gastric carcinoma) [99], the causative agents of tubercu-
losis (Myobacterium tuberculosis) [100], leprosy (Myobacterium leprae) [101, 102],
brucellosis (Brucella melitensis) [103], and syphillis (Treponema pallidum) [104], as
well as Salmonella enterica, which causes enteric fever [105]. In addition, ancient
sequences have been recovered from the protozoan parasite Plasmodium falciparum,
the causative agent of malaria [106]. In addition to studies targeting particular mi-
croorganisms, a number of ancient microbiomes have been sequenced from various
ancient specimens, including from calcified dental plaque [107] and calcified ab-
scesses from the remains of a woman [108].
1.2.1 Viral sequences isolated from ancient remains
Following the recovery of ancient bacterial sequences from whole genome shotgun
sequencing datasets of bronze age individuals [41, 78], an analogous search for evi-
dence for viruses in ancient remains and the recovery of their genomes using similar
techniques became a focus. Table 1.1 lists the studies published on ancient viruses
up to June 2019. The first successful attempt to extract a viral sequence from ancient
13
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remains was published by Taubenberger et al., in 1997 [109]. The paper presents
nine sequence fragments of five segments of the influenza A/H1N1 virus that caused
the 1918 influenza pandemic, isolated from formalin-fixed, paraffin-embedded lung
tissue samples [109]. The oldest DNA, RNA and human viruses sequenced to date
are as follows. The oldest putative viral sequence is from a 140,000 year old tomato
mosaic tobamovirus from Greenlandic ice cores, but its authenticity has been ques-
tioned based on close sequence similarity between the ancient and the modern vi-
ral sequences [110]. The oldest ancient RNA virus sequence is from a 1000 year
old zea mays chrysovirus isolated from maize kernels [111]. The oldest human vi-
ral sequence is a 7,000 year old hepatitis B virus sequence isolated from a human
tooth [112]. Prior to May 2018, the oldest properly authenticated ancient exogenous
human viral sequence was from a 450 year old hepatitis B virus isolated from an
Italian mummy [113].
In addition to the oldest viral sequences mentioned above, younger sequences have
also been recovered, including a 350 year old hepatitis B virus sequence from a
Korean mummy [114], two variola virus sequences from 360 and 170 years ago
[115, 116], and a partial 300 year old variola virus sequence [117].
Compared to other microorganisms, the study of ancient viruses is complicated by
three factors [34]: the first is that many viruses have RNA genomes (the master
species list collated by the International Committee on Taxonomy of Viruses lists
2346 out of 5559 virus species with a single- or double-stranded RNA genome).
Most aDNA studies target human DNA only, since viruses are not the main focus
of the studies, and the resulting sequences contain all the information needed for the
study of the human genome. In those studies, RNA is not amplified at all. This
makes the discovery of exogenous viruses with an RNA genome from those sample
preparations impossible. Second, RNA genomes have been assumed to be less stable
over time post-mortem [64] and therefore not as well preserved as their DNA coun-
terparts, possibly again influencing researchers’ motivation to study ancient RNA
viruses2. Finally, the sampling material used for aDNA studies is often taken from
teeth or bone (mainly the petrous bone), due to the high endogenous DNA content of
those materials, and also because teeth and bones are often the only tissues that are
preserved. This has limited the viruses that have been detected to a relatively small
set of DNA viruses that cause either chronic or lethal infections with high viral titres
in the blood, such as hepatitis B virus, parvoviruses, anelloviruses, orthopoxviruses,
adenoviruses, and herpesviruses.
2Little is known about the way viral genetic material is preserved in ancient samples. We do not
know if the genetic material survives inside capsids or outside, which may affect the preservation of the
genetic material [118].
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Virus Authors Year of
publica-
tion
Description Authentic-
ation
Refer-
ence
Anellovirus Bédarida et al. 2011 One sequence, human dental pulp, 200 years old. 1, 2, 9, 10 [119]
Avipoxvirus Parker et al. 2011 19 sequences, finches and mockingbirds from the Gala-
pagos islands, 120 years old.
1, 2, 3, 4,
6
[120]
Barley stripe mosaic
virus
Smith et al. 2014 One sequence, isolated from a Barley grain, 750 years
old.
1, 2, 8, 9,
10
[121]
Barley yellow dwarf
virus
Malmstrom et
al.
2007 Coat protein sequences, isolated from herbarium speci-
mens of grasses, 1917–1942 CE.
1, 2, 4, 6 [122]
Hepatitis B virus Bar Gal et al. 2012 One sequence, isolated from a Korean mummy, 16th
century.
1, 2, 3, 6,
7, 10
[114]
Patterson Ross
et al.
2018 One sequence, isolated from an Italian mummy, 16th
century.
1, 2, 3, 8,
10
[113]
Krause-Kyora
et al.
2018 Three sequences, isolated from teeth, 1000, 5000, and
7000 years old.
1, 2, 3, 8,
9, 10
[112]
Mühlemann et
al.
2018 12 sequences, isolated from teeth and bones, 822 to 4488
years old.
1, 2, 3, 8,
9, 10
[79]
Influenza A/H1N1 Taubenberger
et al.
1997 One sequence, isolated from a formalin-fixed, paraffin-
embedded, lung tissue sample, 100 years old.
3, 4, 7, 9,
10
[109]
Monkeypox Tiee et al. 2018 93 sequences, isolated from museum specimens of
African striped squirrels, up to 130 years old.
1, 2, 4, 10 [123]
Papillomavirus Fornaciari et
al.
2003 One sequence, isolated from an Italian mummy, 16th
century.
2, 4, 7 [124]
Larsen et al. 2018 One sequence, isolated from packrat middens, 27,000
years old.
1, 2, 10 [125]
Human Parvovirus
B19
Toppinen et al. 2015 43 sequences, isolated from putative Finnish casualties
during WW II, approx. 75 years old.
1, 2, 9, 10 [126]
Mühlemann et
al.
2018 10 sequences, isolated from teeth and bones, 500 to 6800
years old.
1, 2, 3, 8,
9, 10
[80]
Pithovirus Legendre et al. 2014 One sequence isolated from a sample of Siberian per-
mafrost which was grown in culture, dated to 30,000
years old.
11 [127]
Simian T-cell
leukemia virus
Calvignac et
al.
2008 One sequence, isolated from an African green monkey,
1913.
1, 2, 3, 4,
5, 6, 7, 10
[128]
Human T-cell
leukemia virus
Li et al. 1999 One sequence, isolated from an Andean mummy, 1500
years old.
2, 3, 4, 7,
10
[129]
Tomato mosaic to-
bamovirus
Castello et al. 1999 17 sequences of tomato mosaic tobamovirus, isolated
from ice cores from Greenland, 500–140,000 years old.
2, 4, 6 [130]
Variola virus Biagini et al. 2012 One sequence fragment, isolated from a mummy in
Siberian permafrost, 17th to early 18th century.
1, 2, 6 [117]
Duggan et al. 2016 One sequence, isolated from a Lithuanian mummy, 17th
century.
1, 2, 3, 8,
9, 10
[116]
Pajer et al. 2017 Two sequences isolated from Czech museum specimens,
60 and 160 years old.
2 [115]
Mühlemann et
al.
unpub-
lished
Three high- and ten low-coverage sequences, isolated
from teeth and bones, 550 – 1900 CE.
1, 2, 3, 8,
9, 10
unpub-
lished
Zea mays chryso-
virus 1
Peyambari et
al.
2018 three sequences of Zea mays chrysovirus 1, isolated
from maize kernels from Arizona, US, 1,000 years old.
1, 2 [111]
Various Appelt et al. 2014 Metagenomic characterisation of a 14th century copro-
lite.
1, 2 [131]
Ng et al. 2014 Caribou feces associated virus and Northwest Territories
cripavirus, isolated from frozen caribou feces, 700 years
old.
1, 2, 6, 7 [132]
Table 1.1: Previously published studies of ancient exogenous viruses. Only studies with se-
quences from before 1950 were included. For a review of more modern (as well as ancient) virus
studies, see Tsangaras and Greenwood, 2018 [34]. Rows are sorted alphabetically by virus name
and then by year of publication. The ‘Authenticated’ column uses the following abbreviations: 1:
Physically isolated work areas. 2: Negative controls (extraction, PCR controls). 3: Repeated ampli-
fication from the same and different extracts. 4: Inverse correlation between amplification efficiency
and length of amplification. 5: Associated remains. 6: Reproduction in a second independent labo-
ratory. 7: Cloning of amplification products and sequencing of multiple clones. 8: Damage patterns.
9: Phylogenetic analyses support ancient origin. 10: Preservation of host DNA. 11: The virus was
recovered using tissue culture techniques.
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1.2.1.1 How ancient viral sequences could improve our
understanding of virus evolution
Understanding how viruses change over time or in response to the environment is
relevant for human and animal health. For example, it can help to understand the
development of antiviral resistance and immune evasion, as well as improve our gen-
eral knowledge of evolutionary processes, such as extinction, substitution rates, and
recombination. Viruses have fast mutation rates, large population sizes, and short
generation times [2]. This allows researchers to observe evolutionary processes in
real time, which is rarely possible in higher organisms. A good example is research
on the influenza virus. Researchers have been able to visualise the antigenic evolu-
tion of seasonal influenza A/H3N2 [133], understand the global circulation patterns
of the virus [134], and can identify specific mutations causing antigenic changes that
result in the escape from prevailing immunity [33]. This work has informed vaccine
choices for seasonal influenza. It has also added to the general understanding of how
immunity due to influenza infection and vaccination develops over time [135].
Viruses, like any organism, evolve via natural selection. Diversity is a prerequisite
for adaptive change in the face of selection pressure. In viruses, diversity arises
as a result of processes including point mutations, recombination, re-assortment (in
viruses with segmented genomes), and horizontal gene transfer [2]. How quickly
viruses accumulate changes in their genome is a central part of our understanding of
their natural history, including pathogenesis [136], the likelihood of the emergence
of novel viruses [137], and the timescales of virus evolution [35]. The rate at which
mutations occur in the genome per unit of time, round of replication, or generation
is called the ‘mutation rate’. Viral mutation rates approximately correspond to the fi-
delity of the polymerase used in replication: viruses with an RNA genome, which use
a more error prone RNA-dependent RNA polymerase for replication, mutate rapidly
(on the order of 10-5 – 10-3 substitutions per site per cell infection), while DNA
viruses, replicating using a DNA polymerase with the ability to correct errors, mutate
more slowly (on the order of 10-8 – 10-5 substitutions per site per cell infection). The
mutation rate of retroviruses, which replicate using reverse transcriptases, falls be-
tween the two [35, 138]. Mutation rates can be estimated by comparing the changes
in the genome sequences of the original virus and the progeny virus after one round
of infection. However, this method can be confounded by sequencing error or effects
of selection. An alternative is to use Luria–Delbrück fluctuation tests, which involve
counting rare mutations to an easily observable phenotype, such as resistance to a
drug [139]. This frequency is then adjusted to account for the number of generations
and genome replications to obtain the mutation rate [35].
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While many of the mutations that arise are deleterious or neutral, some may be se-
lected for, due to their beneficial phenotype, and ultimately reach high frequency
in the virus population. Possible phenotypic changes include adaptation to differ-
ent cell types or receptors, immune evasion, or replication in different hosts (e.g.,
[33, 140, 141]). The rate at which mutations are fixed at the population level per site
in the genome per unit of time is called the ‘substitution rate’. Four factors govern
the substitution rate: the mutation rate, generation time, effective population size, and
the fitness effects of mutations [35]. In order to infer substitution rates and calculate
divergence dates between sequences, we need a model of how mutations accumulate
over time, a ‘molecular clock model’. The original molecular clock model suggested
that mutations accumulate at the same rate on all lineages in a phylogeny [142, 143].
Since many datasets violate the assumption of the original molecular clock [144],
relaxed molecular clock models were developed, in which rates may vary between
branches [142, 145]. There are different ways to vary the rates between branches
of a phylogenetic tree, such as by assuming 1) a small number of different rates,
clustered across the tree (local clock); 2) a small number of different rates, but not
clustered across the tree (discrete clock); 3) different rates for all branches, which ei-
ther correlate between branches (autocorrelated relaxed clock), or are independently
and identically distributed (uncorrelated relaxed clock) [145]. The molecular clock
can only give measurements on an absolute timescale (such as days or years) if it is
calibrated with some form of time information [142]. Calibrations can be of three
types:
− Calibration of nodes in the tree using external information. Calibrations can be
based on the fossil record, divergence times of the host based on the assumption
of co-evolution, or on biogeographic processes such as island formation [142,
146, 147].
− The substitution rate can be known from previous work. For example, if the
virus being studied is integrated in the germ line of the host, the host substitu-
tion rate can be used.
− If the virus population is measurably evolving3, sequences sampled at different
time points, so-called heterochronously sampled sequences, can be used to
calibrate the molecular clock [142, 148, 149]. Datasets of heterochronously
sampled sequences that span a wide time range are rare, since most available
viral sequences are less than 50 years old.
3A measurably evolving population is defined as “a population from which molecular sequences can
be taken at different points in time, among which there are a statistically significant number of genetic
differences.” [148]. This requires either a wide range of sampling times, or a high mutation rate [148].
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Methods for the inference of substitution rates can be based on linear regressions
of root-to-tip distances in a phylogenetic tree and sampling dates, and on maxi-
mum likelihood or Bayesian frameworks [35, 142]. Probably the most commonly
used software package for the inference of substitution rates for viruses is that pro-
vided by BEAST [150, 151]. BEAST is based on Bayesian inference and uses the
Markov chain Monte Carlo algorithm to explore different model parameter values.
This allows the simultaneous inference of the substitution rate, tree topology, and
demographic processes. Methods used to infer substitution rates are based on two
well-known assumptions, both of which may lead to an artificial inflation of the rate,
if violated [35]. Firstly, they assume that the sampled sequences are not recombi-
nant, and secondly that the sequences contain only mutations that have been fixed.
Since the latter is rarely the case, the substitution rate that is inferred is thus likely a
composite of the mutation and the substitution rates.
On the basis of the fidelity of different polymerases, it has been proposed that RNA
viruses should have faster substitution rates than DNA viruses [35]. In general, RNA
viruses have been found to be rapidly-evolving, with substitution rates in the range
of 10-5 to 10-2 substitutions per site per year (s/s/y) and DNA viruses have been
considered slowly-evolving, with rates between 10-9 to 10-6 s/s/y [2,152,153]. How-
ever, there are exceptions to the general trend of rapidly-evolving RNA and slowly-
evolving DNA viruses. For example, some RNA viruses evolve with a rate that is
slower than that which was generally assumed for RNA viruses, including the simian
foamy viruses (1.7x10-8 s/s/y) [154] and rodent associated hantavirus (0.7x10-7 –
2.2x10-6 s/s/y) [155]. Also, some single-stranded DNA viruses are thought to evolve
at rates closer to those of RNA viruses, for example canine parvovirus (1.7x10-4
s/s/y in the capsid protein VP2 and 7.9x10-5 s/s/y in the nonstructural protein NS1)
[156], human parvovirus B19 (1.0 – 4.0x10-4) [126, 157, 158], circovirus SEN-V
(7.32x10-4 s/s/y) [159], and tomato yellow leaf curl virus (4.63x10-4 s/s/y) [160].
While this list is not exhaustive, it is interesting to note that the substitution rates
for the slowly-evolving RNA viruses have all been inferred using external calibra-
tions, while the substitution rates for the rapidly-evolving DNA viruses have all been
inferred using heterochronously sampled sequences. The trend that rates estimated
over a longer timescale (using calibrations from fossils, assumptions about virus-
host co-divergence, or other external events) are significantly lower than rates esti-
mated over shorter timescales (using modern heterochronously sampled sequences),
is known as the ‘time dependent rate phenomenon’ [38, 152, 161, 162]. The time de-
pendent rate phenomenon has been observed in many viruses, including hepatitis B
virus and JC Polyomavirus. For hepatitis B virus, Zhou and Holmes (2007), inferred
a rate of 7.72x10-4 s/s/y using heterochronously sampled sequences [37] whereas us-
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ing external calibrations based on human migrations, Paraskevis et al. (2015) found
the rate to be 3.7x10-6 s/s/y [36]. For JC polyomavirus, under the assumption of
co-divergence with humans as they left Africa, a rate of approximately 4x10-7 s/s/y
was inferred [163], but using sequences sampled over the span of 34 years, the rate
was found to be two orders of magnitude higher [164]. The causes of the time de-
pendent rate phenomenon are debated, and include that substitution rates observed
over short time scales are inflated due to the presence of transient mutations, se-
quencing error, changes in virus biology and selection pressure over time, calibration
errors (such as assuming that the time of population divergence and genetic diver-
gence correspond), and substitution model inaccuracy resulting in underestimation
of saturation [161].
Before the advent of aDNA sequencing techniques, virologists assumed that viruses
do not leave a fossil record [2], with viruses that have integrated into the germ line
of the host genome [165], and the sequences from before 2018 listed in Table 1.1,
being the exceptions. As a result of the sparsity of ancient viral sequences, we only
have a limited understanding of historical viral diversity, even going back just a few
decades. It is unclear if viruses in the past were closely related to their modern
counterparts, or whether they were much more diverged, as might be expected based
on their high mutation rates. Furthermore, even though phylogenetic tools such as
BEAST have been widely used to study virus evolution and infer substitution rates
and most recent common ancestor dates, it has been impossible to test them exten-
sively on non-artificial sequences older than a few decades. In terms of public health
and pandemic preparedness, it would be informative to have an understanding of the
variation of a particular virus that existed in the past, in order to learn of types of
changes that may arise in the future.
Nevertheless, the small number of viral sequences a few hundred years old (Table
1.1) and sequences from endogenous viral elements (EVEs) have provided valuable
information about the evolutionary history of viruses. This is illustrated by research
on the influenza A/H1N1 virus that caused the 1918 influenza pandemic.
In 1997, Taubenberger et al. presented partial sequences of five segments of the
A/H1N1 virus which caused the 1918 influenza pandemic, and complete sequences
for all eight segments followed. Initially, Taubenberger et al. (1997) found the
virus to be most closely related to strains that infect humans and swine [109]. Later
work pointed to the emergence of the virus after a human H1 virus acquired the
neuraminidase and internal protein genes from an avian virus [166]. Access to se-
quences from the influenza 1918 virus also allows researchers to study mutations that
may lead to human adaptation of the virus. Hemagglutinin sequences recovered from
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13 individuals that died at different times during the pandemic suggest an adaptation
from more avian-like to more human-like receptor binding over the course of the
pandemic, due to a change from glycine to aspartic acid at position 225 (H3 num-
bering) [167]. Tumpey et al. (2005) reconstructed the influenza 1918 virus using
reverse genetics and found that it caused more severe lung pathology and reached
125 to 39,000 times higher virus titres in the lungs of mice four days post infection
than the epidemic H1N1 viruses circulating between 1930 to 1990 that were used as
controls [168]. The influenza 1918 virus caused death of embryonated chicken eggs
in contrast to the control epidemic H1N1 viruses and had the ability to replicate in
the absence of trypsin [168]. It also lacked a multibasic cleavage site in the hemag-
glutinin, which is found in highly pathogenic influenza H5 and H7 viruses [109].
However, although the 1918 influenza virus was more virulent than epidemic H1N1
viruses, the additional virulence is not sufficient to account for the high mortality
rates that were observed during the pandemic [169]. An increased expression of pro-
inflammatory chemokines and suppression of the type I interferon response, together
with the exposure history to previously circulating influenza viruses, may have con-
tributed to the high death rate during the pandemic [169–171].
While the influenza virus causing the 1918 pandemic is an example of a relatively re-
cent sequence, important information can be gained from sequences from EVEs that
can be millions of years old. EVEs are sequences of viruses that have integrated into
the germline of the host and are passed on from generation to generation [172]. In
animals, most EVEs are derived from retroviruses [165, 173]. However, EVEs have
also been found from non-retroviral families, including parvoviridae, hepadnaviri-
dae, bornaviridae, and orthomyxoviridae [165]. Sequences of EVEs accumulate
changes at the rate of evolution of the host, thereby preserving sequence information
about the virus that would otherwise most likely be lost due to the fast viral mutation
rates [2]. Together with approximate dates of when the integration event took place,
researchers can use the sequences of EVEs to calibrate molecular clocks and gain an
understanding of how long a virus may have been associated with a certain host. For
example, using an endogenous hepadnavirus found in the genome of the zebra finch,
Gilbert and Feschotte (2010) found that the integration event took place at least 19
million years ago and were able to infer a substitution rate in the order of 10-8 s/s/y,
1000-fold lower than the rate inferred from extant hepadnaviruses [37, 174].
The work done on the 1918 influenza virus and the EVEs indicate that ancient viral
sequences can improve our understanding of virus evolution, in terms of studying
substitution rates, and understanding virus origins and mutations associated with par-
ticular phenotypes. Ancient DNA sequencing techniques have made it possible to
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recover ancient viral sequences that are older than the ancient exogenous (i.e., non-
integrated) viral sequences that have been previously recovered (Table 1.1). Such
viral sequences will allow us to obtain a better understanding about viral substitution
rates over longer time scales, as well as past viral diversity and geographic distribu-
tion.
1.3 APPROACH AND DATASETS
The work presented in chapters 2, 3, and 4 is based on the screening of aDNA whole
genome shotgun datasets comprising of 1653 humans (see Table 1.2). Figure 1.1
shows the locations of the samples, and Table 1.2 provides further descriptions and
references. The individuals were sequenced for the purpose of analysing the human
genome (see corresponding references in Table 1.2), and some have also subsequently
been screened for bacterial pathogens, resulting in the finding of Bronze Age Yersinia
pestis sequences [78]. The goal of the virus screening was not to provide a character-
isation of the entire metagenome or virome of the ancient individuals, but rather to –
after the initial screening – identify and describe sequences of specific viruses. The
datasets were assembled and sequenced by Prof. Eske Willerslev, Dr. Lasse Vinner,
Dr. Ashot Margaryan, Dr. Peter de Barros Damgaard, Prof. Morten Allentoft, Dr.
Hugh McColl, Dr. Constanza de la Fuente Castro, Prof. Andrea Manica, Dr. Ep-
pie Jones, and Prof. Turi King. Targeted virus capture was performed by Dr. Lasse
Vinner.
Dataset ENA accession Number
of Indi-
viduals
Age range
(years)
Reference Chapter
Viking unpublished 555 880–1,100 [175] 3, 4
South East Asia PRJEB26721 32 300–4,400 [176] 3, 4
Iron Age PRJEB20658 142 500–4,500 [44] 2, 3, 4
Bronze Age PRJEB9021 168 1,400–5,400 [41] 2, 3, 4
Baikal Hunter Gatherers PRJEB26349 31 3,800–7,100 [43] 3, 4
Kolyma PRJEB29700, PRJEB26336 25 800–31,600 [177] 3, 4
Neolithic unpublished 659 500–7,000 unpublished 3, 4
Various PRJEB11364, PRJEB18067,
PRJEB20614, PRJEB20616,
PRJEB13189, PRJEB11995,
PRJEB14817, SRP039766
41 1,736–
13,770
[178–185] 3, 4
Table 1.2: Human shotgun NGS datasets screened for viruses in this thesis. The ‘Chap-
ter’ column indicates the chapter(s) of this thesis in which the dataset is relevant.
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Paleolithic (6) Mesolithic (59)
Neolithic (173) Bronze Age (149)
Iron Age (145) Viking Age (520)
Medieval (33) Historical (13)
Figure 1.1: Map of the locations of the samples analysed during this PhD. Samples are
plotted on different maps according to approximate sample age. Paleolithic: older than
30,000 years, Mesolithic: 30,000 – 10,000 years, Neolithic: 10,000 – 6000 years, Bronze
Age: 5,000 – 3,000 years, Iron Age: 3,000 – 1,200 years, Viking Age: 1,200 – 900 years,
Medieval: 900 – 300 years, Historical: 300 – present. Location and approximate age infor-
mation was available for 1098 out of 1653 samples. For the 329 samples in the ‘Unknown’
panel, the age is not known, but their location is.
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CHAPTER 2: ANCIENT HEPATITIS B VIRUSES FROM
THE BRONZE AGE TO THE MEDIEVAL
PERIOD
2. ANCIENT HEPATITIS B VIRUS
PREFACE
A version of this chapter was previously published as (* denotes equal contribu-
tion):
Barbara Mühlemann*, Terry C. Jones*, Peter de Barros Damgaard*, Morten E. Al-
lentoft*, Irina Shevnina, Andrey Logvin, Emma Usmanova, Irina P. Panyushkina,
Bazartseren Boldgiv, Tsevel Bazartseren, Kadicha Tashbaeva, Victor Merz, Nina
Lau, Vàclav Smrcˇka, Dmitry Voyakin, Egor Kitov, Andrey Epimakhov, Dalia Pokutta,
Magdolna Vicze, T. Douglas Price, Vyacheslav Moiseyev, Anders J. Hansen, Ludovic
Orlando, Simon Rasmussen, Martin Sikora, Lasse Vinner, Albert D. M. E. Osterhaus,
Derek J. Smith, Dieter Glebe, Ron A. M. Fouchier, Christian Drosten, Karl-Göran
Sjögren, Kristian Kristiansen, Eske Willerslev. Ancient Hepatitis B viruses from the
Bronze Age to the Medieval period. Nature, 557, 418–423 (2018).
It has been modified to fit the style of a dissertation.
I performed the screening of the datasets in collaboration with Terry Jones, assem-
bled the consensus sequences, did the phylogenetic analyses (with input by Christian
Drosten), authentication via damage patterns, genome properties, figures and tables
(except the recombination, and sequence identity figures and tables), and wrote the
text in collaboration with Terry Jones and with input from all co-authors. The re-
combination analysis, genotyping, the analysis of similarity to modern sequences,
and authentication via BLASTn was done by Terry Jones. The sequencing work was
performed by Peter de Barros Damgaard and Morten Allentoft. PCR confirmation
and targeted virus capture of a subset of samples was performed by Lasse Vinner,
and capture probes were designed by Anders Hansen. In addition to this descrip-
tion, I have noted in the legends of figures and tables if they were contributed by
others.
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2.1. ABSTRACT
2.1 ABSTRACT
Hepatitis B virus (HBV) is a major cause of human hepatitis. There is considerable
uncertainty about the timescale of evolution of the virus and its association with hu-
mans. Here we present 12 full or partial ancient HBV genomes that are between
approximately 0.8 and 4.5 thousand years old. The ancient sequences group either
within or in a sister relationship with extant human or other ape HBV clades. Gener-
ally, the genome properties follow those of modern HBV. The root of the HBV tree is
projected to between 8.6 and 20.9 thousand years ago, and we estimate a substitution
rate of 8.04x10-6 – 1.51x10-5 nucleotide substitutions per site per year. In several
cases, the geographical locations of the ancient genotypes do not match present-day
distributions. Genotypes that today are typical of Africa and Asia, and a subgenotype
from India, are shown to have an early Eurasian presence. The geographical and tem-
poral patterns that we observe in ancient and modern HBV genotypes are compatible
with well-documented human migrations during the Bronze and Iron Ages [41, 44].
We provide evidence for the creation of HBV genotype A via recombination, and for
a long-term association of modern HBV genotypes with humans, including the dis-
covery of a human genotype that is now extinct. These data expose a complexity of
HBV evolution that is not evident when considering modern sequences alone.
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2.2 INTRODUCTION
HBV is transmitted perinatally or horizontally via blood or genital fluids [186]. The
estimated global HBsAg seroprevalence is 3.6%, ranging from 0.01% (UK) to 22.38%
(South Sudan) [187]. In high endemicity areas, in which HBsAg seroprevalence is
over 8%, 70–90% of the adult population show evidence of past or present infec-
tion measured by the presence of any of HBsAg, anti-HBs, or anti-HBc [188–190].
The young and the immunocompromised are most likely to develop chronic HBV
infection, which can result in high viraemia over years to decades [186]. Approxi-
mately 257 million people are chronically infected and around 887,000 died in 2015
owing to associated complications [190]. Despite the prevalence and public health
impact of HBV, its origin and evolution remain unclear [191, 192]. Inference of
HBV nucleotide substitution rates is complicated by the fact that the virus genome
consists of four overlapping open reading frames [193], and that mutation rates dif-
fer between phases of chronic infection [194]. Studies based on heterochronous se-
quences, sampled over a relatively short time period, find higher substitution rates,
whereas rates estimated using external calibrations tend to be lower, leading to a wide
range of estimated HBV substitution rates (7.72x10-4 – 3.7x10-6 substitutions per site
per year) [36, 37, 195]. Human HBV is classified into at least nine genotypes (A–I)
based on sequence similarity of at least 92.5% within genotypes [196], with a het-
erogeneous global distribution [192, 193] (Fig. 2.1a). Attempts to explain the origin
of genotypes using human migrations have been inconclusive. The hypothesis that
HBV co-evolved with modern humans as they left Africa 60–100 thousand years ago
(ka) has been contested owing to the basal phylogenetic position of genotypes F and
H, which are found exclusively in the Americas [191]. HBV also infects non-human
primates (NHP), and the human and other great ape HBVs are interspersed in the phy-
logenetic tree, possibly due to cross-species transmission [197]. Given the variability
of estimated substitution rates, the incongruence of the tree topology with some hu-
man migrations and the mixed topology of the NHP and human HBV sequences in
the phylogenetic tree, there remains considerable uncertainty about the evolutionary
history of HBV. Recent advances in the sequencing of ancient DNA (aDNA) have
yielded important insights into human evolution, past population dynamics [40] and
diseases [78, 96]. However, ancient sequences have been recovered for only a hand-
ful of exogenous human viruses, including influenza virus (sample approximately
100 years old) [198], variola virus (sample approximately 360 years old) [116] and
HBV (samples approximately 340 and 450 years old) [113, 114]. The knowledge
gained from these cases emphasizes the general importance of ancient sequences for
the direct study of long-term viral evolution. HBV has several characteristics that
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make it a good candidate for detection in an aDNA virus study: its long-lasting vi-
raemia during chronicity, with high titres of serum HBV DNA (>2,000 International
Units (IU)/mL, 1IU=5 viruses) [2, 186], the relative stability of its virion [199], and
its small, circular and partially double-stranded DNA genome [193]. Here we present
12 ancient HBV sequences between 0.8 and 4.5 thousand years old (kya), identified
by screening shotgun sequencing datasets from 167 Bronze Age and 137 predomi-
nantly Iron Age individuals from central to western Eurasia with a sample age range
of approximately 7.1–0.2 kya.
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Figure 2.1: Geographical distribution of analysed samples and modern genotypes. a)
Distribution of modern human HBV genotypes [192]. Genotypes relevant to this chapter are
shown in colour, the others in black. Coloured shapes indicate the locations of the HBV-
positive samples included for further analysis. b) Locations of analysed Bronze Age sam-
ples [41] are shown as circles and Iron Age and later samples [44] are shown as triangles.
Coloured markers indicate HBV-positive samples. Ancient genotype A samples are found
in regions in which genotype D predominates today, and HBV-DA27 is of subgenotype D5
which today is found almost exclusively in India.
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2.3 METHODS
2.3.1 HBV datasets
The following HBV datasets were used in the present study:
Dataset 1
Dataset 1 comprises 26 HBV genomes, covering all species in the Orthohepadnaviri-
dae. This includes one sequence each from the human HBV genotypes (A–I, and J),
orangutan, chimpanzee, gorilla, gibbon, woolly monkey, woodchuck, ground squir-
rel, Arctic ground squirrel and horseshoe bat, four sequences from roundleaf bats,
and three sequences from tent-making bats, largely following a previous publica-
tion [200].
10 sequences from human genotypes (genotype in parentheses): AM282986 (A),
D23678 (B), AB117758 (C), AB126581 (D), AB205192 (E), X69798 (F), AB056513
(G), AY090454 (H), AF241409 (I), AB486012 (J).
Four sequences from NHPs: AF305327 (Chimpanzee), AY781180 (Gibbon), AJ131-
567 (Gorilla), AF193863 (Orangutan).
12 from other Orthohepadnaviridae representatives: KC790373 (Roundleaf bat),
KC790374 (Roundleaf bat), KC790376 (Roundleaf bat), KC790375 (Roundleaf bat),
KC790377 (Horseshoe bat), KC790378 (Tent-making bat), KC790380 (Tent-making
bat), KC790381 (Tent-making bat), NC_004107 (Woodchuck), NC_001484 (Ground
squirrel), U29144 (Arctic ground squirrel), AF046996 (Woolly monkey).
Dataset 2
Dataset 2 comprises 124 HBV genomes, from humans and NHPs. This set contains
92 sequences from a previous publication [36] (excluding incomplete sequences), 7
additional genotype D sequences, the Korean mummy genotype C sequence [114],
the 12 ancient sequences from the present study and 12 full genomes selected from
a set of 9,066 full HBV genomes downloaded from NCBI [201] on 24 August 2017
(Entrez query: hepatitis b virus[organism] not rna[title] not
clone[title] not clonal[title] not patent[title] not rec-
ombinant[title] not recombination[title] and 3000:4000[s-
equence length]) corresponding to the closest, non-artificial match for each of
the ancient sequences. Dates for these sequences were acquired by looking for a
date of sample collection in the NCBI entry, or the paper in which the sequence was
first published. If a range of dates was mentioned, the mean was used. If no date
of sample collection was found in this way, either the year of the publication of the
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paper, or the year of addition of the sequence to GenBank was used, whichever was
earlier.
85 human sequences from Paraskevis et al. (2015) [36] ((sub)genotype in parenthe-
ses): AB076679 (A1), AB116084 (A1), AB453988 (A1), AY738142 (A2), GQ477499
(A2), AY934764 (A3), FJ692556 (A3), FJ692598 (A3), FJ692611 (A3), GQ161813
(A3), GQ331046 (A4), AB073858 (B1), AB033555 (B3), AB219429 (B3), AB219430
(B3), AP011089 (B3), AB073835 (B4), AB287316 (B5), AB287318 (B5), AB287320
(B5), AB287321 (B5), DQ463789 (B5), DQ463792 (B5), AB241117 (B), DQ993686
(B), AB111946 (C1), AB112066 (C1), AB112472 (C1), DQ089767 (C1), X75656
(C3), X75665 (C3), AB048704 (C4), AB048705 (C4), AF241411 (C5), AP011100
(C5), AP011102 (C6), AP011103 (C6), AP011106 (C8), AP011108 (C9), FJ899792
(D1), JN642140 (D1), GQ477453 (D2), GQ477455 (D2), JN642160 (D2), JN642163
(D2), JN688710 (D3), JN688711 (D3), GQ922005 (D4), HE974378 (D4), KJ470893
(D4), KJ470896 (D4), KJ470898 (D4), FJ904430 (D7), FJ904436 (D7), AB033559
(D), AB048701 (D), AB048702 (D), AB188243 (D), AB210818 (D), AM494716
(D), AY796031 (D), AY902768 (D), DQ315779 (D), X80925 (D), X75657 (E), X75664
(E), AY090458 (F1a), AB116654 (F1b), FJ657525 (F1b), AY090455 (F2a), AY311369
(F2a), DQ899144 (F2b), DQ899146 (F2b), AB116549 (F3), X75663 (F3), AF223962
(F4), AB166850 (F), AB056513 (G), AB064312 (G), AF405706 (G), AB059660 (H),
AB375163 (H), AY090454 (H), AY090457 (H), AB486012 (J).
7 NHP sequences from Paraskevis et al., (2015) [36]: AY330911 (Chimpanzee),
AJ131571 (Gibbon), AY781180 (Gibbon), U46935 (Gibbon), AJ131567 (Gorilla),
AF193863, EU155824 (Orangutan).
7 additional human genotype D sequences: AB033558, GQ205382, GQ205389,
GQ205384, GQ205377, GQ205385, GQ205378.
1 Korean mummy genotype C sequence from [114]: JN315779
12 ancient sequences from the present study: ERS2295383 (DA27), ERS2295384
(DA29), ERS2295385 (DA45), ERS2295386 (DA51), ERS2295387 (DA119), ERS22-
95388 (DA195), ERS2295389 (DA222), ERS2295390 (RISE154), ERS2295391
(RISE254), ERS2295392 (RISE386), ERS2295393 (RISE387), ERS2295394 (RISE563).
The 12 modern sequences that are closest to each of the ancient sequences: KP322603
(DA27), KC875319 (DA29), KP341007 (DA45), KP322600 (DA51), FN545831 (DA119),
EU859952 (DA195), KP322602 (DA222), FM209516 (RISE154), AF222323 (RISE254),
GQ331047 (RISE386), KC774243 (RISE387), AB032433 (RISE563).
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Dataset 3
Dataset 3 comprises 124 HBV genomes, from humans, NHPs and a variety of other
Orthohepadnaviridae host species, including woolly monkey, roundleaf bat, tent-
making bat, ground squirrel, Arctic ground squirrel, woodchuck and snow goose.
This set contains 113 sequences that were obtained from the union of 91 sequences
from Paraskevis et al., (2015) [36] and 29 from Drexler et al., (2013) [200], plus 11
additional sequences (giving 124 sequences in total).
113 sequences formed by the union of:
91 sequences from Paraskevis et al., (2015) [36]. These are the 92 listed above in
Dataset 2, excluding AF405706, which resulted in a duplicate once gaps were re-
moved from the multiple sequence alignment including all ancient genomes. 27
sequences from Drexler et al., (2013) [200]: AB056513, AB117758, AB126581,
AB205192, AB486012, AF046996, AF111000, AF193863, AF241409, AF305327,
AJ131567, AJ131568, AM282986, AY090454, D23678, KC790373, KC790374,
KC790375, KC790376, KC790377, KC790378, KC790380, KC790381, NC_001484,
NC_004107, U29144, X69798.
11 additional sequences: AB032433, AB493845, DQ298161, DQ336682, GQ205385,
GQ331047, GQ475343, GQ922004, JN040772, KF679991, KJ470892.
Dataset 4
Dataset 4 comprises 3,505 HBV genomes. Of these, 3,384 are from a previous publi-
cation [202], divided into ten human genotypes. To these, we added 17 chimpanzee,
56 gorilla, 12 gibbon and 36 orangutan full HBV genome sequences downloaded
from NCBI on 18 January 2017, resulting in 14 genome categories.
3384 HBV genomes from Bell et al., (2016) [202].
17 Chimpanzee sequences: AB368296, AF222322, AF222323, AF305327, AJ131575,
D00220, FJ798098, FJ798099, JQ664502, JQ664503, JQ664504, JQ664505, JQ66-
4506, JQ664507, JQ664508, JQ664509, U46935.
56 Gibbon sequences: AJ131568, AJ131569, AJ131570, AJ131571, AJ131572, AJ1-
31573, AJ131574, AY077735, AY077736, AY781177, AY781178, AY781179, AY7-
81180, AY781181, AY781182, AY781183, AY781184, AY781185, AY781186, AY7-
81187, EU155821, EU155822, EU155823, EU155824, EU155825, EU155826, EU1-
55827, EU155828, EU155829, HQ603058, HQ603059, HQ603060, HQ603061,
HQ603062, HQ603063, HQ603064, HQ603065, HQ603066, HQ603067, HQ603068,
HQ603069, HQ603070, HQ603071, HQ603072, HQ603073, HQ603074, HQ603075,
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HQ603076, HQ603077, HQ603078, HQ603079, HQ603080, HQ603081, HQ603082,
KT893897, U46935.
12 Gorilla sequences: AJ131567, FJ798095, FJ798096, FJ798097, JQ664502, JQ66-
4503, JQ664504, JQ664505, JQ664506, JQ664507, JQ664508, JQ664509.
36 Orangutan sequences: AF193863, AF193864, EU155821, EU155822, EU155823,
EU155824, EU155825, EU155826, EU155827, EU155828, EU155829, HQ603058,
HQ603059, HQ603060, HQ603061, HQ603062, HQ603063, HQ603064, HQ603065,
HQ603066, HQ603067, HQ603068, HQ603069, HQ603070, HQ603071, HQ603072,
HQ603073, HQ603074, HQ603075, HQ603076, HQ603077, HQ603078, HQ603079,
HQ603080, HQ603081, HQ603082.
2.3.2 Dating of ancient samples
Dating of samples was performed by collaborators. Sample ages were determined
by direct 14C dating. These ages were calibrated using OxCal [203] (version 4.3)
using the IntCal13 curve [204]. Table 2.1 shows the 14C age and standard deviation
for each sample. This is followed by the median probability calibrated age before
present (cal. bp). RISE386 was 14C dated twice, with ages (standard deviation) of
3,740 (33) and 3,775 (34); a rounded mean of 3,758 (34) was used for its calibration.
DA29 was dated at 822 years using 14C and also at about 700 years using multi-
proxy methods: the former date was used for consistency. The dates for DA119,
DA222, RISE548, RISE556, RISE568 and RISE597 are best estimates, based on
sample context.
2.3.3 Data and data processing
We analysed 101 Bronze Age samples published in Allentoft et al., (2015) [41], 137
predominantly Iron Age samples published in de Barros Damgaard et al., (2018) [44]
and 66 additional samples from the Bronze Age. A total of 114.58x109 Illumina
HiSeq 2500 sequencing reads were processed.
AdapterRemoval [205] (version 2.1.7) was used with its default settings to remove
adaptors from all sequences, to trim N bases from the ends of reads and to trim
bases with quality equal and smaller than 2. Reads were aligned against a human
genome (GRCh38, https://www.ncbi.nlm.nih.gov/grc/human) using BWA [206] (ver-
sion 0.7.15-r1140, mem algorithm). Reads that did not match the human genome
were then mapped against the NCBI viral protein reference database containing 274,038
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viral protein sequences (downloaded on 31 August 2016) using DIAMOND [207]
(version 0.8.25). Protein matches were grouped into their corresponding viruses.
Reads matching HBV were found in 25 samples.
The non-human reads from the samples that had more than three proteins matching
HBV using DIAMOND were selected for a subsequent BLAST [25] (version 2.4.0)
analysis. A BLAST database was made from Dataset 3, and samples were matched
using BLASTn (with arguments -task blastn -evalue 0.01). Matching
reads with bit scores greater than 50 for all samples (except DA222 (70) and DA45
(55)) were selected for subsequent processing. The number of reads selected from
the BLAST matches, per sample, is shown in Table 2.1.
2.3.4 PCR confirmation and virus capture
PCR confirmation and virus capture was performed by Lasse Vinner. Capture probes
were designed by Lasse Vinner and Anders J. Hansen. For a full description, please
refer to [79].
Real-time PCR was established using primers and TaqMan probes as previously de-
scribed [208], which were used to amplify a 91-base-pair amplicon of the HBV
genome. Four samples were tested in total, two low-coverage (DA85, DA89) and
two high-coverage (DA195, DA222) samples.
Fourteen samples with sufficient sample material were selected for virus capture
(DA27, DA29, DA45, DA51, DA85, DA89, DA119, DA195, DA222, RISE254,
RISE386, RISE416, RISE568 and RISE556).
The resulting reads were compared to Dataset 2 using BLASTn (with arguments -
task blastn -evalue 0.01). Matching reads with bit scores greater than 50
for all samples (except DA222 (70) and DA45 (55)) were selected for subsequent
processing. In total, 6,757 reads matched HBV in the capture data.
2.3.5 Sequence authenticity
The following evidence leads us to believe that the ancient HBV sequences are au-
thentic and that the possibility of contamination can be excluded:
1. Standard precautions for working with aDNA were applied [63].
2. Sequences were checked for typical aDNA damage patterns using mapDam-
age [209] (version 2.0.6). Whenever sufficient amounts of data were avail-
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able (>200 HBV reads), we found C→T mutations at the 5’ end, typical of
aDNA [67] (see Fig. 2.2a, c).
3. Capture was performed on DNA extracts of sample DA222, with and without
pretreatment by uracil-specific excision reagent (USER) [210]. After USER
treatment (3 h at 37 ◦C) of the aDNA extract, the damage pattern is eliminated
(Fig. 2.2b).
4. As the ancient viruses are from three different HBV genotypes (A, B and D)
and a clade in sister relationship to chimpanzee and gorilla HBVs, any argu-
ment that samples were contaminated would have to account for this diversity
as well as the sequence novelty.
5. HBV sequences were identified in 25 of 304 analysed samples (Table 2.1),
showing that the findings cannot be due to a ubiquitous laboratory contaminant.
6. Despite the low frequency of positive samples, we sequenced extraction blanks
to provide additional evidence against the possibility that the HBV sequences
stemmed from sporadic incorporation, amplification and sequencing of back-
ground reagent contaminants into the aDNA libraries. The negative extraction
controls were amplified for 40 PCR cycles, and BLASTn was used to match
the read sequences against Dataset 3, with the same parameters used for the
ancient samples. Because the ancient HBV-positive reads used to assemble
genomes all had bit scores of at least 50 (see section 2.3.3), we filtered the
negative extraction control BLASTn output for reads with a bit score greater
or equal to 45. No reads (out of 23 million) matched any HBV genome at that
level.
7. HBV is a blood-borne virus that is mainly transmitted by exposure to infectious
blood and that does not occur in the environment [186], making contamination
during archaeological excavation extremely unlikely.
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Figure 2.2: Ancient DNA damage patterns. The frequencies of the mismatches observed between
the HBV reference sequences (Table 2.1) and the reads are shown as a function of distance from the 5’
end. C→T (5’) and G→A (3’) mutations are shown in red and blue, respectively. All other possible
mismatches are shown in grey. Insertions are shown in purple, deletions in green and clippings in
orange. The count of reads matching HBV for each sample is shown in parentheses. a) Damage
patterns for RISE563, DA222, DA119, RISE254, DA195, DA27, DA51, RISE386, RISE387, DA29,
DA45, RISE416 and RISE154. b) Damage patterns for DA222 without (left) and with (right)
USER treatment. c) Damage patterns with 10, 20, 50, 100, 200, 500 and 1,000 reads sampled from
RISE563, in which each opaque line corresponds to one replicate set of reads. Only C→T (in red)
and G→A (in blue) mutations are shown.
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2.3.6 Consensus sequences
Reads from the original sequencing and from the capture were aligned to a reference
genome (Table 2.1) in Geneious [211] (version 9) using medium sensitivity / fast and
iterate up to 5 times. Because aDNA damage often clusters towards read termini [67],
the resulting alignments were carefully curated by hand to remove non-matching ter-
mini of reads if the majority of the read showed a very good match with the reference
sequence.
2.3.7 Genotyping
Performed by Terry Jones. All reads used to construct the ancient HBV consensus se-
quences were matched against the full NCBI nucleotide database (downloaded 28 De-
cember 2016) using BLAST. Of these reads, 97.5% had HBV as their top match. All
ancient consensus sequences were matched against the full HBV genomes of dataset
4 with the Needleman-Wunsch algorithm [212], as implemented in EMBOSS50 (ver-
sion 6.6.0.0). For each ancient sequence, the percentage of sequence identity with the
most similar representative of each modern genotype and four NHP species is listed
in Table 2.11. The Needleman-Wunsch algorithm was also used to calculate the pair-
wise sequence similarity between all ancient sequences (Table 2.12).
2.3.8 Recombination analysis
In order to gain an overview of possible recombination events present in dataset 2
and the 12 ancient sequences, a TreeOrder scan was performed as implemented in
SSE (version 1.3) [213]. TreeOrder scan visualises changes of sequence positions in
phylogenetic trees inferred from successive sections, or windows, of an alignment.
A window of 500 base pairs and step size of 50 base pairs was used. Changes in
tree order are shown if they have above 70% bootstrap support [235]. 100 bootstrap
replicates were performed for each window. The woolly monkey HBV sequence
(GenBank Accession Number: AF046996) was used as the outgroup. Subsequently,
a GoupingScan was run as implemented in SSE (version 1.3) [213], using the se-
quences in dataset 2, after removing the sequence AB486012 (J). The remaining
sequences in dataset 2 were assigned to 10 groups (genotypes A, B, C, D, E, F,
G, H, and the Gibbon/Orang Utan clade, and the Chimpanzee/Gorilla clade). The
GroupingScan measures how deeply embedded a test sequence (in this case, each
of the 12 ancient sequences in turn) is in a group of reference sequences, measured
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by the grouping score. A grouping score >0.5 is indicative that the test sequence
falls within a particular group. The grouping score is calculated over successive win-
dows of an alignment. We used a window size of 250 base pairs and a step size of
50 base pairs. 100 bootstrap replicates were performed. The recombination analy-
sis described below was performed by Terry Jones. Furthermore, the recombination
detection program (RDP4) [214] (version 4) was used to search for evidence of re-
combination within the 12 ancient sequences and a selection of 15 modern human
and NHP sequences (Supplementary Methods in [79]). Recombination with HBV-
RISE387 as the recombinant and HBV-DA51 as one parent, was suggested at posi-
tions 1567–2256, by seven recombination methods (RDP [214], GENECONV [215],
BootScan [216], MaxChi [217], Chimaera [218], SiScan [219], and 3Seq [220])
with P values from 1.179x10-6 to 5.336x10-11 (Table 2.4, 2.5). The same recom-
bination was suggested for all 4 ancient genotype A and two modern genotype A
sequences. Graphical evidence of the recombination and the predicted break point
distribution for sequences HBV-RISE386 and HBV-RISE387 from three methods
(MaxChi, Bootscan and RDP) is shown in Fig. 2.7.
2.3.9 Initial maximum likelihood phylogeny and phyloge-
netic network
An initial maximum likelihood tree was generated to ascertain whether the ancient
sequences fall within the primate HBV clades. Dataset 1 and the ancient sequences
were aligned in MAFFT [221] (version 7). The maximum likelihood tree was con-
structed using PhyML [222] (version 20160116), optimizing topology, branch lengths
and rates. We used a general time reversible (GTR) substitution model, with base fre-
quencies determined by maximum likelihood, and a maximum likelihood-estimated
proportion of invariant sites and 100 bootstraps (Fig. 2.3). Furthermore, a Neigh-
bourNet phylogenetic network was constructed based on a MAFFT alignment of
dataset 2 and the ancient sequences, using SplitsTree [223] with a GTR substitution
model.
2.3.10 Dated coalescent phylogenies
To check for a temporal signal in the data, root-to-tip regressions and date randomiza-
tion tests were performed. For the root-to-tip regression, input trees were calculated
using dataset 2 with the addition of a woolly monkey sequence (GenBank Accession
Number: AF046996) as an outgroup. Three phylogenetic algorithms were used;
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neighbour joining, maximum likelihood (PhyML), and Bayesian (MrBayes [224]
(version 3.2.5)) methods (Supplementary Figs. 1–3 in [79]). For maximum like-
lihood and Bayesian methods, root-to-tip distances (in substitutions per site) were
extracted from optimized tree topologies (maximum likelihood and maximum clade
credibility trees, respectively). For the neighbour joining method, root-to-tip dis-
tances were averaged over 1,000 bootstrap replicates. Root-to-tip distances were
extracted using TempEst [225] (version 1.5). Regression analyses were performed
with SciPy (version 0.16.0) [226]. For the date randomization tests, we used three
different approaches to randomize tip dates. First, tip dates were randomized between
all sequences in the phylogeny. Second, tip dates were randomized only among the
ancient sequences presented here, as well as the Korean mummy sequence (Gen-
Bank accession number JN315779), while the modern sequences retained their cor-
rect ages. Third, dates were randomized within a clade. For each of the three ap-
proaches, we performed three independent randomizations. This resulted in a total of
nine analyses, which were run for 100,000,000 generations each, under the relaxed
log-normal clock model and coalescent exponential population prior. We also ran the
same analyses under a strict clock and coalescent Bayesian skyline population prior,
which were run for 20,000,000 generations. We used a GTR substitution model with
unequal base frequencies, four gamma rate categories, estimated gamma distribution
of rate variation and estimated proportion of invariant sites, as found by bModel-
Test [227] (version 1.0.4). None of the analyses using the relaxed clock converged
(effective sample size <200). This is most probably because the misspecification of
the dates leads to incongruence between the sequence and time information. Under
the strict clock model, all runs converged, and none of the 95% HPD intervals of the
root age overlapped between the randomized and the non-randomized runs, fulfilling
the criteria for evidence of a temporal signal [228].
Dated phylogenies were estimated using BEAST2 [150] (version 2.4.4, prerelease).
We used a MAFFT alignment of dataset 2. To account for the influence of recom-
bination events on the dating of phylogenetic trees, we also performed all dating
analysis on positions 1 – 1400 of a MAFFT alignment of dataset 2 after the ex-
clusion of the genotype G sequences (hereafter referred to as ‘partial alignment’),
since the TreeOrder scan results (Fig. 2.4) indicate that that section of the align-
ment does not contain recombination events. Using bModelTest [227], we selected a
GTR substitution model with unequal base frequencies, four gamma rate categories,
estimated gamma distribution of rate variation and estimated proportion of invari-
ant sites. Proper priors were used throughout. Path sampling, as implemented in
BEAST2, was performed to select between a strict or relaxed log-normal clock and
a coalescent constant, exponential or coalescent Bayesian skyline population prior
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(Table 2.6). Log marginal likelihood values were compared using a Bayes factor
test. A Bayes factor in the range of 3–20 implies positive support, 20–150 strong
support and >150 overwhelming support [229]. The relaxed log-normal clock model
in combination with a coalescent exponential population prior was favoured (Table
2.6). Note that there is a slight preference of the coalescent Bayesian skyline pop-
ulation prior instead of the coalescent exponential population prior under a relaxed
log-normal clock (Bayes factor: 2.88) for the partial alignment. However, since this
does not imply positive support [229], the same coalescent exponential population
prior was used for the complete and the partial alignment (Table 2.6). Trees were in-
ferred using the complete and partial alignments under all six combinations of clock
models and population priors. The Markov chain Monte Carlo analysis was run until
parameters reached an effective sample size >200, sampling every 2,000 generations.
Convergence and mixing were assessed using Tracer [230] (version 1.6). For the fi-
nal tree shown in figure 3.6, the final tree files were subsampled to contain 10,000
or 10,710 (for the relaxed log-normal clock, coalescent exponential population prior)
trees, with the first 25% of samples discarded as burn-in. Maximum clade credibility
trees were made using TreeAnnotator (version 2.4.4 prerelease).
To formally test the ‘Out of Africa’ hypothesis of HBV evolution, calibration points
were tested using path sampling as implemented in BEAST2 for the full and partial
alignment of dataset 2. Calibration points were constrained as follows: for the split
of genotypes F and H, the most recent common ancestor (MRCA) of all genotype
F and H sequences was constrained using a uniform (13,400:25,000) distribution, as
this is the range of estimates for when the Americas were first colonized [231, 232].
For the split of subgenotype A3 in Haiti, the MRCA of FJ692598 and FJ692611 was
constrained using a uniform (200:500) distribution, owing to the timing of the slave
trade to Haiti [233]. For the split of C3 in Polynesia, the MRCA of X75656 and
X75665 was constrained using a uniform (5,100:12,000) distribution, owing to the
range of estimates for the MRCA of Polynesian populations [36, 234]. Calibration
points were tested under both a relaxed log-normal clock, coalescent exponential
population prior, and a strict clock, Bayesian skyline population prior.
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2.4 RESULTS AND DISCUSSION
Shotgun sequence data were previously generated from 167 Bronze Age [41] and
137 predominantly Iron Age [44] individuals from central to western Eurasia with
a sample age range of approximately 7.1–0.2 kya. We identified reads that matched
the HBV genome in 25 samples (Table 2.1), spanning a period of almost 4,000 years,
from several different cultures and with a broad geographical range (Fig. 2.1b, Table
2.1). Using TaqMan PCR, we tested two samples (DA195 and DA222) with high
genome coverage and two samples (DA85 and DA89) with low genome coverage
for the presence of HBV. The high-coverage samples tested positive, whereas the
low-coverage samples tested negative (Table 2.3). This is consistent with shotgun
sequencing being more effective than targeted PCR for analysing highly degraded
DNA [58]. On the basis of the availability of sample material, libraries from 14
samples were selected for targeted enrichment (capture) of HBV DNA fragments
(Supplementary Tables 1, 2 in [79]). This resulted in increased genome coverage
and an average of a 2.4-fold increase in the number of HBV-positive reads (Table
2.2). We obtained 17.9–100% HBV genome coverage from the sequence data, with
genomic depth ranging from 0.4x to 89.2x (Table 2.2). We selected 12 samples for
phylogenetic analyses. Criteria for inclusion were at least 50% genome coverage and
clear aDNA damage patterns after capture (Fig. 2.2a). For an initial phylogenetic
grouping, we estimated a maximum likelihood tree using the ancient HBV genomes
together with modern human, NHP, rodent and bat HBV genomes (dataset 1, see
Methods). All ancient viruses fell within the diversity of Old World primate HBV
genotypes, which includes all human and other great ape genotypes with the excep-
tion of human genotypes F and H (Fig. 2.3).
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Sample Location Culture 14C age (s.d.) Median cal BP
age/estimate
App-
rox.
Age
Sex Individual age Sample type
DA27 Halvay 3, KAZ Hun-Sarmatian 1641 (33) 1543 1610 M N/D N/D
DA29 Karasyur, KAZ Golden Horde 849 (25) 755 822 M N/D N/D
DA45 Omnogobi, MNG Xiongnu 2083 (27) 2053 2120 M N/D N/D
DA51 Keden, KYR Saka 2220 (37) 2230 2297 M N/D N/D
DA85 Japyrik, KYR Hun 1781 (46) 1702 1769 M N/D N/D
DA89 Berygavoya, KAZ Turk 1315 (45) 1247 1314 M N/D N/D
DA119 Poprad, SVK North Carpathian N/D 1500 1567 M N/D N/D
DA195 Sandorfalva-Eperjes, HUN Hungarian Scythian 2479 (35) 2578 2645 F N/D N/D
DA222 Butakty, KAZ Karluk N/D 1200–1000 1167 M N/D N/D
RISE99 L Bedinge, SWE Nordic Late Neolithic 3713 (30) 4045 4112 M Adult N/D
RISE154 Szczepankowice, POL Unetice 3522 (24) 3784 3851 F Adult tooth
RISE254 Szàzhalombatta-Földvàr,
HUN
Vatya 3631 (29) 3942 4009 M N/D tooth
RISE391 Tanabergen II, KAZ Sintashta 3612 (34) 3921 3988 F 30–35 tooth
RISE386 Bulanovo, RUS Sintashta 3758 (34) 4121 4188 M 30–40 N/D
RISE387 Bulanovo, RUS Sintashta 3822 (33) 4215 4282 N/D N/D tooth
RISE416 Nerquin Getashen, ARM Middle Bronze Age 3259 (40) 3488 3555 M Infant N/D
RISE478 Schöngeising, GER Bronze Age 3164 (34) 3391 3458 M Adult N/D
RISE509 Bateni, RUS Afanasievo 4186 (27) 4728 4795 F 20–25 tooth
RISE533 Arano, ITA Early Bronze Age 3657 (37) 3980 4047 N/D N/D tooth
RISE548 Temrta IV, RUS Yamnaya N/D 5000–4300 4717 M Senilis (55+) tooth
RISE554 Afontova Gora, RUS Late Bronze Age hunter-
gatherer
2782 (30) 2879 2946 M N/D tooth
RISE556 Manching-Oberstimm, GER Bell Beaker N/D 4500–4000 4317 F Adult tooth
RISE563 Osterhofen-Altenmarkt,
GER
Bell Beaker 3955 (35) 4421 4488 M Adult tooth
RISE568 Brandy`sek,CZE Early Slav N/D 1350–1150 1317 F Infant tooth
RISE597 Turlojiske, LTU Late Bronze Age N/D 3500–3000 3317 M Adult tooth
Table 2.1: Overview of samples with reads matching HBV. Cal BP: calibrated years before
present (taken as 1950 AD); ND: not determined (samples for which dating was not performed,
or for which osteological sex was undetermined).
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Sample Prote-
ins
Dia-
mond
Reads
Dia-
mond
Reads
BLASTn
Bit
score
cut-off
Captured
reads
BLASTn
Reads
aligned in
Geneious
Reference Coverage
of consen-
sus before
capture
Cover-
age
depth
before
cap-
ture
Coverage of
consensus
Cover-
age depth
DA27 7 309 890 50 8 890 DQ315779 86.11% 15.3x 90.00% 14.3x
DA29 7 149 179 50 44 222 DQ315779 84.22% 3.7x 87.50% 4.8x
DA45 4 29 110 55 118 215 AB073858 67.03% 1.9x 87.20% 4.3x
DA51 7 54 127 50 595 712 DQ315779 69.42% 1.9x 99.20% 14.5x
DA85 4 14 27 50 6 N/D DQ315779 29.80% 0.7x 35.80% 0.5x
DA89 7 5 51 50 0 N/D DQ315779 17.90% 1.0x 17.90% 1.0x
DA119 7 155 385 50 2272 2597 AY738142 86.00% 7.2x 98.80% 53.1x
DA195 7 353 694 50 774 1445 AY738142 99.41% 12.6x 99.90% 29.2x
DA222 7 2269 2855 70 1318 4132 DQ315779 98.81% 61.2x 100% 89.2x
RISE99 2 2 N/D N/D N/D N/D N/D N/D N/D N/D N/D
RISE154 7 17 137 50 N/D 128 AB073858 N/D N/D 57.20% 2.0x
RISE254 7 158 211 50 1304 1491 DQ315779 52.58% 5.2x 99.00% 36.6x
RISE391 7 18 42 50 N/D N/D AB073858 N/D N/D 34.60% 0.9x
RISE386 7 94 240 50 140 331 AY738142 86.28% 4.2x 97.80% 7.0x
RISE387 7 154 344 50 N/D 284 AY738142 N/D N/D 86.60% 6.2x
RISE416 6 4 14 50 137 N/D AY738142 10.60% 0.3x 75.80% 3.5x
RISE478 3 2 N/D N/D N/D N/D N/D N/D N/D N/D N/D
RISE509 2 2 N/D N/D N/D N/D N/D N/D N/D N/D N/D
RISE533 6 3 N/D N/D N/D N/D N/D N/D N/D N/D N/D
RISE548 5 5 19 50 N/D N/D AB073858 N/D N/D 17.90% 0.5x
RISE554 2 1 N/D N/D N/D N/D N/D N/D N/D N/D N/D
RISE556 2 2 N/D 50 32 N/D AY738142 N/D N/D 28.00% 0.6x
RISE563 7 1499 4817 50 N/D N/D AB188243 N/D N/D 100% 79.3x
RISE568 7 6 7 50 9 N/D AB073858 N/D N/D 33.90% 0.4x
RISE597 3 1 N/D N/D N/D N/D N/D N/D N/D N/D N/D
Table 2.2: Mapping statistics of samples with reads matching HBV. ‘Proteins Diamond’ denotes
the number of HBV proteins matched by HBV sequencing reads using DIAMOND, ‘Reads Dia-
mond’, the number of sequencing reads that matched HBV using DIAMOND; ‘Reads BLASTn’,
the number of sequencing reads that matched HBV; ‘Captured reads BLASTn’, the number of reads
from the capture that matched HBV using BLASTn; ‘Bit score cut-off’, the bit score cut-off above
which matching reads were used to form consensus sequences; ‘Reads aligned in Geneious’, the
number of reads matching against reference sequence in Geneious, ‘Reference’ gives the accession
number of the sequence that was used to map the reads against in Geneious to make the consensus,
‘Coverage before capture’ and ‘Coverage depth before capture’ show the coverage and depth of the
consensus sequence, excluding the reads from the capture. ‘Coverage consensus’ and ‘Coverage
depth’, the percentage of the consensus genome covered by matching reads and average depth of
coverage across the reference genome as reported by Geneious. When reading sample information
across a row, an N/D (not determined) cell will be encountered when processing on that sample
was concluded, either owing to too few matching reads or consensus coverage less than 50%. Sam-
ples for which no capture was done (RISE563, RISE387, RISE154, RISE391, RISE548, RISE533,
RISE99, RISE478, RISE509, RISE554, RISE597) and samples for which no pre-capture estimates
are available due to the low number of matching reads (RISE556) are also denoted as ‘N/D’.
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Sample % of HBV reads per sam-
ple
CT-value HBV DNA qPCR conclusion Remarks
DA222 7.45E-05 31 Positive M
DA195 2.82E-05 40.52 Positive F
DA85 6.41E-07 >45 Negative
DA89 2.85E-06 >45 Negative
DA351 (neg.) NA >45 Negative
Negative ancient samples (n=4) NA >45 Negative
NTC (n=8) NA >45 Negative
Enriched HBVpos library pool 1 NA >40 Positive
Enriched HBVpos library pool 2 NA 35.39 Positive
Enriched HBVneg library pool 3 NA >45 Negative
Enriched HBVneg library pool 4 NA >45 Negative
Table 2.3: TaqMan PCR results. Four extracts from samples with HBV reads were selected for
TaqMan PCR confirmation: two with a large proportion of HBV reads (DA222 and DA195), two
with a small proportion of HBV reads (DA85 and DA89) and one with no HBV reads (DA351). HBV
was detected in extracts from DA222 and DA195, whereas the three low- and zero-read samples were
negative, as were all no-template controls. Table contributed by Lasse Vinner.
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Figure 2.3: Hepadnaviridae maximum likelihood tree. This figure shows 26 Orthohepadnaviri-
dae sequences (Dataset 1, see Methods), including the ancient HBV sequences. Ancient genotype
A sequences are shown in red, the ancient genotype B sequence in orange, ancient genotype D se-
quences in blue and novel genotype sequences in green. The tree was constructed in PhyML [222],
optimizing for topology, branch lengths and rates, with 100 bootstraps (see Methods). The x-axis
denotes substitutions per site (s/s).
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Recombination is known to occur in HBV [235]. For an overview of possible re-
combination events, we visualised changes in tree order for subsequent sections of
an alignment of HBV sequences using TreeOrder scan [213]. Figure 2.4 shows that
changes to the phylogenetic relationship between genotypes occur mainly between
alignment positions ∼1400 – 3221, except for genotype G, which also changes tree
order around position 300. The ancient sequences group with a single genotype
across the whole genome, with the exception of HBV-RISE387 and HBV-DA29. To
gain additional information about possible recombination events between the ancient
and the modern sequences, we performed a GroupingScan [213] (Fig. 2.5). The
GroupingScan computes a grouping score for successive windows along the align-
ment as a measure of how embedded a test sequence (here, each of the 12 ancient
sequences in turn) is in a group of non-recombinant sequences (corresponding to the
modern HBV genotypes A – H, and non-human primate sequences). Using a win-
dow size of 250 base pairs, the GroupingScan highlighted possible recombination
events in HBV-RISE387 (with genotype G), -RISE386 (with genotype D), -DA195
(with genotype D), -DA29 (with genotype E), and -DA45 (with gibbon and orang
utan sequences). Furthermore, sequences HBV-RISE154, -RISE254, and -RISE563
appear to have contributions from a variety of different genotypes (D, E, and G) as
well as the non-human primate sequences. This may reflect the absence of reference
sequences closely related to HBV-RISE154, -RISE254, and -RISE563 in the dataset.
The possible recombination events in HBV-DA45 and HBV-DA195 are not present
if a larger window size of 500 base pairs is used (Fig. 2.6). Since the GroupingScan
measures how embedded a test sequence is in a group of non-recombinant sequences,
it can only compare a single test sequence to a group of reference sequences. We also
used seven different recombination detection programs implemented in RDP4 [214],
in order to investigate whether a single ancient sequence has recombined with an
ancient or modern sequence. We do not find evidence for a recombination event be-
tween HBV-DA45 and a gibbon or orang utan sequence or between HBV-DA29 and
modern genotype E. Should the recombination event with genotype E indicated by
the GroupingScan be correct, the age of HBV-DA29 (∼822 years old) together with
the fact that a similar recombination event is not observed in the older ancient geno-
type D sequences, indicate that the recombination event may have taken place around
∼800 years ago. Using RDP4, we find evidence of a recombination event between
HBV-DA51 and an unknown parent which formed the ancient genotype A sequences.
Although a recombination event between HBV-DA51 and the ancient genotype A se-
quences cannot have occurred owing to sample ages, the logical interpretation is that
an ancestor of HBV-DA51 was involved in the recombination. The same recombina-
tion is also suggested for the two modern genotype A sequences that were included
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in the analysis. The ancient genotype B (HBV-DA45), a modern genotype B and
two modern genotype C sequences were not similarly flagged, which suggests that
the possible recombination occurred after genotypes A, B, and C had diverged. The
predicted recombination break points (Table 2.4, 2.5 and Fig. 2.7) correspond closely
to the polymerase gene. It is therefore possible that the polymerase from an unknown
parent and the remainder of the genome from an HBV-DA51 ancestor recombined to
form the now-ubiquitous genotype A about 7.4–9 kya (Fig. 3.6, Table 2.7 and Meth-
ods). Similar recombination events that involved the creation of genotypes E, G and
a currently circulating B/C recombinant have previously been identified [235].
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Figure 2.4: TreeOrder scan of modern and ancient HBV sequences. The x-axis shows
the genome position, the y-axis the relative position of sequences in a phylogenetic tree, com-
puted over successive windows of 500 base pairs, incrementing by 50 base pairs. Changes
in tree order with >70% bootstrap support are shown. The woolly monkey sequence (NCBI
accession number: AF046996) was used as the outgroup. Modern and ancient sequences
are shown as dotted and continuous lines, respectively. Genotypes are labelled on the left in
their respective colours, ‘WM’ indicates the woolly monkey sequence, and ‘NHP’ indicates
sequences from non-human primates. Ancient sequences are labelled on the right. The grey
bars at the top of the figure indicate the positions of genes in the HBV genome.
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Figure 2.5: GroupingScan of ancient HBV sequences. The x-axis shows the genome position, the
y-axis the grouping score, computed over successive windows of 250 base pairs, incrementing by
50 base pairs. The grouping score indicates how deeply embedded a test sequence is in a group of
reference sequences. A grouping score >0.5 (indicated by a dotted line) indicates grouping of the
test sequence within a specific group. The horizontal bars at the top of the figures on the first line
indicate the positions of genes in the HBV genome.
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Figure 2.6: GroupingScan of ancient HBV sequences. The x-axis shows the genome position, the
y-axis the grouping score, computed over successive windows of 500 base pairs, incrementing by
50 base pairs. The grouping score indicates how deeply embedded a test sequence is in a group of
reference sequences. A grouping score >0.5 (indicated by a dotted line) indicates grouping of the
test sequence within a specific group. The horizontal bars at the top of the figures on the first line
indicate the positions of genes in the HBV genome.
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Figure 2.7: Genotype A recombination break-point evidence. RDP4 [214] was used to analyse
the set of 12 ancient sequences plus a representative set of 15 modern human and NHP sequences.
The seven recombination programs used by RDP4 suggested that all genotype A sequences are
recombinants, with the genotype D sequence HBV-DA51 as the minor parent and an unknown major
parent. The obvious interpretation is that recombination formed an ancestor of the oldest sequences,
evidence of which is still present in the less-ancient and the modern representatives. The figure
shows the graphical evidence and predicted recombination break-point distribution for the two oldest
genotype A sequences, HBV-RISE386 and HBV-RISE387, according to three of the RDP4 methods
(MaxChi, Bootscan and RDP). In all subplots, the predicted location of the break points is shown as
a dashed vertical line and the surrounding grey area shows the 99% confidence interval for the break
point. Subplots on the same row share their y-axis and those in the same column share their x-axis.
The horizontal bars at the top of the figures on the first line indicate the positions of genes in the HBV
genomes. a) HBV-RISE386 analysed by MaxChi. b) HBV-RISE386 analysed by Bootscan. c)
HBV-RISE386 analysed by RDP. d) HBV-RISE387 analysed by MaxChi. e) HBV-RISE387
analysed by Bootscan. f) HBV-RISE387 analysed by RDP. Figure made by Terry Jones.
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Method Number of sequences Average P value
RDP 6 1.641x10-6
GENECONV 6 2.450x10-6
BootScan 6 1.179x10-6
MaxChi 6 3.494x10-6
Chimaera 6 2.332x10-6
SiScan 6 5.336x10-11
3Seq 6 7.319Ex10-8
Table 2.4: The P values assigned to the predicted genotype A recombination by the seven
methods used by RDP4 [214], in the order given by RDP4. The number of sequences in
which the recombination was predicted is always six, corresponding to the four ancient and
two modern genotype A sequences. Table made by Terry Jones.
Sample Begin Begin 99% Confidence Interval End End 99% Confidence Interval
RISE387 1567 1498–1638 2256 2130–2937
RISE386 1593 1498–1638 2248 2130–2937
DA195 1633 1498–1638 2247 2130–2937
DA119 1633 1498–1638 2247 2130–2937
KJ854705 1642 1498–1638 2247 2130–2937
LC074724 1622 1498–1638 2256 2130–2937
Table 2.5: The predicted start and end break points for each of the six genotype A se-
quences. Sequences are ordered from oldest to youngest. The 99% confidence intervals for
the start and end points are shown, and are identical for all sequences. The predicted break
points are close to the boundaries of the polymerase. For example, for the modern genotype
A sequence LC074724, the polymerase is found in regions 1–1623 and 2307–3221 and the
predicted break points are 1622 and 2256. If recombination formed an HBV-RISE387/HBV-
RISE386 ancestor, it is possible that the entire polymerase gene was contributed by one par-
ent. Table made by Terry Jones.
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Figure 2.8: NeighborNet phylogenetic network. The phylogenetic network was constructed using Split-
sTree [223], using a GTR substitution model. Ancient genotype A sequences are shown in red, ancient
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Figure 2.9: Root-to-tip regression and date randomization tests. a) Regression of root-
to-tip distances and ages performed in SciPy. Branch lengths were extracted using Tem-
pEst [225] from trees inferred using neighbour joining, maximum likelihood and Bayesian
methods. Shaded areas show 95% confidence intervals. Slopes are 1.01x10-5, 1.20x10-5 and
4.21x10-6, and correlation coefficients are 0.45 (R2 = 0.2), 0.36 (R2 = 0.13) and 0.51 (R2 =
0.26), for maximum likelihood, Bayesian and neighbour joining trees, respectively. b) Date
randomization tests under the strict clock model. The median and 95% HPD interval for
the substitution rates are given. The rate for the correctly dated tree is shown in red. Dates
were randomized within all sequences, within the ancient sequences only, and within each
genotype. None of the 95% HPD intervals for the randomized runs overlaps with the 95%
HPD intervals for the correctly dated runs, suggesting the presence of a temporal signal in
the data.
For detailed phylogenetic analyses, we used a set of 112 reference human and NHP
HBV sequences (dataset 2, see Methods). A NeighborNet phylogenetic network
based on these reference sequences and the 12 ancient sequences was constructed,
to visualise the relationship between sequences while taking into account any recom-
bination events (Fig. 2.8). Four sequences (HBV-RISE387, -RISE386, -DA195,
and -DA119) group within or basal to genotype A, four group with genotype D
(HBV-DA51, -DA27, -DA222, and -DA29), one with genotype B (HBV-DA45), and
three with the Chimpanzee and Gorilla sequences (HBV-RISE154, -RISE254, and
-RISE563). Regression of root-to-tip genetic distances against sampling dates, as
well as date randomization tests, showed a clear temporal signal in the data (Fig.
2.9 and Supplementary Figs. 1–3 in [79]), suggesting that molecular clock models
can be applied. A dated coalescent phylogeny was constructed using BEAST2 [150]
(Fig. 3.6). The molecular clock was calibrated using tip dates. Strict and relaxed
log-normal molecular clocks were tested with coalescent constant, exponential and
Bayesian skyline population priors (Table 2.6). Model comparisons favoured a re-
laxed molecular clock model with log-normally distributed rate variation and a coa-
lescent exponential population prior (Table 2.6). The median root age of the result-
ing tree is estimated to be 11.6 kyr (95% highest posterior density (HPD) interval:
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8.6–15.3 kyr) and the median clock rate is 1.18x10-5 substitutions per site per year
(95% HPD interval: 9.21x10-6–1.45x10-5 substitutions per site per year). Under a
strict molecular clock, a coalescent Bayesian skyline population prior was favoured,
in which case the median root age is 15.6 kyr (95% HPD interval: 13.7–17.8 kyr)
and the median substitution rate is 9.48x10-6 substitutions per site per year (95%
HPD interval: 8.3x10-6–1.07x10-5 substitutions per site per year) (Tables 2.6, 2.7,
2.8).
Since recombination can affect the topology and dating of phylogenetic trees, we also
inferred dated coalescent trees for the non-recombinant section of the genome from
position 1 – 1400 and with the removal of genotype G (hereafter referred to as ‘partial
alignment’), as indicated by TreeOrder scan (Fig. 2.4). Most recent common ances-
tor (MRCA) age for the root as well as for different genotypes and sub-clades for the
full and partial alignments are shown in Fig. 2.11a. We do not observe differences
in MRCA age inferred from the complete and the partial alignments where the 95%
highest posterior density intervals do not overlap, except for genotypes B and C (Ta-
bles 2.7, 2.8). Figures 2.11b–d show schematic trees for the complete alignment (Fig.
2.11b), and the the partial alignment (using a strict clock (Fig. 2.11c), and a relaxed
clock (Fig. 2.11d)), indicating that changes in genotype B and C MRCA age are as-
sociated with differences in the tree topology. The substitution rates inferred under
different clock models and population priors for the complete and partial alignments
do not differ such that the 95% highest posterior density intervals no longer overlap
(Table 2.8). Thus, apart from the MRCA age of genotypes B and C, recombination
does not seem to affect the inferred dates and substitution rates.
Under the complete and partial alignment, and all model parameterizations used here,
the substitution rate that we find (Table 2.8) is lower than rates estimated from phy-
logenies built using either modern heterochronous sequences [37] or sequences from
mother-to-child transmissions [236] but higher than rates inferred using external cal-
ibrations based on human migrations [36]. A lower rate is consistent with previous
work [237] in which it was shown that, although mutation rates may be high, muta-
tions within an individual often revert back to the genotype consensus and thus rarely
lead to long-term sequence change. It is also consistent with the time-dependent rate
phenomenon, observed for many viruses, which suggests that short-term evolution-
ary rates are higher than long-term rates [162]. The ancient HBV genome data enable
us to formally evaluate hypotheses concerning HBV origins using path sampling of
calibrated phylogenies based on appropriate external divergence date assumptions.
We tested several calibration points that would be implied by a co-expansion of HBV
with humans after leaving Africa for support of congruence between migrations and
53
2. ANCIENT HEPATITIS B VIRUS
geographical locations of HBV clades [36]. We find weak evidence for the split of
the F and H clade occurring between 13.4 and 25.0 kya under a strict, but not a re-
laxed clock model for the complete alignment and strong support under the strict and
the relaxed clock for the partial alignment. We do not find support for the divergence
of subgenotype C3 strains between 5.1 and 12.0 kya (hypothesized to have led to its
distribution in different regions of Polynesia [36]). Using the complete alignment,
we do not find support for divergence of Haitian A3 strains from other genotype A
strains between 0.2 and 0.5 kya under either strict or relaxed clock models, but weak
support for the partial genome under a strict clock (Table 2.9).
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Figure 2.10: Dated maximum clade credibility tree of HBV. A log-normal relaxed clock and
coalescent exponential population prior were used. Grey horizontal bars indicate the 95% HPD
interval of the age of the node. Larger numbers on the nodes indicate the median age and 95%
HPD interval of the age (in parentheses) under a strict clock and Bayesian skyline tree prior. Clades
of genotypes C (except clade C4), E, F, G and H are collapsed and shown as dots. The figure
includes a possible tenth genotype, J, based on a single human isolate. Taxon names for ancient
samples indicate era (BA, Bronze Age; IA, Iron Age or later), sample name, sample age in years,
ISO 3166 three-letter abbreviation of country of sequence origin, and region of sequence origin.
Taxon names for modern samples indicate human genotype or subgenotype or host species if non-
human, GenBank accession number, sample age in years, ISO 3166 three-letter abbreviation of
country of sequence origin, and region of sequence origin. The x-axis shows time into the past, in
years.
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Figure 2.11: Time to most recent common ancestor and tree topology for dif-
ferent genotypes and parts of the HBV genome. a) Time to most recent common
ancestor (shown on the y-axis) for different genotypes or clades (shown on the x-
axis). b – d) Schematic trees showing the tree topologies inferred using the com-
plete genome, a relaxed log-normal clock (b), the partial alignment from positions
1 – 1400, leaving out genotype G due to recombination, using a strict clock and
coalescent Bayesian skyline population prior (c), or a relaxed log-normal clock and
a coalescent exponential population prior (d). Scale bars in figures b – d indicate
time in years.
In the dated coalescent phylogeny, four ancient sequences (from youngest to oldest:
HBV-DA119, HBV-DA195, HBV-RISE386 and HBV-RISE387) group with geno-
type A. The first three are well within the 7.5% nucleotide divergence criterion that
was used to delimit membership in HBV genotypes, and HBV-RISE387 is right on
this limit (7.51%) [196] (Table 2.11). The three oldest samples lack a six-nucleotide
insertion at the carboxyl end of the core gene (C) that is present in all modern geno-
type A viruses [193] (Table 2.10). HBV-RISE387 encodes a stop codon in its pre-core
peptide that would have ablated the expression of the immune modulator HBe antigen
(HBeAg), a phenomenon that is known to occur in modern HBV infections (Table
2.10). This characteristic viral mutant is usually found in chronic HBV carriers who
seroconverted from HBeAg to anti-HBe. RISE386 and RISE387 have archaeolog-
ically been dated to only about 100 years apart and both come from the Bulanovo
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Model (clock,
population
prior)
Strict,
Constant
Strict, Ex-
ponential
Strict,
Skyline
Relaxed-
log., Con-
stant
Relaxed-
log., Expo-
nential
Relaxed-
log., Sky-
line
Likelihood -50556.68 -50503.88 -50499.63 -50500.28 -50324.79 -50334.43
Strict, Con-
stant
-50556.68 0 52.8 57.048 56.4 231.88 222.24
Strict, Expo-
nential
-50503.88 0 4.25 3.6 179.08 169.44
Strict, Skyline -50499.63 0 -0.65 174.83 165.2
Relaxed-log.,
Constant
-50500.28 0 175.48 165.85
Relaxed-log.,
Exponential
-50324.79 0 -9.64
Relaxed-log.,
Skyline
-50334.43 0
(a) Path sampling results computed using the complete alignment of dataset 2.
Model (clock,
population
prior)
Strict,
Constant
Strict, Ex-
ponential
Strict,
Skyline
Relaxed-
log., Con-
stant
Relaxed-
log., Expo-
nential
Relaxed-
log., Sky-
line
Likelihood -
19461.4298
-
19434.7391
-
19423.04876
-
19419.85918
-
19385.12528
-
19382.24344
Strict, Con-
stant
-19461.43 0 26.69 38.38 41.57 76.30 79.19
Strict, Expo-
nential
-19434.74 0 11.69 14.88 49.61 52.49
Strict, Skyline -19423.05 0 3.19 37.92 40.81
Relaxed-log.,
Constant
-19419.86 0 34.73 37.62
Relaxed-log.,
Exponential
-19385.12 0 2.88
Relaxed-log.,
Skyline
-19382.24 0
(b) Path sampling results computed using the partial alignment (positions 1 – 1400) of dataset
2.
Table 2.6: Results of testing different clock models and population assumptions to be
used for dated phylogenies. Different combinations of clock models and population as-
sumptions are compared by comparing their log marginal likelihoods. Abbreviations are
as follows: ‘Strict’: strict clock, ‘Relaxed-log.’: relaxed log-normal clock, ‘Constant’: co-
alescent constant population prior, ‘Exponential’: coalescent exponential population prior,
‘Skyline’: coalescent Bayesian skyline population prior, ‘likelihood’: log marginal likeli-
hood estimate. Log marginal likelihoods (shown in the second row and column of Table a
and b) were computed using path sampling, as implemented in BEAST2 [150]. Numbers in
columns and rows 3 – 8 in Tables a and b are Bayes factors, computed by subtracting the
log marginal likelihood of the row model from the log marginal likelihood of the column
model. According to previous work [229], a Bayes factor in the range of 3–20 implies posi-
tive support, 20 – 150 strong support and >150 overwhelming support. Positive Bayes factors
indicate support for the column model, and negative Bayes factors indicate support for the
row model. a) Path sampling results for the complete genome alignment of dataset 2. b)
Path sampling results for the partial alignment (positions 1 – 1400 of dataset 2).
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Clade Complete, MRCA
age in years (95%
HPD interval),
Strict, Skyline
Partial, MRCA age
in years (95% HPD
interval), Strict,
Skyline
Complete, MRCA
age in years (95%
HPD interval),
Relaxed-log.,
Exponential
Partial, MRCA age
in years (95% HPD
interval), Relaxed-
log., Exponential
A 8221 (7438, 9076) 7403 (6474, 8543) 6699 (5566, 8148) 6423 (5373, 7719)
B 4883 (4264, 5556) 9754 (8379, 11471) 4590 (3468, 6025) 8599 (6969, 10719)
C 5501 (4782, 6356) 8050 (6442, 9824) 4886 (3499, 6534) 7024 (4564, 10000)
D 4158 (3669, 4683) 4035 (3426, 4813) 3921 (3077, 5044) 3913 (3004, 5040)
E 1016 (712, 1358) 1211, (774, 1756) 857 (331, 1670) 1011 (390, 1892)
G 181 (96, 287) N/A 173 (70, 334) N/A
F 4737 (4053, 5538) 3973 (3112, 4966) 4068 (2698, 5679) 3971 (2676, 5595)
H 1713 (1365, 2109) 1232 (819, 1686) 1539 (832, 2498) 1045 (493, 1767)
F/H 7341 (6224, 8603) 6820 (5290, 8560) 6040 (4001, 8637) 5961 (3737, 8641)
Chimp./Gorilla 5281 (4469, 6146) 5355 (4138, 6749) 4523 (2653, 6508) 4669 (2687, 6977)
Gibbon/J/Orang. 7391 (6384, 8484) 8722 (7208, 10590) 5604 (3852, 7700) 6630 (4475, 9189)
RISE154/RISE254
/RISE563
8239 (7502, 9141) 7864 (6769, 9202) 6716 (5626, 8078) 6954 (5692, 8572)
Table 2.7: Median MRCA age of individual nodes under a strict clock and Bayesian
skyline population prior or under a relaxed log-normal clock and coalescent exponential
population prior. Columns prefaced with ‘Partial’ were inferred using a partial alignment
of positions 1 – 1400 of dataset 2, columns prefaced with ‘Complete’ were inferred using
the complete genome. Abbreviations are as follows: ‘Strict’: strict clock, ‘Relaxed-log.’:
relaxed log-normal clock, ‘Constant’: coalescent constant population prior, ‘Exponential’:
coalescent exponential population prior, ‘Skyline’: coalescent Bayesian skyline population
prior.
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Model (clock, population prior) Root age in years (95% HPD
interval)
Substitution rate (substitution-
s/site/year)
Complete, Strict, Constant 16038 (14023, 18140) 9.27x10-6 (8.14x10-6, 1.05x10-5)
Partial, Strict, Constant 16385 (13136, 20067) 8.43x10-6 (6.81x10-6, 1.02x10-5)
Complete, Strict, Exponential 15840 (13969, 18056) 9.24x10-6 (8.04x10-6, 1.04x10-5)
Partial, Strict, Exponential 15501 (12526, 18855) 8.46x10-6 (6.86x10-6, 1.03x10-5)
Complete, Strict, Skyline 15593 (13688, 17795) 9.48x10-6 (8.3x10-6, 1.07x10-5)
Partial, Strict, Skyline 15347 (12330, 18492) 8.85x10-6 (7.31x10-6, 1.07x10-5)
Complete, Relaxed-log. Constant 14561 (9551, 20940) 1.16x10-5 (8.63x10-6, 1.45x10-5)
Partial, Relaxed-log. Constant 15086 (9462, 22092) 1.0x10-5 (7.53x10-6, 1.29x10-5)
Complete, Relaxed-log. Exponen-
tial
11623 (8613, 15275) 1.18x10-5 (9.21x10-6, 1.45x10-5)
Partial, Relaxed-log. Exponential 12064 (8263, 16593) 1.04x10-5 (7.68x10-6, 1.32x10-5)
Complete, Relaxed-log. Skyline 12923 (8762, 18415) 1.23x10-5 (9.68x10-6, 1.51x10-5)
Partial, Relaxed-log. Skyline 13085 (8052, 18184) 1.07x10-5 (8.18x10-6, 1.34x10-5)
Table 2.8: Median root age and substitution rates under different clock models and pop-
ulation priors. Abbreviations are as follows: ‘Strict’: strict clock, ‘Relaxed-log.’: relaxed
log-normal clock, ‘Constant’: coalescent constant population prior, ‘Exponential’: coales-
cent exponential population prior, ‘Skyline’: coalescent Bayesian skyline population prior.
Rows prefaced with ‘Partial’ were inferred using the genome segment between positions 0 to
1400, rows prefaced with ‘Complete’ were inferred using the complete genome.
site in Russia, but their viruses have only 93.34% sequence identity (Table 2.12),
which indicates the existence of substantial localized HBV diversity about 4.2 ka.
The ancient sequence HBV-DA45 phylogenetically groups with genotype B and has
97.65% sequence identity with modern genotype B (Table 2.11). Sequences HBV-
DA27, HBV-DA29, HBV-DA51 and HBV-DA222 phylogenetically group with the
modern genotype D. They have high sequence identity (96.99–98.74%) with modern
genotype D sequences (Table 2.11), and have the typical 33-nucleotide deletion in the
preS1 region, encoding the three HBV surface proteins [193] (Table 2.10). Sequences
HBV-RISE154, HBV-RISE254, and HBV-RISE563 are in a sister relationship with
the chimpanzee-gorilla HBV clade (Fig. 3.6). HBV-RISE254 and HBV-RISE563
have the same 33-nucleotide deletion in the preS1 sequence that is shared with NHP
HBVs and human genotype D (Table 2.10). HBV-RISE563 does not encode a func-
tional pre-core peptide (Table 2.10). On the basis of sequence similarity across the
whole genome, HBV-RISE563 and HBV-RISE254 together might be classified as a
new human HBV genotype that is extinct today, and HBV-RISE154 might possibly
be classified as another (Tables 2.11, 2.12). However, HBV-RISE154 has low genome
coverage, which precludes an exact calculation. The sister relationship of these three
sequences with modern chimpanzee and gorilla HBVs could be interpreted as a con-
sequence of relatively recent transmission(s) of HBV from humans to NHPs [197].
However, other scenarios and confounding factors are possible, as these lineages are
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deeply separated in the tree. Incomplete lineage sorting combined with viral extinc-
tion (possibly boosted by massive recent reductions in great ape populations) should
be considered. More data on current and, if possible, ancient HBVs will be necessary
to reach definitive conclusions. The geographical locations of some of the ancient
virus genotypes do not match the present-day genotype distribution, and also do not
match dates and/or locations inferred in previous studies of HBV. Although the data
presented here are limited, they provide important spatio-temporal reference points
in the evolutionary history of HBV. Their synopsis suggests a more complicated an-
cestry of present-day genotypes than previously assumed, especially in light of recent
insights into the history of human migration.
We find genotype A in south-western Russia by 4.3 kya (in samples RISE386 and
RISE387) in individuals belonging to the Sintashta culture, and in a Hungarian sam-
ple (DA195) from the Scythian culture. The western Scythians are related to the
Bronze Age cultures of western steppe populations [44] and their shared ancestry sug-
gests that the modern genotype A may descend from this ancient Eurasian diversity
and not, as previously hypothesized, from African ancestors [238, 239]. This is also
consistent with the phylogeny (Fig. 3.6), as well as the fact that the three oldest an-
cient genotype A sequences (HBV-DA195, HBV-RISE386 and HBV-RISE387) lack
the six-nucleotide insertion found in the youngest (HBV-DA119) and in all modern
genotype A sequences. The ancestors of subgenotypes A1 and A3 could have been
carried into Africa subsequently, via migration from western Eurasia [240]. The an-
cient HBV genotype D sequences were all found in Central Asia. HBV-DA27, found
in Kazakhstan and dated to 1.6 ka, falls basal to the modern subgenotype D5 se-
quences that today are found in eastern India [241]. Based on the observation that
genotypes go extinct and can be created by recombination, the ancient sequence data
show that the diversity that we observe today is only a subset of the diversity that
has ever existed. These data support a scenario in which all present-day HBV diver-
sity arose only after the split of the Old World and New World genotypes (25–13.4
ka). Any attempt to interpret the currently known HBV tree based on human migra-
tions that happened before this event will necessarily result in anomalies that cannot
be reconciled, such as the basal position of genotypes F and H and the apical po-
sition of subgenotype C4, which is found exclusively in indigenous Australians. If
HBV did co-evolve with ancient modern humans as they left Africa as previously
proposed [191], most of the pattern of earlier diversity has been replaced by changes
that happened after the split of the Old and New World genotypes. Genotypes F and
H would therefore be remnants of the earlier now-extinct diversity, and the arrival
of subgenotype C4 in Australia would have taken place long after the split between
Old and New World genotypes, as supported by the tree in Fig. 3.6. Alternatively,
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there could have been a New World origin of HBV or the virus could have been in-
troduced into humans from a different host. Our data do not allow us to speculate
either way.
To our knowledge, we report the oldest exogenous viral sequences recovered from
DNA of humans or any vertebrate, and show that it is possible to recover viral se-
quences from samples of this age. We show that humans throughout Eurasia were
widely infected with HBV for thousands of years. Despite the age of the samples
and the imperfect diagnostic test, our dataset contained a high proportion of HBV-
positive individuals. The actual ancient prevalence during the Bronze Age and there-
after might have been higher, reaching or exceeding the prevalence typically found
in contemporary indigenous populations [188].
This clearly establishes the potential of HBV as powerful proxy tool for research
into human spread and interactions. The data from ancient genomes reveal aspects
of complexity in HBV evolution that are not apparent when only modern sequences
are considered. They show the existence of ancient HBV genotypes in locations
incongruent with their present-day distribution, contradicting previously suggested
geographical or temporal origins of genotypes or sub-genotypes; evidence for the
creation of genotype A via recombination and the emergence of the genotype outside
Africa; at least one now-extinct human genotype; ancient genotype-level localized
diversity; and provide further evidence that the magnitude of viral substitution rates
inferred from heterochronously sampled sequences is dependent on the time interval
over which the sequences were sampled. Together, these findings suggest that the
difficulty in formulating a coherent theory for the origin and spread of HBV may be
due to genetic evidence of an earlier evolutionary scenario being overwritten by rela-
tively recent alterations, as has previously been suggested in the context of recombi-
nation [235]. The lack of ancient sequences limits our understanding of the evolution
of HBV and very probably of other viruses. Discovery of additional ancient viral
sequences may provide a clearer picture of the true origin and early diversification of
HBV, enable us to address questions of palaeo-epidemiology, and broaden our under-
standing of the contributions of natural and cultural changes (including migrations
and medical practices) to human disease burden and mortality.
61
2. ANCIENT HEPATITIS B VIRUS
Hypothesis Strict, Sky-
line
Relaxed-
log.,
Exponential
Node age
(years)
Likelihood Bayes factor Node age Likelihood Bayes factor
A3 (200:
500)
841 -50502.94 3.3 667 -50388.15 63.36
C3 (5100:
12,000)
1897 -50532.75 33.12 1983 -50388.13 63.34
F/H (13,400:
25,000)
7341 -50493.15 -6.48 6040 -50388.05 63.25
(a) Path sampling results computed using the complete alignment of dataset 2.
Hypothesis Strict, Sky-
line
Relaxed-
log.,
Exponential
Node age
(years)
Likelihood Bayes factor Node age Likelihood Bayes factor
A3 (200:
500)
538 -19419.2 -3.85 456 -19383.79 -1.34
C3 (5100:
12,000)
1,844 -19443.99 20.94 1,745 -19384.39 -0.73
F/H (13,400:
25,000)
6,820 -19392.12 -30.93 5,961 -19355.51 -29.61
(b) Path sampling results computed using the partial alignment (positions 1 – 1400) of dataset
2.
Table 2.9: Results of testing different calibration point hypotheses under a strict clock
and Bayesian skyline population prior or under a relaxed log-normal clock and coa-
lescent exponential population prior. The ‘Hypothesis’ column refers to the following
hypothesis tests: A3: the split of the Haitian A3 sequences (FJ692611, FJ692598) took place
200 - 500 years ago. C3: the split of the Melanesian C3 sequences (X75656, X75665) took
place 5,100 - 12,000 years ago. F/H: the split of genotypes F and H took place 13,400 -
25,000 years ago. Nodes were constrained using an uniform distribution. Positive values
for the Bayes factor indicate support for the model without the constraint, negative values
support the model with the constraint for the hypothesis that was tested. The column ’Node
age (years)’ shows the age of the node to which the hypothesis test applies when it is inferred
without constraints. Abbreviations are as follows: ‘Strict’: strict clock, ‘Relaxed-log.’: re-
laxed log-normal clock, ‘Exponential’: coalescent exponential population prior, ‘Skyline’:
coalescent Bayesian skyline population prior, ‘Likelihood’: log marginal likelihood estimate.
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Sample Genotype
of closest
modern
sequence
Sequence
identity
to closest
modern
sequence
Genome
length
Predicted
serotype
Insertions / deletions Predicted
HBeAg sta-
tus
DA119 A3 97.8% 3221 adw2 6-nucleotide insertion at the C terminus
of the core region
Positive
DA195 A3 96.1% 3215 adw2 None Positive
RISE386 A 95.3% 3215 adw2 None Positive
RISE387 A 92.5% 3215 adw2 None Negative; PreC
stop codon
DA45 B1 97.6% 3215 ayw1 None Positive
DA29 D3 98.6% 3182 ayw2 33-nucleotide deletion at the N terminus
of the preS1 region
Positive
DA222 D3 98.7% 3182 ayw2 33-nucleotide deletion at the N terminus
of the preS1 region
Positive
DA27 D5 97.2% 3182 ayw2 33-nucleotide deletion at the N terminus
of the preS1 region
Positive
DA51 D1 97% 3182 ayw2 33-nucleotide deletion at the N terminus
of the preS1 region
Positive
RISE154 Chimpanzee 92.5% Ambiguous adw2* Ambiguous Positive
RISE254 Chimpanzee 94% 3182 adw2 33-nucleotide deletion at the N terminus
of the preS1 region
Positive
RISE563 Gorilla 92.7% 3182 adw2 33-nucleotide deletion at the N terminus
of the preS1 region
Negative; PreC
stop codon
Table 2.10: Genome properties of ancient sequences included in phylogenetic analyses. Geno-
type groups are sorted by increasing sample age. The serotype was predicted following Table 1 in
Kay and Zoulim, 2007 [242]. *Serotype could not be determined unambiguously, owing to lack of
coverage.
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Sample A B C D E F G H I J Chimp Gibbon Gorilla Orang
Utan
DA119 97.27 92.60 92.94 92.38 92.05 88.42 90.62 88.24 93.32 89.78 92.10 91.15 92.95 90.98
DA195 96.11 92.16 92.59 92.06 92.00 88.24 90.32 87.68 93.22 89.37 92.13 91.65 92.32 90.99
RISE386 95.32 92.55 92.96 92.83 91.87 88.57 90.22 87.94 93.79 89.60 92.33 91.43 92.64 91.34
RISE387 92.49 90.70 91.70 91.74 91.06 88.57 91.42 88.60 91.54 88.96 91.55 90.75 91.37 90.65
DA45 91.89 97.65 96.04 90.47 90.55 87.70 88.11 88.06 91.07 89.40 91.50 91.79 91.58 90.53
DA27 91.67 91.28 92.96 97.21 93.15 88.77 89.93 87.83 91.08 89.63 92.43 92.24 92.57 90.31
DA29 91.46 90.50 92.79 98.64 93.21 87.82 89.41 87.64 90.82 88.66 91.10 90.74 91.94 89.66
DA51 92.10 91.32 93.24 96.99 93.47 88.48 90.28 88.04 91.11 89.30 91.55 91.54 92.26 90.40
DA222 92.29 91.61 93.88 98.74 93.55 88.66 90.01 88.23 91.45 89.23 92.16 91.99 93.29 90.63
RISE154 90.86 91.07 92.11 91.76 91.81 89.20 91.26 88.91 91.62 90.05 92.54 92.36 92.26 92.36
RISE254 92.04 91.66 92.32 92.56 92.80 89.25 91.20 88.86 91.49 90.47 94.03 93.25 93.93 92.96
RISE563 90.63 90.43 90.70 91.41 91.27 88.83 90.51 88.75 90.27 89.16 92.30 91.94 92.66 91.08
Table 2.11: Best consensus sequence identity with 14 groups of HBV full genomes. The
Needleman-Wunsch algorithm (as implemented in EMBOSS50) was used to globally align each
sample consensus sequence against each of the 3,384 full HBV genomes of Dataset 4 (see Meth-
ods). The table shows the best nucleotide similarity percentage for each sample consensus against
14 genome groups from the full set of HBV genomes. In cases in which the consensus length is less
than the genome length, the given figure is the percentage of identical nucleotides in the matching
region, not counting any alignment gaps or ambiguous consensus nucleotides. For each sample, the
genome group with the highest identity is highlighted in bold. Table contributed by Terry Jones.
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Sample DA195 RISE386 RISE387 DA45 DA27 DA29 DA51 DA222 RISE154 RISE254 RISE563
DA119 96.79 95.99 92.69 92.08 91.87 91.97 92.37 92.41 91.39 92.23 90.78
DA195 95.86 92.72 91.83 92.15 91.50 92.47 91.83 91.34 91.91 90.36
RISE386 93.34 92.34 92.74 92.55 92.97 92.64 91.66 92.63 91.07
RISE387 90.60 91.50 91.33 91.89 91.75 91.78 92.12 91.26
DA45 89.73 89.39 90.75 90.38 90.43 90.97 89.66
DA27 96.42 97.24 97.31 91.45 92.49 91.39
DA29 96.62 98.06 90.72 91.52 90.48
DA51 97.12 91.83 92.66 91.44
DA222 91.57 92.53 91.28
RISE154 94.39 93.02
RISE254 95.77
Table 2.12: Inter-consensus sequence identity. The Needleman-Wunsch algorithm was
used to globally align all ancient sample consensus sequences against one another. The table
shows the nucleotide identity percentage for each alignment. In cases in which the consensus
lengths were unequal, the given figure is the percentage of identical nucleotides in the match-
ing region, not counting any alignment gaps or ambiguous consensus nucleotides. Table
contributed by Terry Jones.
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CHAPTER 3: ANCIENT HUMAN PARVOVIRUS B19
IN EURASIA REVEALS ITS LONG-TERM
ASSOCIATION WITH HUMANS
3. ANCIENT HUMAN PARVOVIRUS B19
PREFACE
A version of this chapter was previously published as (* denotes equal contribu-
tion):
Barbara Mühlemann*, Ashot Margaryan*, Peter de Barros Damgaard*, Morten E.
Allentoft*, Lasse Vinner, Anders J. Hansen, Andrzej Weber, Vladimir I. Bazaliiskii,
Martyna Molak, Jette Arneborg, Wieslaw Bogdanowicz, Ceri Falys, Mikhail Sablin,
Vàclav Smrcˇka, Sabine Sten, Kadicha Tashbaeva, Niels Lynnerup, Martin Sikora,
Derek J. Smith, Ron A. M. Fouchier, Christian Drosten, Karl-Göran Sjögren, Kris-
tian Kristiansen, Eske Willerslev, Terry C. Jones. Ancient human parvovirus B19 in
Eurasia reveals its long-term association with humans. PNAS, 115(29), 7557–7562,
(2018).
It has been modified to fit the style of a dissertation.
I did all computational analyses, figures and tables, except the recombination analy-
sis, and figures and tables related to that, which were done by Terry Jones. The se-
quencing work was performed by Ashot Margaryan, Peter de Barros Damgaard and
Morten Allentoft. Targeted virus capture of the DA251 sample was performed by
Lasse Vinner. I wrote the text with input from Terry Jones and the other co-authors.
Andrzej Weber, Jette Arneborg, Niels Lynnerup, Ceri Falys, Wieslaw Bogdanowicz,
and Martyna Molak-Tomsia wrote the section on the archaeological context of sam-
ples in the Supplementary Information. In addition to this description, I have noted
in the legends of figures and tables if they were contributed by others.
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3.1. ABSTRACT
3.1 ABSTRACT
Human parvovirus B19 (B19V) is a ubiquitous human pathogen associated with a
number of conditions, such as fifth disease in children and arthritis and arthralgias in
adults. B19V is thought to evolve exceptionally rapidly among DNA viruses, with
substitution rates previously estimated to be closer to those typical of RNA viruses.
On the basis of genetic sequences up to ∼70 years of age, the most recent common
ancestor of all B19V has been dated to the early 1800s, and it has been suggested
that genotype 1, the most common B19V genotype, only started circulating in the
1960s. Here we present 10 genomes (63.9–99.7% genome coverage) of B19V from
dental and skeletal remains of individuals who lived in Eurasia and Greenland from
∼0.5 to ∼6.9 thousand years ago (kya). In a phylogenetic analysis, five of the ancient
B19V sequences fall within or basal to the modern genotype 1, and five fall basal to
genotype 2, showing a long-term association of B19V with humans. The most recent
common ancestor of all B19V is placed ∼12.6 kya, and we find a substitution rate
that is an order of magnitude lower than inferred previously. Further, we are able to
date the recombination event between genotypes 1 and 3 that formed genotype 2 to
∼5.0 to ∼6.8 kya. This study emphasizes the importance of ancient viral sequences
for our understanding of virus evolution and phylogenetics.
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3.2 INTRODUCTION
Infection with human parvovirus B19 (B19V) can have a number of different out-
comes, from asymptomatic or non-specific symptoms to fifth disease (erythema in-
fectiosum) in children, arthritis and arthralgias in adults, and hydrops fetalis in preg-
nant women. It can also lead to transient or persistent erythroid aplasia and aplastic
crisis in people with underlying hematological disorders [243, 244]. Management of
B19V infections is generally limited to symptomatic treatment, as there are currently
no vaccines or antivirals [243]. The virus replicates in erythroid precursor cells in the
bone marrow [245]. After the initial infection, viral DNA is detectable in multiple
human tissues, including kidney, lymph nodes, heart, testes, and synovial tissue, in
symptomatic and asymptomatic individuals [246–251].
The persistence of viral DNA in an infected individual is thought to be lifelong, and
the persisting virus corresponds to the virus genotype of the initial infection [252].
B19V can be transmitted via the respiratory or blood-borne route. The virus can
be detected in the saliva and is present in the blood in high concentrations (1013
virions/ml) during the viraemic phase of the infection [243, 253]. In blood donors,
seroprevalence of B19V is around 60% on average, and the rate of new individuals
infected per year is estimated at between 0.5% and 1% [254].
B19V is a single-stranded DNA (ssDNA) virus with a genome of ∼5,600 nucleotides.
The coding region is flanked by terminal repeats of 383 nucleotides and contains three
major proteins: the nonstructural protein NS, the capsid proteins VP1 and VP2, and
the minor proteins 11 kDa, 9 kDa, and 7.5 kDa [243].
B19V belongs to the Erythrovirus genus in the Parvoviridae family [243]. There
are three genotypes, with genotype 1 having ∼10% sequence divergence from geno-
types 2 and 3 and genotypes 2 and 3 having ∼5% sequence divergence between
each other [255]. Genotypes 1 and 3 are further split into two subgroups, a and b,
with sequence divergence of about 5% [256, 257]. All three genotypes form a single
serotype [258]. The distribution of the three genotypes is not spatially and temporally
uniform: genotype 1 has a worldwide distribution [259], genotype 2 is found mainly
in elderly adults in northern Europe [252], and genotype 3 is found in Sub-Saharan
and West Africa, South America, and France [256]. Because genotype 2 is today
only found in tissues of people born before the 1970s, it has been hypothesized that it
was replaced by genotype 1 and that genotype 1 originated in the second half of the
20th century [158].
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B19V is deemed unique among the DNA viruses because its substitution rate, in-
ferred from modern heterochronous sequences, is unusually high, in the range of
1.0–4.0x10-4 nucleotide substitutions per site per year (s/s/y) [126, 157, 158], which
is more similar to substitution rates of RNA viruses than either single-stranded or
double-stranded DNA viruses [35].
Recent advances in sequencing ancient DNA (aDNA) have provided important in-
sights into past human population dynamics [40] and the evolution of bacterial hu-
man pathogens [78, 105], but have only recently been applied to viruses [79, 116].
Viral sequences recovered from aDNA samples have provided important reference
points for the calibration of molecular clocks [79, 116]. These samples can also pro-
vide insight into the spatiotemporal distribution of past viral variants and strains [79].
B19V has characteristics that should favor molecular preservation, including a DNA
genome, high viraemia, and a stable nonenveloped virion [260]. Indeed, the per-
sistence of B19V DNA in bones from individuals deceased ∼70 years ago has been
established [126]. Here, we extend our knowledge of the virus further back in time
and present 10 B19V coding region sequences (63.9 to 99.7% genome coverage) re-
covered from humans living in Eurasia and Greenland between ∼0.5 and 6.9 kya,
leading to an improved understanding of the timescale of B19V evolution.
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3.3 METHODS
3.3.1 Archaeological context of samples
Information about the archaeological context of samples was contributed by An-
drzej Weber, Jette Arneborg, Niels Lynnerup, Ceri Falys, Wieslaw Bogdanowicz,
and Martyna Molak-Tomsia, and can be found in the Supplementary Information
to [80].
3.3.2 Sample preparation, capture and sequencing
Sample preparation and sequencing were performed as described in Allentoft et al.,
(2015) [41]. One sample (DA251) was selected for virus capture. Capture was per-
formed as described in Mühlemann et al., (2018) [79] with pre-treatment by uracil-
specific excision reagent (USER).
3.3.3 Datasets
Below follows a description of the datasets used in this study:
Dataset 1:
Used for bwa and blast analysis, 11 complete genomes:
Genotype 1: FN669502, DQ357065, AF113323
Genotype 2: AJ717293, DQ333427, HQ340602
Genotype 3: NC004295, AY083234, AY083234, AJ249437
Bovine parvovirus: NC_001540
Dataset 2:
Reference sequences used to make consensuses in Geneious. Only the coding region
was used.
Genotype 1: M13178
Genotype 2: AY044266
Genotype 3: AJ249437
Dataset 3:
Representative dataset of complete parvovirus B19 genomes used for genotype as-
signment. All sequences under taxid 10798 (Human parvovirus B19) and taxid
344889 (unclassified Erythrovirus) were downloaded from NCBI on 18 October 2017.
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Sequences that were shorter than 4000 nucleotides were removed, as well as se-
quences from patents or sequences designated as artificial or recombinant. Only
coding region was used. The final dataset contains 102 sequences:
KX752821, AJ781038, KM393165, KM393168, KM393167, KM393166, AB126268,
AB126267, AB126266, KM065415, KC013340, KT310174, KR005643, DQ225150,
DQ225149, KR005644, KR005641, KR005640, KR005642, NC_000883, AY386330,
KM065414, KM393163, M13178, FN598218, FN598217, Z70560, Z68146, DQ4083-
01, AB030693, AB030673, KM393-164, AY028237, KC013329, KC013325, Z70528,
KT268312, KC013305, AF113323, M24682, Z70599, AY504945, AB126271, AB1-
26264, AB126263, AB126262, AB126269, AF162273, FJ591158, KC013343, KC0-
13324, KC013308, KM393169, AB030694, DQ293995, KC013316, DQ225151,
KC013321, KC013344, KC013338, KC013331, KC013314, KC013312, KC013333,
KC013346, KC013351, KC013313, KC013327, KC013332, AB126265, KC013322,
DQ225148, AB126270, DQ357065, DQ357064, KF724387, AY903437, AY044266,
DQ333426, AB550331, EF216869, AJ717293, KF724386, DQ333428, AY064476,
AY064475, AY647977, AY083234, AY582124, DQ234779, DQ234778, DQ408305,
DQ408302, DQ408304, DQ408303, FJ265736, AY582125, DQ234775, DQ234771,
DQ234769, NC_004295, AJ249437.
Dataset 4:
Dataset used for phylogenetic and saturation analyses. The dataset contains 77 se-
quences from dataset 3 in addition to the 10 ancient sequences analysed in more
detail:
AJ781038, KM393165, KM393168, KM393166, AB126267, AB126266, KM065415,
KC013340, KT310174, DQ225150, DQ225149, KR005641, KR005640, AY386330,
KM393163, M13178, FN598218, Z70560, Z68146, DQ408301, AB030673, KM393-
164, KC013329, KC013325, KT268312, KC013305, AF113323, Z70599, AY504945,
AB126271, AB126262, AB126269, AF162273, FJ591158, KC013343, KC013324,
KC013308, KM393169, AB030694, DQ293995, KC013316, DQ225151, KC013321,
KC013312, KC013333, KC013346, KC013313, KC013327, AB126265, AB126270,
DQ357065, DQ357064, KF724387, AY903437, AY044266, DQ333426, AB550331,
EF216869, AJ717293, KF724386, DQ333428, AY064476, AY064475, AY647977,
AY083234, AY582124, DQ234779, DQ234778, DQ408305, DQ408302, DQ408304,
DQ408303, FJ265736, DQ234775, DQ234771, DQ234769, AJ249437, DA251,
DA336, DA337, RISE569, NEO105, VK6, VK143, VK154, VK477, DA66.
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3.3.4 Identification, consensus sequence generation, and
authentication of ancient Parvovirus B19
We screened shotgun sequencing data from 1578 individuals from Eurasia from 0.2
to 24 kya for the presence of reads matching B19V. AdapterRemoval [205] (version
2.1.7) was used with its default settings to remove adaptors from all sequences, to
trim N bases from the ends of reads, and to trim bases with quality <= 2. Reads
were aligned against a human genome (GRCh3855) using bwa [206] (version 0.7.15-
r1140, mem algorithm). Reads that did not match the human genome were aligned
to Dataset 1 using bwa (version 0.7.15-r1140, mem, aln, and aln -l algorithms).
Samples for which the reads matching B19V covered >30% of the coding region
of the B19V genome were also aligned to Dataset 1 using BLASTn [25] (version
2.4.0) (with arguments -task blastn -evalue 0.01). One sample (DA251)
was selected for virus capture (see above). The resulting reads were also aligned
to Dataset 1 using BLASTn, as described above, and matching reads were added to
the reads matching B19V using bwa and BLASTn from DA251. Reads matching
using bwa and BLASTn were combined and compared against the complete NCBI
nt database downloaded on 28-12-2016. Only reads with their highest match against
sequences that contained any of the words ‘B19’, ‘Parvo’, or ‘Erythro’ (case insensi-
tive), were retained. To make the consensus sequences, reads were aligned to Dataset
2 in Geneious [211] (version 9) using Medium sensitivity / fast and iterate up to
5 times. The reference with the highest number of matching reads was used as a
template for constructing the consensus sequence. Alignments were inspected and
damaged ends were trimmed manually. Reads were checked for C→T damage at
the 5’ end, typical for aDNA using mapDamage [209] (version 2.0.6).
3.3.5 Phylogenetic analysis
All phylogenetic analyses were performed using a Mafft alignment [221] (version 7)
of Dataset 4. A maximum likelihood phylogeny was inferred using PhyML [222]
(version 20160116). The TN93 substitution model was used and topology, branch
lengths, and rates were optimized. 100 bootstrap replicates were performed. The
final trees show nodes with support values less than 70 as polytomies. Saturation
was assessed using DAMBE [261] (version 6). Transition and transversion frequen-
cies were plotted using the graphics option. Formal saturation tests were performed
in DAMBE using the method of Xia [261, 262], using a proportion of 0.3 invariant
sites. Root-to-tip regressions were performed on three different trees: 1) A neighbor
joining tree inferred in Geneious using the TN93 substitution model. 1000 bootstrap
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replicates were performed. 2) The ML tree inferred above. 3) A Bayesian tree in-
ferred in MrBayes [224] (version 3.2.5), using the TN93 substitution model, invariant
sites, and gamma distributed rate heterogeneity among sites. Root-to-tip distances
were extracted in TempEST [225] (version 1.5), using the ‘best-fitting-root’ param-
eter, and the regression analysis was performed in SciPy [226]. Date randomization
tests were performed in BEAST2 [150] (version 2.4.4, prerelease) to test whether
the temporal signal in the data is sufficient for a dated phylogenetic analysis. Us-
ing bModelTest [227] (version 1.0.4), we selected a 123,143 substitution model with
unequal base frequencies, four gamma rate categories, estimated gamma distribution
of rate variation, and estimated proportion of invariant sites. We used a strict clock
and coalescent constant population prior. The clock rate was constrained using a uni-
form (1x10-9 to 1x10-3 s/s/y) prior. Two different randomizations were performed in
replicates of five: 1) Tip dates were randomized for all sequences. 2) Only tip dates
of the ancient sequences were randomized. As a criterion for a temporal signal, we
employed CR2 described in [228], where there is evidence for a temporal signal if
none of the 95% HPD intervals of the substitution rate overlap between the random-
ized and the correctly dated run. The Markov chain Monte Carlo (MCMC) analysis
was run for 40,000,000 generations, all parameters reached an effective sample size
(ESS) >200, sampling every 2000 generations. Dated coalescent phylogenies were
inferred using BEAST2 [150]. We used a 123,143 substitution model with unequal
base frequencies, four gamma rate categories, estimated gamma distribution of rate
variation, and estimated proportion of invariant sites. The molecular clock was cal-
ibrated using tip dates. Proper priors were used throughout; specifically, we used a
uniform (1x10-9 to 1x10-3 s/s/y) prior on the clock rate. Path sampling, as imple-
mented in BEAST2, was used to select the best fitting population prior: per path
sampling run, 50 steps with a chain length of 1,000,000 generations were run (Ta-
ble 3.5). Log marginal likelihood values were compared using a Bayes factor test.
For the final tree shown in Figure 3.6, a strict clock and coalescent Bayesian skyline
population prior were used. The MCMC analysis was run for 60,000,000 generations
until all parameters reached an ESS >200, sampling every 2000 generations. Further-
more, a tree was inferred under a relaxed log-normal clock and coalescent Bayesian
skyline population prior. Genotypes were constrained to be monophyletic, as sup-
ported by the maximum likelihood tree (Fig. 3.5). The MCMC chain was run for
226,000,000 generations, sampling every 2000 generations. Convergence and mix-
ing were assessed using Tracer [230] (version 1.6). Additionally, trees were inferred
for each genotype separately, for the minor (positions 1877–3352) and major (posi-
tions 1–1876, 3353–4354) parent sections of the genome, and for genotype 1 and 3
sequences together using the same parameters as for the final tree above. The MCMC
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chain was run for 40,000,000 generations, except for the genotype 2 separately, which
was run for 60,000,000 generations. We sampled every 2000 generations. The final
tree files were subsampled to contain 20,000 trees, or 22,500 for the strict clock and
coalescent Bayesian skyline run, with the first 25% of samples discarded as burn-in.
Maximum clade credibility trees were calculated using TreeAnnotator (version 2.4.4
prerelease).
3.3.6 Genotype assignment
Percent sequence identity was calculated between all sequences in dataset 3. Loca-
tions with undefined bases were omitted.
3.3.7 Recombination analysis
The recombination analysis described in this section was performed by Terry Jones.
Recombination analysis was performed using seven algorithms built into RDP4 [214].
The algorithms are RDP [263], GENECONV [215], BootScan [216], MaxChi [217],
Chimaera [218], SiScan [219], and 3Seq [220]. The analysis involved the 10 ancient
sequences of this paper, plus the 13 following modern sequences:
Genotype 1: AB126262, AB126267, AB126270, DQ357064, DQ357065, M13178
Genotype 2: AY044266, DQ333426, KF724386
Genotype 3: AY582124, DQ234775, DQ408305, FJ265736
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3.4 RESULTS
3.4.1 Identification and authentication
We screened shotgun DNA sequencing data representing dental or skeletal remains
of 1,578 ancient human individuals (∼0.2 to 24.0 kya) recovered from across Eurasia,
Southeast Asia, and Greenland for the presence of reads matching B19V. A total of
20 samples had reads covering >30% of the coding region of B19V, 10 of which had
coverage >50% (Table 3.2). The samples with coverage >50% were between ∼0.5
and ∼6.9 thousand years old and from different archaeologically defined cultures
(four Viking Age Scandinavians, three Early Neolithic to Early Bronze Age Baikal
Hunter-Gatherers, one early Slav from the Czech Republic, and one Tian Shan Hun)
(Table 3.2). The individuals came from a wide geographic range, spanning Europe,
Central Asia, and Greenland (Fig. 3.1 and Table 3.2). The samples with coverage
>50% showed DNA damage patterns typical for aDNA [67] when at least 100 reads
were available (8 of 10 samples; Fig. 3.2). Clear damage patterns could not be defini-
tively identified when there were fewer than 100 reads (2 of 10 samples); there was no
evidence for this being for any reason other than a low number of reads. Authenticity
of the ancient B19V sequences presented here is further supported by our compliance
with standard precautions for working with aDNA [63] and because B19V sequences
were found in only 20 of 1,578 ancient human individuals, which would not be ex-
pected in case of ubiquitous laboratory contaminant. Finally, the ancient sequences
mostly occupy basal positions in the phylogenetic tree, with short branch lengths
from the trunk, for which the only explanation is that they are ancestors of modern
strains.
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Figure 3.1: Geographic locations of the samples with reads matching B19V. Samples are
coloured by age. Squares indicate genotype 1, circles genotype 2. Empty symbols indicate sam-
ples with 30–50% coverage of the coding region, filled symbols samples with >50% coverage of
the coding region that were included for further analysis. Samples that were negative for B19V are
shown as small grey symbols (samples outside Eurasia are omitted for clarity).
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Figure 3.2: Ancient DNA damage patterns for the samples included for further analysis. The
frequencies of the mismatches observed between the B19V reference sequences (see Table 3.1)
and the reads are shown as a function of distance from the 5’ end. C→T (5’) and G→A (3’)
mutations are shown in red and blue, respectively. All other possible mismatches are reported in
grey. Insertions are shown in purple, deletions in green, and clippings in orange. The number of
reads matching B19V for each sample is shown in parentheses. Note that the number of reads for
DA251 is lower here than in Table 3.1. This is because Table 3.1 includes the reads from the USER
treated sequencing (see Methods).
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BWA BLASTn BWA
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nce*
VK139 255 226 494 477 38 40% 0.5x 799 40 799 617 46 40.8% 0.5x 2
VK141 315 290 724 559 39 33.3% 0.3x 1210 40 1210 701 41 35% 0.5x 2
VK143 463 428 991 747 109 73.2% 1.6x 1144 40 1144 987 120 67.3% 1.6x 2
VK154 359 315 913 711 124 72.6% 1.5x 1771 40 1771 931 134 71.4% 1.6x 2
VK155 564 525 862 242 53 41% 0.7x 347 40 347 273 57 41.5% 0.7x 2
VK160 379 325 669 575 42 74% 0.7x 1086 40 1086 669 57 51.1% 0.8x 2
VK223 164 151 208 197 48 36.6% 0.5x 295 40 295 220 56 36.5% 0.5x 2
VK275 1861 1692 3276 961 59 38.4% 0.7x 1361 40 1361 1219 58 38% 0.7x 2
VK477 2305 2181 3014 2665 238 92.8% 3.2x 3217 40 3219 3027 242 87.7% 3.1x 2
VK548 394 376 514 366 40 42.1% 0.5x 1325 40 1325 1172 44 41.2% 0.5x 2
VK6 2251 2028 3696 3437 284 48.4% 4.0x 4686 40 4686 4675 301 82.5% 4.0x 2
DA55 62 64 101 109 35 33.7% 0.5x 346 40 346 173 63 43.8% 0.8x 1
DA66 541 513 356 692 324 95.7% 4.7x 1123 40 1125 1084 535 99.7% 7.8x 1
DA68 187 183 136 116 64 36.4% 0.5x 185 40 189 161 88 45.7% 0.7x 1
RISE392 107 96 392 151 39 33.2% 0.7x 206 50 207 207 56 36.8% 0.9x 1
RISE569 1494 1366 2304 2307 229 85.5% 2.7x 3238 40 3240 3234 285 84.1% 3.4x 2
DA251 150 140 352 351 45 47.5% 0.7x 663 40 663 458 73 54.2% 1.0x 1
DA251-
user
2165 40 N/D 2586 228 82.8% 3.2x 1
DA336 218 198 495 421 74 62.6% 1.1x 762 40 762 498 92 63.9% 1.3x 1
DA337 1378 1267 2649 2480 728 96.6% 11.3x 3369 40 3371 2729 883 98.4% 13.5x 1
NEO105 3967 3768 4623 4109 184 84.1% 2.2x 1838 40 4734 4386 219 83.6% 2.4x 1
Table 3.1: Mapping statistics of samples with reads matching B19V. * Reference accession number: 1:
M13178, 2: AY044266.
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Sample Location Culture 14C age
(s.d.)
Mean
calBP
age (s.d.)
Estimated age
(years, AD)
Age
(years)
Sex Individual
age
Sample
type
VK139 Fyn, DEN Viking N/D N/D 1000 1000 M tooth
VK141 Fyn, DEN Viking N/D N/D 1000 1000 F tooth
VK143 Oxford, UK Viking N/D N/D 880–1000 1077 M petrous
VK154 Bodzia, POL Viking N/D N/D 980/990–
1030/1035
1000 F early
adultus
tooth
VK155 Bodzia, POL Viking N/D N/D 1000 1000 F tooth
VK160 Kurevanikka, RUS Viking N/D N/D 1000 1000 M tooth
VK223 Gnezdovo, RUS Viking N/D N/D 1000 1000 M tooth
VK275 Fyn, DEN Viking N/D N/D 1000 1000 M tooth
VK477 Gotland, SWE Viking N/D N/D 1000 1000 F tooth
VK548 N. Trondelag, NOR Viking N/D N/D 1000 1000 F tooth
VK6 Eastern Settlement, GRL Viking N/D N/D 1000 1000 F >40y. tooth
DA55 Tian Shan, KGZ Saka 2034
(32)
1992
(48)
N/A 2059 M
DA66 Tian Shan, KGZ Hun 1546
(33)
1451
(47)
N/A 1518 F
DA68 Tian Shan, KGZ Hun 1479
(31)
1365
(35)
N/A 1432 F
RISE392 Stepnoe VII, RUS Sintashta 3626
(33)
3942
(53)
N/A 4009 M tooth
RISE569 Brandysek, CZE Early slav 1300
(30)
1237
(34)
N/A 1304 Inf II tooth
DA251 Lake Baikal (Shamanka II),
RUS
Early ne-
olithic
5955
(72)
6795
(90)
N/A 6862 M 25–35y. tooth
DA336 Lake Baikal (Shamanka II),
RUS
EBA 3723
(70)
4079
(107)
N/A 4146 M
DA337 Lake Baikal (Shamanka II),
RUS
EBA 3593
(67)
3900
(99)
N/A 3967 M? 17–18y.
NEO105 Bazaiha, RUS Historical pe-
riod
415 (25) 477 (42) N/A 544 tooth,
bone
Table 3.2: Overview of samples with reads matching B19V. Columns 4–7 refer to the 14C
age in years before the present (BP) and standard deviation, the mean calibrated age BP and
standard deviation, the archaeological age estimated from the sample context, and the sample
age used in the phylogenetic analyses corresponding to the mean calibrated age BP relative
to 2017, respectively.
3.4.2 Similarity to modern genotypes
We compared the ancient sequences with all published non-artificial, complete B19V
genomes in GenBank (Fig. 3.5a). Five ancient sequences are most similar to geno-
type 1 (DA66, DA251, DA336, DA337, NEO105), and five to genotype 2 (RISE569,
VK6, VK143, VK154, VK477). The mean pairwise sequence identity between the
ancient and the modern sequences is below the mean within-genotype pairwise se-
quence identity of the modern sequences (blue and red dashed lines in Fig. 3.5a).
None of the ancient sequences are more diverged from any modern sequence than
the modern genotypes are from each other (dashed black lines in Fig. 3.5a); hence,
we consider them part of the current genotypes and do not propose that they should
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be classified as new genotypes. We did not find any differences, such as insertions
or deletions, between the ancient and the modern sequences. Of the samples with a
genome coverage between 30% and 50% that were not included in the phylogenetic
analysis, three had the highest number of reads matching genotype 1, and seven best
matched genotype 2 (Fig. 3.5b).
3.4.3 Recombination analysis
The write-up, figures (Figs. 3.3 and 3.4) and table (Table 4.3) in this section (section
3.4.3) were contributed by Terry Jones and are included here for completeness.
We performed recombination analyses using RDP4 [214] on the 10 ancient sequences
with coverage >50% and a selection of 13 modern genotype 1–3 sequences, selected
to represent the modern diversity. All seven recombination detection algorithms used
by RDP4 identified all eight genotype 2 sequences included in the analysis (three
modern and five ancient sequences) as potential recombinants, with very high prob-
abilities (Table 4.3). Recombination plots for the RDP and MaxChi algorithms of
the RDP4 package for all eight genotype 2 sequences are shown in Figs. 3.3 and
3.4. In all cases, the major parent was found to be most similar to one of the mod-
ern genotype 3 sequences included in the analysis, and the minor parent to resemble
an ancient genotype 1 sequence most similar to DA337. To determine the timing of
the recombination, we subsequently removed DA337, DA66, and a modern sequence
(AB126262). Only after the removal of these three sequences was DA251, our oldest
sequence, found to be the minor parent, indicating that the recombination event most
likely took place between DA251 and DA337. Because of the age of the samples,
the major parent clearly cannot be a modern sequence, suggesting that a genotype 3
ancestor and a genotype 1 virus that existed sometime during the evolutionary span
from DA251 (6.9 kya) to DA337 (4.0 kya) recombined to form genotype 2. The
identification of genotype 2 as a recombinant and the inferred recombination break-
points closely correspond to the results of Shen et al., (2016) [264] in their analysis
of modern B19V sequences (Figs. 3.3 and 3.4).
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Recombination
algorithm
Number of sequences de-
tected in (DA337)
Average P value
(DA337)
Number of sequences de-
tected in (DA251)
Average P value
(DA251)
RDP 8 8.043 x 10-7 7 1.037 x 10-7
GENECONF 2 1.125 x 10-2 4 4.386 x 10-4
BootScan 8 5.227 x 10-13 7 3.517 x 10-7
MaxChi 8 3.281 x 10-10 7 5.144 x 10-8
Chimera 8 3.940 x 10-10 7 1.770 x 10-9
SiScan 8 1.349 x 10-12 7 1.293 x 10-11
3Seq 8 1.265 x 10-11 7 1.032 x 10-10
Table 3.3: Recombination analysis number of sequences and P values. There were 8 genotype 2
sequences in the recombination analysis. Columns 2 and 3 show the number of genotype 2 sequences
in which the recombination was detected (maximum 8) and the average P value when the genotype
1 sample DA337 (4.0 kya) was selected as the minor parent. When genotype 1 sequences DA337,
DA66, and the modern sequence AB126262 are removed from the analysis, DA251 (6.9 kya) is
chosen as the minor parent, also with strong P values (columns 4 and 5). Recombination breakpoints
and confidence intervals are given in the legend of Fig. 3.4. Table contributed by Terry Jones.
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Figure 3.3: Recombination analysis using the RDP algorithm in the RDP4 package for eight
genotype 2 sequences. Recombination analysis using RDP4 [214] was performed on all 10 ancient
sequences and a selection of 13 modern genotype 1–3 sequences. All seven recombination detection
algorithms used by RDP4 identified all genotype 2 sequences (including the 5 ancients) as potential
recombinants, with strong P values (Table 4.3). In all cases, the major parent was suggested to be a
genotype 3 sequence and the minor parent an ancient genotype 1 sequence. Values for the predicted
breakpoints (shown as vertical dashed lines) and 99% confidence intervals (shaded in grey) are given
in Fig. 3.4. The horizontal bars at the top of the figures on the first line indicate the positions of the
NS1 and VP1/2 genes in the genome. Figure contributed by Terry Jones.
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Figure 3.4: Recombination analysis using the MaxChi algorithm in the RDP4 package for
eight genotype 2 sequences. The start and end breakpoints were predicted as AY044266 (1877–
3352), DQ333426 (1877–3324), KF724386 (1878–3388), RISE569 (1876–3332), VK6 (1838–
3332), VK143 (1902–3332), VK154 (1877–3352), VK477 (1877–3332). In all cases, the 99% con-
fidence interval for the start breakpoint was 1822–1943. For all cases except VK477 (2885–3034),
the 99% confidence interval for the end breakpoint was 3239–3399. In all cases, the 99% confidence
interval (shaded in grey) of the inferred recombination breakpoints (vertical dashed lines) includes
the start and end values (1889 and 3280) found by (Shen et al., (2016) [264]) who also identified
genotype 2 as a genotype 1/3 recombinant. The horizontal bars at the top of the figures on the first
line indicate the positions of the NS1 and VP1/2 genes in the genome Figure contributed by Terry
Jones.
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Figure 3.5: Phylogenetic analyses and sequence similarity. a) Pairwise sequence identity be-
tween ancient and modern sequences by genotype. Dashed and continuous blue and red lines
denote the mean and maximum sequence divergence within a modern genotype, respectively. Black
dashed lines show the mean sequence divergence between genotypes (genotype 1 vs genotype 2:
0.89; genotype 1 vs genotype 3: 0.87; genotype 2 vs genotype 3: 0.91). b) Number of reads
matching against each genotype. c) Maximum likelihood (ML) tree. The ML tree was inferred
using PhyML, using the TN93 substitution model and optimizing for topology, branch lengths, and
rates, with 100 bootstrap replicates (see Methods). The x-axis denotes substitutions per site (s/s).
Ancient genotype 1 sequences are shown in blue and ancient genotype 2 sequences in red. Taxon
names indicate: dataset name, sample name, age, country abbreviation of sequence origin and region
of sequence origin. d) Pairwise transition and transversion frequencies plotted against P dis-
tance (sequence identity). If saturation occurs, the transversion frequencies should be higher than
the transition frequencies at large P distances. This is not the case here, and no signal of saturation
can be detected.
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Figure 3.5: cont. e) Regression of root to tip distances and sample age. Branch lengths
were inferred using neighbor joining, maximum likelihood, and Bayesian methods. Root-
to-tip distances were extracted using TempEst [225], selecting ‘best-fitting-root’ and the
regression analysis was performed in SciPy [226]. Shaded areas represent the 95% confi-
dence. The slopes are 3.0x10-6, 1,4x10-5, and 1.4x10-5 and the correlation coefficients are
0.38 (R2=0.15), 0.66 (R2=0.44), and 0.7 (R2=0.48) for NJ, ML, and Bayesian methods, re-
spectively. f) Date randomization tests. The rate and 95% HPD interval inferred using
correctly dated sequences is shown in red. Two types of randomization were performed in
replicates of 5, either randomizing tip dates of all sequences, or randomizing tip dates of just
the ancient sequences. None of the 95% HPD intervals of the randomized runs overlap with
the 95% HPD intervals of the correctly dated run, suggesting a good temporal signal in the
data.
3.4.4 Phylogenetic analysis
A phylogenetic tree inferred using maximum likelihood methods confirmed that the
ancient sequences fall within the diversity of known B19V sequences (Fig. 3.5c).
Five ancient sequences (DA66, DA251, DA336, DA337, NEO105) fall within or
basal to genotype 1, and five (RISE569, VK6, VK143, VK154, VK477) fall basal
to genotype 2, consistent with the sequence similarity result presented earlier. Sub-
stitution saturation is known to affect the phylogenetic signal, and hence the infer-
ence of phylogenetic trees. However, by plotting transition and transversion fre-
quencies against genetic distance (Fig. 3.5d) or by testing for substitution saturation
using DAMBE (Table 3.4) [262], we did not find evidence for saturation in our se-
quences.
numOTU Iss Iss.cSym T DF P Iss.cAsym T DF P
4 0.211 0.85 90.675 3042 0 0.84 89.314 3042 0
8 0.192 0.844 98.212 3042 0 0.764 86.067 3042 0
16 0.199 0.83 98.869 3042 0 0.676 74.731 3042 0
32 0.189 0.81 102.134 3042 0 0.561 61.139 3042 0
Table 3.4: Results from testing for substitution saturation in DAMBE. Tests for sub-
stitution saturation were performed in DAMBE, according to Xia et al., (2017) [261]. The
proportion of invariant sites was set to 0.3. If the Iss is smaller than Iss.cSym and Iss.cAsym,
there is no evidence for saturation, as is the case here.
To infer dated coalescent trees, sufficient temporal signal must be present in the data.
A regression of root-to-tip distances from trees inferred using neighbor joining, max-
imum likelihood, and Bayesian methods all showed a temporal signal in the data (Fig.
3.5e). Date randomization tests [228, 265] performed in BEAST2 [150] also support
86
3.4. RESULTS
the presence of a temporal signal (Fig. 3.5f). Dated coalescent trees were conse-
quently inferred using BEAST2 (Fig. 3.6) [150]. In the following text, 95% highest
posterior density (HPD) intervals are given in parentheses. We inferred a substitution
rate of 1.22x10-5 (1.04x10-5–1.40x10-5) s/s/y and a root age of 10.1 (9.0–11.3) kya
under a strict clock and a coalescent Bayesian skyline population prior (Table 3.5)
and a substitution rate of 1.67x10-5 (1.24x10-5–2.14x10-5) s/s/y and a root age of 8.4
(7.0–11.1) kya under a relaxed log-normal clock and a coalescent Bayesian skyline
population prior, with identical topologies. The time to the most recent common an-
cestor of genotypes 1, 2, and 3 are 7.1 (6.9–7.3), 1.9 (1.7–2.1), and 2.5 (2.1–3.0) kya,
respectively, under a strict clock and 7.3 (6.9–7.9), 1.7 (1.4–2.0), and 1.5 (0.8–2.4)
kya, respectively, under a relaxed log-normal clock.
Model (clock, popula-
tion)
Strict, constant Strict, exponential Strict, Bayesian sky-
line
likelihood -25519.8 -25516.8 -25470.1
Strict, constant -25519.8 0 2.97 49.7
Strict, exponential -25516.8 -2.97 0 46.73
Strict, Bayesian skyline -25470.1 -49.7 -46.73 0
Table 3.5: Model testing for different population priors. Models were compared using
path sampling, as implemented in BEAST2. Log marginal likelihood values were compared
using a Bayes factor test. A positive value for the Bayes factor implies support for the column
model, a negative value support for the row model. A Bayes factor in the range of 3–20 im-
plies positive support, 20–150 strong support, and >150 overwhelming support [229]. ‘like-
lihood’ refers to the log marginal likelihood estimate. Abbreviations are as follows: ‘Strict’:
strict clock, ‘Relaxed-log.’: relaxed log-normal clock, ‘Constant’: coalescent constant pop-
ulation prior, ‘Exponential’: coalescent exponential population prior, ‘Skyline’: coalescent
Bayesian skyline population prior.
Recombination is known to affect the accuracy of phylogenetic analyses. Hence, to
better understand the effect of recombination on the dated B19V tree, we inferred
trees under a strict clock and coalescent Bayesian skyline population prior for the
three genotypes individually, dating the most recent common ancestor of genotypes
1, 2, and 3 to 6.9 (6.9–6.9) kya, 1.6 (1.4–1.8) kya, and 0.6 (0.1–6.1) kya, respectively.
Further, we inferred trees under a strict clock and coalescent Bayesian skyline popu-
lation prior for the full genome, but excluding all genotype 2 sequences (Fig. 3.7b),
and separately for the region of the minor (Fig. 3.7c) and major (Fig. 3.7d) parent.
The maximum root age was inferred to be 12.6 (10.4–15.2) kya when only the mi-
nor parent was considered (Fig. 3.7c); however, the 95% HPD interval of the root
ages overlapped in all cases. The 95% HPD interval on the split of genotype 2 from
genotype 1 in Fig. 3.7c) suggests that the recombination event that formed genotype
2 occurred between 5.0–6.8 kya.
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Figure 3.6: Maximum clade credibility tree inferred in BEAST2. A strict clock and coalescent
Bayesian skyline population prior were used. The substitution rate is inferred as 1.22x10-5 s/s/y
(95% HPD interval, 1.04x10-5–1.40x10-5 s/s/y), and the root age as 10.1 kya (95% HPD interval,
9.0–11.3 kya). The x-axis denotes time into the past, in years. Taxon names: genotype/historical
period, accession number/sample identifier, sample age, country abbreviation of sequence origin
and region of sequence origin, as determined by the Standard country or area codes for statistical
use (42). Horizontal grey bars indicate 95% HPD intervals of node ages.
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Figure 3.7: Trees inferred using BEAST2 from different regions of the B19V genome. Trees
were inferred using a strict clock and coalescent Bayesian skyline population prior. Positions of
ancient genotype 1 and ancient genotype 2 sequences are shown as blue or red tips, respectively.
Collapsed modern genotype 1, 2, and 3 sequences are shown as blue, red, and yellow dots, respec-
tively. 95% HPD intervals of node ages are shown by grey horizontal bars. The x-axis denotes time
into the past, in years. Vertical grey dashed lines indicate, from left to right, the maximum height of
the root and the maximum and minimum height of the genotype 3 clade. a) Tree from Fig. 2 using
the full coding region. b) Tree using the full coding region, excluding genotype 2 sequences. c)
Tree using the minor parent (positions 1,877–3,352 of the alignment). d) Tree using the major
parent (positions 1–1,876 and 3,353–4,354 of the alignment).
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3.5 DISCUSSION
We show that it is possible to recover and sequence single-stranded ancient viral DNA
molecules from human skeletons that are up to ∼6.9 thousand years old. Although
Toppinen et al., (2015) [126] found that human B19V DNA can persist in human
bone for decades, the fact that ssDNA is able to persist for ∼6.9 kya may seem sur-
prising, given that depurination and deamination occur about four times faster in
ssDNA than in double-stranded DNA [64]. However, single-stranded B19V DNA
may be protected by the viral capsid, by self-annealing of ssDNA during preserva-
tion, or through the binding of ssDNA to the inside of the viral capsid, as observed
in canine Parvovirus [266]. This finding also provides hope for the retrieval of RNA
viruses from archaeological samples, notwithstanding the traditional view of RNA as
too unstable for long-term survival [64].
By computational screening of shotgun data from 1,578 ancient individuals, we found
20 samples with reads matching 30–99.7% of the B19V coding region, eight of which
had a majority of reads matching genotype 1 and 12 matching genotype 2. No sample
had a majority of reads matching genotype 3. The phylogenetic positioning of the
ancient genotype 1 sequences may suggest a ladder-like evolution, in which older
virus strains go extinct as they are replaced by novel variants, as observed in modern
genotype 1 sequences [158].
The ancient sequences allow us to revise the current timelines for B19V evolution.
Specifically, we show that B19V has been associated with humans for thousands of
years, given our finding of ancient sequences as old as ∼6.9 kya that are still most
similar to genotype 1. This rules out the suggestion that genotype 1 only arose after
World War II [126,158]. However, endogenous parvovirus-derived genomes found in
a large range of mammals suggests that the virus may be considerably older than 12.6
kya [165]. Furthermore, we find a substitution rate of 1.22x10-5 s/s/y, approximately
an order of magnitude lower than rates inferred solely from modern B19V sequences
[126, 157, 158]. Our rate estimate is in line with rates estimated for other single- and
double-stranded DNA viruses [35]. The fact that we find lower rates when sampling
over the course of a longer period, as opposed to sampling over the course of a shorter
period, is consistent with the phenomenon of time dependency of substitution rates
[152,162]. The most likely cause of this phenomenon are the inability of evolutionary
models to account for saturation (Peter Simmonds, personal communication). Other
causes, such as changes in selection pressure and virus biology, as well as transient
mutations have been mentioned [161]. Since viral substitution rates decay gradually
with increasing measuring period, changes in selection pressure and virus biology are
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deemed unlikely [38, 152]. Inferred B19V substitution rates may decrease as older
ancient sequences are discovered and incorporated into future analyses.
It has been shown previously that genotype 2 was formed by a recombination between
genotypes 1 and 3 [264]. Using the position of the ancient sequences as shown in
Fig. 3.7c), we were able to date this recombination event to between 5.0 and 6.8 kya.
Recombination leads to the underestimation of root ages in dated coalescent trees,
which is what we observed when comparing trees inferred from the full genomes
(Fig. 3.7a) with trees inferred from only genotypes 1 and 3 (Fig. 3.7b) or from the
minor parent (Fig. 3.7c). Interestingly, we did not find the same when inferring a tree
using the major parent (Fig. 3.7d), where the root age is underestimated, similar to
the full tree in Fig. 3.7a). However, in all cases, the 95% HPD intervals of the root
ages overlap.
On the basis of our data, it is possible to hypothesize a geographical separation be-
tween the ancient genotype 1 sequences, found in Central Asia, and ancient genotype
2 sequences, found in Europe and Greenland. However, this may simply be a result
of sampling bias due to the small number of positive samples. Although no ancient
genotype 3 sequences have been found, there appears to be no feature inherent to
the biology of genotype 3 that inhibits long-term preservation of its DNA [258], as
the genotype has been found in remains of World War II soldiers by Toppinen et al.,
(2015) [126].
This small number of ancient samples of B19V has allowed us to revise previous
best estimates of rate of evolution and the timespan of the association of B19V with
humans, both by an order of magnitude. Similar gains in our understanding of the
evolutionary processes of other pathogens, and for improving phylogenetic inference
methods when no ancient sequences exist, surely await.
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CHAPTER 4: DIVERSE VARIOLA VIRUS LINEAGES
CIRCULATED IN NORTHERN
EUROPE DURING THE VIKING AGE
4. ANCIENT VARIOLA VIRUS
PREFACE
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Margaryan, Peter de Barros Damgaard, and Constanza de la Fuente Castro. In addi-
tion to this description, I have noted in the legends of figures and tables if they were
contributed by others.
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4.1 ABSTRACT
We present thirteen cases of smallpox from humans living in northern Europe, in-
cluding eleven from the Viking Age (∼800–1100 Common Era). Viral sequences
isolated from these individuals reveal a now-extinct sister clade to the variola viruses
in circulation prior to the eradication of smallpox. We date the most recent common
ancestor of all now known variola viruses to ∼1,600 years ago. A diverse pattern of
gene inactivation shows that the Viking age viruses were following multiple parallel
evolutionary paths. Sixteen genes disrupted in modern variola viruses are intact in
the Viking age viruses, nine of which are immune modulators that affect virulence in
the related vaccinia virus. Identical gene-inactivating mutations in five other genes
indicate a single zoonotic introduction of variola virus into humans. These findings
reveal a richer and more diverse genetic history of variola virus than previously sus-
pected.
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4.2 INTRODUCTION
Variola virus, the causative agent of smallpox, is estimated to have caused 300–
500 million deaths in the 20th century alone [10]. Despite the eradication of small-
pox, there are ongoing concerns regarding the re-emergence of a smallpox-like dis-
ease, either due to accidental or deliberate re-introduction of variola virus, adaptation
of monkeypox virus to man, or via zoonosis or genetic engineering of another or-
thopoxvirus [267–269]. Thus, a better understanding of the evolutionary history of
variola virus is of substantial interest.
The orthopoxviruses are a genus of the Poxviridae and have large, linear, double-
stranded DNA genomes [270]. They differ in the range of mammalian host species
they infect and the severity of the disease they cause: Variola virus (VARV) and
camelpox virus (CMLV) have a narrow host range and can be highly virulent, while
taterapox virus (TATV), infecting gerbils, does not cause significant morbidity [10,
271]. Cowpox virus (CPXV), monkeypox virus (MPXV), and vaccinia virus (VACV)
infect several host species, with varying severity of disease. VACV, whose origin
and reservoir host is unknown [272], generally has low virulence in humans, elic-
its an immune response that is protective against VARV, and was used as the vac-
cine during the smallpox eradication campaign [10]. VACV infection of mice is
a useful model for studying orthopoxvirus gene function in vivo. Orthopoxvirus
genomes are typically between ∼186,000 and ∼220,000 nucleotides (nt) long and
contain between 179 and 212 genes [10]. Conserved genes, necessary for virus
transcription and replication, are located in the central ∼100,000 nt region of the
genome, and are commonly used in phylogenetic inference. In vitro and in vivo stud-
ies show that orthopoxvirus genomes also contain many genes important for mod-
ulating host innate immunity and determining host range, but whose deletion does
not prevent virus replication [7, 273]. Those are located near the genome termini,
and are variable between different orthopoxvirus species. The factors governing host
range and virulence of orthopoxviruses are complex and not fully understood. For
example, some genes that promote VACV virulence are inactivated in the more vir-
ulent VARV [274–276], while in other cases the loss or inactivation of host immune
system-modulating genes in VACV can result in increased virulence [7].
The timeline of the emergence of smallpox in humans is unclear. Analysis of se-
quences from a 17th century Lithuanian mummy (VARV-VD21) [116], two Czech
museum specimens from the 19th and 20th century [115], and VARV from the 20th
century sampled during the eradication campaign, dates their most recent common
ancestor (MRCA) to the 17th or 18th centuries [115,116,277,278]. However, written
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records of possible smallpox infections date back to at least 3000 years ago (ya), and
mummified remains suggestive of smallpox date to 3570 ya [279, 280]. Due to the
absence of sequences older than ∼360 years, a large gap remains in our knowledge
of the evolution of VARV.
Here we present three high-coverage and 10 low-coverage VARV sequences from
northern Europe. Eleven of the samples (including the three with high-coverage) are
dated between ∼550–1100 Current Era (CE), and two between 1800–1900 CE.
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4.3 MATERIAL AND METHODS
4.3.1 Datasets
Ancient sequences:
aVARV-VK382, aVARV-VK388, aVARV-VK470.
Dataset 1 (Human tree):
51 VARV sequences plus the ancient sequences listed above.
L22579, DQ441420, DQ441421, DQ437581, DQ437588, DQ441417, DQ441418,
DQ441435, DQ441436, DQ441427, DQ441446, DQ441445, DQ441444, DQ437584,
DQ441428, DQ441429, DQ441430, DQ441431, DQ441432, DQ441442, DQ437591,
DQ441424, DQ441425, DQ441438, DQ441439, DQ437590, DQ441440, DQ441441,
DQ437582, DQ441433, DQ437585, DQ437586, DQ441448, DQ437580, DQ437587,
DQ437592, DQ437589, DQ441423, DQ441443, DQ437583, Y16780, DQ441419,
DQ441447, DQ441416, DQ441426, DQ441437, DQ441434, NC_001611, V563:
LT706528, V1588: LT706529, VARV-VD21: BK010317
Dataset 2 (full Maximun likelihood tree):
Dataset 1 plus the following sequences (abbreviations: TATV: Taterapox virus, CMLV:
Camelpox virus, ECTV: Ectromelia virus, CPXV-Gri: Cowpoxvirus Gri, CPXV-Ger:
Cowpoxvirus Germany, CPXV-BR: Cowpoxvirus Brighton Red, VACV: Vaccinia
virus, VACV-Ank: Vaccinia virus Ankara, VACV-COP: Vaccinia virus Copenhagen,
MPXV-Zai: Monkeypox virus Zaire, HPXV: Horsepox virus):
TATV: DQ437594 (NC_008291), CMLV M-96: AF438165 (NC_003391) , CMLV-
CMS: AY009089, ECTV: NC_004105, ECTV: KY554976, ECTV: JQ410350, ECTV:
KJ563295, CPXV: KC813508, CPXV-Gri: X94355, VACV-Ank: AM501482, CPXV:
HQ420893, VACV: AY313848, VACV: KF179385, CPXV: DQ437593, VACV: KJ12-
5439, CPXV: KC813493, VACV: JX489138, CPXV: HQ420895, CPXV: KC813509,
CPXV: HQ420897, CPXV: KC813492, CPXV: HQ420894, CPXV: KC813511, CPXV:
NC_003663, CPXV: HQ420899, CPXV: HQ420896, MPXV-ZAI: NC_003310, CMLV:
KP768318, HPXV: DQ792504, MPXV: DQ011156, Akhmeta: MH607143, VACV:
NC_006998, VACV-COP: M35027
Dataset 3 (References for analysis of gene-inactivating mutations):
17 sequences as described in Hendrickson et al., (2010) [270].
CMLV: AF438165 (NC_003391), CPXV-BR: AF482758 (NC_003663), CPXV-Ger:
DQ437593, CPXV-Gri: X94355, ECTV: AF012825 (NC_004105), MPXV-WR: AY60-
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3973, MPXV-ZAI: AF380138 (NC_003310), TATV: DQ437594 (NC_008291), HSPV:
DQ792504, RPXV: AY484669, VACV-MVA: U94848, VACV-COP: M35027, VACV-
WR: AY243312 (NC_006998), VARV-BRZ: DQ441419, VARV-KUW: DQ441433,
VARV-SLN: DQ441437, VARV-SAF: DQ441436
4.3.2 Sample preparation, screening, authenticity
Thirty-two samples were selected for enrichment of viral target sequences in library
by capture, based on the availability of additional sampling material and the pres-
ence of reads matching orthopoxviruses using Kraken [281] and DIAMOND [207]
(version 0.9.23) algorithms. A total of 1653 humans living in Eurasia and the Amer-
icas between ∼31,630 and ∼150 ya were screened. Eleven of the 32 individuals
had already been enriched for viral target sequences in library capture in a previous
study [79]. From the remaining samples, uniquely dual-indexed sequencing libraries
(2–6 libraries/sample) were prepared from 1–3 ancient DNA (aDNA) extracts/sam-
ple. Libraries were pooled into capture reactions containing 1183–1667 ng/rxn. Hy-
bridisation and sequencing were performed as described previously [79].
In order to confirm the presence of authentic orthopox reads, reads from the capture
were mapped against a set of nine reference genomes distributed across the orthopox
phylogeny using Bowtie2 [282] (version 2.3.2). For each reference genome, both
end-to-end (-end-to-end) and local (-local) alignment were performed, using
a modification of the ‘very sensitive’ preset allowing for an additional mis-
match in the seed alignment (-N 1). Following this approach, a sample was consid-
ered a likely positive for infection with an ancient VARV according to the following
criteria:
− At least 30 unique reads with MQ30 mapping against the VARV genome.
− Mapped reads randomly distributed across the entire VARV genome (Con-
tributed by Martin Sikora, not shown).
− Lowest read edit distances against either CMLV, TATV, or VARV (Contributed
by Martin Sikora, not shown).
A sample was considered a confirmed positive if, in addition to the above, the reads
showed clear ancient DNA damage patterns as revealed by mapDamage [209]. Fur-
thermore, in all ancient samples, 100% to 97.4% of all reads identified as described
above, had orthopoxvirus as their best match when using BLASTn [25] (version
2.8.1) to map against the entire NCBI nt database downloaded on January 4, 2019.
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The fact that 10 of the 11 Viking age ancient samples group phylogenetically as a
novel clade in sister relationship to modern VARV further supports authenticity.
To assemble the reads used for the generation of consensus sequences and the inves-
tigation of gene-inactivating mutations, reads from the capture were mapped against
orthopoxvirus reference genomes using DIAMOND (version 0.9.23), and BWA [206]
(version 0.7.15-r1140) (mem and aln (with and without the -l option) algorithms).
Reads from all mapping algorithms were combined and de-duplicated for further
use.
4.3.3 Generation of consensus sequences
Orthopoxviruses differ in their gene content [270, 274]. As we do not know which
genes are present in the ancient viruses, assembling a full genome by mapping to
a modern reference sequence is impossible. We therefore constructed ancient con-
sensus sequences only for the conserved central section of the genome, from gene
VACV-COP F4L to gene VACV-COP A24R. Reads were aligned to a TATV reference
sequence (accession: NC_008291) using Geneious [211] (version 9), medium sensi-
tivity, fast parameters. In the resulting alignments, we manually trimmed damaged
ends, and set C/T and G/A mutations at positions with less than five reads coverage
to ‘N’.
4.3.4 Recombination analyses
The recombination analyses and the associated table and text in this section were
contributed by Terry Jones. Seven algorithms, as implemented in the RDP4 [214]
(version 4.9.5) package, were used to search for evidence of recombination in a se-
lection of 10 orthopoxvirus sequences. The algorithms were: 3Seq [220], BootScan
[216], Chimaera [218], GENECONV [215], MaxChi [217], RDP [263], and SiS-
can [219]. The sequences (with accession numbers in parentheses) were: Akhmeta
(MH607143), CMLV (AY00-9089), CPXV (KC813492), CPXV (KC813508), TATV
(NC_008291), VARV-VD21 (BK010317), VARV (NC_001611), aVARV-VK382, aVARV-
VK388, and aVARV-VK470. A region of 55 nucleotides of aVARV-VK470 was
identified as being of possible recombinant origin, but by only one RDP4 algorithm
(GENECONV), with aVARV-VK388 as the major parent with the minor contribution
from an unknown parent. The RDP4 program issued the caveat that the proposed re-
combination signal may be attributable to a process other than recombination. Simi-
larly, a region of 261 nucleotides in aVARV-VK382 was flagged as a possible recom-
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binant by three algorithms (3Seq, BootScan, and GENECONV), again with aVARV-
388 as the major parent and a contribution from an unknown parent, and with the
same caveat. No recombination signal was detected with aVARV-aVARV-VK388 as
the recipient sequence.
4.3.5 Phylogenetic analyses
4.3.5.1 Maximum likelihood trees
Separate trees were made from Datasets 1 and 2. The sequences were aligned using
MAFFT [221] (version 7). Maximum likelihood (ML) trees were generated using
RAxML-ng [283] (version 0.7.0 BETA) with a K81uf+G+I (selected using bModel-
Test [227]) substitution model, and an ML estimate of tree topology, branch lengths,
substitution rates, and nucleotide frequencies and support estimated using 1000 boot-
strap replicates.
4.3.5.2 Low-coverage samples trees
Analyses described in this section were performed by Martin Sikora. The EPA-ng al-
gorithm [284] (version 0.3.4) was used to infer the positions of consensus sequences
from the low-coverage samples (VK108, VK138, VK168, VK255, VK281, VK359,
VK515, VK533, FIN1, and KHA1) on the ML tree made from Dataset 2, includ-
ing the sequences from the three high-coverage samples. For all samples, consensus
sequences were obtained by extracting the majority allele from BAM files mapped
against a VARV reference genome (accession number NC_001611.1) using the local
alignment approach, to reduce the impact of genotyping errors due to post-mortem
DNA damage (Fig. 4.2). The resulting consensus sequence was aligned to the multi-
sequence alignment of Dataset 2 from which the original ML tree was inferred (see
‘Maximum likelihood trees’, above) using MAFFT (version 7.407) with the -add
and -keeplength options. EPA-ng was run using the same model parameters
as used for the original ML tree (K81uf+G+I). Placements of low-coverage samples
were further analyzed using gappa [285] (version 0.1.0), and the uncertainty in place-
ments for each sample was visualized using likelihood weight ratios (LWRs) on the
reference tree using the ggtree [286] (version 1.14.6) package in R [287] (version
3.5.2).
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4.3.5.3 Dated coalescent trees using BEAST2
We performed a linear regression of root-to-tip dates against sampling dates. Root-
to-tip distances were extracted using TempEst [225] (version 1.5) from the ML tree
inferred from Dataset 1 and the sequences from the three high-coverage samples in
Fig. 4.3 (Dataset 1). The regression analysis was performed in SciPy [226]. Dated
coalescent trees were inferred using BEAST2 [150] (version 2.4.7). Forty-eight mod-
ern VARV sequences were used, as well as two published ancient sequences from
Czech Republic, and VARV-VD21 (Dataset 1). Using bModelTest [227] (version
1.0.4), we selected a TPM1 substitution model with unequal base frequencies, invari-
ant sites, and gamma distributed rate heterogeneity among sites. The prior on the
clock rate was constrained using a uniform(1x10-9–1x10-3 substitutions / site / year
(s/s/y)) prior. Proper priors were used throughout. Trees were inferred using strict and
relaxed log-normal molecular clocks, as well as constant and exponential coalescent
and Bayesian skyline population priors. The Markov chain Monte Carlo analysis was
run for 100M generations, sampling every 2000 generations. An effective sample size
>200 was reached for all relevant parameters, and convergence and mixing was as-
sessed using Tracer [230] (version 1.6.0). Final tree files were sub-sampled to contain
10,000 trees and Maximum Clade Credibility trees were summarised using TreeAn-
notator (version 2.2.4 prerelease). Path sampling, as implemented in BEAST2, was
used to select the best fitting molecular clock and population prior. Per path sampling
run, 50 steps with a chain length of 1,000,000 generations were run. Likelihood val-
ues were compared using a Bayes factor test [229].
4.3.5.4 Investigating gene-inactivating mutations
In order to assess gene content in absence of a reference genome, we investigated
the presence of gene-inactivating mutations in the ancient samples by comparison
of alignments made to 17 orthopoxviruses. Information about the location of ho-
mologous genes in 17 orthopoxvirus reference genomes (Dataset 3) is presented in
Supplementary Table 1 of Hendrickson et al. (2010) [270]. This was used to ac-
quire sequences of homologous genes of those 17 reference sequences. Excluding
cases where a gene is absent in a reference sequence, this leads to 3422 sequences
for 219 genes. Supplementary Table 1 in Hendrickson et al., (2010) [270] was also
used to acquire information on the presence, absence, fragmentation, and truncation
of genes in the 17 reference sequences. Reads for each ancient sample were matched
against each reference gene sequence using BLASTn [25], and consensus sequences
for each gene were generated using BWA [206] (version 0.7.15-r1142-dirty) (aln al-
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gorithm) and samtools [288] (version 1.9). Only consensus sequences which covered
more than 50% of the reference gene sequence and whose median matching read bit
score was within 2 of the highest median bit score (so as to avoid excluding matches
with almost-identical bit scores) among all available reference genes were consid-
ered further. Ancient consensus sequences and read alignments for each gene were
manually inspected for the presence of stop codons, and insertion and deletions that
indicated the inactivation of the gene in Geneious. Gene-inactivating mutations were
classified as either certain or uncertain. The criteria for a certain gene-inactivating
mutation were: 1) There is a mutation that leads to a stop codon (insertion / dele-
tion / point mutation) which is covered by more than four reads. 2) The consensus
sequence is against a reference that is truncated or fragmented. The criterium for an
uncertain gene-inactivating mutation was: 1) There is a mutation that leads to a stop
codon which is covered by less than or equal to four reads. Seeing as the filtering
often returned more than one possible consensus sequence per gene and per sample,
the information about gene-inactivating mutations was aggregated across multiple
consensus sequences. Thus, overall, a gene-inactivating mutation in the ancient se-
quence was deemed to be present if a) there was a gene-inactivating mutation in all
the consensus sequences for the best-matching reference genes, or b) there was a
gene-inactivating mutation in some and an uncertain gene-inactivating mutation in
all other consensuses. Gene-inactivating mutations were deemed to be uncertain if
all consensuses had an uncertain inactivating mutation, or if one or some consensuses
had an inactivating mutation but the other(s) did not. If only some consensuses had
an uncertain gene-inactivating mutation, and there was no gene-inactivating muta-
tion in others, the gene was deemed to be present. Figures 4.7a-d show all genes
considered and the ancient gene consensus sequences that were considered further
and whether or not they contained a stop codon. Figure 4.8 shows the inactivation of
genes over time in mVARV, CMLV, TATV, aVARV and the internal phylogenetic tree
nodes that connect them. The number of gene-inactivating mutations at each tip and
internal node is plotted against time, with the ages of the internal nodes taken from
the dated coalescent tree inferred using a log-normal relaxed clock and a Bayesian
skyline population prior (Fig. 4.6). A gene-inactivating mutation is deemed to be
present in an internal node if there is a gene-inactivating mutation in the same loca-
tion in both children. If one or two uncertain gene-inactivating mutations are present
in a child, the gene-inactivating mutation in the parent internal node is also shown as
uncertain. Figure 4.9 provides additional information, allowing the direct comparison
of the presence and absence of inactivating mutations on a per-gene basis.
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4.4 RESULTS AND DISCUSSION
To investigate the earlier evolutionary history of VARV, we screened shotgun high-
throughput sequencing data from skeletal and dental remains of 1653 humans living
in Eurasia and the Americas between ∼31,630 and ∼150 ya. 555 of those were from
northern Europe and western Russia and were context-dated to the Viking Age. Based
on matches against orthopoxvirus reference sequences and the availability of addi-
tional sampling material, 32 were selected for enrichment of viral target sequences
in library by capture, as described [79]. Thirteen individuals showed clear evidence
of VARV infection (Table 4.1, Fig. 4.2). Of these 13 samples, 11 were Viking age
individuals from northern Europe and western Russia, and two were from the 19th
century from western Russia (Fig. 4.9a).
In three (hereafter ‘high-coverage’) samples (VK382, VK388, and VK470), there
were sufficient reads to produce clear DNA damage patterns characteristic of an-
cient DNA, with elevated miscoding lesions towards the termini [57], and sufficient
read coverage (>1.6x) to construct consensus sequences covering 86.8% to 99.6% of
the conserved central region of the orthopoxvirus genome. The remaining 10 (here-
after ‘low-coverage’) samples consist of four samples (VK168, VK281, VK533, and
FIN1) with clear DNA damage patterns but low coverage (<0.74x), and six likely-
positive samples (VK108, VK138, VK255, VK359, VK515, and KHA1) whose read
counts were too low to produce clear DNA damage patterns (Table 4.1, Fig. 4.2).
The consensus sequences for the three high-coverage samples were collectively most
similar to each other, and then to TATV (Table 4.2).
Before inferring phylogenetic trees based on the conserved central region of the
genome, we tested whether modern VARVs show evidence of genomic segments that
descend from a virus population containing the Viking age VARVs and whether the
high-coverage Viking age VARV sequences were themselves recombinants. We ex-
amined the Viking age sequences and six representative sequences from related mod-
ern orthopoxvirus species for evidence of recombination using seven algorithms from
the RDP4 toolset [214]. Although two short regions (261 and 908 nts of the ∼100,000
nt central region of the VARV genome) of the high-coverage sequences were flagged
as possibly due to recombination with other unknown ancient sequences, the evi-
dence of any recombination was highly uncertain. None of the modern sequences
in the selection were produced by recombination with any other modern or ancient
sequence from the selection (Table 4.3).
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Sample Date (CE) Site Sex Individual
age (years)
Sample type Clear DNA
damage
Coverage
category
Read-count Coverage of
genome
Coverage
depth
VK388 550–750 Nordland, NOR M 12–17 Tooth Yes High 20,585 0.990 8.13x
VK470 900–1100 Gnezdovo, RUS F Unknown Tooth Yes High 19,069 0.971 7.92x
VK382 700–800 Öland, SWE M Over 15 Tooth Yes High 5,980 0.842 2.37x
VK281 885–990 Zealand, DEN M 30–35 Tooth Yes Low 1,910 0.499 0.81x
VK168 880–1000 Oxford, GBR M 16–25 Petrous Yes Low 1,965 0.428 0.7x
VK533 800–1050 Öland, SWE * 50–60 Tooth Yes Low 611 0.207 0.25x
FIN1 1800–1900 Varzino, RUS F 40–45 Tooth Yes Low 95 0.023 0.03x
VK515 950–1025 Nordland, NOR M 18–22 Tooth No Low 124 0.03 0.04x
VK359 700–800 Öland, SWE M Over 15 Tooth No Low 62 0.013 0.01x
KHA1 1800–1900 Yamalo-Nenetskiy, RUS N/D 3–4 Petrous No Low 38 0.012 0.01x
VK108 800–1000 Malmo, SWE F Unknown Tooth No Low 55 0.01 0.01x
VK138 approx. 1000 Fyn, DEN M 25–35 Tooth No Low 41 0.01 0.01x
VK255 950–1000 Gnezdovo, RUS F Unknown Tooth No Low 30 0.01 0.01x
Table 4.1: Overview of samples with reads matching orthopoxviruses. From left to right, the columns refer to the sample name, approximate sample date
as estimated from the archaeological context, the site where the sample was found (DEN: Denmark, GBR: Great Britain, NOR: Norway, RUS: Russia, SWE:
Sweden), the sex of the individual, the age of the individual at the time of death, the type of tissue that was sequenced, whether a clear DNA damage pattern is
evident in the sample sequencing reads (Fig. S1), and whether genome coverage is high (>1.6x) or low (<0.74x) (Fig. S2). N/D: not determined. Eleven of the
samples date from the Viking Age (∼800–1100 CE, with sample names starting with ‘VK’) or immediately prior to it and are from Scandinavian countries,
western Russia, or the UK. Rows are ordered by decreasing coverage depth. *VK533 was identified as female by osteology, but is genetically male.
105
4. ANCIENT VARIOLA VIRUS
Figure 4.1: Geographical location and phylogenetic placement of the ancient samples. a) Map
showing the geographical location of the samples. The high-coverage sample locations are indi-
cated with solid red circles and low-coverage sample locations with open red circles. The location of
published sample VARV-VD21 is shown in blue. Grey dots indicate locations of screened samples
in which VARV was not detected (samples from South-East Asia and the Americas are omitted for
clarity). Eight of the Viking age samples were from Denmark, Norway, and Sweden (Table 4.1). b)
Maximum likelihood tree showing the placement of the low-coverage samples. Low-coverage
samples were placed onto the tree using EPA-ng. Clades that do not have any low-coverage samples
placed on them are collapsed and indicated by black circles. The full tree is shown in Fig. 4.3. The
coloured branches indicate the branch with the highest likelihood weight ratio for each low-coverage
sample. Branch thickness indicates the number of low-coverage samples placed on the branch by
EPA-ng. The scale bar indicates substitutions per site (s/s).
Closest
CMLV
Closest
TATV
Closest mod-
ern VARV
VARV-VD21 aVARV-
VK382
aVARV-
VK388
VARV-VD21 0.986 0.988 0.998 1
aVARV-VK382 0.991 0.994 0.99 0.991
aVARV-VK388 0.991 0.994 0.99 0.991 0.998
aVARV-VK470 0.99 0.992 0.989 0.99 0.996 0.996
Table 4.2: Sequence similarity between VARV-VD21, aVARV-VK382, aVARV-VK388, and
aVARV-VK470 consensus sequences and relevant orthopox reference sequences. The closest
modern VARV was selected, excluding the two sequences recovered from Czech museum speci-
mens published in Pajer et al. (2017) [115].
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Figure 4.2: Ancient DNA damage patterns. The frequencies of the mismatches observed between
the orthopoxvirus reference sequences and the reads are shown as a function of distance from the 5’
end. C→T (5’) and G→A (3’) mutations are shown in red and blue, respectively. All other possible
mismatches are shown in grey, and bases with soft-clipping are shown in orange. The number of
reads matching the orthopoxvirus reference sequence for each sample is shown in parentheses.
Sequence Suggested breakpoints Detecting algorithm (P value)
aVARV-VK382 7928 (7624–8106) and 8189 (8110–8285) 3Seq (8.27x10-3), BootScan (2.619x10-6),
GENECONV (3.683x10-4)
aVARV-VK470 1034 (undetermined) and 1942 (undetermined) GENECONV (2.337x10-3)
Table 4.3: RDP4 recombination analysis. An RDP4 analysis found evidence of recombination in
only small regions of three of the aVARV sequences. The suggested breakpoints offsets are for the
ungapped sequences and indicate the most likely breakpoint location, followed by the 99% confi-
dence interval of the breakpoint if determined. Detecting algorithms are followed by the average P
value in parentheses. aVARV-VK388 was the suggested major parent in all cases, with an unknown
minor parent. In all cases the RDP4 program issued the caveat that the proposed recombination
signal may be attributable to a process other than recombination. No recombination signal was de-
tected with aVARV-VK388 as the recipient sequence. No evidence was found to suggest that any
other sequence in the selection is the product of recombination involving any aVARV sequence.
Table contributed by Terry Jones.
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To establish the phylogenetic placement of the three sequences from the high-coverage
samples in relation to the overall diversity of the orthopoxviruses, we inferred an ML
tree including sequences from the three high-coverage samples and 84 sequences
chosen to represent the full orthopoxvirus diversity. The resulting tree (Figs. 4.9b,
4.3) shows that the Viking age sequences form a now-extinct monophyletic ancient
VARV-like (aVARV) clade in a sister relationship with the clade consisting of all
modern VARV and VARV-VD21 (collectively referred to as mVARV).
The evolutionary placement algorithm implemented in EPA-ng [284] can be used to
place reads or partial sequences into a previously-inferred phylogenetic tree. Con-
firming the presence of the aVARV clade, the algorithm places seven of the eight
Viking age low-coverage samples (VK108, VK168, VK255, VK281, VK359, VK515,
and VK533) within the aVARV clade, and the other low-coverage Viking age sample
(VK138) on the branch connecting the mVARV and aVARV clades. The two low-
coverage samples dated to the 19th century (FIN1 and KHA1), are placed within the
mVARV clade (Figs. 4.1b, 4.4).
A prior condition for making dated phylogenetic trees is the existence of a temporal
signal in the sequence data. A linear regression of root-to-tip distances from an ML
tree that includes sequences from the high-coverage samples and mVARV shows
clear evidence of clock-like evolution (Fig. 4.5), supporting earlier results [116,277].
Consequently, we proceeded to infer dated coalescent trees using BEAST2 [150]
under six different evolutionary models (Table 4.4). Under the best-fitting model,
the MRCA of the combined mVARV and aVARV sequences is dated to 1.6 thousand
years ago (kya) (95% highest priority density interval (HPD95): 2.1–1.4 kya). The
age of the aVARV clade is estimated to be 1.5 kya (HPD95: 1.7–1.3 kya). The age of
the MRCA of the mVARV clade is dated to 0.43 kya (HPD95: 0.47–0.35 kya), and
0.3 kya (HPD95: 0.42–0.2 kya) for the mVARV clade without VARV-VD21, both of
which are in line with previous molecular dating analyses [115,116,277,278] (Table
4.5, Fig. 4.6).
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Figure 4.4: Best placements of low-coverage samples. The maximum likelihood tree from Fig.
4.3 showing the most likely placements of confirmed (blue) and likely (red) samples. Terminal
branch lengths of low-coverage samples are likely elongated because of increased inaccuracies in
the consensus sequences, due to low coverage. The x-axis denotes substitutions per site (s/s). The
tree is rooted with Akhmeta_NA_NA_MH607143_Vani_2010. Figure contributed by Martin Sikora.
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Figure 4.3: Maximum likelihood tree of the orthopoxviruses and the Viking age high-coverage
samples used for EPA analysis. Sequences were aligned using MAFFT. The tree was inferred
using RAxML-ng with a K81uf+G+I substitution model, and an ML estimate of tree topology,
branch lengths, substitution rates, and nucleotide frequencies and support estimated using 1000
bootstrap replicates. Ancient sequences from this publication are shown in red, the ancient se-
quence from Duggan et al., (2016) in blue [116]. Taxon names: virus/historical period, sample
age relative to 2017, country abbreviation of sequence origin and region of sequence origin, as
determined by the Standard country or area codes for statistical use, accession number/sample iden-
tifier, additional remarks. The x-axis denotes substitutions per site (s/s). The tree is rooted with
Akhmeta_NA_NA_MH607143_Vani_2010.
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Figure 4.5: Linear regression of root-to-
tip distances against sampling dates. Root-
to-tip distances were extracted from an ML
tree including the three high-coverage sam-
ples and mVARV sequences using TempEst
[225], with the ‘best-fitting-root’ option. The
regression analysis was performed in SciPy
[226]. Shaded areas represent 95% confidence.
Mean sample ages were used. The slope is
4.09x10-6 and the correlation coefficient is 0.99
(R2=0.99).
Model (molec-
ular clock, pop-
ulation prior)
Strict,
coalescent
constant
Strict, coa-
lescent ex-
ponential
Strict,
Bayesian
skyline
Log-
normal
relaxed,
coalescent
constant
Log-
normal
relaxed,
coalescent
exponen-
tial
Log-
normal
relaxed,
Bayesian
skyline
Likelihood -152877.65 -152876.67 -152870.85 -152807.89 -152807.42 -152801.48
Strict, coales-
cent constant
-152877.65 0 0.98 6.8 69.76 70.23 76.17
Strict, coales-
cent exponen-
tial
-152876.67 -0.98 0 5.82 68.78 69.25 75.19
Strict, Bayesian
skyline
-152870.85 -6.8 -5.82 0 62.96 63.43 69.37
Log-normal
relaxed, coales-
cent constant
-152807.89 -69.76 -68.78 -62.96 0 0.47 6.41
Log-normal
relaxed, coales-
cent exponen-
tial
-152807.42 -70.23 -69.25 -63.43 -0.47 0 5.94
Log-normal re-
laxed, Bayesian
skyline
-152801.48 -76.17 -75.19 -69.37 -6.41 -5.94 0
Table 4.4: Model testing for different clock models and population priors. Models were com-
pared using path sampling, as implemented in BEAST2. Log marginal likelihood values (‘like-
lihood’) were compared using a Bayes factor test. A positive value for the Bayes factor implies
support for the column model, a negative value support for the row model. According to Kass and
Raftery, a Bayes factor in the range of 3–20 implies positive support, 20–150 strong support, and
>150 overwhelming support [229].
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Model (molecular
clock, population
prior)
Median root ages Substitution
rate (s/s/y)
Root aVARV clade mVARV
clade
VARV clade
Strict, coalescent
constant
1692 (1556,
1841)
1520 (1443,
1596)
433 (403,
470)
330 (297, 368) 4.99x10-6
(4.36x10-6,
5.61x10-6)
Strict, coalescent
exponential
1697 (1572,
1847)
1522 (1448,
1603)
435 (404,
471)
335 (303, 370) 4.97x10-6
(4.34x10-6,
5.62x10-6)
Strict, Bayesian
skyline
1697 (1566,
1845)
1522 (1446,
1599)
435 (403,
471)
336 (302, 371 4.98x10-6
(4.36x10-6,
5.65x10-6)
Log-normal re-
laxed, coalescent
constant
1578 (1349,
1957)
1451 (1323,
1607)
424 (349,
556)
303 (203, 408) 5.54x10-6
(4.12x10-6,
6.94x10-6)
Log-normal re-
laxed, coalescent
exponential
1724 (1391,
2301)
1513 (1348,
1731)
430 (348,
556)
303 (209, 412) 5.05x10-6
(3.49x10-6,
6.55x10-6)
Log-normal re-
laxed, Bayesian
skyline
1636 (1364,
2138)
1472 (1330,
1664)
434 (346,
570)
304 (203, 423) 5.37x10-6
(3.9x10-6,
6.91x10-6)
Previously pub-
lished
Duggan et al.,
2016 [116],
Strict, coalescent
constant
372–429 224–283 8.5x10-6
(7.3x10-6,
9.6x10-6)
Smithson et al.,
2017 [278]
454–568 345–457 No rate pub-
lished
Pajer et al., 2017
[115]
667 322 No rate pub-
lished
Porter et al., 2017
[277]
372–463 / 375–
419
5.44x10-6
(4.73x10-6,
6.16x10-6)
/ 8.27x10-6
(7.48x10-6,
9.10x10-6)
Table 4.5: Median root ages and substitution rates inferred using BEAST2 under different
clock models and population priors, compared to previously published estimates. Numbers
in parentheses indicate 95% highest posterior density intervals. A TPM1 substitution model with
unequal base frequencies, invariant sites, and gamma distributed rate heterogeneity among sites was
used throughout.
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Figure 4.6: Maximum clade credibility tree inferred with BEAST2. A log-normal relaxed clock
and coalescent Bayesian skyline population prior are used, as well as a TPM1 substitution model
with unequal base frequencies, invariant sites, and gamma distributed rate heterogeneity among
sites. The substitution rate is inferred as 5.4x10-6 s/s/y (95% HPD interval: 3.9x10-6 to 6.9x10-6
s/s/y), and the root age as 1,636 years old (yo) (95% HPD interval: 1,364 to 2,140 yo). The x-axis
denotes time into the past, in years. aVARV sequences in this paper are shown in red, the ancient
sequence from Duggan et al., 2016 [116] in blue. Taxon names: virus/historical period, sample
age relative to 2017, country abbreviation of sequence origin, accession number/sample identifier,
additional remarks. Horizontal grey bars indicate 95% HPD intervals of node ages. P-I and P-II
refer to primary clade I and primary clade II, respectively [289].
113
4. ANCIENT VARIOLA VIRUS
Several genes are inactivated or lost in mVARV viruses compared to other orthopox-
viruses, possibly due to host adaptation [270, 274]. We therefore compared and con-
trasted the gene content of sequences from the three high-coverage aVARV samples,
mVARV, plus CMLV and TATV (the orthopoxviruses most closely related to aVARV)
(Figs. 4.7a–d). We find a gradual inactivation of genes over time (Fig. 4.8). Loss of
host-range genes has been correlated with an increase in host specificity [273], sug-
gesting that the aVARVs may have had a broader host range than mVARV. However,
host range in poxviruses is likely to be a multigenic trait depending on the cooper-
ation of several genes, as is the case in myxoma virus [290] and VACV [291–295].
The differential pattern of gene inactivation thus does not necessarily imply that the
aVARVs had a host tropism for animals other than humans, although this is a possi-
bility.
We next considered the presence and inactivation of specific genes (Fig. 4.9), by
first examining the pattern within the aVARV clade, and then comparing that to the
pattern in the mVARV clade.
Within just the aVARV clade, we observe a diverse pattern of gene inactivation, (Figs.
4.7a–d), 4.9) among 14 genes that are inactivated in some, but not all, of the se-
quences from high-coverage samples. These results show that the overall consistent
pattern of gene loss and inactivation in mVARV was preceded by a period during
which there were co-circulating VARV strains with a diverse pattern of gene inacti-
vation. Diversity within the aVARV clade is further supported by the phylogenetic
placement of the low-coverage samples (Fig. 4.4). Geographic dispersion and mo-
bility in the Viking Age with subsequent isolation, may have led to the creation and
co-circulation of the diverse lineages in the aVARV clade. The uniformity in the
mVARV clade may reflect the eventual dominance of one particular strain. Before
that state was reached, and because different subsets of genes can evidently be lost
independently, the virus appears to have performed a simultaneous parallel explo-
ration of the space of possible combinations of gene inactivation, as shown in the
aVARV clade.
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Figure 4.7: Similarity and presence and inactivation of genes in the ancient samples. a) VARV-
VD21. b) aVARV-VK382. c) aVARV-VK388. d) aVARV-VK470. Genes are shown on the x-axis.
The figures are split in two parts. The bottom part shows the presence (filled in circle), absence
(empty circle) and inactivation (plus sign) of genes in black in the 17 orthopoxvirus reference se-
quences from Dataset 3. The top part shows the similarity of the reads from an ancient sample to
the modern gene sequence. If an ancient sample had reads covering more than 50% of the reference
gene sequence, and the median bit score was within 2 of the highest median bit score for a particular
gene, a coloured dot is shown in the row of the modern virus in question. The row labelled ‘High-
est’ indicates the reference sequence with the highest bit score for each particular protein. A black
square indicates that the modern reference sequence of a gene is inactive. A plus sign indicates a
gene-inactivating mutation in the ancient consensus sequence, and a minus sign indicates an uncer-
tain gene-inactivating mutation in the ancient consensus sequence. Black triangles in the top two
rows indicate known host range [273] and diploid genes [270], respectively. Five genes on either
side of the genome are greyed out and were not considered in other analyses, since they are diploid
and identical. Gene labels correspond to the end offset of the gene in CPXV-Gri/GER, the name of
the VACV-COP homolog, if applicable, separated by ‘|’. A figure with better resolution can be found
at http://antigenic-cartography.org/barbara/phd-thesis/.
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Figure 4.8: Gene inactivation over time. The number of genes with gene-inactivating mutations is
shown on the y-axis, plotted against time (in years before present) on the x-axis. The evolutionary
relationships between the nodes and tips (as given by the ML tree in Fig. 4.1) are indicated by solid
lines. Dates for internal nodes are taken from the dated coalescent tree in Fig. 4.6, estimated using
a relaxed log-normal clock and a Bayesian skyline population prior. Gene counts for internal nodes
are inferred based on identical gene-inactivating mutations in their descendant viruses. Note that
no age has been inferred for the node ancestral to CMLV, TATV, and the ancestor of mVARV and
aVARV, because those viruses evolved in different hosts. Therefore, the root node is shown on the
left-hand side of the figure at an arbitrary time point, and is connected by dotted lines to indicate the
uncertain timing of gene inactivations en route to those three descendant nodes. Blue dots indicate
counts of gene-inactivating mutations that can be determined with certainty (including genes that are
absent in VARV and that have no coverage in the ancient samples). The counts for the data points
plotted with an ‘x’, vertically above tips or internal nodes, also include gene-inactivating mutations
that cannot be identified with confidence and genes with no coverage in the ancient samples when
they have coverage in VARV.
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Figure 4.9: Gene-inactivating mutations. The cladogram on the left shows the topology
of the phylogenetic relationship between the mVARV, the aVARV sequences we report in
this paper, and TATV and CMLV (see trees in Figs. 4.1b), and 4.6). Each row to the right
corresponds to the virus at that level in the cladogram, including rows with inferred gene state
for internal nodes (top six rows). The 54 columns represent genes that are either absent or
that have an inactivating mutation in at least one of the virus rows. Genes with inactivating
mutations for a particular virus or node are shown in red, and those that cannot be identified
with certainty (Materials and Methods) in grey. Genes that are absent in a modern virus are
dark blue, and those with no coverage in VARV-VD21, and the aVARV sequences are light
blue. In cases where full coverage might not be available (VARV-VD21 and the aVARV
sequences), genes with partial coverage are marked with a black dot. Gene labels indicate
the final offset of the gene in CPXV-Gri/GER and the name of the VACV-COP homolog
[270], if applicable, separated by ‘|’. Genes are grouped into eight categories: A) Inactivated
in mVARV and aVARV sequences. B) Inactivated in mVARV and uncertain inactivations
in some but not all aVARV sequences. C) Inactivated in mVARV, but present in aVARV
sequences. D) Inactivated in mVARV, but present in some but not all aVARV sequences.
E) Inactivated in mVARV, and uncertain inactivations in aVARV sequences. F) Present in
mVARV, but absent in some aVARV sequences. G) Present in mVARV, but with uncertain
inactivations in some aVARV sequences. H) Absent or no coverage in mVARV and aVARV
sequences, and with gene-inactivating mutations in CMLV or TATV.
To focus on the differences between the mVARV and aVARV clades, we organized
gene presence or inactivation status into eight categories, A–H (Fig. 4.9, and Ap-
pendix A). We found three groups of these categories of particular interest: genes
inactive in both clades (categories A and B), genes inactive in mVARV but active in
at least one aVARV sequence (categories C, D, and E), and genes active in mVARV
but inactivated in at least one aVARV sequence (category F).
In the first group of interest (genes inactive in both clades), the exact position of mu-
tations in genes that are inactivated in both mVARV and aVARV allows us to infer
whether intact genes were likely present in the common ancestors of these viruses
(Fig. 4.9, Appendix A). Of the 16 genes that are inactivated in both mVARV and
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aVARV, five (A25L, A37R, A39R, C8L, and possibly 20088) have an identical in-
activating mutation in the mVARVs and aVARVs (category A and B in Fig. 4.9,
Appendix A). This indicates a single introduction of the ancestor of mVARV and
aVARV into humans, and the continuous evolution of VARV in humans for at least
the last ∼1600 years. This is as opposed to multiple independent introductions with
subsequent gene-inactivating mutations in identical positions in all five genes. The
other 11 genes that are inactivated in both clades, but in different ways, suggest a de-
gree of parallel evolution within the human host after the divergence of the mVARV
and aVARV clades.
In addition, a gene inactivated in both mVARV and aVARV may have induced a
similar outcome after infection of humans. The VACV gene encoding a soluble
IL-1β receptor is inactive in VACV strain Copenhagen (VACV-COP) (gene B16R)
but functional in VACV strain Western Reserve (VACV-WR) where it is called gene
B15R [296]. Infection of mice with either VACV-COP or VACV-WR in which the
gene B15R was inactivated, resulted in a febrile response [276]. Conversely, infec-
tion with either virus expressing a functional IL-1β receptor prevented the induction
of fever [276]. Human infections with VARV, which all have a disrupted B16R gene,
are accompanied by high fever [10]. The absence of B16R in the aVARV clade may
suggest that disease caused by those viruses also included high fever.
In the second group of interest (categories C, D, and E in Fig. 4.9), 16 genes are
inactivated in mVARV but are present or have an undetermined status in some or all
of the aVARV sequences. Nine of these genes (B7R, A40R, C2L, K1L, F3L, A35R,
A52R, A55R, and CrmE) encode known virulence factors or immunomodulators in
VACV, three of which are members of the kelch-like family (C2L, A55R, and F3L,
Appendix A) [7]. Deletion of the kelch-like proteins C2L or A55R in VACV-WR
leads to increased lesion size in intradermally infected mice [297, 298], while the
virulence of VACV lacking F3L is reduced in the same model [299]. Deletion of
kelch-like proteins has also been proposed to reduce the host range and virulence
of CPXV-GRI90 in vitro [300]. Also in contrast with mVARV, aVARV-VK382 and
aVARV-VK388 encode a predicted functional guanylate kinase (A57R). This gene
is otherwise only active in CPXV, and appears to have been lost independently in
CMLV, TATV, mVARV, and aVARV-VK470 (Appendix A), suggesting that the gene
was functional in their common ancestor.
Finally, in the third group (category F in Fig. 4.9), two genes (E5R and C1L) are
inactivated in at least one aVARV but in none of the mVARV sequences. The effect
of the inactivation of E5R and C1L in VACV is unknown.
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Hypotheses regarding the earliest history of VARV have been derived exclusively
from often ambiguous historical accounts, and the visual examination of mummies
dating from as early as 3570 ya [279, 280]. The aVARV sequences push the date of
the oldest definitive VARV infections back by ∼1000 years. The dates of the earliest
likely presence of smallpox in specific regions are difficult to determine from written
records and have in some cases been a matter of dispute [10, 279, 280, 301]. Ancient
DNA sequences can resolve such questions by providing clear evidence of VARV
presence in time and space. The dating of the aVARV samples, from as early as
550 CE, matches that of multiple written accounts of likely smallpox infections in
southern and western Europe from the late 6th century onwards [10, 279, 280, 301–
303]. Our finding of the virus in northern Europe at these times disproves various
suggestions of first introductions involving later dates. For example, the introduction
(or later establishment) of smallpox into Europe via returning Crusaders [10, 272],
into Europe via Spain during the Moorish invasion of 710 CE [272], or into England
by Norman invaders in 1241–2 CE [304], as well as the claim that the virus had not
reached northern Europe by 1000 CE [10]. The written record, together with the
confirmed aVARV infections, suggest a pan-European presence of the virus by the
end of the Viking Age at the latest, as has been suggested for parts of southern and
western Europe based purely on written records [279, 280, 302].
We found evidence of VARV in 11 of 555 Viking age individuals (∼2%). If aVARV,
like mVARV [10], did not lead to persistent infections and if no viral particles re-
mained in teeth or bone following an acute infection, these individuals all died with
an active infection. The 11 samples we identified as positive were likely not the only
infections however, because the presence of viral DNA in ancient teeth and bones is
almost certainly an imperfect diagnostic test of viral infection and because VARV is
not thought to be viremic for the entire duration of the illness [10]. We can consider
what this 2% figure might indicate, depending on the character of aVARV infections
in northern Europe during the Viking Age. If the infections were very rarely fatal, as
with modern variola minor [10,280], the rate would represent an overall approximate
prevalence of VARV. At the other extreme, if the disease was often fatal, as observed
for variola major [10, 280], apart from two individuals who died of other causes, it is
possible that all nine others died as a result of their infections. In that case, the rate
might be indicative of the overall percentage of deaths due to smallpox. Both num-
bers would be an underestimate, due to the imperfect diagnostic test. By comparison,
the London Bills of Mortality show a percentage of deaths due to smallpox as ∼2%
in 1650 CE [305].
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The Viking age VARV samples reveal a now-extinct virus clade with a diverse pattern
of gene inactivation that differs markedly from modern viruses. Following a single
introduction ∼1.6 kya, VARV followed at least three parallel evolutionary paths. This
surprising new snapshot of the evolution of the virus comes from a restricted geo-
graphic and temporal range. Given the long global spread of smallpox, it can be
expected that additional ancient sequences will further increase our knowledge of the
diversity and evolution of VARV.
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In the previous three chapters, I showed that it is possible to recover hepatitis B virus
(HBV), human parvovirus B19 (B19V), and variola virus (VARV) genomes from hu-
man DNA samples up to ∼4,500, ∼6,900, and ∼1,400 years old, respectively. Another
group has concurrently showed the same for a ∼7,000 year old HBV sequence [112].
The previous chapters have presented the three largest datasets of ancient viral se-
quences described to date. In the absence of ancient sequences, our understanding
of important aspects of viral evolution has been based on extrapolations from mod-
ern data. Upon inclusion of the ancient sequences, we find a complexity of virus
evolution that had not been appreciated when only modern sequences were consid-
ered:
− The close sequence similarity of some of the ancient HBV and B19V se-
quences to sequences of genotypes still circulating today is surprising, given
the fast substitution rates observed when considering modern sequences of
those viruses [37,126,157,158]1. In particular, nine out of twelve ancient HBV
sequences, the oldest of which is ∼4,300 years old, and all ten available B19V
sequences (up to ∼6,900 years old), can be assigned to modern genotypes, ac-
cording to the genotype definition criteria used for modern sequences2.
− At the same time, the studies on ancient viral sequences revealed variants of the
virus that are now extinct, such as the high-coverage ancient VARV sequences,
or the ancient HBV sequences most closely related to modern non-human pri-
mate HBVs. This shows that virus diversity existed in the past which we have
no knowledge of when only considering modern sequences, and which could
change current interpretations about the origins of modern variants of those
viruses.
− Furthermore, dated coalescent trees inferred using modern and the ancient se-
quences show that for HBV and B19V, extrapolations of most recent common
1We observe between 92.5% to 98.7% and 95.2% to 98.2% sequence similarity to modern se-
quences, for HBV and B19V, respectively.
2For HBV, sequence differences within human genotypes are up to 7.5%, and up to 4.5% within
subgenotypes [193]. Furthermore, modern genotypes and subgenotypes are informally characterised
by sequence length, insertions and deletions, serotype, preferred transmission route, and pathogenicity
[193, 242]. Non-human primate sequences are not divided into genotypes. For B19V, genotypes are
defined based on sequence identity, with sequence difference ∼10% within genotype 1, and ∼5% within
genotypes 2 and 3 [243, 255].
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ancestor dates and substitution rates are very sensitive to the inclusion of the
ancient sequences. The results also call into question some of the current think-
ing about substitution rates (see chapter 5.1, below).
− The ancient sequences provide spatio-temporal reference points during the evo-
lution of particular viruses. This allowed us to revise narratives about timings,
origins, and first introductions of virus variants in certain geographic areas,
such as the postulated origin of HBV genotype A in Africa, or the presence of
the ancestor of modern VARV in Europe.
− Finally, the ancient sequences provide a catalogue of variation that has existed
in the past, which may highlight features of the virus that are more prone to
change in the future. These include the genes lost along the evolutionary path
to modern VARV, or the absence of the typical six nucleotide insertion for
HBV genotype A in the three oldest genotype A sequences. The phenotypic
characterisation of some of this variation may improve our understanding of
its fitness effects, the pathogenicity of the virus in the past, and the potential of
the virus to change in the future. This is exemplified by the work on the recon-
structed influenza A/H1N1 virus from the 1918 pandemic, which highlighted
an increased lethality in mice and suggested the presence of a novel cleavage
mechanism of the hemagglutinin [168]. Furthermore, studying the efficiency
of vaccines, antivirals, and diagnostic tests on the ancient viruses may provide
information about their utility in the future.
Even though ancient viral sequences have improved our understanding of the evolu-
tion of HBV, B19V, and VARV, a note of caution is appropriate at this stage. The
ancient sequences currently available (twelve, ten, and three (and an additional ten
low coverage) ancient sequences, for HBV, B19V and VARV, respectively) are a tiny
number over a very large temporal and spatial range, and it would be premature to as-
sume that they represent the final story about the evolution of HBV, B19V, and VARV.
Further ancient sequences will most likely expand and refine some of the conclusions
drawn in chapters 2 – 4, in particular about the spatio-temporal distribution of geno-
types, past genetic diversity, and divergence dates. While we have taken great care to
not make claims that are wrong due to the small amount of data that was available to
us, and make appropriate caveats, additional ancient sequences may not always agree
with the results presented in the previous chapters.
While studying the ancient sequences for each pathogen on its own offers valuable
insights into its evolution, I next expand on one overarching topic from the work on
both HBV and B19V, concerning the low substitution rates inferred for those viruses
126
5.1. SUBSTITUTION RATES
when the ancient sequences are included, as opposed to the high rates when only
modern sequences are considered.
5.1 SUBSTITUTION RATES
The substitution rates we estimated using the ancient HBV and B19V sequences and
a set of modern sequences are about an order of magnitude lower than the rates es-
timated using modern sequences alone. The decrease of substitution rates inferred
over longer timescales using the ancient sequences is in agreement with observations
that others have made: rates estimated using external calibrations such as dated fos-
sils or biogeographic events that can be millions of years old, are lower than rates
estimated using modern heterochronously sampled sequences, which may only span
a timescale of a few weeks to decades [37,152,161,162]. This phenomenon is called
the ‘time dependent rate phenomenon’ [161]. For viral substitution rates, it has been
shown that the process of rate decay with increasing sampling interval is gradual and
can be described with a power-law relationship [152]. Rate decay is similar for dif-
ferent Baltimore groups [152]. Using the ancient sequences, we can also observe
a somewhat gradual rate decay in the HBV and B19V datasets when subsequently
adding older sequences, although rates inferred from modern sequences alone are
higher, possibly due to the absence of temporal signal [113] (Fig. 5.1).
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Figure 5.1: Decrease of substitution rate
with increasing sampling interval in the
HBV and B19V datasets. Rates were
inferred under a strict clock and coales-
cent Bayesian skyline population prior for
datasets generated by successively adding
the next-oldest sequence (sequences of the
same age were added together). Rates com-
puted from modern sequences alone were
omitted, due to the suspected lack of tem-
poral signal. Modern rates were: HBV:
4.0x10-5, (95% HPD interval: 4.8x10-6,
1.0x10-4) s/s/y, B19V: 1.39x10-4, (95%
HPD interval: 9.01x10-5, 1.86x10-4) s/s/y.
Interestingly, VARV does not show the same downward trend of the substitution rate
as HBV and B19V when older ancient sequences are included. The rate we find
(5.4x10-6 s/s/y (95% HPD interval: 3.9x10-6 to 6.9x10-6 s/s/y)) is only slightly lower
than the rates Duggan et al., (2016) inferred using similar methods to us (BEAST 1.7
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[306] as opposed to BEAST2), both with and without the ∼360 year old Lithuanian
mummy sequence [116]. This may be caused by the already strong temporal signal in
the modern data alone, the relatively young age of the oldest ancient VARV sequence
(∼1,400 years) compared to HBV (∼4,500 years) and B19V (∼6,900 years), as well as
by the tree topology, where the ancient sequences fall basal to the modern sequences
in the tree, as opposed to within or between existing clades.
Ho et al., (2011) discuss possible causes of the discrepancies in substitution rate
observed over short and long timescales [161]. They include that substitution rates
observed over short timescales are inflated due to the presence of sequencing errors,
transient mutations, and calibration errors (such as assuming that the time of popula-
tion divergence and genetic divergence correspond). Substitution rates inferred over
long timescales may be underestimated due to substitution model inaccuracy and
inaccuracy when modelling rate heterogeneity among sites, resulting in underestima-
tion of saturation. Furthermore, changes in virus biology and selection pressure over
time may also lead to changes to the substitution rate over different timescales [161].
At least two of those possible causes are now considered unlikely: Since rate decay is
gradual over time and comparable between different Baltimore groups [152,162], ex-
planations that would result in discrete changes in substitution rate, or that would af-
fect viruses in different Baltimore groups differently, such as short-timescale changes
in virus biology or selection pressure, seem unlikely [38,152,307]. Also, deleterious
mutations may be removed quickly from the population, which would mean that they
have little effect on long term substitution rates [307].
The datasets used in this thesis have the widest time span ever used for molecu-
lar dating analyses of viruses based on heterochronous data. At the same time, the
viral diversity in these datasets is a severe under-sampling of the actual viral diver-
sity present during the time span the datasets cover. This is especially pronounced
at deeper time scales, since the modern viral diversity is more extensively sampled
(though most likely still incomplete). While the ancient sequences provide impor-
tant calibration points for molecular dating analyses, the under-sampling of the viral
diversity, especially at deeper timescales, likely impacts the result of such analyses.
I would like to focus on two areas that are affected by this. Firstly, under-sampling
can lead to difficulties in determining which mutations are fixed, and secondly, it
may exacerbate problems with adequately modelling the substitution process when
performing molecular dating analyses.
The substitution rate is defined as the rate at which mutations become fixed in the pop-
ulation, measured as substitutions per site in the genome per time interval [35]. ‘Fix-
ation’ refers to the process where at a particular site in the genome, one nucleotide or
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amino acid completely replaces another within a population [308]. The rate of fixa-
tion depends on the population size and the fitness effect of the mutation [308]. In a
dataset that is well-sampled in space and time, informally determining which muta-
tions are becoming fixed is relatively straightforward, via identifying positions with
changing frequencies of nucleotides or amino acids. However, in the context of stud-
ies on datasets that include sparsely sampled viral sequences thousands of years old,
there are two problems related to the word ‘fixed’ in the definition of the substitution
rate. The first is that as a result of the severe under-sampling of the viral diversity
in such datasets, we cannot know whether observed mutations are present in enough
individuals to be considered fixed. The second problem, more subtle, is that the word
‘fixed’ in the definition of the substitution rate contains an unacknowledged implicit
time component. In the almost ubiquitous ‘substitutions per site per year’, the ‘year’
unit of time is rarely considered, and has been an appropriate and useful yardstick for
datasets consisting of modern sequences only. Unless a nucleotide at a particular site
arises and never changes to another nucleotide, a substitution is only fixed over a cer-
tain time interval (1 day, 10 years, 100 years etc.) before being replaced by another.
But in the context of datasets including sequences thousands of years old, substitu-
tions that may look fixed over a timescale of a single year, may appear as transient
mutations over a much longer timescale. When looking at a set of sequences sampled
over a short time interval, many more substitutions appear as fixed, even though in
the long term they may change, or the lineages may go extinct. These two problems
mean that in the context of current ancient DNA studies of viral populations, there is
no clear understanding of what constitutes a fixed substitution, and therefore it is also
unclear which substitutions should be relevant in the calculation of the substitution
rate.
Models of sequence evolution are theoretically able to correct for multiple changes
at the same site [308]. Estimates of divergence dates with closely-related mod-
ern sequences sampled over short timescales correspond well with epidemiologi-
cal evidence of those divergence events. For example, by estimating the most re-
cent common ancestor of swine and human segments of the pandemic 1918 H1N1
virus, molecular dating analyses suggest the emergence of the virus shortly before
1918 [166]. Likewise, the divergence date of HIV group M corresponds well with
the growth of major cities in the area where ancestral forms of the virus can still be
found in wild chimpanzee communities [309]. However, current models of sequence
evolution may not be able to adequately correct for multiple changes at the same
site over larger timescales and large evolutionary distances [310], which may lead
to lower substitution rates inferred over large timescales. For example, Wertheim
and Kosakovsky Pond (2011) observed that purifying selection may lead to artifi-
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cially young divergence dates for modern heterogenously sampled pathogens [311].
Furthermore, using simulations, Soubrier et al., (2012) showed that not sufficiently
taking into account rate heterogeneity among sites leads to the underestimation of
substitution rates in a time-dependent manner [312].
Using the ancient sequences, I can show that substitution rates may not only depend
on the time scale of measurement, but also on the number of sequences of inter-
mediate age between the youngest and the oldest sequence included in the dataset.
For B19V, the substitution rate estimated with modern sequences and just the old-
est ancient sequence (DA251) is lower than the substitution rate estimated from the
same data but including the other nine ancient sequences of intermediate age (Fig.
5.2).
Figure 5.2: Kernel density estimation
of the substitution rate for B19V in-
ferred using all 10 ancient and the
modern sequences (complete, black), or
only the modern sequences and the old-
est (DA251) ancient sequence (complete-
individually, blue). The substitution rate
estimated using just DA251 and the mod-
ern sequences is lower than the substitution
rate estimated using all 10 ancient and the
modern sequences. The substitution rate
was inferred in BEAST using a strict clock
and coalescent Bayesian skyline population
prior.
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Furthermore, the substitution rate inferred for B19V genotype 1 and the oldest ancient
sequence (DA251) increases gradually as more ancient sequences with ages between
DA51 and the modern sequences are included (in this case samples NEO105, DA66,
and DA337) (Fig. 5.3). This pattern of rate decay as fewer intermediate sequences
are included may be additional evidence that the substitution model used is unable
to accurately model the substitution process when sequences of intermediate age are
not present in the data. Therefore, the fact that dating analyses incorporating ancient
sequences severely under-sample the viral diversity at deeper timescales may lead to
artificially lower substitution rates.
If we do have a model of sequence evolution that correctly accounts for all changes
that have taken place over the evolutionary history of a virus, or if we had access to
all sequences of a virus that ever existed, what would the substitution rate be? Given
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Figure 5.3: Substitution rates inferred
for B19V genotype 1 and the oldest an-
cient sequence (DA251, 6862 years old
(yo)), with different number of interme-
diate sequences also included. The sub-
stitution rate was inferred in BEAST using
a strict clock and coalescent Bayesian sky-
line population prior. The x-axis indicates
the number of ancient sequences included
with the modern genotype 1 sequences: 1:
DA251 only, 2: DA251 and either NEO105
(544 yo), DA66 (1,518 yo), or DA337
(3,967 yo). DA336 was excluded due to
its similar age to DA337 (4146 yo) and
its lower coverage. 3: DA251 and either
NEO105 and DA55, NEO105 and DA337,
and DA66 and DA337. 4: NEO105, DA66,
DA337, DA251.
the results in Fig. 5.3, one may argue that the rate would be closer to that observed
when we estimate rates using just the modern sequences.
While the ‘time dependent rate phenomenon’ can be caused by a number of factors,
substitution rates will always depend on the timeframe of measurement, unless we
have access to a subset of sequences representative of all changes that have taken
place over the evolutionary history of a particular virus (as indicated by the often
reasonable inference of events happening close to the present), or we have a model of
sequence evolution that can accurately account for the changes that have taken place
over the evolutionary history of those sequences. Substitution rates inferred over
long timescales using ancient viral sequences may therefore be an artificial construct
influenced by two factors. First, which mutations are considered as fixed, and over
which timescales. Second, (in the absence of evolutionary models able to account
for all intermediate changes, or sequences representative of all changes during the
evolutionary history of a virus), the timescale over which sequences are available for
analysis, including the youngest and oldest sequences, as well as the distribution and
diversity of sequences within that timeframe.
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5.2 LIMITATIONS, FUTURE WORK, AND ETHICAL
CONCERNS WHEN WORKING WITH ANCIENT
VIRUSES
The results presented in the previous three chapters improve our understanding of
the evolution of HBV, B19V, and VARV. Yet, there are a number of challenges when
studying ancient viruses. In the following section, I expand on the limitations that
studies on ancient viruses still face and avenues of future work.
First, as mentioned in chapter 1.3, the datasets that we screened for this thesis have
originally been sequenced to study human population genetics. The viral sequences
that are of interest to virologists, are only a by-product from the shotgun next genera-
tion sequencing that was used to generate the reads of the human genomes. Screening
data from such studies is a powerful approach for virus discovery, since a large num-
ber of individuals have already been sequenced, and will continue to be sequenced
in the future, thus increasing the chance of finding viral sequences. However, there
are two major downsides of this approach when studying ancient viruses, which I
have already touched on in chapter 1.2.1: one, current protocols for the sequencing
of genetic material from ancient remains only allows for the sequencing of DNA,
precluding us from finding ancient RNA viruses. Two, most likely only DNA viruses
which cause deadly acute or chronic infections with high viral titres in the blood can
be found in such data. This limits the viral species that can likely be detected using
this approach to a subset of all human pathogenic viruses, that includes hepatitis B
virus, human parvovirus B19, anelloviruses, orthopoxviruses, adenoviruses, and her-
pesviruses. In order to recover a more diverse set of viruses, different tissues could be
sequenced, such as mummified tissue [113, 114], formalin-fixed, paraffin-embedded
tissue [109], or other museum specimens [115]. Furthermore, it would be very in-
teresting to attempt to sequence RNA viruses from ancient specimens, since RNA
viruses exhibit rapid mutation rates, and can cause severe morbidity and mortality
among humans [35, 138]. Experience in the laboratory suggests that RNA degrades
more easily than DNA. The presence of cellular RNAses are assumed to quickly de-
grade RNA in a deceased individual. However, in conditions that disfavour RNase
activity, such as aridity, RNA degradation is influenced by the chemical properties of
the molecule [313]. The hydroxyl group at the 2’ position of the ribose can attack
the adjacent phosphodiester bond, resulting in hydrolytic cleavage of the RNA back-
bone. On the other hand, the hydroxyl group of the ribose increases the strength of
the N-glycosidic bond that joins the ribose and the base, making RNA less suscep-
tible to depurination and depyrimidation than DNA [313]. Finally, RNA is able to
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form secondary structures, which may favour its preservation in some cases. There-
fore, no clear evidence exists that RNA cannot persist over long periods of time un-
der ideal preservation conditions [313]. The presence of ancient RNA sequences
has been demonstrated in 1,400 year old cress seeds, as well as in an 723 year
old maize kernel [314], and most recently, in permafrost-preserved liver tissue of
a 14,300-year-old Pleistocene canid, and two wolf skins from before 1869 CE and
1925 CE [315]. Ancient viral RNA sequences have been sequenced by Smith et al.,
2014 [121], sequencing a 750 year old Barley Stripe Mosaic Virus, and by Peyam-
bari et al., 2018 [111], sequencing a 1000 year old plant virus. I am not aware of any
human RNA virus sequences older than the A/H1N1 influenza virus from the 1918
pandemic that have been sequenced so far, and this is certainly be an exciting av-
enue for further research [316]. In addition to sequencing of ancient DNA and RNA,
immunological (immunochromatographic detection, enzyme-linked immunosorbent
assay, and immunohistochemical analysis) and analytical (mass spectrometry) meth-
ods could provide insight into the presence of viruses in ancient samples, especially
in cases where nucleic acids cannot be recovered [57, 317].
Second, like studies based on ancient human genetics, studies of ancient viruses face
limitations in terms of DNA preservation [63, 68]. Whether or not viral DNA is pre-
served better or worse than endogenous or environmental DNA is currently unknown.
We also do not know whether ancient viral DNA generally persists inside a viral cap-
sid, thus possibly better protecting it from degradation than the host DNA [118].
Krause-Kyora et al., (2018) [112] identified HBV core proteins using liquid chro-
matography mass-spectrometry in samples ∼1000 and ∼7000 years old, suggesting
that at least for HBV, core proteins may be stable in the long term.
Third, identification of viral sequences in metagenomic samples, ancient or not, re-
lies on the presence of related sequences in public databases. Those databases are
almost certainly an under-representation of the total viral diversity [20, 29, 30], and
therefore it is possible that some ancient viruses are missed in the screening. Also,
even though the evidence on HBV and B19V suggests otherwise, it may be possible
that ancient viruses have diverged such that they cannot be detected using current se-
quence matching algorithms. The second part of this thesis introduces an unfinished
approach to solve this problem, matching unknown sequences based on predicted
secondary structures rather than by assign correspondence of nucleotides or amino
acids between two sequences, as employed by most currently used tools.
Apart from the biological limitations, there are a number of ethical issues surrounding
the work with ancient DNA and the viral sequences found therein.
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First, ancient material is a limited resource and taking a sample from a mummy or
skeleton for aDNA extraction is a destructive process. Apart from possible DNA,
teeth and bones may contain important morphological information, which is lost from
destructive sampling of ancient remains for DNA extraction. Care must thus be taken
to make sure the maximum amount of knowledge can be gained from an ancient
specimen, whether it is ultimately used for sequencing (be it through whole genome
shotgun sequencing or targeted capture), for morphological or isotope analyses, or
saved for later studies when technology may be more advanced.
Second, aDNA researchers have been criticised for being insensitive towards the
communities and descendants of the individuals from which the samples are taken
[318]. There is potential that the information gained from studying ancient genetic
material negatively affects the identity of communities and individuals, disputes over
territory and repatriation of remains, or leads to the release of stigmatising informa-
tion, such as disease susceptibility [318]. Who (and if) should be asked for consent
before sampling is often unclear, and may involve multiple stakeholders [318]. Since
the sequences presented in this thesis are from individuals that are not directly cul-
turally affiliated, this was not an issue here, but it may be in the future, should I begin
to study viral sequences from individuals with direct ties to communities.
Finally, there may be concerns about biosecurity and biosafety around the work on
ancient pathogens [34]. Some suggest that work on ancient samples may lead to the
unintentional exposure to or accidental recovery and release of intact and infectious
virus from ancient remains [34, 127]. Given what is known about decay kinetics of
DNA over time [68], it would be highly surprising to find infectious virus in ancient
remains. All viral sequences presented in the previous three chapters were assembled
from reads that showed damage patterns typical for aDNA, suggesting that no live
virus was present. Furthermore, no infectious VARV has ever been isolated, even
though researchers have tried to do so repeatedly using a variety of sampling ma-
terials, including museum specimens, samples recovered from permafrost, smallpox
scabs, and mummified material [319]. The same is true for unpublished attempts
to isolate the A/H1N1 virus from the 1918 pandemic from four samples found in
permafrost [320]. However, there has been one case of the recovery of a replication-
competent Pithovirus (Pithovirus sibericum) from permafrost [127]. Given the quick
degradation of DNA after the death of the host and the experience from the past
decades, the risk of recovering a viable virus from ancient material which subse-
quently leads to infections seems to be negligible, but care should be taken when
examining specimens where virus preservation may be suspected, such as samples
found in permafrost [319, 321]. Furthermore, there may be concerns about the pos-
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sibility that the work on ancient viruses could provide others with information that
could be used to do harm, for example mutations leading to higher virulence, trans-
missibility, or vaccine escape. Such information could come either from the exami-
nation of the sequence directly (requiring some previous knowledge of what may be
an interesting mutation), or from subsequent experiments performed on viruses res-
urrected based on an ancient sequence using reverse genetics. While researchers can
learn some phenotypic information about a virus from its sequence (such as HBeAg
status and serotype in HBV [242]), it is very difficult or impossible to draw con-
clusions about the virulence of a virus from the sequence alone, suggesting that the
sequence information of ancient pathogens itself is of limited concern. In some cases,
it may be possible to resurrect an ancient virus, or parts thereof, from the sequences
that are recovered during aDNA studies. Tumpey et al., (2005) have done so for
the A/H1N1 virus from the 1918 pandemic [168]. In such cases, the potential risks
from accidental or deliberate release of the resurrected virus and of possible findings
about mechanisms for increased virulence or transmissibility, need to be weighted
against the potential benefits, such as improved knowledge about the virus itself and
its evolution, the continuing usability of vaccines, diagnostic tests and antivirals, and
potential new targets for antiviral drug development. Phenotypic characterisation of
ancient viruses must be evaluated carefully, taking into consideration the cost and
benefits of doing and not doing the work [321].
5.3 CONCLUSION
The ancient viral sequences that were recovered from human remains provide a win-
dow into the past existence of three human pathogens. They reveal a surprising degree
of sequence conservation over time, but also new and unexpected features. Further
study of these ancient sequences will improve our understanding of virus biology,
allow us to improve the models used to study virus evolution, and may lead to a bet-
ter understanding of disease burden and mortality in the past. Future sequencing of
ancient viruses from different sample types, animals other than humans, and of an-
cient RNA viruses, will further advance our understanding of virus evolution. The
research area of studying viral sequences recovered in ancient remains is still in its
infancy and future discoveries surely await.
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The goal of sequence matching in the context of metagenomic analyses is to iden-
tify an unknown sequence by comparing it to one or multiple known reference se-
quences. This information can then be used for example, to identify the species
in a sample (e.g., [86, 322, 323]), to estimate species abundance (e.g., [322, 324]),
and to profile microbial community function (e.g., [324]). Sequence matching al-
gorithms have been used to study the microbial composition of many environments,
including patient samples [325], sea water [323], sewage [322], and ice cores [86],
to name just a few. At least 70 tools for matching unknown sequences generated by
NGS technology to reference genomes have been published since 2007, concurrent
with the advent of NGS technology [26]. Methods for sequence matching can be di-
vided into those that are alignment-based and those that are alignment-free [27,326].
Alignment-based methods compare sequences by looking for the correspondence be-
tween nucleotides or amino acids in the query1 and the subject, with some leniency
built in for mismatches and gaps, depending on the algorithm. Alignment-free meth-
ods do not produce an alignment. Instead, they compare the query and the subject
by looking at measures not related to the correspondence of nucleotides or amino
acids between the two sequences, such as the frequencies of subsequences of a pre-
determined length [326].
Methods for alignment-based sequence matching typically rely on either hash tables
or the Burrows-Wheeler transform [26]. Algorithms based on hash tables first ex-
tract subsets of nucleotides or amino acids, called ‘words’, from the subject. A hash
function converts each word to a location in the hash table, where the nucleotide
or amino acid position of the word in the subject is stored. Words can either be
contiguous stretches of nucleotides or amino acids of pre-determined length, or they
can be ‘spaced’, where within a stretch of nucleotides or amino acids, only a sub-
set is taken into account. In the second step, the algorithm extracts words from the
query using the same method used for the subject, and screens for identical words
in the query and the subject using the hash table. Subsequently, the matching algo-
rithm extends the alignment from the initial matching words, using dynamic program-
ming and an algorithm-dependent scoring function, to account for mismatches and
gaps [26]. One of the most widely used tools for sequence matching, the basic local
1In the subsequent sections, I refer to the unknown sequence as the ‘query’ and the known reference
sequence the query is compared to as the ‘subject’, following the language of BLAST [25].
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alignment search tool (BLAST) and its variants2, are based on hash tables [25, 26].
Some tools based on hash tables do not extend the alignments, and instead classify
queries directly from the initial matching words. Examples are ‘Kraken’ and ‘Tax-
onomer’ [281, 327]. The absence of the extension step greatly increases the speed
of these algorithms [281, 327]. Using simulated data with reads on average 92 bp
in length, Kraken and Megablast classify 1.5 million and 7,143 reads per minute, re-
spectively, with comparable accuracy [281]. Methods based on the Burrows-Wheeler
transform include BWA [206] and Bowtie 2 [282]. The Burrows-Wheeler transform
takes a subject and returns a sorted sequence and an index. The index allows fast
look-up of queries in the subject [26]. Aligners based on Burrows-Wheeler trans-
formations are generally faster than aligners based on hash tables followed by the
extension of the alignment from the initial word match, since the costly extension
step is mostly avoided [26].
Alignment-free methods quantify sequence similarity without taking into account
the correspondence of nucleotides or amino acids in the query and the subject [326].
Most alignment-free methods are either based on the statistics of k-mer frequencies
(‘k-mer-based’ methods), or methods that evaluate the information content between
full-length sequences (‘information theory-based’ methods) [326]. Methods based on
k-mer frequencies assume that similar sequences share similar k-mers (subsequences
of length k). Such methods extract all possible k-mers of a predetermined length
from the query and the subject, and construct k-mer frequency vectors for each se-
quence. The similarity between the two vectors can be measured using for example,
the cosine of the angle between the two vectors. Alternatively, the distance between
the endpoints of the vectors in high-dimensional space can be measured using a dis-
tance measure, such as Euclidean distance [326,328]. Furthermore, k-mer frequency
vectors of known sequences can be used to a train machine learning algorithm, such
as a Naive Bayesian Classifier, to identify k-mers from an unknown sequence [329].
k-mer based methods include NBC [329] and TETRA [330]. Methods based on in-
formation theory investigate the amount of information shared between the query
and the subject using measures of complexity and entropy. The complexity of a se-
quence can be measured using compression algorithms, as more complex sequences
are less compressible [326]. If the compression of the concatenation of two sequences
is similar to the compression of each sequence individually, the sequences are of
2Five different variants of BLAST exist (parentheses indicate whether the query (first element in the
parentheses) or the subject (second element in the parentheses) are nucleotide or amino acid sequences):
BLASTn (nucleotide – nucleotide, three varieties: Megablast, discontinuous Megablast, BLASTn),
BLASTp (protein – protein, four varieties: BLASTp, PSI-BLAST, PHI-BLAST, DELTA-BLAST),
BLASTx (nucleotide – protein), tBLASTx (protein – nucleotide, six frame translation), tBLASTn (nu-
cleotide – nucleotide, six frame translation) [25].
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similar complexity [326]. Entropy approaches measure the uncertainty of finding a
given subsequence in a larger sequence (the rarer the subsequence, the higher its en-
tropy) [326]. Alignment-free methods used in metagenomic analyses are typically
based on k-mer frequencies [326].
Most studies attempting to identify viral sequences in NGS datasets use alignment-
based tools. Nooij et al., (2018) found that of 46 workflows published specifically
for virus metagenomics, 43 used alignment-based tools (26 of those were BLAST
variants) and three used profile Hidden Markov models (pHMM, see below). None
used alignment-free methods [331].
While the screening of NGS datasets from many sources has uncovered a large diver-
sity of previously unknown viruses [20, 29], there are still gaps in our knowledge of
virus diversity, such as an almost complete absence of RNA viruses recovered from
bacteriophages and amoeba [28, 29]. Our inability to find viruses in these parts of
the tree of life may partly reflect the inadequacy of current virus discovery methods,
alongside insufficient sampling and biological causes [28, 29]. When two homolo-
gous nucleotide or amino acid sequences have diverged such that the sequence sim-
ilarity between them is close to the level that would be expected between random
sequences, algorithms based on sequence similarity become formally unable to iden-
tify homologies without also producing an unacceptably large number of false posi-
tive matches, providing no hint as to how to differentiate between the false positives
and the true positives. Sequence matching algorithms based on Hidden Markov Mod-
els and position-specific scoring matrices aim to address this problem of identifying
sequences of homologous proteins that have diverged at the nucleotide or amino acid
level. Tools include Position-Specific Iterative (PSI)-BLAST [332], and the HM-
MER [333] and HH-suite [334] software packages. PSI-BLAST uses the significant
matches of the comparison of an amino acid query against an amino acid sequence
database using BLASTp, to build a position-specific scoring matrix. The position-
specific scoring matrix is then used to search for further matches, which are itera-
tively incorporated into the matrix. This allows the detection of similarity between
amino acid sequences for which BLASTp is not able to identify statistical similarity,
for example between the histidine triad proteins and galactose-1-phosphate uridylyl-
transferase proteins [332]. The HMMER and HH-suite packages both contain tools
to build pHMMs from multiple sequence alignments, to compare them against ref-
erence pHMMs or reference sequences, and to compare queries against reference
pHMMs [333,334]. pHMMs are probabilistic models that represent the evolutionary
changes in viruses based on a multiple sequence alignment. The pHMM contains
states that represent sites in the multiple sequence alignment, with probabilistic state
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transitions that summarise the insertions, deletions, mutations, and matches seen at
the site. Databases of viral pHMMs, such as vFam and viral OGs, are available for the
detection of viral sequences [335, 336]. pHMMs have been successfully used for the
identification of contigs of viral origin and to detect remote homologies among pro-
tein sequences thought to be genus specific in RNA viruses [337,338]. However, they
require long sequences to work well (sequences identified as viral using pHMMs by
Bzhalava et al., (2018) were on average 3,362 bp long) [337]. Furthermore, pHMMs
rely on multiple sequence alignments which are based on nucleotide or amino acid
sequences and require careful curation to adequately represent existing data and the
evolutionary relationships therein [339]. pHMMs are therefore dependent on the cur-
rently available reference sequences, which most likely do not adequately represent
the complete virus diversity [339]. Finally, some tools detect sequences that code for
specific viral proteins. For example, ViralPro allows the detection of highly diverged
phage proteins, such as the capsid and tail proteins, using a combination of pHMMs,
amino acid and secondary structure composition [340]. The disadvantage of such
tools is that they are of course restricted to a limited set of proteins and require long
(>3000 base pairs) or complete protein sequences to work well [340, 341].
In summary, currently available methods for the screening of NGS datasets for viruses
do not adequately address the problems posed by highly diverged viral sequences.
While it is possible to identify sequences that correspond to a certain virus protein,
like ViralPro does for the viral capsid and tail proteins [340], a general tool that can
identify highly diverged viral sequences does not yet exist. To be of practical use,
such a tool would need to be based on a computationally efficient algorithm, since
NGS datasets and reference databases frequently contain millions or billions of se-
quences, and it would need to work well in the face of distortion due to mutations,
insertions, deletions, and sequencing errors. Furthermore, the algorithm would ide-
ally be able to deal with the short sequences (between 50 to 600 base pairs in length)
generated by NGS technology.
6.1 TWO COMPONENTS OF A SEQUENCE MATCH-
ING ALGORITHM
When developing an algorithm for sequence matching, we found it useful to think
about two components separately: first, the alphabet that is used to compare se-
quences; and second, the algorithm that performs the comparison, based on the pre-
viously chosen alphabet. For example, BLASTn compares sequences based on a
nucleotide alphabet, using a hash table and dynamic programming [25].
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6.1.1 The alphabet
Current sequence matching algorithms typically use nucleotide or amino acid alpha-
bets [26, 326, 331]. Alphabets can be based on features that correspond to biological
function and that are easily interpretable by humans, but they need not be. What may
look like a big difference using one alphabet may not be detectable using another.
For example, a synonymous change will be visible using a nucleotide alphabet, but
will not be visible using an amino acid alphabet. We can exploit this phenomenon
for the comparison of highly divergent sequences. In order to detect relationships
between sequences that have no or limited similarity at the nucleotide or amino acid
level, one option is to think about the structure of the protein that the amino acid se-
quence folds into. The structure of a protein is more conserved than its sequence [32],
and major secondary structure elements retain conformation, even under consider-
able sequence divergence [342]. Thus, proteins without sequence similarity at the
nucleotide or amino acid level may still share a similar structure and it may be pos-
sible to exploit such structural information to detect highly diverged sequences. Two
examples highlight the potential of incorporating structural information when study-
ing viral sequences. By passing sequence as well as structural information to the
phylogenetic tree inference algorithm MrBayes, the support of a phylogenetic tree
of right-handed polymerases increases compared to a phylogenetic tree made from
sequence or structural information alone [343,344]. It has also been shown that using
a stochastic model of sequence-structure evolution, phylogenetic trees can be calcu-
lated with significantly reduced alignment and topological uncertainty compared to a
phylogenetic tree inferred using sequence information alone [345].
Using an alphabet that encodes information at the structural level may allow us to
compare structurally homologous sequences with limited similarity at the amino acid
level. To determine which structural features lend themselves to be incorporated into
such an alphabet, we can consider if there are any discrete components that make up
a protein structure. Protein structure refers to the three-dimensional arrangement of
atoms in a protein molecule. The shape of a protein is determined by its amino acid
sequence and by its environment. Four conceptual levels underlying protein structure
are differentiated [346]:
Primary structure: the linear sequence of amino acids in a sequence.
Secondary structure: secondary structures are formed when local regions of the
amino acid sequence fold into specific shapes. Protein secondary structures take the
forms of alpha helices, beta strands, beta sheets, and loops. The secondary structure
is determined by the pattern of hydrogen bonds formed between the amine hydrogen
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and the carbonyl oxygen atoms of the backbone of an amino acid. Alpha helices are
helical structures whose shape comes from the formation of regularly-spaced hydro-
gen bonds between the amine hydrogen and the carbonyl oxygen atom of the amino
acid backbone. Three different types of alpha helices are distinguished, according
to the number of amino acids per turn. The normal alpha helix has 3.6, the alpha
helix 3-10 has three, and the alpha helix pi has five amino acids per turn. Helices
are often positioned near the core of a protein. The part of the helix facing the inside
of a protein usually consists of hydrophobic residues, while the amino acids facing
outwards are hydrophilic. This leads to a typical repeated pattern of hydrophobic and
hydrophilic amino acids in alpha helices [347]. Beta strands typically consist of three
to ten amino acids. Beta strands have a propensity for valine, isoleucine, cysteine,
phenylalanine, tyrosine, and threonine [348]. If hydrogen bonds are formed between
the amine hydrogen and the carbonyl oxygen atoms of two different beta strands, they
form a beta sheet. The strands in a beta sheet can be orientated in a parallel or anti-
parallel arrangement. Loops do not have a defined structure and are typically found
at the surface of the protein. Residue side chains of amino acids in loops generally
do not form hydrogen bonds with other secondary structure elements.
Tertiary structure: the three-dimensional shape of a protein. The tertiary struc-
ture is produced by the folding of the secondary structure chain. It is governed
by bonds between amino acid side chains, such as hydrogen, ionic, and disulfide
bonds [346].
Quaternary structure: a protein with a quaternary structure is composed of two
or more separate, folded amino acid chains, also called subunits, joined together by
weak bonds. Not all proteins have a quaternary structure [346].
Apart from the shape of a protein, a number of other discrete structural features may
be identified. These include amino acids such as cysteine, which are involved in the
formation of disulfide bonds important for protein stability [349]. Further, regions
important for the function of a protein, such as catalytic sites, and sites involved in
the binding of metal ions, molecules or other proteins, are often short (3 – 20 amino
acids in length) and highly conserved [349]. Thus, in order to detect a match (i.e., in
our case, a structural correspondence) between highly diverged viral sequences, we
can use an alphabet representing features that can be identified from an amino acid
sequence, and that would be structurally conserved. These include the secondary
structures described above, amino acids most likely to be conserved (tryptophan,
cystein) [350, 351], sequence motifs [349, 352], and features based on amino acid
properties.
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6.1.2 The matching algorithm
Having decided on the features of the alphabet, we can think about the structure of
the algorithm that could be used to perform the comparison. Before designing a
sequence-matching algorithm to compare highly diverged biological sequences, it is
worth considering whether similar problems have been solved in other fields. In par-
ticular, the problem of rapidly comparing a fragment of an unknown pattern against a
large database of known patterns, and doing so in a way that is robust to differences
that may be present between two related patterns.
6.1.2.1 An analogy with music matching
The field of Music Information Retrieval is concerned with retrieving information
from audio signals. That information can then be used to compare pieces of music,
classify songs by genre, identify the artist, automatically transcribe notes or lyrics, or
search music collections [353]. Most relevant to the problem of biological sequence
comparison are strategies developed in the field of Music Information Retrieval that
enable the comparison of songs and song fragments. Broadly, two techniques can be
used to compare and search audio signals: systems based on metadata, often using
text-based search; and systems based on content, which compare audio signals based
on features within the audio data [353].
Metadata-based systems: the most common way to access music is through tex-
tual metadata. For example, the internet radio station ‘Pandora’ relies on a manu-
ally curated database of songs and their attributes to suggest songs to listeners that
they might like. Metadata can include the artist, song title, and genre, among oth-
ers. However, as databases become larger, maintaining good metadata becomes an
increasingly difficult task. For each song in Pandora’s database, it takes an expert
about 30 minutes to enter the metadata [353]. Some metadata based systems also
have the drawback that they do not allow the user to search for music that they do
not know how to construct a successful search for [353]. In the context of sequence
matching, metadata-based systems are not relevant.
Content-based systems: content-based systems identify music based on the con-
tent of the audio. The algorithms generally have two processing stages: in the first
stage, features are extracted from the audio recording, to reduce dimensionality and
to achieve a simpler representation that is easier to compare. In the second stage,
the features of two pieces of audio are compared, and distance between them is
calculated [354]. Two types of features can be extracted from an audio recording,
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generally described as high- and low-level features. High-level features use intuitive
musical concepts such as melody, rhythm, and harmony to describe the content of
the music [353]. Using high-level information allows, for example, query by hum-
ming applications, wherein music is identified and retrieved after the user hums a
melody [353]. However, extracting these high-level features is often difficult, for
example when multiple instruments are playing different melodies simultaneously.
Low-level features are not necessarily meaningful in a perceptual or musical way and
do not have to be interpretable by humans [354]. Such features can, for example, be
spectrogram peaks, which are time-frequency points that have a higher energy than
all their neighbours in a region centered around those points [355]. Others are spec-
tral subband centroids or spectral flatness [354]. In either case, features need to be
efficient to compute, robust to distortions and noise present in the audio, and must
be able to identify the recording unambiguously [354]. After feature extraction, the
feature vector of the unknown song or song fragment has to be compared against the
feature vectors of known songs stored in a database. In order to quantify the dif-
ference between the two feature vectors, a distance has to be calculated based on a
distance metric. Common distance metrics include correlation measures, Euclidean
distance, and Hamming distance [354].
Content-based systems of music retrieval share many similarities with sequence match-
ing. Firstly, it must be possible to compare a short audio fragment against a large
database of known songs. This is similar to the problem of comparing short nu-
cleotide or amino acid queries against a large database of known reference sequences.
Secondly, the identification of an audio fragment must be possible even if there is loss
of signal during recording or transmission, or ambient noise. Similarly, sequence
comparison must work even if there is noise from mutations, sequencing errors, or
recombination. Finally, given the high and increasing number of songs, and the large
number of comparisons that are made, an algorithm for music matching must be fast.
The same applies to sequence matching, where typically millions or billions of short
NGS sequences are compared against reference sequence databases which are rapidly
increasing in size. The similarities in the problems faced by content-based systems
of music retrieval and sequence matching algorithms just mentioned, suggest that
content-based music retrieval systems may offer a promising framework on which to
model algorithms for sequence matching.
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6.1.2.2 A closer look at the Shazam music-matching algorithm
Shazam is a commercial content-based music-matching algorithm, which implements
matching based on audio features, and allows the identification of songs based on
recordings of fragments of the original piece of music [355]. According to Avery
Wang, the developer of the Shazam algorithm ‘The algorithm is noise and distor-
tion resistant, computationally efficient, and massively scalable, capable of quickly
identifying a short segment of music captured through a cellphone microphone in the
presence of foreground voices and other dominant noise, and through voice codec
compression, out of a database of over a million tracks.’ [355].
Figure 6.1: Feature extraction in the Shazam algorithm. Reproduced from Wang, 2003
[355].
According to Wang’s publication from 2003 [355], the Shazam algorithm extracts
features from each song in the database as well as from the incoming song fragment.
The features are spectrogram peaks, which are peaks in a time-frequency plot (Fig.
6.1A). This reduces a complicated spectrogram to a sparse set of coordinates (Fig.
6.1B), which are easier to compare between songs. Shazam employs three criteria
when selecting features: features should be close to each other in time, so that dis-
tant events do not affect the feature. They also need to be reproducible independent
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of their position in the song, and robust to distortion due to recording or ambient
noise. And finally, each feature must contain enough information to limit the proba-
bility of false positive matches. In order to increase the information content of each
spectrogram peak, and to accelerate the search process, each detected peak is paired
with another peak: to achieve this, ‘anchor points’ are chosen, and the anchor point
is paired with points that are within a pre-defined target zone (Fig. 6.1C). Pairs of
points and the time interval between them form an entry in a hash table and map to
the time offset from the first of the two frequency points to the beginning of the song
as well as the title of the song (Fig. 6.1D). The pairs of points in the song sample are
compared to the pairs for each complete song in the hash table. For each matching
pair, the time offsets into the song fragment and the complete song are subtracted
and the resulting time differences are bucketed in a histogram. If there is a match
between a song in the database and the song sample, there will be many matching
pairs with an almost identical offset difference and the histogram will have a clear
peak. Shazam can correctly identify songs in the presence of considerable levels of
background noise. For a corrupted song fragment 15 seconds in length, the correct
song can be identified even if only 1–2% of all pairs in the song fragment actually
contribute to the match [355].
Shazam-like algorithms have recently been used for earthquake detection [356] and
the analysis of sequence data generated by the Oxford Nanopore MinION sequencer
[357], with reasonable and limited success, respectively.
6.1.2.3 Adaptation of principles of the Shazam algorithm to sequence
matching
The adaptation of principles from the Shazam algorithm for matching biological se-
quences is attractive for many reasons. First, the problems are conceptually similar,
with short fragments of linear patterns being compared against longer patterns. Sec-
ond, the fact that the Shazam algorithm performs 20 million searches per day [358] is
evidence that such algorithms can be scaled. Third, biological sequence comparison
can be based on secondary structures or other features in the amino acid sequence that
carry structural information. Identifying these with moderate accuracy may be rela-
tively fast, and ensures that the structural features considered can be found within the
short length of an NGS read. Fourth, due to the high number of entries in the database
and the statistical nature of the matching, the identification of structural features does
not have to be correct at all times. As with music matching, even a very high level of
noise may not inhibit rapid and accurate matching. Finally, the envisaged algorithm
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will not have to match features sequentially (in the order they occur in the sequence),
and may therefore be more robust to insertions and deletions.
The factors outlined above allow for optimism that using a Shazam-like approach,
it may be possible to construct an algorithm that will allow the matching of se-
quences based on predicted structural features. Chapter 7 of this thesis will provide
an overview of the current version of the ‘light matter’ algorithm we have developed
and chapter 8 presents preliminary results and discusses existing problems with the
algorithm and avenues for its improvement. Details of methods for evaluating the
algorithm during development, the structural features that were developed, methods
for assessing the significance of a match, and methods for scoring a match, are in
Appendix B. Additional results not presented in chapter 8 are in Appendix C.
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This chapter describes the basic structure of the ‘light matter’ algorithm. It is mod-
elled after the commercial music-matching algorithm ‘Shazam’, as published by
Wang in 2003 [355], due to the similarity of the challenges in sequence and music
matching that are outlined in the introduction of this part of the thesis.
The light matter algorithm takes amino acid sequences as input. In the following
sections, I refer to the unknown sequence as the ‘query’, and the known sequence
that the query is compared to as the ‘subject’, mirroring the terminology used by
BLAST [25].
The basic steps of the light matter algorithm are:
1. Identification and pairing of features in query and subject sequences.
2. Matching of paired features between query and subject sequences.
3. Histogram binning of matching pairs based on relative offset differences.
4. Identification of significant bins.
5. Scoring of matches with significant bins.
These basic steps will be outlined in more detail below. For descriptions on the
rationale and parameterisation of the algorithm, I include references to the relevant
sections in Appendix B.
1) Identification and pairing of features in query and subject sequences (Fig.
7.1a).
In order to compare two sequences, we identify features in the sequences that we
expect to be structurally conserved. Features must fulfil the following criteria:
1. Feature detection must be independent of the position of the feature in the
sequence, to allow the matching of features in sequence fragments to those in
complete sequences.
2. Features need to be robust to distortion from mutations, sequencing errors, or
insertions and deletions.
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3. Features need to be small enough so that it is possible to identify them in a
sequence of around 65 amino acids, due to the short length of reads typical of
Next Generation Sequencing (NGS) technologies.
In order to fulfil these criteria, we use secondary structures, sequence motifs, and
amino acids that are conserved, as well as features based on amino acid properties.
We divide features into two classes, landmarks and trigonometry (trig) points. Land-
marks correspond to secondary structures (e.g., alpha helices and beta strands), se-
quence motifs, and conserved amino acids, whereas trig points are based on the se-
quence of amino acid properties and different conserved amino acids than those used
by the landmarks. Once the features are identified, they are paired. We can enforce a
minimum and maximum distance between features that are paired, to ensure that pairs
do not involve features that are too close or too far from one another in the sequence.
Furthermore, we can limit the number of pairs that each feature can be involved in.
When pairing features, we allow a landmark to pair with a landmark or with a trig
point, but we do not allow trig points to pair with each other. For each landmark,
we first form pairs with all landmarks that are within the minimum and maximum
distances specified, moving from closest to farthest, and we then form pairs with all
trig points within the minimum and maximum distance specified, until the number
of pairs allowed per landmark is reached. Twenty-two landmark and six trig point
feature finders were implemented and are described in Appendix B.2.
2) Matching of paired features between query and subject sequences (Fig. 7.1b).
For each pair in the query and the subject, the feature identities, the distance between
the features, and the offset from the start of the sequence to the first feature in the pair
are stored. The information for the subjects is pre-computed and stored in a database.
The feature identities consist of a unique symbol for each type of feature, and option-
ally the length of the feature. Feature lengths and distances between features can be
scaled logarithmically and the scaled lengths will then be used for further processing
steps in the algorithm. This allows features to match, even if they do not have exactly
the same length, and are not exactly the same distance apart. Feature lengths are
by default scaled by using the integer part of the logarithm base 1.35 of the feature
length and the distance between features is scaled by taking the integer part of the
logarithm base 1.1 of the distance between features. The base of the logarithm can
be varied by the featureLengthBase and the distanceBase parameters, respectively.
Figure 7.2 shows the effect of scaling a distance of a particular length. Logarithmic
scaling scales similar longer distances to the same distance, thus reducing the sensi-
tivity of the algorithm. Finally, pairs in the query and the subject are compared. Two
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pairs match, if they have the same feature identities, separated by the same (scaled)
distance.
3) Histogram binning of matching pairs based on relative offsets (Fig. 7.1c, d).
If the subject and the query are similar, they should have multiple feature pairs in
common, with similar distances between their relative offsets. We call the distance
between their relative offsets the ‘delta’. Deltas from all matching pairs are entered
in a histogram. We can scale the deltas linearly (using the deltaScale parameter, Fig.
7.2) prior to entering them in the histogram, to allow matching pairs to fall into the
same histogram bin, even if they do not have exactly the same delta. If the subject and
the query have multiple feature pairs in common, at similar relative offsets (and hence
with the same deltas), the histogram will have a peak, identifying a match.
4) Identification of significant bins.
To automate the inspection of histograms and assess the significance of a match, we
need a quantitative metric to decide whether a histogram has one or more bins that
are high enough to be indicative of a significant match. We calculate a significance
cut-off defined as the theoretical maximum number of pairs that will be present in the
highest bin if there is a perfect match between the subject and the query, multiplied
by a user-defined significance fraction. Any bin that is higher than the significance
cut-off is considered significant. Different methods for determining significance, as
well as the rationale for choosing the current method to assess significance of bins,
are outlined in appendix B.3.
5) Scoring of matches with significant bins.
After a match with at least one significant bin has been identified, the features in the
pairs in the bin(s) need to be examined and assigned a score, reflecting the distance
between the two sequences. Given that we want to compare sequences using pre-
dicted structural features, this score should correlate with the structural reality. Two
types of scoring can be done, firstly by computing a score for each significant bin,
and only reporting the highest score, a ‘bin score’, and secondly, by computing an
‘overall score’, which incorporates information from multiple bins. The scores are
between 0.0 and 1.0, with 1.0 being the highest, representing full correspondence of
feature pairs between the query and the subject.
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Figure 7.1: Step 1–3 of the light matter algorithm. a) Identification and pairing of features in
query and subject sequences. Landmarks are shown in green, trig points in blue. Grey brackets
indicate which features are paired, assuming a maxDistance of 7. b) Matching of paired features
between query and subject sequences. Red brackets indicate matching pairs, the red shaded areas
show which pairs match, darker red shaded areas indicate overlapping pairs. c) Calculating relative
offsets (deltas). Deltas are calculated as the difference between the distances from the start of the
sequence to the first feature of the subject and the query. In c) orange brackets indicate the size of
the deltas, orange numbers their values. d) The histogram of deltas resulting from matching the
subject and query in this example.
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Figure 7.2: Scaling parameters. The dis-
tanceBase, shown in blue, scales the dis-
tance between two features in a pair using
logarithm base 1.1 of the distance. The fea-
tureLengthBase (red) scales the length of
a feature, where applicable, using a loga-
rithm base 1.35 of the feature length. The
deltaScale (orange) scales the deltas ob-
tained by subtracting the offsets of two
matching pairs, and here has been set to
1. Horizontally flat regions of the vari-
ous lines indicate regions of equality (e.g.,
for histogram binning) to group similar raw
values in order to reduce sensitivity due
to feature locations or lengths that do not
match exactly.
Three bin score methods were implemented (see Appendix B.4.1) and the one found
to be the most appropriate, which we call the ‘FeatureAAScore’, is described here.
The FeatureAAScore consists of a product of the score for the matched region and a
length normaliser. The score for the matched region is a fraction where the numerator
is the number of all amino acids in features in the subject and the query that match,
and the denominator is the number of all amino acids in features in the subject and the
query in the overall region spanned by all features in the bin. The length normaliser is
the count of all amino acids in features in the region of the bin divided by the count of
all amino acids in features in the whole sequence, for either the query or the subject,
depending on which fraction is higher. Note that the bin with the highest score may
not be the one with the highest number of pairs.
The overall score (called the ‘GreedySignificantBinScore’) is calculated using the
same principle as the FeatureAAScore, except that multiple bins are taken into ac-
count. Bins are added to the overall score calculation sequentially. Significant bins
are ordered by their FeatureAAScore. The overall score is first set to the FeatureAAS-
core of the best bin. Subsequent bins are then incorporated into the overall score until
the overall score drops, at which point the overall score calculation concludes.
Technicalities
The light matter algorithm was written in Python 3.5, and was tested on Mac OSX
(Yosemite, El Capitan, and High Sierra).
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A lot of work has gone into the development of the light matter algorithm and its eval-
uation. In this chapter, I present what I consider the salient experiments that show the
substantial difficulties in the approach of performing matching based on predicted
structural features. To save the reader from the myriad details of the implementa-
tion of the feature finders, significance and scoring methods, as well as additional
experiments on the evaluation of various aspects of the algorithm, I describe those in
Appendices B and C. All of these experiments ultimately revealed substantial difficul-
ties with the approach. Two years into the development of the light matter algorithm,
I was given the opportunity to attempt to identify viral sequences in NGS datasets
from ancient remains, which led to the work that now forms the first part of this the-
sis. On returning to the light matter algorithm when writing this thesis, I realise that
different approaches for the identification of highly diverged sequences may now be
more appropriate, given recent technical developments. These are mentioned in the
final section of this chapter, together with a general outlook of the future of the light
matter algorithm.
Evaluation of secondary structure finders based on test datasets of se-
quences with known structural similarity
Since the light matter algorithm performs sequence comparisons based on predicted
structural features, it is obviously desirable that its scores correlate well with mea-
sures of structural similarity. To evaluate the algorithm from that perspective, I
compiled five test datasets containing pairwise similarity measures of amino acid se-
quences based on both the structural similarity (measured by the Dali Z-score1 [360])
and sequence similarity (measured by the BLAST bit score [361]).
The test datasets were constructed based on the sequence and structure information
available from the Protein Data Bank (PDB)2. They consist of sequences of the major
1As a general rule, a Dali Z-score above 20 means the two structures are definitely homologous,
between 8 and 20 means the two are probably homologous, between 2 and 8 is a grey area, and a
Z-score below 2 is not significant [359].
2PDB is the primary repository for three-dimensional structural data on proteins and other biological
macromolecules [362]. PDB stores the protein name, atomic coordinates of the structure, the sequence,
the secondary structure element (if any) for each amino acid in the sequence, authors, key references,
and derived data, such as quality assessment and fold classification [347].
163
8. RESULTS AND DISCUSSION
histocompatibility complex (dataset ‘2HLA’), the RNA dependent RNA polymerase
(datasets ‘4MTP’ and ‘Polymerase’), the virus capsid protein (dataset ‘4PH0’), and
the influenza haemagglutinin protein (dataset ‘HA’). For further details on the test
datasets, see Appendix B.1.2.
The amino acid sequence and the correct secondary structure class (if any) of each
amino acid can be acquired from all proteins in PDB. The secondary structure anno-
tations can be used to evaluate the performance of the light matter algorithm when
the secondary structures are identified correctly. This is achieved via the use of fea-
ture finders that use the secondary structure annotations in PDB to identify secondary
structure features with perfect accuracy. I refer to these feature finders that are used
in the following evaluations as the ‘perfect finders’ (Appendix B.1.1). The perfect
finders make it possible to establish an important performance baseline for the algo-
rithm, based on prior knowledge of structure taken from PDB. If secondary structure
features are identified with 100% accuracy, how well does the algorithm do at finding
overall structural similarity? If the results are only mediocre, there is a clear sign that
the approach has some algorithmic limitations that are independent of the ability to
identify secondary structures.
In addition to the perfect finders, three families of experimental finders that iden-
tify secondary structures are available to the light matter algorithm: the basic sec-
ondary structure finders identify alpha helices based on patterns of hydrophobic and
hydrophilic amino acids in the sequence, and beta strands by screening for a sequence
of at least six amino acids from the set [V, I, C, F, Y, T] [348] (Appendix B.2.1.1); the
GOR4 finders identify alpha helices and beta strands based on the GOR4 secondary
structure prediction algorithm (Appendix B.2.1.1); and the substring finders identify
alpha helices and beta strands based on substrings of amino acid sequences that are
known to occur frequently those secondary structures (Appendix B.2.1.1)3.
I used the five test datasets in combination with the perfect finders and the three
families of experimental finders to investigate the correlation of the scores assigned
by the light matter algorithm (‘light matter scores’) with the Dali Z-scores. Figure
8.1 shows a grid of scatter plots, where the plots in each column show the light matter
scores computed with different combinations of secondary structure finders plotted
against the Dali Z-scores of that particular match. A linear regression was fitted to
the data, with lines in green (for positive correlation) or red (for negative correlation),
and its parameters given in the title of each subfigure. Rows of plots correspond to
3The names of the landmark finders that were used are: perfect finders: ‘PDB AlphaHe-
lix_combined’ and ‘PDB ExtendedStrand’; basic finders: ‘AlphaHelix’ and ‘BetaStrand’; GOR4 find-
ers: ‘GOR4AlphaHelix’ and ‘GOR4BetaStrand’; substring finders: ‘AC AlphaHelix_combined’ and
‘AC ExtendedStrand’.
164
different test datasets (top to bottom: 2HLA, 4MTP, HA, 4PH0, Polymerase). The
first column shows the scores calculated when the secondary structures are identified
correctly, using the perfect finders. The subsequent columns from left to right show
the matches calculated with the basic finders, the GOR4 finders, and the substring
finders.
In all but one of the finder combinations and test datasets in Fig. 8.1, there is a posi-
tive correlation between the light matter scores and the Dali Z-scores. The correlation
between light matter scores and Dali Z-scores is best when the secondary structures
are identified correctly (column one). Out of the three experimental finders, the sub-
string finders (column four) lead to the best correlation between the scores computed
by the light matter algorithm and the Dali Z-scores. Using the basic finders (column
two) leads to a large number of matches with light matter scores of 0.0. The same is
true to a lesser extent for the GOR4 finders shown in column three. The scores of 0.0
can be explained by the number of features that each set of finders identifies in the
five test datasets: the basic finders identify a total of 275 features, the GOR4 finders
identify 13,931 features, while the substring finders identify 56,550 features. This
suggests that the basic secondary structure finders and the GOR4 finders are unable
to identify enough features for a valid comparison.
While the correlation of the scores is best when the secondary structures are iden-
tified correctly, as shown in column one, there is also a wide range of light matter
scores that are assigned to a narrow range of Z-scores and vice versa. For exam-
ple, the second row in the first column of Fig. 8.1 shows that in the 4MTP test
dataset, for comparisons with Z-scores in the region of 20, the light matter scores
assigned range from about 0.3 to 0.6. Likewise, matches with a light matter score
of 0.4 have Z-scores between 2 to 23. Also, looking at all datasets, there is little
differentiation in the light matter scores assigned to comparisons with low Z-scores
as opposed to high Z-scores. This is apparent when considering the scores in the HA
test dataset, where all sequences have Z-scores of 20 and above. The lowest light
matter scores assigned to matches in the HA dataset are approximately 0.4, while
in the other datasets, light matter scores of that magnitude are assigned to matches
with much lower Z-scores. The fact that these problems occur even with the correctly
identified secondary structures, illustrates that the matching and scoring of the light
matter algorithm, as currently implemented, must be improved to achieve acceptable
results. All these problems are of course true to an even greater extent for the less
accurate secondary structure finders.
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Figure 8.1: Correlation of light matter scores and Dali Z-scores, using different com-
binations of landmark finders. Each row corresponds to a different test dataset, top to
bottom: 1) 2HLA. 2) 4MTP. 3) HA. 4) 4PH0. 5) Polymerase. Each column corresponds to
a different combination of landmark finders, from left to right: 1) Perfect finders. 2) Basic
finders. 3) GOR4 finders. 4) Substring finders. The ‘Peak’, ‘Trough’, and ‘AminoAcids’
trig point finders, a significance fraction of 0.01, a FeatureLengthBase of 1.01, DistanceBase
of 1.1, DeltaScale of 1.0, and a MaxDistance of 1000 were used throughout. Lines indicate
the linear regression, with coefficients in the title of each subfigure. A green regression line
indicates a positive correlation, a red regression line a negative correlation.
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Evaluation of secondary structure finders based on visualisations of
the three-dimensional protein structure
While the examination of correlations between the light matter and Dali Z-scores
provides a broad overview of the performance of the light matter algorithm, it tells
us nothing about the factors involved in the calculation of the light matter score.
It is therefore necessary to investigate matches of interest in isolation, for example
by using visualisations that show the location of features on the three-dimensional
protein structures and how the features match between structures according to the
light matter algorithm. This complements the investigation above: not only do I want
to know if features are being identified, but also whether the matching of the identified
features between sequences corresponds to reality. This may help us to understand
the discrepancies between the light matter scores and the Dali Z-scores observed in
Fig. 8.1. In the following section, I will focus on the discrepancy in four example
matches. Two have low light matter scores but high Z-scores, and two have high light
matter scores and low Z-scores. For each match, I show the two structures next to
each other, with the features identified by the substring finders highlighted4.
Figures 8.2 and 8.3 show two examples for the comparison of structures that have Z-
scores that indicate that the sequences are definitely homologous (>20) [359], but that
are assigned low light matter scores (0.21 and 0.3). Examining the three-dimensional
structures in Figs. 8.2 and 8.3, shows that they look similar visually, with a simi-
lar arrangement of secondary structures, as indicated by the high Z-score assigned
by the Dali algorithm. The figures also highlight the features identified by the sub-
string finders. Features identified as alpha helices are in brown, features identified as
beta strands in green, and features that match between the two structures in red. The
colouring shows that many secondary structure elements are not identified as features
at all, or that alpha helices are identified as beta strands and vice versa. Furthermore,
the features that are matching between the two structures, as indicated in red and by
white connecting lines, often do not belong to secondary structures that are struc-
turally equivalent (i.e., for example, a pair containing an alpha helix matches another
pair containing an alpha helix, but the two alpha helices are from different regions in
the two structures). The light matter scores in this case does not accurately reflect the
structural similarity, as it is based on an incorrect correspondence between secondary
structures.
4In addition to the landmark finders (‘AC AlphaHelix_combined’ and ‘AC ExtendedStrand’), the
following parameters were used: a significance fraction of 0.01, a FeatureLengthBase of 1.01, Dis-
tanceBase of 1.1, DeltaScale of 1.0, and a MaxDistance of 1000.
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Figure 8.2: Structures of 4MTP (right) and 2CJQ (left). ‘AC AlphaHelix_combined’ in
brown, ‘AC ExtendedStrand’ in green, matching features in red. White lines show features in
matching pairs. FeatureAAScore light matter score: 0.3. Dali Z-score: 25.6.
In Figs. 8.4 and 8.5, I show two examples of matches with relatively high light matter
scores of 0.47 and 0.61, and Z-scores of 3.0 and 3.5. Why does the light matter
algorithm assign scores that are seemingly too high? In the two matches shown,
the sequences coding for these protein structures are of different lengths (634 versus
308 amino acids for 4MTP and 2G1H, and 634 versus 98 amino acids for 4MTP
and 1H6K), and the structures are not visually similar. The visual impression thus
agrees with the low Z-scores. The length discrepancy between the sequences that
code for the structures can artificially increase the light matter score. The length
normalisation that is performed in the FeatureAAScore calculation rewards matches
where the matching pairs are distributed across the entire query and / or subject.
Indeed, for the comparisons in Figs. 8.4 and 8.5, the length normalisers are 0.898 and
0.821, respectively. Furthermore, in both cases, there are relatively few non-matching
features within the matched region, which also leads to high matched region scores
(0.512 and 0.879, respectively). Finally, as in the examples in the previous section,
the location of the matching features (as indicated by white lines in Figs. 8.4 and 8.5)
shows that they are often not structurally equivalent.
Limitations of the light matter algorithm and its evaluation
The evaluations based on the correlation between light matter scores and Dali Z-
scores, as well as the more detailed investigation of a small number of matches us-
ing visualisations of the three-dimensional structures, show that the performance of
the light matter algorithm using features based on secondary structures is not good
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Figure 8.3: Structures of 3CDW (right) and 1KHV (left). ‘AC AlphaHelix_combined’ in
brown, ‘AC ExtendedStrand’ in green, matching features in red. White line show features in
matching pairs. FeatureAAScore light matter score: 0.21. Dali Z-score: 33.0.
Figure 8.4: Structures of 4MTP (right) and 2G1H (left). ‘AC AlphaHelix_combined’ in
brown, ‘AC ExtendedStrand’ in green, matching features in red. White lines show features in
matching pairs. FeatureAAScore light matter score: 0.47. Dali Z-score: 3.0.
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Figure 8.5: Structures of 4MTP (right) and 1H6K (right). ‘AC AlphaHelix_combined’
in brown, ‘AC ExtendedStrand’ in green, ‘AminoAcidsLm’ in pink, matching features in
red. White lines show features in matching pairs. FeatureAAScore light matter score: 0.61.
Z-score: 3.5.
enough for its intended purpose. The evaluations highlight that the light matter al-
gorithm has limitations due to difficulties with secondary structure identification and
matching of corresponding features between structures. Furthermore, there may also
be limitations to the approach of evaluating the light matter algorithm, in particular
due to the reliance on measures of structural similarity based on tertiary structures,
as inferred by the Dali algorithm.
Limitations of the algorithm due to secondary structure identification
The evaluations presented earlier show that the performance of the light matter algo-
rithm using features based on secondary structures is not adequate, for the following
reasons:
− The basic secondary structure finders and finders based on the GOR4 algorithm
do not identify a sufficient number of features based on secondary structures
to allow for matches to be identified, which results in light matter scores of
0.0, even when there is close structural similarity. Furthermore, the visual
examination of matches with lower than expected light matter scores (Figs. 8.2
and 8.3) suggests that the substring finders also do not always identify sufficient
secondary structures.
172
− The visual inspection of matches with light matter scores lower or higher than
expected shows that even if secondary structure features can be identified, there
may be matches between secondary structures that are not structurally equiv-
alent. This can lead to matches with lower than expected scores on the one
hand, and may also lead to matches with scores higher than expected on the
other.
− Finally, while not directly related to the identification of secondary structures,
the score calculation may be flawed in cases where a short sequence is com-
pared to a long one (an artefact of the FeatureAAScore calculation, Appendix
B.4).
The broad correlations between the light matter scores and the Dali Z-scores suggest
that the algorithm is able to identify structural relatedness. But the frequent occur-
rence of light matter scores lower or higher than expected show that the performance
of the light matter algorithm is not currently good enough for its intended purpose.
Limitations of evaluation due to reliance on Z-scores
When evaluating the light matter algorithm, I relied heavily on the Z-scores computed
by the Dali algorithm as a measure of structural similarity. However, structural simi-
larity measured by comparing tertiary structures, as the Dali algorithm does, may not
always accurately reflect how similar two structures are. Apart from quantitatively
measuring the distance between tertiary structures, structural similarity is often dis-
cussed subjectively. Protein structures that are subjectively considered to be similar
may not be similar when the distance between them is measured quantitatively. This
may be the case when two structures are compared and one of them has a ligand
bound to it (e.g. Fig. C.8 in Appendix C.2), or is in a different conformation. A fur-
ther example is the proposed similarity between the Herpes Simplex Virus Glycopro-
tein B and the Vesicular Stomatitis Virus G protein (Fig. 8.6), which are subjectively
described as ‘so similar’ and ‘Glycoproteins from two entirely different viruses share
the same novel structure,...’ [363]. Indeed, they share the same domains with a similar
arrangement of secondary structures. However, the Dali algorithm assigns a Z-score
between 2.4 and 3.7, depending on the chains that are compared, and BLASTp re-
ports a bit score of only 19.6 between chains of the two structures. Thus, according to
the two quantitative measures, there is no structural or amino acid sequence similarity
between the two proteins, in contrast to the subjective assessment.
Given that the light matter algorithm performs comparisons based on predicted sec-
ondary structure features, there could be scenarios where it detects similarity between
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Figure 8.6: Subjective structural
similarity Ribbon diagrams of the
ectodomain trimers of glycoprotein B
of Herpes Simplex Virus (left) and G
protein of Vesicular Stomatitis Virus
(right). On a single subunit, corre-
sponding domains are coded in yel-
low, orange, blue, and red; the extra
domain V on glycoprotein B is pink.
In both cases, the other two subunits
are white and pale grey (Figure and
caption modified from [363]).
two structures that is not detected by the Dali algorithm. Should we ignore such a
match on the basis of a low Z-score? Or could the light matter algorithm be a tool
to detect similarity between sequences coding for structures such as the ones in Fig.
8.6, that cannot be detected by the Dali algorithm (should it perform well enough
in the future)? I would argue in favour of the similarity detected by the light matter
algorithm, since the algorithm is not sensitive to changes in the conformation of the
tertiary structure. However, systematically evaluating this behaviour would require a
way of evaluating the light matter algorithm that does not rely on structural similarity
measured at the tertiary level. For example, visually inspecting the three-dimensional
structures of the sequences that are being compared would be helpful to get a more
detailed insight into the equivalence of two structures, which may not be reflected in
the Dali Z-score, but would also be impractical to do at a large scale.
Future work
The evaluations presented in this chapter show that the features on which the se-
quence comparison is based in the light matter algorithm needs to be improved.
Currently, features are based on predicted secondary structures and other structural
features. It may be possible to make improvements at this level, by implementing
features based on profile hidden Markov models of complete viral proteins, as im-
plemented in the vFam database [335], or partial sequences of viral proteins [339].
In addition, features that are less descriptive of the protein structure could be im-
plemented. For example, the amino acid sequence could be transformed into a nu-
merical vector, using representations such as the electron-ion potential, or the Voss
representation [364]. This vector could then be analysed using time series data min-
ing techniques such as the discrete wavelet transform [364], to provide features for
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the light matter algorithm. The light matter algorithm is built in a modular fashion,
making it easy to add additional feature finders, thus facilitating future collaborative
development. The examination of the three-dimensional structures of matching se-
quences showed that there are frequent matches between pairs of features that are
not structurally equivalent. It may be possible to alleviate this problem by looking
for identical triplets of features between two sequences, instead of pairs of features.
This would make matches more specific, but false negative features would also have
a bigger impact. Matching with triplets would also lead to new challenges with the
implementation of triplet formation, and would probably lead to a bigger database
size due to the increased number of possible feature combinations.
Outlook for the light matter algorithm
While the current results presented in this chapter do not exclude that it will even-
tually be possible to implement adequate feature detection and scoring for the light
matter algorithm, it has not been possible to do so up to now. Therefore, the obvi-
ous question to ask at the end of this chapter is whether there is any indication that
the algorithm will eventually be useable for detecting highly diverged, homologous
viral sequences. The success of the ‘Shazam’ application shows that the overall ap-
proach of the algorithm is effective and highly scaleable [355], which is encouraging.
Whether it is possible to develop adequate features to base the sequence comparison
on, is more difficult to predict, and is most likely the area in which improvements
will have the strongest effect on the performance of the algorithm.
One approach to make the light matter algorithm useful in the short term, is to at-
tempt to initially make it work well on just a selected class of viral proteins, instead
of attempting to implement an algorithm that is of completely general applicabil-
ity. Features could be selected and the algorithm parameterised to identify a specific
group of proteins, such as the Jelly-roll capsid protein, the Superfamily 3 helicase, or
the RNA-dependent RNA polymerase [365]. Such an approach would probably be
the most realistic and quickest way for the algorithm to become useable, but it is also
a problem that has already been solved by others (e.g., [340]). Another option may
be to apply the algorithm to problems other than the identification of unknown se-
quences. Features detected by the algorithm could be used as additional information
for the classification of known sequences, or could be incorporated into phyloge-
netic analysis to possibly increase support in trees. Therefore, while this project was
difficult and ultimately without clear results and success, some level of optimism
remains.
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Work on the light matter algorithm started in late 2014. Given that more than four
years have passed since then, another question is whether the approach of match-
ing sequences based on predicted structural features is still a promising approach for
the identification of sequences of unknown origin and therefore worthy of additional
work. This consideration is especially important in light of improvements in sequenc-
ing technology and protein structure prediction during the last four years. Single
molecule sequencing technology, commercialised by Oxford Nanopore Technologies
and Pacific Biosciences, is now widely available and allows the routine production
of much longer sequencing reads, making it possible to directly sequence viral nu-
cleic acids without an amplification step [366]. Long reads or full genomes would
improve the performance of the light matter algorithm, but such sequences could also
be classified more easily using other methods, such as profile hidden Markov mod-
els or by exploiting information about gene arrangement [339, 340]. Furthermore, at
the end of 2018, it was announced that the AlphaFold software won the 13th Criti-
cal Assessment of Structure Prediction, a bi-annual competition on protein structure
prediction. The advance in prediction accuracy achieved by AlphaFold was an ad-
vance of roughly double the improvement achieved in the previous competitions in
2014 and 2016 [367, 368]. Further progress in protein structure prediction, which
may come in the near future, combined with longer sequences available from single
molecule sequencing technology, might turn the problem of sequence comparison
into a problem of comparing structures, which will require different approaches to
performing the comparison and interpreting the results than those which the light
matter algorithm uses. Further improvements in sequencing technology and structure
prediction will therefore most likely improve the results of the light matter algorithm,
but may also render it obsolete in the future.
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CONCLUSION
This thesis highlights both the benefits and the outstanding issues when screening
next generation sequencing (NGS) datasets for viruses.
The first part of the thesis showed the potential of viral sequences recovered from
screening NGS datasets from individuals living as far back as the late Pleistocene, to
improve our understanding of virus evolution. The ancient hepatitis B virus, human
parvovirus B19, and variola virus sequences reveal some of the diversity of those
viruses over the past hundreds or thousands of years, and also provide evidence for
genotype extinction. They allowed us to re-estimate most recent common ancestor
dates and substitution rates, and in some cases make inferences about the possible
correlations with human migrations. Furthermore, the lower substitution rates we
inferred with the ancient sequences, as compared to just using modern sequences,
highlight some of the problems with the current thinking about substitution rates.
Studying virus evolution with sequences recovered using techniques developed in
the field of aDNA research is an area of research still in its infancy. The work pre-
sented in chapters 2 – 4 of this thesis represents some of the first large-scale studies
on ancient viral sequences, and is mainly descriptive of the sequences recovered in
the datasets. In the future, in addition to screening of datasets that will be generated
for studies on human population genetics, targeting specific historical or virological
questions will become important. For instance, elucidating the origin and spread of
HBV genotypes F and H in the Americas, or the origin of the modern non-human pri-
mate HBVs are possible questions that we may be able to answer. In addition, aDNA
techniques could be applied to identify putative causative agents of past epidemics
described in the historical literature, such as the Antonine plague. Furthermore, se-
quencing of ancient RNA viruses, if possible, will most certainly lead to exciting new
insights.
The ancient sequences of hepatitis B virus, human parvovirus B19, and variola virus
presented in the first part of this thesis, were identified using standard sequence
matching tools. Such tools mainly compare sequences at the nucleotide and amino
acid level, and are unable to detect similarity between sequences that may code for
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proteins with similar structures, but without apparent nucleotide or amino acid se-
quence similarity. In the second part of the thesis, I describe an attempt to develop
an algorithm to match sequences based on predicted structural features, with the goal
of being able to identify highly diverged sequences that still retain similarity at the
structural level. The development of the algorithm was ultimately not successful,
in part due to difficulties in feature identification. Advances in single-molecule se-
quencing technology and structure prediction since the start of the development of the
algorithm in late 2014, may allow researchers to develop different and possibly more
effective approaches for identifying highly diverged sequences in the future.
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A. DESCRIPTION OF VARIOLA VIRUS GENE FUNCTIONS
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In the following text, numbers correspond to the final offset of the gene in CPXV-
Gri/GER [270] and the name of the VACV-COP homolog [270], if applicable. If the
gene is absent in VACV-COP, the CPXV naming convention is used.
Gene status is organized into eight categories, denoted A–H.
VARV and VARV-VD21 gene status Category: aVARV gene status (gene count)
Inactivated A: inactivated in all (11)
B: certain or uncertain inactivations in some
but not all (5)
C: present in all (4)
D: present in some but not all (9)
E: uncertain inactivations (3)
Present F: absent in some (2)
G: uncertain inactivations in some (17)
Table A.1: Gene inactivation and presence categories. Gene status is divided into eight
categories A–H. The table shows categories A–G and the number of genes in each. For clarity,
categories A–G are organized in two groups, according to whether the gene is inactivated or
present in VARV and VARV-VD21. An eighth category, H (with gene count 3), is used for
genes that are absent or with no coverage in VARV, VARV-VD21, and aVARV sequences,
and that have gene-inactivating mutations in CMLV or TATV.
A) Genes inactivated in VARV, VARV-VD21, and the aVARV
sequences.
This includes 11 genes, A25L (150930), A39R (165419), A37R (163060), C8L (31175),
20088, B2R;B3R (182986), 26765, A9L (135109), 202711, C13L;C14L (204801),
and A53R (176775).
A25L: A-type inclusion protein [270]. VARV-VD21 and all aVARV sequences share
their gene-inactivating mutations with modern VARV and CMLV. Coverage of refer-
ence sequence (TATV): VARV-VD21: 100%, aVARV-VK382: 94%, aVARV-VK388:
99.8%, aVARV-VK470: 99.2%.
A39R: Semaphorin, secreted glycoprotein. Immunomodulator [7, 270]. Loss of the
gene from VACV-COP does not affect growth in vitro, or virulence in a mouse in-
tranasal model, and has only a slight effect on lesion size in an intradermal mouse
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model. Expression of VACV-COP A39 by VACV-WR, which does not naturally ex-
press the gene, leads to an increase in the severity and persistence of skin lesions after
intradermal infection of mice [369]. Histological examination of mouse skin suggests
that A39 has direct or indirect pro-inflammatory properties [369]. aVARV-VK388
and VACV-WR share the same gene-inactivating mutation. aVARV-VK382 has a 1
nucleotide (nt) deletion, resulting in a novel stop codon. aVARV-VK470 also has a
novel stop codon. Coverage of reference sequence (TATV): VARV-VD21: 100%,
aVARV-VK382: 60.9%, aVARV-VK388: 100%, aVARV-VK470: 100%.
A37R: Unknown [270]. Modern VARV, VARV-VD21, and all aVARV sequences
share the same stop codon. Coverage of reference sequence (CPXV-BR): VARV-
VD21: 100%, aVARV-VK382: 91.5%, aVARV-VK388: 100%, aVARV-VK470:
24.1%.
C8L: Unknown [270]. A novel, identical stop codon in VARV-VD21, and all aVARV
sequences. Coverage of reference sequence (CPXV-BR): VARV-VD21: 100%, aVARV-
VK382: 91.2%, aVARV-VK388: 100%, aVARV-VK470: 95.5%.
20088: CPXV019. Ankyrin [270]. The aVARV sequences share a stop codon caused
by a 1 nt insertion. There are additional stop codons in the sequence, one of which
agrees with the stop codon in VARV. Coverage of reference sequence (TATV): VARV-
VD21: 14.3%, aVARV-VK382: 77.4%, aVARV-VK388: 100%, aVARV-VK470:
100%.
B2R;B3R: Schlafen. Immunomodulator [270]. aVARV-VK382, aVARV-VK388, and
aVARV-VK470 share the same stop codon. Coverage of reference sequence (CMLV):
VARV-VD21: 45.2%, aVARV-VK382: 41.7%, aVARV-VK388: 45.1%, aVARV-
VK470: 45.8%.
26765: CPXV025. ANK/F-box protein related to host range [273]. Identical stop
codons in all aVARV sequences. Coverage of reference sequence (VARV-SAF):
VARV-VD21: 100%, aVARV-VK382: 97.8%, aVARV-VK388: 100%, aVARV-VK470:
99.6%.
A9L: Membrane protein [270]. Differing stop codons in all aVARV sequences. VARV-
VD21 agrees with VARV-BRZ [273]. Coverage of reference sequence (VARV-BRZ):
VARV-VD21: 96.2%, aVARV-VK382: 100%, aVARV-VK388: 100%, aVARV-VK470:
100%.
202711: CPXV215. Kelch-like protein [270]. VARV-VD21, aVARV-VK382, and
aVARV-VK470 share a gene-inactivating mutation with VARV. aVARV-VK388 does
not have coverage in later part of the sequence, and may agree with VARV too. Cov-
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erage of reference sequence (CPXV-Ger): VARV-VD21: 49.4%, aVARV-VK382:
31.8%, aVARV-VK388: 48%, aVARV-VK470: 49.2%.
C13L;C14L: Unknown [270]. VARV-VD21, aVARV-VK382, aVARV-VK470, and
VARV share the same gene-inactivating mutation. aVARV-VK382 and aVARV-VK470
also have novel stop codons toward the N-terminus of the sequence when aligned
against TATV. aVARV-VK388 has a novel stop codon mutation. Coverage of ref-
erence sequence (TATV): VARV-VD21: 100%, aVARV-VK382: 100%, aVARV-
VK388: 100%, aVARV-VK470: 100%.
A53R: Also called CrmC, is a tumor necrosis factor receptor homolog that plays an
important role in antiviral response and inflammation [273]. Expression of the CPXV
or VACV-USSR A53R gene in VACV-WR leads to increased virulence in a mouse
intranasal model [370]. Deletion of A53R in Tiantian VACV does not lead to a change
of lesion size upon intradermal infection of rabbits, but resulted in virus attenuation in
the mouse intranasal and intracranial model [371]. Gene-inactivating mutations agree
in all aVARV sequences. Coverage of reference sequence (CPXV-Ger): aVARV-
VK382: 80.6%, aVARV-VK388: 100%, aVARV-VK470: 100%.
B) Genes inactivated in VARV, VARV-VD21, and certain or uncertain
inactivations in some but not all aVARV sequences.
This includes five genes, C9L (29281), B16R (194427), B12R (191696), 193435*,
and A44L (168244).
C9L: ANK/F-box protein related to host range [273], and an antagonist of the type I
interferon response [372]. aVARV-VK388 and aVARV-VK470 share the same stop
codons, some of which are shared with modern VARV. aVARV-VK382 has no cover-
age in the region that has a 2 nt insert that leads to the frameshift in aVARV-VK388
and aVARV-VK470, so the stop codons are different. Coverage of reference sequence
(TATV): VARV-VD21: 58.5%, aVARV-VK382: 74.3%, aVARV-VK388: 91.7%,
aVARV-VK470: 92.1%.
B16R: IL1β receptor [270]. Inactive in VACV-COP, but active in VACV-WR, where it
is referred to as B15R. ‘Deletion of B15R from vaccinia virus accelerated the appear-
ance of symptoms of illness and mortality in intranasally infected mice, suggesting
that the blockade of IL-1β by vaccinia virus can diminish the systemic acute phase
response to infection and modulate the severity of the disease.’ [296]. VARV and
VARV-VD21 share the same gene-inactivating mutation. The aVARV sequences have
different initial gene-inactivating mutations, but some of the downstream stop codons
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agree with VARV. Coverage of reference sequence (TATV): VARV-VD21: 100%,
aVARV-VK382: 78.9%, aVARV-VK388: 100%, aVARV-VK470: 100%.
B12R: Has 33% amino acid similarity to B1, a serine/threonine kinase. However, B12
lacks enzymatic activity [373]. There is no coverage for aVARV-VK382. aVARV-
VK388, aVARV-VK470, and VARV-VD21 are closest to modern VARV, based on
sequence similarity, and have the same gene-inactivating mutation, caused by a 1 nt
insertion at position 238 of modern VARV-BRZ, -SLN, -SAF, and -KUW. Coverage
of reference sequence (VARV-SAF): VARV-VD21: 100%, aVARV-VK388: 100%,
aVARV-VK470: 85.2%.
193435*: pCPXV0030. Surface glycoprotein [270]. VARV-VD21 and VARV have
the same gene-inactivating mutation. The gene-inactivating mutations in aVARV-
VK388 and TATV agree; some of the mutations are also present in VARV. aVARV-
VK382 is most similar to CPXV in terms of insertions and deletions, but we have
no coverage in the second half of the CPXV gene, so it is impossible to determine
if there is a gene-inactivating mutation towards the C-terminus of the gene. There
is no coverage for aVARV-VK470. Coverage of reference sequence (VARV-SLN):
VARV-VD21: 100%, aVARV-VK382: 57.1%, aVARV-VK388: 92.9%.
A44L: 3-beta-hydroxysteroid dehydrogenase [275]. Deletion of A44L in VACV-
WR does not affect viral replication in CV-1 cells in vitro, but the virus is atten-
uated in a mouse intranasal model [275]. A44 synthesizes steroid hormones, in-
duces immunosuppression, and contributes to the virulence of VACV-WR in mice
[374, 375]. This gene is disrupted in all sequenced VARV hitherto. All aVARV
sequences share the same stop codon. In aVARV-VK382, the stop codon is only
covered by one read and is therefore listed as ‘uncertain’. Coverage of reference
sequence (CMLV): VARV-VD21: 100%, aVARV-VK382: 94%, aVARV-VK388:
100%, aVARV-VK470: 100%.
C) Genes inactivated in VARV and VARV-VD21, but present in all
aVARV sequences.
This includes four genes, E7R (68913), B6R (186591), C5L (33086), and B7R (187178).
E7R: EEV myristylated soluble protein [376]. Inactivation does not affect known
biological properties of the virus [377]. Coverage of reference sequence (TATV):
aVARV-VD21: 100%, aVARV-VK382: 88%, aVARV-VK388: 100%, aVARV-VK470:
100%.
186
B6R: Ankyrin [270]. Coverage of reference sequence (TATV): aVARV-VD21: 100%,
aVARV-VK382: 90%, aVARV-VK388: 100%, aVARV-VK470: 100%.
C5L: Genome uncoating and DNA replication factor [372]. Coverage of reference se-
quence (CPXV-Gri): aVARV-VD21: 100%, aVARV-VK382: 88%, aVARV-VK388:
100%, aVARV-VK470: 100%.
B7R: is an endoplasmic reticulum-associated, putative chemokine binding protein.
Virulence factor in VACV-WR [378]. Its deletion leads to the attenuation (smaller le-
sions) of VACV-WR in a murine intradermal model, but not in the murine intranasal
model [378]. Coverage of reference sequence (TATV): aVARV-VD21: 100%, aVARV-
VK382: 61%, aVARV-VK388: 100%, aVARV-VK470: 99% (the first two amino
acids do not have coverage).
D) Genes inactivated in VARV and VARV-VD21, but present in some
but not all aVARV sequences.
This includes nine genes, 22682, A40R (165942), 215231, A57R (180331), C2L
(35634), K1L (41155), F3L (47695), 168145, and A35R (161464).
22682: CPXV020. Unknown [270]. VARV-VD21, aVARV-VK382, and aVARV-
VK388 share the same stop codon. aVARV-VK470 is functional, and has reads
covering 100% of the CMLV reference genome. Coverage of reference sequence
(CMLV): VARV-VD21: 100%, aVARV-VK382: 65.5%, aVARV-VK388: 95.1%,
aVARV-VK470: 100%.
A40R: Surface glycoprotein, immune modulator, related to C-type lectin-like pro-
teins. Disruption of the A40R gene in VACV did not affect virus plaque size, in
vitro growth rate and titre, EEV formation, or virus virulence in a murine intranasal
model, but led to smaller lesions in the mouse intradermal model [379, 380]. Cover-
age of reference sequence (CPXV-Gri): VARV-VD21: 100%, aVARV-VK382: 66%,
aVARV-VK388: 100%, aVARV-VK470: 39%. A novel stop codon is present in
aVARV-VK388.
215231: pCPXV0002. N-methly D-aspartate receptor-like protein [270]. Gene-
inactivating mutations agree in aVARV-VK388 and aVARV-VK470, present in aVARV-
VK382. Coverage of reference sequence (CMLV): aVARV-VK382: 72.8%, aVARV-
VK388: 100%, aVARV-VK470: 100%.
A57R: Guanylate kinase. An inactive gene in VACV-Cop and VACV-WR, with the
same gene-inactivating mutation in mVARVs [274]. A57 is predicted to only be func-
187
A. DESCRIPTION OF VARIOLA VIRUS GENE FUNCTIONS
tional if it has an additional 5’ region that contains an ATP binding domain [381]. In
VARV, VARV-VD21, VACV-COP, VACV-WR, VACV-MVA, and RPXV, the gene is
inactivated by an 11 nt deletion relative to CPXV. In HPXV, ECTV, TATV, CMLV,
MPXV-ZAI, MPXV-WR, and aVARV-VK470, the gene is inactivated by nucleotide
substitutions leading to a stop codon, or 1 nt insertions or deletions that cause a
frameshift. The mutation that breaks MPXV-ZAI and MPXV-WR is identical, and the
deletion that breaks aVARV-VK470 is also present in ECTV, although ECTV breaks
earlier due to a substitution. CPXV-Ger, CPXV-Gri, CPXV-BR, aVARV-VK382,
and aVARV-VK388 all contain the 5’ region with the ATP binding domain. Cover-
age of reference sequence (CPXV-Gri): VARV-VD21: 100%, aVARV-VK382: 78%,
aVARV-VK388: 100%, aVARV-VK470: 100%.
C2L: Kelch-like proteins with putative host-range function [382]. Deletion of C2L
in VACV has no effect on growth in vitro, but has altered plaque morphology [297].
Deletion of C2L in VACV also does not affect virulence in a mouse intranasal model,
but leads to larger lesions and more cell infiltration in a mouse intradermal model
[297]. Thus, C2L contributes to cell cytopathic effect and reduces immunopathology
in vitro [297]. Coverage of reference sequence (CPXV-Ger): VARV-VD21: 100%,
aVARV-VK382: 85%, aVARV-VK388: 100%, aVARV-VK470: 100%. A novel stop
codon is present in aVARV-VK470.
K1L: NFκB inhibitor, and human SAMD9 inhibitor [291, 383]. Plays a role in an-
tiviral response and inflammation, and is a known host-range gene [273] since its
deletion in VACV-COP results in a replication defect in rabbit RK13 cells [293].
The presence of a functional K1L gene in aVARV-VK382 and aVARV-VK388, as
well as the presence of different gene-inactivating mutations in CMLV, TATV, and
VARV [273] suggest that the gene was lost independently in CMLV, TATV, and
VARV after the divergence of the aVARV clade and mVARV ∼1.6 kya. Coverage
of reference sequence (CPXV-Gri): VARV-VD21: 100%, aVARV-VK382: 86%,
aVARV-VK388: 100%, aVARV-VK470: 100%. A novel stop codon is present in
aVARV-VK470.
F3L: Kelch-like protein [270]. Deletion of F3L in VACV leads to smaller lesions in
a mouse intradermal model, as indicated by smaller lesions, and alterations in the in-
nate immune response [299]. Coverage of reference sequence (TATV): VARV-VD21:
100%, aVARV-VK382: 93%, aVARV-VK388: 100%, aVARV-VK470: 100%. A
novel stop codon is present in aVARV-VK470.
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168145: CPXV181. Unknown [270]. Coverage of reference sequence (CMLV):
VARV-VD21: 100%, aVARV-VK382: 100%, aVARV-VK388: 100%, aVARV-VK470:
100%. A novel stop codon is present in aVARV-VK470.
A35R: Virulence factor [7, 270]. Inhibits MHC class II-restricted antigen presenta-
tion, immune priming of T lymphocytes, and subsequent chemokine and cytokine
synthesis [384]. Coverage of reference sequence (RPXV): VARV-VD21: 100%,
aVARV-VK382: 85.8%, aVARV-VK388: 100%, aVARV-VK470: 100%. A novel
stop codon is present in aVARV-VK382.
E) Genes inactivated in VARV and VARV-VD21, and uncertain
inactivations in aVARV sequences.
This includes three genes, A52R (175891), A55R (178726), and 214439.
A52R: Intracellular Bcl2-like protein, blocks NFκB activation, and contributes to vir-
ulence in VACV [385–387]. Deletion of A52R from VACV leads to attenuation in
a murine intranasal model [385]. The uncertain stop codon is identical between all
aVARV sequences. The stop codon in VARV-VD21 is novel. Coverage of refer-
ence sequence (CPXV-Ger): VARV-VD21: 100%, aVARV-VK382: 89.8%, aVARV-
VK388: 100%, aVARV-VK470: 100%.
A55R: Kelch-like protein, immunomodulator [7, 270]. Deletion of A55R in VACV-
WR does not affect growth rate in vitro but leads to a different plaque morphology and
cytopathic effect. It also leads to larger lesions in a murine intradermal model, hence
affecting the host response to infection in vivo [298]. Coverage of reference sequence
(CPXV-Gri): VARV-VD21: 53.2%, aVARV-VK382: 85%, aVARV-VK388: 100%,
aVARV-VK470: 99.7%. An uncertain novel stop codon in aVARV-VK470, covered
by two reads.
214439: pCPXV0002. CrmE. Tumor necrosis factor (TNF) receptor homolog. CrmE
inhibits the cytotoxic and apoptotic activities of human, but not mouse or rat TNF in
vitro. In a murine intranasal model, VACV-USSR recombinants lacking CrmE are
attenuated. Expression of CrmE in VACV-WR enhances virulence in the murine
model [370]. Absent in both VARV-VD21 and modern VARV. A novel stop codon is
present in aVARV-VK382, at nucleotide position 70 relative to CPXV-Gri, but only
has coverage of one read. The gene appears to be functional in aVARV-VK388 and
aVARV-VK470. CrmE sequences present in aVARV-VK388 and aVARV-VK470 are
most closely related to CPXV-Gri and CPXV-Ger. Coverage of reference sequence
(CPXV-Ger): aVARV-VK382: 97.6%, aVARV-VK388: 100%, aVARV-VK470: 100%.
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Active CrmE orthologs are only found in CPXV-Gri, CPXV-Ger, VACV-LIS, VACV-
Lc16m8, VACV-Lc16mO, and VACV-USSR strains, but are absent in all other VACV
strains as well as in HSPV, RPXV, VARV, and TATV, and are truncated in CMLV
and ECTV [273]. Gene-inactivating mutations are present in identical positions in
MPXV, ECTV, and CPXV-BR, suggesting that the inactivation arose either in an an-
cestral virus, or as a result of horizontal gene transfer or recombination events [273],
in which case aVARV-VK388 and aVARV-VK470 may have also received their ver-
sion of CrmE in a similar fashion.
F) Genes present in VARV and VARV-VD21, but absent in some aVARV
sequences.
This includes two genes, E5R (66488) and C1L (37242).
E5R: Virosome component protein [270, 388]. Functional in aVARV-VK388. Novel
identical stop codons in aVARV-VK382 and aVARV-VK470. The stop codon in
aVARV-VK382 is listed as uncertain, since read coverage is below four. Coverage of
reference sequence (CMLV): VARV-VD21: 100%, aVARV-VK382: 94.8%, aVARV-
VK388, and aVARV-VK470: 100%.
C1L: Unknown. Bcl-2-like [270]. Coverage of reference sequence (VARV-KUW):
VARV-VD21: 100%, aVARV-VK382: 85%, aVARV-VK388: 99.1%, aVARV-VK470:
100%. A novel stop codon is present in aVARV-VK388.
G) Genes present in VARV and VARV-VD21, but with uncertain
inactivations in some aVARV sequences.
This includes 17 genes, C10L (23924), A49R (172501), B18R (197359), A47L (170515),
B17L (194473), B20R (200936), A10L (135433), E9L (69869), J6R (103459), D1R
(112743), A3L (127555), A12L (139081), A18R (143956), A22R (146293), A24R
(150952), A33R (160360), and A36R (162202).
A number of genes in this set are related to virus replication, so their putative absence
should be treated with caution. The D1R gene is included in this category despite
having five reads that indicate a gene-inactivating mutation. Because the mutation
is due to a G→A change and the reads have identical start and end positions, it is
assumed that the reads are PCR duplicates, and that the apparent mutation is actually
DNA damage.
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H) Genes absent or no coverage in VARV, VARV-VD21, and aVARV se-
quences, and with gene-inactivating mutations in CMLV or TATV.
This includes three genes, K6L;K5L (45027), 202819, and B10R (190433).
K6L;K5L: Monoglyceride lipase (putative); lysophospholipase-like protein [270].
202819: CPXV216, VACV-WR-B13R. CrmA, serine protease inhibitor. Inhibits
both extrinsic apoptosis and the host inflammatory response [7, 389, 390]. Dele-
tion of CrmA has no effect [391] or leads to attenuation of VACV-WR in the in-
tranasal murine model, and leads to larger skin lesions in the intradermal murine
model [380].
B10R: Unknown [270].
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B.1. TOOLS TO EVALUATE THE LIGHT MATTER
ALGORITHM
In order to create the light matter algorithm described in the second part of this thesis,
the following components had to be implemented: the features that are identified by
the algorithm, the significance methods used to assess if the histogram peaks con-
stitute significant matches, and methods for scoring the matches that were identified
as significant. Also, tools were needed to evaluate and visualise the different com-
ponents of the algorithm. In the process of implementing these components, a high
number decisions had to be made. In some cases, these were made based on out-
side evidence, sometimes different alternatives were tested, and in other cases the
seemingly most straight-forward option was chosen. In this chapter, I describe these
components, starting with the methods for evaluation and visualisation, since those
will be used in later parts of the chapter, and then move on to describe the develop-
ment of features, significance methods, and scoring methods.
B.1 TOOLS TO EVALUATE THE LIGHT MATTER
ALGORITHM
The development and optimisation of the light matter algorithm requires tools to
evaluate its results. Given that the algorithm is built to compare sequences based on
predicted structural features, it makes sense to evaluate its performance using pairs
of sequences for which the structural and sequence similarity is known. The pro-
tein data bank (PDB) provides such information. Founded in 1971, the PDB is the
primary repository for three-dimensional structural data on proteins and other bio-
logical macromolecules [362]. Since 2003, the repository has been managed by an
international consortium, the world-wide Protein Data Bank, whose partners include
the Research Collaboratory for Structural Bioinformatics, the Macromolecular Struc-
ture Database at the European Bioinformatics Institute, the Protein Data Bank Japan,
and others [392]. The information stored in PDB includes the protein name, atomic
coordinates of the protein structure, the sequence, authors, key references, and also
some derived data, such as quality assessment and fold classification [347].
Using the structure and sequence information from PDB, two areas of the light matter
algorithm can be evaluated: firstly, the identification of features based on secondary
structures, and secondly, the scores that are assigned to a match and how they corre-
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spond to the structural reality. Furthermore, visualisations of the location and pairing
of features on a sequence and on a three-dimensional structure help to improve our
understanding of the behaviour of the algorithm.
B.1.1 Evaluation using perfect finders
Identification of features that can meaningfully detect similarity between sequences
is a crucial step in the light matter algorithm. While some features can be identi-
fied unambiguously (types of amino acids that are highly conserved, features based
on amino acid properties, and sequence motifs), the identification of features based
on secondary structures is more error-prone. In order to evaluate feature identifica-
tion and performance of the light matter algorithm, knowing the actual locations of
secondary structures within a sequence is necessary. We can use that information to
evaluate two things: first, whether the feature finders designed to identify secondary
structures are functioning correctly, and second, we can compare the behaviour of
the light matter algorithm using the correct secondary structure information to its be-
haviour using the imperfect features based on secondary structures that are identified
by the experimental landmark feature finders.
Apart from the coordinate files of the structure and information such as the sequence
or the authors, each PDB entry also contains the type of secondary structure each
amino acid in the amino acid sequence occurs in. The secondary structures are as-
signed using the DSSP algorithm, based on the positions of the atoms in the protein
structure and by calculating hydrogen bond energy between all atoms [393]. Eight
types of secondary structure elements are assigned letter codes as follows [393]: Al-
pha helix (H), Alpha helix 3-10 (G), Alpha helix pi (I), Residue in isolated beta bridge
(part of a beta strand, B), Extended strand (participates in beta ladder, E), Hydrogen
bonded turn (pieces of helix too short to be a helix, T), Bend (region of high curva-
ture, S), and Coil (residues that are not in any of the above conformations, C). Thus,
if a sequence is present in PDB, the secondary structure information assigned to it
can be used to extract features which use the correctly-annotated secondary structure
categories. For the purpose of evaluating the feature finders based on predicted sec-
ondary structures, and the performance of the light matter algorithm under correctly
identified secondary structure features, we implemented five idealised (i.e., ‘perfect’)
landmark finders based on the PDB entries. The landmark finders identify the alpha
helix, alpha helix 3-10, alpha helix pi, and extended strand secondary structures, as
well as a finder for all three alpha helix types combined. The finders were named
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‘PDB AlphaHelix’, ‘PDB AlphaHelix_3_10’, ‘PDB AlphaHelix_pi’, ‘PDB Extend-
edStrand’ and ‘PDB AlphaHelix_combined’.
B.1.2 Evaluation using test datasets of sequences with
known structural similarity
The scores that are generated by the light matter algorithm need to be biologically
relevant. Given that the algorithm compares sequences based on predicted structural
features, scores of sequence similarity (such as the BLAST bit score) do not provide
enough resolution over large evolutionary distances to evaluate the light matter al-
gorithm. Therefore, we use the correlation between measures of structural similarity
between proteins and the scores obtained from the light matter algorithm for evalu-
ation. The sequence and structural information from PDB allowed me to construct
five test datasets of pairs of sequences where the structural similarity and sequence
similarity are known.
I constructed five test datasets, referred to as ‘2HLA’, ‘4MTP’, ‘Polymerase’, ‘HA’,
and ‘4PH0’. Two datasets consist of sequences of viral RNA dependent RNA poly-
merases (the 4MTP and Polymerase datasets), and one dataset each of sequences of
the major histocompatibility complex (2HLA), influenza haemagglutinin (HA), and
viral capsid proteins (4PH0). Structural similarity was measured using the Dali Z-
score. The Dali algorithm computes the Z-score by comparing two distance matrices
of distances between C-alpha atoms within a protein [360]. Sequence similarity was
measured using the bit score reported by BLASTp. The bit score measures sequence
similarity by scoring matches between sequences using amino acid replacement fre-
quencies [394].
Dataset Number of sequence pairs Median sequence length
2HLA 141 275
4MTP 215 563
Polymerase 484 563
HA 169 328
4PH0 113 215
Table B.1: Number of sequence pairs and sequence lengths in each test dataset. Se-
quence lengths are given in amino acids.
The sequences in the Polymerase dataset are from Cˇerny` et al., (2014) [343] and the
sequences in the HA dataset were provided by David Burke. The 2HLA, 4MTP, and
4PH0 datasets were constructed by comparing the 2HLA:A, 4MTP:A, and 4PH0:A
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structures against all known structures using the online Dali server [395]. The re-
sulting list of similar structures was subsampled, to achieve an even spread across
the whole range of Dali Z-scores. In the 4PH0 dataset, I also removed all sequences
that contained the words ‘complex’ or ‘muta’ in the title, in an attempt to only in-
clude structures that were not a in complex with a ligand or that had known mu-
tations. The reduced lists of sequences from each dataset were compared against
the 2HLA:A, 4MTP:A, and 4PH0:A sequence respectively, using the BLASTp al-
gorithm [25] to acquire the BLAST bit scores as a measure of sequence similarity.
For the Polymerase and HA datasets, pairwise comparisons using BLASTp [25] and
the Dali [360] algorithm were performed to acquire the pairwise sequence and struc-
tural similarity scores. The Polymerase dataset is the largest test dataset, containing
484 distances, whereas the 4PH0 dataset is the smallest, with 113 distances (Table
B.1).
B.1.3 Visualisations
Two types of visualisations were implemented and used in the process of developing
the light matter algorithm, to improve my understand its behaviour:
Terry Jones developed the Horizontal line plot, shown in Fig. B.1. The horizontal
line plot shows how the features are positioned and the way they are paired and then
binned. The two horizontal lines at the bottom and top of the figure indicate the
subject and the query sequences. The small, bold, coloured horizontal lines plotted
over the horizontal lines indicate the landmarks, while the vertical lines indicate the
trig points, where each colour corresponds to a feature type, as per the figure legend.
Features that are involved in a match are shown in the two innermost lines, whereas
features not involved in a match are shown on the two outermost lines. The sloping
lines between the query and the subject connect the matching features. A solid line
denotes matching landmarks, and a dotted line indicates matching trig points. Match-
ing features that are in the same bin are connected with lines with the same colour.
Variations of the plot exist, where the significant bins only (Fig. B.1a), the best bin
only (Fig. B.1b), or all bins are shown.
I developed visualisations to get a visual impression of the three-dimensional struc-
ture and of the location of features on the structure. An example is shown in Fig.
B.2. The structures are displayed in PyMOL [396] using the coordinate files stored
in PDB. It is possible to display multiple structures next to each other, to display dif-
ferent features on each of them, to annotate the features that are involved in a match,
and to display lines between the features that match between two structures.
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(a) (b)
Figure B.1: Horizontal line plot. Subject and query sequences are shown as horizontal lines
at the bottom and top of the figure. Landmarks are shown as coloured lines and trig points as
coloured bars. Matching features are indicated on the inner line, and non-matching features
on the outer line. Matching features in the subject and the query are connected by lines. If
the matching features are in the same histogram bin, the connecting line is in the same colour.
textbfa) only the significant bins are shown, b) only the best bin is shown.
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(a)
(b)
Figure B.2: Viral RNA dependent RNA polymerase structures displayed in PyMOL.
Left: 1XR7:A, right: 1KHV:B. a) Features found by the ‘AC_AlphaHelix’ feature finder are
shown in brown, features found by the ‘AC_ExtendedStrand’ feature finder in green, and
features found by the ‘AminoAcidsLm’ feature finder in mauve. b) Same structures and
colouring as in Fig. a), but features in pairs that match are shown in red.
200
B.2. FEATURES
B.2 FEATURES
Sequence comparisons can be performed using different alphabets. Current sequence
matching algorithms typically use alphabets based on nucleotides or amino acids
[26, 331]. The light matter algorithm compares sequences based on an alphabet of
features that are expected to be structurally conserved. In order to be effective, the
features used in the light matter algorithm must fulfil the following criteria:
1. Feature detection must be independent of position in the sequence, to allow the
matching of features in sequence fragments to those in complete sequences.
2. Features need to be robust to distortion from mutations or sequencing errors.
3. Features must be small enough to identify in a sequence of around 65 amino
acids, due to the short length of reads generated by most Next Generation Se-
quencing (NGS) technologies.
4. Features need to be structurally relevant. This does not mean that they need
to correspond to an exact part of the structure, but they need to carry some
information relevant for the formation of the structure.
Features are divided into two groups, ‘landmarks’ and ‘trigonometry (trig) points’,
and are identified by so called ‘finders’. Landmarks can form pairs with other land-
marks or trig points, but trig points cannot form pairs between each other. The di-
vision of features into landmarks and trig points facilitates the pairing of features.
The description of the Shazam algorithm only provides a rudimentary description
of which features can form pairs with each other [355]. Splitting the features into
two groups, only one of which can initiate the pairing (the landmarks), is a conve-
nient way for us to choose those features. The light matter algorithm implements
landmark finders based on seven types of structural features that are encoded in the
amino acid sequence. All are expected to be relevant for the shape of the protein
structure: alpha helices, including alpha helix 3-10 and alpha helix pi, beta strands,
coils, conserved amino acids such as cysteine and tryptophan, PROSITE motifs and
short linear motifs. All landmark finders available to the algorithm are shown in ta-
ble B.2. Trig points are based on less obvious patterns in amino acid properties and
cannot readily be associated with a particular part of the structure, but may still be
important for the formation and stability of a protein structure. These may include
features such as hydrophobicity patterns or other patterns based on amino acid prop-
erties. All trig points available to the algorithm are shown in table B.3. The following
sections describe how the different feature finders were implemented.
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Landmark name Description
AC AlphaHelix Identifies alpha helices based on substrings marked as alpha he-
lix in PDB (chapter B.2.1.1).
AC AlphaHelix_3_10 Identifies alpha helix 3-10 based on substrings marked as alpha
helix 3-10 in PDB (chapter B.2.1.1).
AC AlphaHelix_pi Identifies alpha helix pi based on substrings marked as alpha he-
lix pi in PDB (chapter B.2.1.1).
AC AlphaHelix_combined Identifies alpha helices based on substrings marked as alpha he-
lix, alpha helix 3-10 or alpha helix pi in PDB (chapter B.2.1.1).
AC ExtendedStrand Identifies extended strands based on substrings marked as ex-
tended strand in PDB (chapter B.2.1.1).
AlphaHelix Identifies alpha helices based on the assumption that an alpha
helix is composed of at least one repeat of one hydrophobic fol-
lowed by three hydrophilic amino acids (chapter B.2.1.1).
AlphaHelix_3_10 Identifies alpha helix 3-10 based on the assumption that an alpha
helix 3-10 is composed of at least one repeat of one hydrophobic
followed by two hydrophilic amino acids (chapter B.2.1.1).
AlphaHelix_pi Identifies alpha helix pi based on the assumption that an alpha
helix pi is composed of at least one repeat of one hydrophobic
followed by four hydrophilic amino acids (chapter B.2.1.1).
BetaStrand Identifies beta strands by screening for a sequence of at least
six consecutive amino acids from the set [V, I, C, F, Y, T] [348]
(chapter B.2.1.1).
BetaTurn Consists of four amino acids. At each position the amino acid
must come from the sequence of sets [N, C, D], [P, S, K], [N, D,
G], [W, G, Y] [397] (chapter B.2.1.1).
AminoAcidsLm Identifies cysteines (chapter B.2.1.3)
GOR4AlphaHelix Identifies alpha helices using the GOR4 algorithm [398] (chapter
B.2.1.1).
GOR4BetaStrand Identifies beta strands using the GOR4 algorithm [398] (chapter
B.2.1.1).
GOR4Coil Identifies coils using the GOR4 algorithm [398] (chapter
B.2.1.1).
Prosite Identifies patterns from the prosite database [349] (chapter
B.2.1.2).
EukaryoticLinearMotif Identifies eukaryotic linear motifs from the ELM database [352]
(chapter B.2.1.2).
PDB AlphaHelix Identifies alpha helices based on the assignment of alpha helices
in PDB (chapter B.1.1). For evaluation only.
PDB AlphaHelix_3_10 Identifies alpha helix 3-10 based on the assignment of alpha he-
lix 3-10 in PDB (chapter B.1.1). For evaluation only.
PDB AlphaHelix_pi Identifies alpha helix pi based on the assignment of alpha helix
pi in PDB (chapter B.1.1). For evaluation only.
PDB ExtendedStrand Identifies beta strands based on the assignment of extended
strands in PDB (chapter B.1.1). For evaluation only.
PDB AlphaHelix_combined Identifies alpha helices based on the assignment of alpha helices,
alpha helix 3-10 and alpha helix pi in PDB (chapter B.1.1). For
evaluation only.
Table B.2: Description of the different landmark feature finders that are used by the light
matter algorithm. Where relevant, chapter numbers are given.
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Trig point name Description
IndividualPeak Based on a window of length three moved along the amino acid se-
quence. If the property values for composition, isoelectric point, and
polarity all are higher for the current amino acid than for the two amino
acids on either side, the current amino acid is an IndividualPeak (chap-
ter B.2.2.2).
IndividualTrough Based on a window of length three moved along the amino acid se-
quence. If the property values for composition, isoelectric point, and
polarity are all lower for the current amino acid than for the two amino
acids on either side, the current amino acid is an IndividualTrough
(chapter B.2.2.2).
Peak Based on a window of length three moved along the amino acid se-
quence. If the sum of the property values for composition, isoelectric
point, and polarity is higher for the current amino acid than for the two
amino acids on either side, the current amino acid is a Peak (chapter
B.2.2.2).
Trough Based on a window of length three moved along the amino acid se-
quence. If the sum of the property values for composition, isoelectric
point, and polarity is lower for the current amino acid than for the two
amino acids on either side, the current amino acid is a Trough (chapter
B.2.2.1).
AminoAcids Tryptophans (chapter B.2.2)
Table B.3: Description of the different trig point feature finders that are used by the light
matter algorithm. Where relevant, chapter numbers are given.
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B.2.1 Landmarks
This sub-chapter describes the development of the landmark finders. First, I will in-
troduce the landmark finders based on secondary structures, then the landmark finders
based on sequence motifs, and finally the one based on amino acids.
B.2.1.1 Landmarks based on secondary structures
Alpha helices and beta strands are integral parts of the structure of a protein [399] and
are often highly conserved [400]. This makes them an obvious choice for landmarks
in the light matter algorithm. Secondary structures can be identified using secondary
structure prediction tools, with the best and most modern tools reaching an accuracy
of about 80% [347]. The first secondary structure prediction algorithms relied on
statistical analysis of sequence composition within the different types of secondary
structures. They calculated the probability of each amino acid to be in a particular
secondary structure, also called amino acid propensities [401]. Examples include the
Chou-Fasman method [402] and the GOR algorithm [403]. The accuracy of these
early prediction methods was between 50% and 60% [404]. Those methods were
improved by calculating amino acid propensities for a window around the residue
of which the secondary structure should be predicted, rather than considering each
residue on its own [401]. Further improvements were made by incorporating multiple
sequence alignments and machine learning approaches, as well as by the availability
of a higher number of three-dimensional structures due to the growth of public struc-
ture databases [347]. Sequences related to the query sequence are identified using
BLAST, PSI-BLAST, or hidden Markov models and converted to a multiple sequence
alignment or a position specific scoring matrix. This information is used as the in-
put to a machine learning method, such as a neural network, k-nearest-neighbour
approach, another hidden Markov model, or a combination thereof [347]. Neural
networks generally have an input layer, a hidden layer, and an output layer. The
network takes an input, in our case a sequence or a sequence profile, and calculates
the output value, which in this case is the secondary structure element of a residue,
based on a set of functions with associated weights in the hidden layer. Tools using
this approach include PHD [405], PSIPRED [406], and SSPro [407], among many
others [347].
For the purpose of the light matter algorithm, secondary structure prediction needs to
be fast and cannot rely on sequence similarity to known sequences, thus ruling out
methods incorporating multiple sequence alignments. This limits us to the earlier,
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less-accurate secondary structure prediction methods, such as the first four versions
of the GOR algorithm [403].
Basic secondary structure finders
Initially, we implemented finders that identify alpha helices based on patterns of hy-
drophobic and hydrophilic amino acids. Beta strands are identified by screening for
a sequence of at least six specific amino acids, while the beta turns have to consist
of a sequence of four amino acids, where at each of the four positions, an amino
acid from a certain set has to occur (see table B.2). The finders are called ‘AlphaHe-
lix’, ‘AlphaHelix_3_10’, ‘AlphaHelix_pi’, ‘BetaStrand’ and ‘BetaTurn’. The alpha
helix and beta strand finders were written by Terry Jones. Table B.4 shows perfor-
mance statistics of the five basic secondary structure finders when evaluating them
against the secondary structure annotations for all sequences in PDB, downloaded on
11 July 2016. The low sensitivity for all five finders suggests that they miss a high
proportion of the respective secondary structures present in PDB. The low precision
for the three alpha helix finders also suggests that they identify a high number of
false positives. These results suggest that the features identified by the five basic sec-
ondary structure finders do not contribute to the algorithm’s performance and should
be replaced by more sophisticated finders, in the interest of computation speed of the
algorithm.
205
B. LIGHT MATTER ALGORITHM: PARAMETERS AND METHODS
AlphaHelix AlphaHelix_3_10 AlphaHelix_pi BetaStrand BetaTurn
True
positive 138,053 139,168 0 44,903 63,583
True
negative 45,286,095 61,165,671 66,180,920 51,762,384 53,567,407
False
positive 474,687 2,726,606 114,089 26,009 75,593
False
negative 20,409,621 2,277,011 13,447 14,475,160 12,601,873
Sensitivity 0.01 0.06 0.00 0.00 0.01
Precision 0.23 0.05 0 0.63 0.46
Table B.4: Performance statistics of the basic secondary structure finders when evalu-
ated using the secondary structure annotations in PDB. The sensitivity is calculated as
(true positives / (true positives + false negatives)) and the precision as (true positives / (true
positives + false positives)). The sequences from PDB were downloaded on 11 July 2016.
GOR4 secondary structure finders
In order to improve the identification of secondary structures, we next implemented
finders that rely on a dedicated secondary structure prediction algorithm. As men-
tioned earlier, for reasons of speed, and since the overall aim is to identify query
sequences without sequence similarity to known sequences, we had to rely on a sec-
ondary structure prediction algorithm that does not require a multiple sequence align-
ment. The GOR method for secondary structure prediction was originally developed
in 1978 by Garnier, Osguthorpe, and Robson [403]. It has since gone through various
refinements, ultimately reaching an accuracy of around 73% in its 5th version [408].
We used the 4th version of the GOR algorithm [398] (GOR4), as it is the most ad-
vanced version of the algorithm that does not require a multiple sequence alignment.
The algorithm has a published accuracy of 64.4% [398]. The Python wrapper of the
GOR4 algorithm was written by Terry Jones.
The database which the GOR4 algorithm uses by default contains 267 sequences,
reflecting the number of structures in PDB around 1996, when the algorithm was
developed. However, given that PDB has expanded since then, I updated the GOR4
database with all sequences in PDB up to 2016, to increase prediction accuracy. To
construct the new database, I followed the steps that were taken to build the orig-
inal database, outlined in Garnier et al., (1996) as closely as possible [398]1. All
sequences and associated structures present in PDB on 3 March 2016 were filtered
for length >50 amino acids and for a resolution <2.5Å. The remaining sequences
were clustered using CD-HIT [409] with a sequence identity cut-off of 30%. For the
1Apart from the steps explained in the following text, Garnier et al., (2016) also excluded sequences
with an R-factor bigger than 25%. Since this information was not easily accessible, I omitted this step.
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resulting 13,329 sequences, the secondary structures assigned to each amino acid in
PDB using DSSP had to be translated from the eight-letter assignment to the three-
letter assignment that is used by GOR4. Finally, the sequences were formatted to be
useable by the GOR4 algorithm. Garnier et al., (1996) [398] test the accuracy of the
GOR4 algorithm using a jackknife test, leaving out one sequence from the database
and predicting its secondary structure from the remaining sequences in the database.
I did the same, once for the 267 sequences from the original GOR4 database and
once for the new database consisting of 13,329 sequences. I could not reproduce
the overall accuracy of 64.4% that Garnier et al., (2016) [398] report using the old
database of 267 sequences, but instead calculated an accuracy of 62.7%. The cause
of this discrepancy may stem from using a slightly different version of the GOR4 al-
gorithm than the one used in the original publication, since the code that is available
online was last modified in 1997. The accuracy of the GOR4 algorithm when using
the new database with 13,329 sequences is 66.4%. When evaluating the old and new
GOR4 databases against the whole PDB database downloaded on 11 July 2016, I
found a sensitivity and precision of 0.598 and 0.453 for the old database and 0.606
and 0.459 for the new database, respectively. I used the five test datasets described
in chapter B.1.2 to investigate the correspondence between scores obtained using the
perfect finders (described in chapter B.1.1) and scores obtained using the old and new
GOR4 databases, respectively (Fig. B.3). Using the old GOR4 database, the scores
from using the GOR4 finders correspond slightly better to the scores obtained from
the perfect PDB finders, but the difference between the two regression lines is not
significant (P value: 0.067). There was no negative effect on runtime when using the
larger database. Given the higher accuracy and slightly higher sensitivity and pre-
cision of the GOR4 algorithm when using the new database, and since there is no
negative effect on the speed of the algorithm, I decided to use the updated version of
the GOR4 database in the light matter algorithm.
Aho-Corasick finders
Secondary structure prediction programs that are able to execute in a useful time-
frame for our purposes, such as the GOR4 algorithm, have an accuracy of around
65% [347, 398]. Thus, their suitability for the light matter algorithm may be limited.
A feature finder that is able to identify secondary structures with a high precision
may be more desirable, even if this also leads to a high number of false positives.
Searching for substrings of amino acid sequences that are known to occur frequently
in certain secondary structures would always identify their corresponding secondary
structures correctly, as well as making some false positive identifications.
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Figure B.3: Correspondence between scores obtained using the perfect PDB finders and
scores obtained using the GOR4 finders using the a) old and b) new GOR4 databases.
The matches come from the five test datasets described in chapter B.1.2. Scores using the
perfect PDB finders and GOR4 finders are shown on the x-axis and y-axis, respectively. The
blue line shows the linear regression and 95% confidence interval. Matches that have a score
of 0.0 using the GOR4 finders (shown as pale dots), were jittered in the y dimension to
improve readability, and were not included in the linear regression. The slope and correlation
coefficient for the old and new databases are 0.75, 0.7 (R2=0.49) and 0.68, 0.66 (R2=0.44),
respectively. There is no significant difference between the regression lines in a) and b)
(P value: 0.067). The ‘GOR4AlphaHelix’ and ‘GOR4BetaStrand’ finders and the ‘PDB
AlphaHelix’, ‘PDB AlphaHelix_3_10’, ‘PDB AlphaHelix_pi’, and ‘PDB ExtendedStrand’
finders were used.
The following sections describe the implementation of landmark finders that are
based on the secondary structure assignments in PDB. The resulting landmark finder
scans an amino acid sequence for the presence of substrings that are known to occur
frequently in a particular secondary structure.
Using the secondary structure assignments in PDB, downloaded on 11 July 2016, I
extracted all strings of amino acid sequences that occur in a certain secondary struc-
ture element longer than four amino acids, as well as all possible substrings thereof,
also longer than four amino acids. Five secondary structure elements were consid-
ered: alpha helix, alpha helix 3-10, alpha helix pi, extended strand, as well as the
three types of alpha helix combined (referred to as ‘alpha helix combined’). Only
PDB structures with a resolution <3.0Å and non-obsolete entries were used. As it is
impractical to use all resulting substrings due to computational limitations, I needed
to select a subset of all substrings that were extracted. Ideally, the substrings in the
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subset should occur often and have a high precision. In order to select substrings,
each substring was matched to all sequences in PDB. If there was a match, and it
occurred in the correct secondary structure element, the match was counted as a true
positive (TP), if the match was in the wrong secondary structure element, it was
counted as a false positive (FP). Multiple subsets of substrings were generated using
different cut-offs for the absolute number of occurrences as well as the percentage of
true positives. If multiple substrings were nested (such as ‘AHGC’ and ‘AHGCA’)
and have the same number of true and false positives, only the shortest substring was
included in the subset. The subsets of substrings were evaluated using the following
criteria: first, the subset of substrings used in the finder should have a high precision
averaged over all substrings in the subset. The precision was calculated using the
following formula:
Precision =
TP
TP + FP
(B.1)
Second, the substrings in the subset should match a high proportion of known sec-
ondary structures in PDB. Third, there should be a good correlation between the
light matter scores calculated using the perfect finders described in chapter B.1.1 and
the finders using the subsets of substrings. And finally, smaller subsets were pre-
ferred, so as to not negatively affect the speed of the algorithm. According to these
criteria, a subset of substrings was selected for each of the five secondary structure
elements.
Table B.5 shows for each of the five secondary structure elements, the total number
of structure strings, the number of unique structure strings, and the number of unique
substrings. Substantially more unique substrings are available for AlphaHelix, Al-
phaHelix_combined, and ExtendedStrand.
Secondary structure
element
Number of struc-
ture strings in PDB
Number of
unique structure
strings in PDB
Number
of unique
substrings
AlphaHelix 1,815,854 381,066 12,169,718
AlphaHelix_3_10 717,799 32,114 61,487
AlphaHelix_pi 2,518 552 2,030
AlphaHelix_combined 2,393,589 410,041 12,895,213
ExtendedStrand 2,548,920 276,463 1,772,181
Table B.5: Number of structure strings and substrings in PDB.
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Figure B.4: Scatter plots of the precision (Percentage of true positives) against the total number
of true and false positives for each substring. a) AlphaHelix, all lengths, b) AlphaHelix_3_10,
all lengths, c) AlphaHelix_pi, all lengths, d) AlphaHelix_combined, all lengths, e) Extended-
Strand, all lengths. Each plot corresponds to a different secondary structure element.
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Figures B.4a–e) show for each secondary structure element, each substring plotted
by its precision on the y-axis and the sum of its true and false positives evaluated
using PDB (which is equal to the number of times the substring occurs in PDB) on
the x-axis. Preferably, substrings used in the landmark finder should occur in the top
right-hand corner of the figure.
Subsets of substrings were chosen by selecting a precision threshold that the substring
has to surpass, as well as a threshold for the number of times a substring has to occur
in PDB. Six subsets were generated for alpha helix, ten for alpha helix 3-10, eight
for alpha helix pi, six for alpha helix combined and seven for extended strand. The
subsets of substrings were evaluated taking into account the following four criteria:
1) average precision of all substrings in the subset, 2) the proportion of sequences in
PDB matched by at least one substring, 3) the proportion of known secondary struc-
ture strings in PDB of a given secondary structure element matched at least once by a
substring, 4) the correlation between the light matter scores calculated using the per-
fect finders described in chapter B.1.1 and the finders using the subsets of substrings.
The correlations were calculated separately for the 4MTP, 2HLA, Polymerase, and
HA test datasets described in chapter B.1.2. Figure B.5 shows the evaluation of the
subsets of substrings according to the four criteria, for each secondary structure el-
ement. The x-axes on all plots indicate the name of the subsets of substrings under
evaluation, where the first number in the name corresponds to the threshold of the
number of occurrences of the substrings in PDB and the second number corresponds
to the threshold for the precision of the substrings in the subset. The data for the
alpha helix 3-10 and alpha helix pi are most likely confounded by the small number
of those secondary structure elements in the test datasets (Table B.5). The subsets
of substrings selected for use in the finder for each secondary structure element are:
alpha helix: 20-0.85, alpha helix 3-10: 1-0.5, alpha helix pi: 1-0.5, alpha helix com-
bined: 20-0.85, and extended strand: 10-0.5. I selected these subsets of substrings
because they have the best combination of correlation between the light matter scores
from the perfect finders and scores using the finders from the subsets of substrings
across the four test datasets (Figs. B.5c, f, i, l, o), as well as the highest possible total
precision (Figs. B.5a, d, g, j, m) and fraction of sequences and structures matched
in PDB (Figs. B.5b, e, h, k, n). The finders that identify the substrings are called
‘Aho-Corasick’ (AC) finders, after the matching algorithm published in 1975 [410].
We refer to the features themselves as ‘AC AlphaHelix’, ‘AC AlphaHelix_3_10’,
‘AC AlphaHelix_pi’, ‘AC ExtendedStrand’, and ‘AC AlphaHelix_combined’. The
landmark finder that identifies the features using the subsets of substrings developed
above was implemented by Terry Jones.
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Figure B.5: Evaluation of subsets of substrings. Plots in each row show the four metrics for
evaluation for each secondary structure element. Subsets of substrings evaluated are plotted on the x-
axis. The first number in the subset name corresponds to the threshold of the number of occurrences
and the second number corresponds to the threshold for the precision. The leftmost column of plots
(a, d, g, j, m) shows the total precision of a subset, calculated by averaging out the precision of
all substrings. The middle column of plots (b, e, h, k, n) shows the fraction of sequences in PDB
that was matched by at least one substring in orange, and the fraction of secondary structures of a
given secondary structure element in perfect matched by at least one substring in grey. The right-
most column (c, f, i, l, o) shows the correlation coefficients between scores obtained using the PDB
finders and scores obtained using the substrings of the respective subsets. Correlation coefficients
are calculated separately for the four test datasets.
214
B.2. FEATURES
1
9
7
5
1
9
8
0
1
9
8
5
1
9
9
0
1
9
9
5
2
0
0
0
2
0
0
5
2
0
1
0
2
0
1
5
Year
0
20000
40000
60000
80000
100000
120000
C
o
u
n
t
Cumulative
Per year
Figure B.6: Structures added to PDB be-
tween 1972 and 2016. The blue line indi-
cates the total number of structures present
in PDB at a particular time. The red line in-
dicates the number of structures that were
added in that particular year.
PDB almost certainly is an incomplete representation of all protein structures on earth
and it can be expected to grow in the future. This is illustrated in Fig. B.6, which
shows the cumulative number of structures added to PDB in blue and the number of
structures added per year in red. It is apparent that the growth of PDB cannot be ex-
pected to slow down in the near future. PDB is therefore highly incomplete, and it is
important to investigate how the subsets of substrings selected to be used in the Aho-
Corasick finders generalise to sequences not currently in PDB. I used the sequences
present in PDB up to each year between 1972 and 2016 (for example 1972–1973,
1972–1974 etc.), and selected subsets of substrings using same parameters as used
for the subsets that were found to perform best according to the evaluation criteria,
resulting in 44 subsets per secondary structure element, one for each year. I evaluated
each subset of substrings for its performance on sequences that were added to PDB
in future years. So, the subset generated using the sequences present in PDB between
1972 and 1980 was evaluated against the sequences present in PDB between 1972
and 1980, 1972 and 1981 and so on. I calculated the quotient of correctly identified
secondary structures by the total number of secondary structures present in PDB at
the time for each year (referred to as the ‘fraction of known structures’). The re-
sults for each secondary structure element are shown in Fig. B.7. Empty circles
show the fraction of known structures present in PDB in the year up to which the
subset of substrings was selected. The blue line extending from each empty circle
indicates how this subset of substrings performs into the future, as measured by the
fraction of known structures present in PDB in future years. The coloured line in-
dicates how the subset of substrings selected up to 2016 performs against structures
in PDB selected in each year into the past. The alpha helix, alpha helix combined
and extended strand show a decreased increase in performance after 1994 and 1998
respectively, suggesting that the current set may be an accurate representation of the
existing but undiscovered secondary structures. For the alpha helix 3-10 and alpha
helix pi secondary structures, no drop off is visible, probably influenced by the low
number of these secondary structure elements (Table B.5). This suggests that the
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subsets of substrings for these two secondary structure elements does not yet contain
a representative set of all secondary structure substrings.
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Figure B.7: Performance of subsets of substrings selected from all sequences present in PDB
from each year using the criteria that were determined on the set from 2016. Performance
was determined using the subset of substrings from each particular year on the subset of sequences
present in PDB in all future years. Performance was measured by the fraction of known structures a
given subset of substrings can identify. Empty circles show the fraction of known structures present
in PDB in the year up to which the subset of substrings was selected. The blue line extending from
each empty circle indicates how this subset of substrings would perform into the future, as measured
by the fraction of known structures present in PDB in future years. The coloured line indicates how
the subset of substrings selected up to 2016 performs against structures in PDB selected in each year
into the past.
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AC
Alpha-
Helix
AC Alpha-
Helix_3_10
AC Al-
phaHe-
lix_pi
AC
AlphaHe-
lix_combined
AC Ex-
tended-
Strand
AC AlphaHelix -
AC AlphaHelix_3_10 0 -
AC AlphaHelix_pi 0 0 -
AC ExtendedStrand 0 0 0 -
AC AlphaHelix_combined 132,663 377 5 0 -
Table B.6: Overlap of substrings in the subsets used in the Aho-Corasick finders.
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Figure B.8: Number and length of substrings in the final subsets, by secondary struc-
ture element. a) The number of substrings in the final subsets, per secondary structure
element. b) The length of substrings in the final subsets, per secondary structure ele-
ment. For all secondary structure elements, the lengths fall in a range from four to eight
amino acids, with peaks at five or six amino acids.
Figure B.8a shows the number of substrings present in each subset and Fig. B.8b
shows the length distribution within each subset. The majority of substrings are five
or six amino acids long. The AlphaHelix and AlphaHelix_combined subsets both
contain a similar number of substrings of similar lengths. Figure B.8a also suggests
that the finders may be of limited use for the identification of AlphaHelix_3_10 and
AlphaHelix_pi, due to the small number of substrings representing those secondary
structure element in the subset. Table B.6 shows the number of substrings that are
in common between the five subsets of substrings. Not surprisingly, all individual
alpha helix subsets have some overlap with the AlphaHelix_combined subset. The
AC_AlphaHelix_combined and the other three AC_AlphaHelix finders should not be
used together, since it would result in the same features being identified twice. There
is no overlap between the subsets of the other secondary structure elements.
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The new finders were evaluated using the test datasets described in chapter B.1.2. All
matches were evaluated using the perfect finders described in chapter B.1.1 and the
Aho-Corasick finders described above. Figure B.9 shows a scatter plot of the scores
calculated using the Aho-Corasick finders with the subsets described above, and the
perfect finders. The blue line and blue shaded area indicate the linear regression and
95% confidence interval. The figure shows that there is a correlation between scores
obtained using the perfect finders and the scores obtained from using the new Aho-
Corasick finders, suggesting that the Aho-Corasick finders identify adequate features
for sequence comparison in the light matter algorithm.
0.0 0.2 0.4 0.6 0.8 1.0
Light matter scores (AC finders)
0.0
0.2
0.4
0.6
0.8
1.0
Li
g
h
t 
m
a
tt
e
r 
sc
o
re
s 
(P
D
B
 f
in
d
e
rs
)
Figure B.9: Correlation between the
scores obtained from using the perfect
PDB finders and the scores obtained us-
ing the Aho-Corasick finders. Scores
were calculated using the test datasets de-
scribed in chapter B.1.2. For visual ref-
erence, the dashed line indicates perfect
correlation. The blue line shows the lin-
ear regression and 95% confidence in-
terval. Slope and correlation coefficient
are: 0.8 and 0.83 (R2=0.68). Perfect
finders: ‘PDB AlphaHelix’, ‘PDB Alpha-
Helix_3_10’, ‘PDB AlphaHelix_pi’, and
‘PDB ExtendedStrand’. Aho-corasick find-
ers used: ‘AC AlphaHelix’, ‘AC AlphaHe-
lix_3_10’, ‘AC AlphaHelix_pi’, and ‘AC
ExtendedStrand’.
B.2.1.2 Landmarks based on sequence motifs
A sequence motif is a short pattern in the nucleotide or amino acid sequence that is
thought to have a particular biological function [411]. The same motifs often occur in
proteins with functional and structural similarity [411]. The view of protein structures
as being rigid and stable is increasingly being recognised as flawed [412]. Up to 50%
of amino acids in eukaryotic sequences are predicted to be disordered [412], meaning
that they do not adopt a fixed three-dimensional structure. Further, in viral proteomes,
between 15 – 23% of segments <30 amino acids in length are disordered [413]. Some
sequence motifs occur predominately in disordered regions of proteins [414]. Given
that motifs are often associated with similar structure and function, and may help
identifying reads matching against disordered regions of a protein, I implemented
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two landmark finders. One is based on the PROSITE [349] and the other on the
Eukaryotic Linear Motif [352] database.
Landmarks based on PROSITE motifs
The PROSITE database contains entries that describe protein domains, families, and
functional sites. For each of these entries, the database also contains the associated
patterns and profiles to identify them [349]. Patterns are between 10 to 20 amino acids
long and include enzyme catalytic sites, prostethic group attachment sites, amino
acids involved in binding a metal ion, cysteines involved in disulfide bonds, and re-
gions involved in binding a molecule or another protein [415]. Patterns are described
by regular expressions. Profiles have a numerical weight for each possible match or
mismatch between a sequence residue and a profile position. Profiles have an ad-
vantage over patterns since they allow for mismatches [415], but they characterise
protein domains over their entire length. This makes them unsuitable as landmarks,
and I focus on patterns instead. The PROSITE database used in the light matter
algorithm (downloaded on 11 November 2015) contains 1,309 patterns.
Landmarks based on short linear motifs
Short linear motifs (SLiMs) are three to eleven amino acids long and are generally
situated in disordered regions of a protein. They mediate protein-protein interactions,
broadly acting either as ligand binding sites or modification sites [414]. Their short
length and location in disordered regions of proteins make SLiMs interesting features
to use as landmarks. First, because their short length makes it possible to identify
them in NGS reads, and second, because they allow me to identify features in dis-
ordered regions of proteins, in contrast to the other finders described so far. The eu-
karyotic linear motif (ELM) database is a manually curated database of SLiMs [352].
Each motif is described by a regular expression pattern. As of 13 July 2016, the ELM
database contains 251 patterns. 49 of those are specific for viral proteins. I wrote a
finder that detects SLiMs using the regular expression patterns in the ELM database.
The finder can use either the complete set of 251 patterns, or the 49 patterns that are
specific to viruses. The finder was evaluated using the 2HLA, 4MTP, Polymerase,
and HA test datasets described in chapter B.1.2. Figure B.10 shows that using just
the virus-specific patterns leads to less matches being assigned a light matter score
of 0.0, and a better correlation between the scores computed by the light matter al-
gorithm and the Z-scores inferred by the Dali algorithm. Hence, I only use the virus
specific database in the feature finder.
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There is only very limited overlap between the PROSITE and the ELM databases,
only one pattern (‘RGD’) is present in both.
221
B. LIGHT MATTER ALGORITHM: PARAMETERS AND METHODS
(a) (b)
(c) (d)
(e) (f)
(g) (h)
Figure B.10: Evaluation of the different ELM subsets. The left column shows the evaluations
using the viral ELMs only and the right column shows all ELMs. Each row is one of the evaluation
datasets described in chapter B.10. Figures a) and b) are the 2HLA dataset, Figs. c) and d) the 4MTP
dataset, Figs. e) and f) the Polymerase dataset and Figs. g) and h) the HA dataset. The y-axes on
all plots shows the Dali Z-scores, and the x-axes indicate the light matter score calculated by the
algorithm.
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B.2.1.3 Landmarks based on amino acids
Some amino acids are more conserved than others. Scoring matrices represent the
relative rates of substitutions, showing how likely one amino acid is to be replaced
by another. Two different kinds of scoring matrices are widely used, the PAM (Point
Accepted Mutations) [350] and BLOSUM (BLOcks SUbstitution Matrix) [351, 394]
matrices. The PAM1 matrix was constructed from proteins that were 85% or more
similar to one another. To simulate different degrees of divergence, the PAM matrix
can be multiplied by itself [394]. Higher numbers in the PAM matrix name refer to
larger evolutionary distance. BLOSUM matrices were constructed from a database
of aligned proteins. For the BLOSUM62 matrix, only protein sequences with 62%
or more sequence conservation were used to calculate the frequencies in the scoring
matrix. The larger the suffix in the BLOSUM matrix name, the shorter the evolu-
tionary distance [416]. Both matrices agree that tryptophan and cysteine are the most
conserved amino acids (see Fig. B.11). Tryptophan has a large aromatic side chain
and cysteine participates in the formation of disulfide bonds. I therefore decided to
use cysteines as landmarks and tryptophans as a trig points in the light matter algo-
rithm. It is possible to use one or multiple additional amino acids as landmarks or trig
points, however I did not test those combinations. One has to keep in mind that the
more different amino acids are used in finders, the more the algorithm will behave as
if the sequence comparisons are done at the amino acid level.
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Figure B.11: Log-odds scores for each
amino acid in the PAM250 and BLO-
SUM62 matrices. Scores were taken from
Dayhoff et al. [350] and Henikoff et al.
[351]. Amino acids are sorted by their
log-odds score in the PAM250 matrix, and
shown on the x-axis by their one-letter ab-
breviation.
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B.2.2 Trigonometry points
Trigonometry (trig) points are the second group of features used by the light matter
algorithm, alongside landmarks. A trig point can only form a pair with a landmark,
not with another trig point. The trig points currently implemented in the algorithm
are either based on amino acids or on specific amino acid property patterns (see table
B.3).
B.2.2.1 Trig points based on amino acids
This trig point finder is analogous to the landmark finder based on amino acids de-
scribed in chapter B.2.1.3. The tryptophans in a sequence are used as trig points, as
this amino acid is highly conserved (see Fig. B.11).
B.2.2.2 Trig points based on amino acid properties
Each amino acid has specific biochemical properties, which may influence protein
evolution. If an amino acid is replaced in a context where the structure needs to be
conserved, the replacing amino acid often has similar properties [417]. Based on this
idea, I implemented two types of trig point finders. The ‘Peaks’ and ‘Troughs’ and the
‘IndividualPeaks’ and ‘IndividualTroughs’ finders. Peaks and Troughs are identified
by sliding a window of length three along the amino acid sequence. If the sum of the
property values for multiple predetermined amino acid properties is higher / lower
for the current amino acid than for the two amino acids on either side, the current
amino acid is a Peak / Trough. Similarly, IndividualPeaks and IndividualTroughs
are identified by sliding a window of length three along the amino acid sequence. If
the property values for multiple predetermined amino acid properties are all higher
/ lower for the current amino acid than for the two amino acids on either side, the
current amino acid is an IndividualPeak / IndividualTroughs.
Xia et al. (1998) studied mitochondrial genes and found that the genetic code appears
to have evolved towards minimising polarity and hydropathy. They also found that
proteins encoded by mitochondrial DNA have more amino acids with typical compo-
sition and isoelectric point values, so that non-synonymous mutations result in small
differences in those properties [417]. Based on their work, I decided to use chemical
composition, isoelectric point, and polarity in the trig point finders.
To investigate the behaviour of the Peak, Trough, IndividualPeak, and Individual-
Trough trig point finders, I used them on sequences from the following virus groups:
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49 bunya-, arena-, and orthomyxovirus sequences, 304 amino acids in length, 65 in-
fluenza haemagglutinin sequences, 549 amino acids in length, 94 Mononegavirales
sequences, 945 amino acids in length, 29 Nidovirales sequences, 210 amino acids in
length, and 23 rhabdovirus sequences, 350 amino acids in length. Sequences other
than the influenza haemagglutinin sequences were provided by Christian Drosten.
The influenza haemagglutinin sequences were provided by David Burke. I was inter-
ested to investigate whether specific amino acids would preferentially be identified
as trig points. Figure B.12 shows the frequencies at which a particular amino acid
is found in a Peak, Trough, IndividualPeak, IndividualTrough, in both a Peak and
IndividualPeak, Peak and IndividualTrough, Trough and IndividualPeak, or Trough
and IndividualTrough, or is not used in a trig point.
Figure B.12: Frequencies at which particular amino acids are found by a par-
ticular trig point finder. Frequencies are shown on the y-axis, and the different
amino acids on the x-axis, denoted by the one-letter amino acid abbreviations.
The following observations can be made. An IndividualPeak is almost always also
a Peak and and IndividualTrough is almost always also a Trough. The same is not
true for Peaks and Troughs. Some amino acids are more frequently assigned to a
Peak or Trough: arginine (R) is most commonly found in Peaks and IndividualPeaks,
together with lysine (K), asparagine (N), and aspartic acid (D); phenylalanine (F)
is most commonly found in Troughs and IndividualTroughs, together with leucine
(L), tryptophan (W), and isoleucine (I). Some amino acids do not form a trig point
around 60% of the time, including alanine (A), glutamic acid (E), glycine (G), proline
(P), and threonine (T). Some amino acids can be found in both Peaks and Troughs,
including cysteine (C), glutamic acid, and glutamine (Q), however, those are also the
amino acids that often are not part of a trig point at all.
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Given the overlap between Peaks and IndividualPeaks and Troughs and Individual-
Troughs, IndividualPeaks and IndividualTroughs do not seem add information when
comparing two sequences other than that provided by the Peaks and Troughs and do
not need to be used by the algorithm.
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B.3 METHODS TO DETERMINE THE SIGNIFICANCE
OF A MATCH
After all features have been identified and paired, the pairs of the subject and the
query are compared. If a pair exists in both the query and the subject, the offsets of the
locations of the first feature in the pair in the query and the subject are subtracted, and
these ‘deltas’ are entered in a histogram. Subsequently, the histogram is assessed to
decide whether the comparison between the query and the subject can be considered
a significant match or not. A significant match should have a distinctive peak in its
histogram, as this indicates a high number of identical pairs with the same relative
sequence offsets in the query and the subject. Note that ‘significant’ here is used
informally, and does not imply formal statistical significance. I implemented three
different methods for assessing whether a histogram has one or multiple bins that are
indicative of a significant match, so-called ‘significance methods’. All significance
methods consider each histogram bin separately and assess whether it is significant. If
no significant bin is present in a histogram, the match as a whole is insignificant and is
not considered further. If a significant bin is found, a score is calculated (see chapter
B.4). Each significance method calculates a ‘significance cut-off’, corresponding to
the minimum bin height in order for a bin to be significant. The term ‘bin height’
refers to the number of pairs or amino acids in pairs in a histogram bin. Figure B.13
illustrates the effects of using the different significance methods on the comparison
between two Bunyaviridae polymerase sequences. Significant bins are shown in red,
insignificant bins in black. The three significance methods are:
MaxBinHeight: the significance cut-off value is the number of pairs in the second-
highest bin when the query is compared against itself. In the histogram from the
comparison of the query and the subject, every bin higher than this cut-off value is
considered significant (Fig. B.13a).
HashFraction: the significance cut-off is calculated based on the theoretical maxi-
mum number of pairs that could be present in the highest bin if there was a perfect
match between query and subject, multiplied by a user-defined ‘significance fraction‘
between 0.0 and 1.0. The theoretical maximum number of pairs that can be present
in the highest bin is equal to the total number of pairs in either the subject or the
query, depending on which of the two has the smaller number of pairs. Any bin that
is higher than the significance cut-off is considered significant (Fig. B.13b).
AAFraction: the AAFraction significance method uses the same principle as the
HashFraction significance method, but rather than considering the number of pairs in
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the bin, it considers the number of amino acids in pairs in the bin. The significance
cut-off is calculated by using the theoretical maximum number of amino acids in
pairs that can be present in the highest bin in a perfect match, multiplied by a user-
defined ‘significance fraction‘ between 0.0 and 1.0. Note that each amino acid is
only counted once, even if it occurs in multiple features that form pairs in a bin (Fig.
B.13c).
In the following sections I describe the influence of the significance methods and the
cut-offs employed on the number of matches that are identified as significant by the
significance methods. I also describe the difference between the AAFraction and the
HashFraction significance methods.
B.3.1 Matches considered significant by different
significance methods
The ideal significance method should identify matches between sequences coding
for proteins with similar structures as significant, and it should disregard matches
between sequences coding for proteins with dissimilar structures. As a general rule,
a Dali Z-score above 20 indicates the two structures are definitely homologous, be-
tween 8 and 20 means the two are probably homologous, between 2 and 8 is a grey
area, and a Z-score below 2 is not significant [359]. For our purposes, any sig-
nificance method and significance cut-off combination that finds a match with Dali
Z-scores above 20 and between 8 and 20 to be insignificant is not desirable. In or-
der to investigate whether the significance methods are effective at marking matches
with Z-scores <8 as insignificant, while keeping matches with higher Z-scores, I
performed the following experiment. I used all pairwise comparisons in the 2HLA,
4MTP, and 4PH0 test datasets to evaluate which of them are considered significant
by different combinations of significance method and significance cut-off. For each
pairwise comparison, I determined whether the match is considered significant by the
MaxBinHeight, HashFraction, and AAFraction significance methods.
Figures B.14b–d) show the fraction of matches that are considered insignificant us-
ing the MaxBinHeight, HashFraction, and AAFraction significance methods, and, in
case of the HashFraction and AAFraction methods, also show the effects of different
significance cut-off values. For reference, Fig. B.14a shows the number of matches
in the test dataset with a particular Z-score as black vertical bars.
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Figure B.13: Illustration of the effect of using different significance methods on the compar-
ison between two Bunyaviridae (bunyamveravirus and oropuchevirus) polymerase sequences.
Significant bins are shown in red, insignificant bins in black. The sequences have an amino acid se-
quence similarity of 67%. a) MaxBinHeight. b) HashFraction. The significance fraction was set
to 0.03. c) AAFraction. The significance fraction was set to 0.2. Note that because the AAFraction
significance method calculates the height of the histogram bins by the number of amino acids rather
than the number of pairs in the bin, the height of the histogram bins in Fig. c) differs from figures a)
and b).
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Figure B.14: The fraction of matches considered insignificant using different significance
methods. To calculate the match, the ‘AC AlphaHelix_combined’, ‘AC ExtendedStrand’ finders
and no trig point finders were used. Z-scores were binned from 0–1, 2–3, 4–7, 8–11, 12–15, 16–19,
and >20 indicated by grey dotted lines. a) The total number of matches in the test datasets with
particular Z-scores are shown as black vertical bars. Blue rectangles show the number of Z-
scores in the range of 0–1, 2–3, 4–7, 8–11, 12–15, 16–19, and >20. b) The fraction of insignificant
matches using the MaxBinHeight significance method. c) The fraction of insignificant matches
using the HashFraction significance method. d) The fraction of insignificant matches using the
AAFraction significance method. In figures b)–d), the y-axis indicates the fraction of insignificant
matches, out of all matches in a particular Z-score bin. In figures c) and d), different colours show
the results using different significance fractions.
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For a less fine-grained representation, I binned the Z-scores from 0–1, 2–3, 4–7, 8–
11, 12–15, 16–19, and >20, denoted by dotted vertical lines or blue shaded areas.
The MaxBinHeight significance method excludes at least 66% of all matches, even
those with Z-scores >20 (Fig. B.14b). This behaviour is undesirable, and this sig-
nificance method was not used in the further development of the algorithm. The
HashFraction and AAFraction significance methods omit between 0.0 to 66%, and
0 to 94% of the matches with Z-scores between 16–19, respectively, depending on
the significance fraction (Figs. B.14c–d). Considering the effect of the significance
fraction, unsurprisingly, the higher the significance fraction, the more comparisons
are marked insignificant. Further, it appears that using a significance fraction of 0.2
for the HashFraction significance method and a significance fraction of 0.25 for the
AAFraction significance method results in the desired effect of ruling out a large pro-
portion of the bad and grey-area comparisons with Z-scores between 0 and 8, while
including most of the matches with Z-scores above 20. The fractions of compar-
isons marked insignificant does not decrease linearly with increasing Z-score. For
example, the HashFraction significance method with a significance fraction of 0.4
only marks about 30% of all comparisons with Z-scores between 4–7 as insignifi-
cant, whereas 68% of all comparisons with Z-scores between 8–11 are marked as
insignificant. When considering each of the three test datasets separately (Fig. B.15)
using the HashFraction significance method with a significance fraction of 0.4, it be-
comes apparent that there is a large variation in the proportion of matches that are
excluded in each Z-score bin between datasets. For example in the Z-score bin be-
tween 16–19, 63% of all matches in the 4MTP dataset are insignificant, while in the
2HLA dataset, almost all matches are significant. What causes this behaviour is cur-
rently unknown, and could be investigated further. Therefore, there is no indication
that a single combination of HashFraction or AAFraction significance methods and
significance cut-offs will perform best under all circumstances. This has to be kept
in mind when setting significance fractions and analysing results.
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Figure B.15: The fraction of matches
considered insignificant using the Hash-
Fraction significance method, for differ-
ent test datasets. The significance fraction
was set to 0.4.
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B.3.2 HashFraction versus AAFraction histograms
The HashFraction and AAFraction significance methods differ in the way their his-
togram bin heights are calculated. The HashFraction significance method determines
the bin height by counting the number of pairs in each bin, while the AAFraction
significance method uses the number of amino acids in pairs in each bin. Each amino
acid is counted only once, even if it occurs in multiple pairs in the same bin. Fig-
ure B.16 shows the effect of these two ways of calculating the bin height on the
shape of the histogram. Three matches were performed with sequences of differ-
ent relatedness. Figures B.16a–b show a bunyamvera (BUNV) sequence compared
against itself, Figs. B.16c–d show the BUNV sequence compared to an oropuchevirus
(OROV) sequence (the amino acid sequences have an identity of 67%), and Figs.
B.16e–f show the BUNV sequence compared to a kibalevirus (KIBV) sequence (the
amino acid sequences have an identity of 45%). Figures B.16a, c, and e) show the
HashFraction histograms, and Figs. B.16b, d, and f) the AAFraction histograms. The
AC AlphaHelix_combined, AC ExtendedStrand finders and no trig point finders were
used. When comparing the HashFraction and AAFraction histograms, it is apparent
that the histogram peaks are more pronounced in the HashFraction histograms. This
can be attributed to the fact that all pairs are counted for the HashFraction histogram
bin height, even if they cover the same amino acids. This is for example the case when
the same landmark forms pairs with multiple trig points. Furthermore, each pair is
weighted equally, no matter how many amino acids it contains. In the AAFraction
significance method, on the other hand, each amino acid is counted once to determine
the bin height, even if it is part of multiple pairs, thus flattening out the peak. The
bin height in the AAFraction significance method is biased towards bins that contain
pairs with features spanning many amino acids. So, a pair that consists of an amino
acid landmark and an amino acid trig point is weighted less than a pair that consists
of an ‘AC alphaHelix’ landmark (which always contains at least four amino acids)
and an amino acid trig point. This behaviour is offset to some extent by the fact that
each amino acid is only counted once. The HashFraction significance method on the
other hand is agnostic to the type and size of the features in the pairs it contains.
Given that the HashFraction leads to more obvious histogram peaks, using it as the
default significance method is more desirable.
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(a) (b)
(c) (d)
(e) (f)
Figure B.16: Histograms for the HashFraction and AAFraction significance methods. Three
matches were performed with sequences of different relatedness. Figures a–b) show a bunyamvera
virus (BUNV) sequence compared against itself, Figs. c–d) show the BUNV sequence compared
to an oropuchevirus (OROV) sequence, and Figs. e–f) show the BUNV sequence compared to a
kibalevirus (KIBV) sequence. Figures a), c) and e) show the HashFraction histograms, Figs b), d),
and f) the AAFraction histograms. The ‘AC AlphaHelix_combined’, ‘AC ExtendedStrand’ finders
and no trig point finders were used.
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B.4 METHODS FOR SCORING MATCHES
Assigning a meaningful score to a match is essential for the interpretation of the re-
sults generated by the light matter algorithm. Given that we are comparing sequences
using predicted structural features, it is desirable that the score should correlate with
conventional measures of structural similarity, under the assumption that these mea-
sures correlate with the structural reality.
The significance methods presented in chapter B.3 report which histogram bins from
a match are significant. For those bins, a score is calculated. Two types of scores can
be calculated: firstly a so-called ‘bin score’, in which a score is calculated for each
significant bin of a match, and only the highest score is reported as the score of the
match, and secondly, an ‘overall score’, which incorporates some or all bins that are
considered significant into the score calculation. All scoring methods assign a score
between 0.0 and 1.0, with 0.0 being the worst, and 1.0 being the best score.
B.4.1 Bin scoring methods
In the bin scoring methods, a score is calculated individually for all significant bins
of a match and the highest score is used as the score to reflect the similarity of the
two sequences that are compared. I implemented two bin scoring methods in the light
matter algorithm:
The MinHashesScore scoring method is based on the idea that in a perfect match, the
maximum number of pairs in the best bin is the number of pairs found in the subject
or the query, depending on which of the two has fewer pairs. This case should receive
the best score of 1.0, and worse matches should be assigned a score lower than that.
Consider the schematic match in Fig. B.17: grey dotted lines denote amino acid
sequences of the query and the subject. The grey shaded area is what I call the
‘matched region’. It is the area of the sequence that contains the features that are
involved in the match between the query and the subject, shown as black boxes, as
well as features that are not involved in the match, shown as orange boxes. Light
green boxes represent unmatched features outside the matched region. Trig points
are omitted for clarity. The MinHashesScore is calculated by dividing the number of
matching pairs in the bin by the total number of matching pairs in either the query or
subject, depending on which contains less pairs (equation B.2).
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MinHashesScore =
M1 +M2
min(US1 +MS1 +BS1 +MS2 + US2 + US3 + US4, UQ1 +MQ1 +BQ1 +MQ2 + UQ2)
(B.2)
For the example in Fig. B.17, the MinHashesScore is calculated as:
MinHashesScore =
2
min(5, 7)
= 0.4 (B.3)
Figure B.17: Schematic of a match to illustrate the bin score calculation. Horizontal
grey dotted lines denote the amino acid sequences. The grey shaded area is the matched
region. Light green rectangles represent unmatched features outside the matched region,
orange rectangles represent unmatched features inside the matched region. Black rectangles
represent matching features inside the matched region. Trig points are omitted for clarity.
The FeatureAAScore consists of a product of the score for the matched region
(MatchedRegionScore) and a length normaliser (LengthNormaliser) (equation B.4).
The score for the matched region is a fraction, where the numerator consist of the
number of all amino acids in features in the subject and the query that match and the
denominator consists of the number of all amino acids in features in the subject and
the query in the region of the bin, regardless of whether they match (equation B.5).
The length normaliser is the count of all amino acids in features in the region of the
bin divided by the count of all amino acids in features in the whole sequence, for
either the query or the subject, depending on which fraction is higher (equation B.6).
The length normaliser is used to give more weight to matches that span a large part
of the query and / or the subject. Note that the bin with the highest score may not be
the bin with the highest number of pairs.
FeatureAAScore = MatchedRegionScore× LengthNormaliser (B.4)
235
B. LIGHT MATTER ALGORITHM: PARAMETERS AND METHODS
MatchedRegionScore =
MS1 +MS2 +MQ1 +MQ2
MS1 +BS1 +MS2 +MQ1 +BQ1 +MQ2
(B.5)
LengthNormaliser = max(
MS1 +MS2 +BS1
US1 +MS1 +BS1 +MS2 + US2 + US3 + US4
,
MQ1 +BQ1 +MQ2
UQ1 +MQ1 +BQ1 +MQ2 + UQ2
)
(B.6)
For the example in Fig. B.17, the equations and score calculations are as follows:
FeatureAAScore =
16
21
×max(11
25
,
10
20
) = 0.762× 0.5 = 0.381 (B.7)
B.4.2 Overall scoring methods
The GreedySignificantBinScore is an overall scoring method. It is calculated using
the same principle as the FeatureAAScore, except that multiple bins are taken into
account. Bins are added to the overall score calculation sequentially, starting with the
bin with the highest FeatureAAScore, then the second highest and so on. The overall
score is first set to the highest FeatureAAScore of all bins. Subsequent bins are
then incorporated into the overall score, starting with the bin with the next highest
FeatureAAScore, until the overall score does not increase anymore. At this point,
the overall score calculation concludes. Consider the example shown in Fig. B.18,
where two significant bins, indicated by two grey shaded areas, are included in the
calculation of the overall score. The equations for overall score calculation are as
follows:
GreedySignificantBinScore = MatchedRegionScore× LengthNormaliser
(B.8)
MatchedRegionScore =
MS1 +MS2 +MS3 +MQ1 +MQ2 +MQ3
MS1 +MS2 +MS3 +MQ1 +MQ2 +MQ3 +BS1 +BQ1
(B.9)
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LengthNormaliser = max(
MS1 +MS2 +MS3 +BS1
MS1 +MS2 +MS3 +BS1 + US1 + US2 + US3
,
MQ1 +MQ2 +MQ3 +BQ1+
MQ1 +MQ2 +MQ3 +BQ1 + UQ1
)
(B.10)
For the example in Fig. B.18, the score is calculated as follows:
MatchedRegionScore =
4 + 4 + 6 + 4 + 4 + 6
4 + 4 + 6 + 4 + 4 + 6 + 3 + 2
=
28
33
= 0.848 (B.11)
LengthNormaliser = max(
4 + 4 + 6 + 3
4 + 4 + 6 + 3 + 2 + 4 + 2
,
4 + 4 + 6 + 2
4 + 4 + 6 + 2 + 4
) = 0.8
(B.12)
GreedySignificantBinScore = 0.848× 0.8 = 0.678 (B.13)
Figure B.18: Schematic of a match to illustrate the overall score calculation. Horizon-
tal grey dotted lines denote amino acid sequences. The grey shaded areas are the matched
regions. Light green rectangles represent unmatched features outside the matched regions,
orange rectangles represent unmatched features inside the matched region. Black rectangles
represent matching features inside the matched regions. Trig points are omitted for clarity.
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B.4.3 Performance of the different scoring methods on test
datasets
The scores that the light matter algorithm assigns should correspond with the struc-
tural reality. To investigate this behaviour I used the MinHashesScore, FeatureAAS-
core, and GreedySignificantBinScore scoring methods described in sections B.4.1
and B.4.2 to infer light matter scores for the matches in the 2HLA, 4MTP, and 4PH0
test datasets. I used the perfect finders2, no trig point finders, and the HashFraction
significance method with a significance cut-off of 0.01. Figures B.19a–c show the
correlation between the Dali Z-scores and the scores computed by the different light
matter scoring methods on the three test datasets.
Visually comparing the scatterplots for the scores computed by the FeatureAAScore
(Fig. B.19a) and GreedySignificantBinScore scoring methods (Fig. B.19b) shows
that they perform similarly, most likely due to the similarity in the score calculation
(the median number of bins considered for the GreedySignificantBinScore calcula-
tion was 2). Due to the similar results of these two scoring methods, it seems best
to only work with the FeatureAAScore, as its calculation involves less steps and is
therefore faster to compute. Comparing the FeatureAAScore and MinHashesScore
(Fig. B.19c), the scores computed by the FeatureAAScore scoring method correlate
somewhat better with the Dali Z-scores. Therefore, I use the FeatureAAScore as
the default scoring method in the light matter algorithm. However, neither scoring
method reflects the structural reality very well, as highlighted by high light matter
scores that are frequently assigned to matches with low (<8) Z-scores, and low light
matter scores assigned to matches with high (>20) Z-scores.
B.4.4 Performance of the FeatureAAScore scoring method
on two edge cases
Since the results from the previous section suggest that the scores computed by the
FeatureAAScore scoring correlate best with the Dali Z-scores, I investigated its per-
formance on two edge cases. On the one hand I investigated matches with a range
of Z-scores that all have a light matter score above 0.99. On the other hand, I in-
vestigated the scores that are assigned to matches between structures that are not
structurally similar, as measured by the Dali Z-score.
2‘PDB AlphaHelix_combined’ and ‘PDB ExtendedStrand’
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Figure B.19: Correlation of the MinHashesScore, FeatureAAScore and GreedySignif-
icantBinScore methods with the Dali Z-score. Scores were calculated by applying the
three scoring methods to the 2HLA, 4MTP, and 4PH0 test datasets, using the PDB AlphaHe-
lix_combined and PDB ExtendedStrand finders, no trig points, and the HashFraction signif-
icance method with a significance cut-off of 0.01. Lines show the linear regression, with the
shaded area showing the 95% confidence interval.
B.4.4.1 Investigating matches with light matter scores of 0.99 to 1.0
Figure B.20 shows the scores computed by the FeatureAAScore scoring method of
the matches in the 4MTP dataset plotted against the Dali Z-scores. Interestingly,
the plot shows a group of matches with Dali Z-scores between 62.2 to 47.1, which
are assigned light matter scores of 0.99 or above (show in red). This would suggest
that even though identical or very similar features are identified by the light matter
algorithm, the tertiary structures are slightly different, leading to different Z-scores.
Figure B.21 shows the structure comparisons and horizontal line plots of three exam-
ples of the matches described above. The example in Figs. B.21a–b) is the 4MTP:A
sequence compared against itself, which has the highest Z-score of 62.2, and where
we would expect the highest light matter score. Figures B.21c–d) show the 4MTP:A
sequence against the 4MTP:D sequence, i.e., two different chains of the same pro-
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tein compared against each other. The match is assigned a FeatureAAScore of 1.0
and a Z-score of 47.1. Looking at the horizontal line plots of those two matches,
it is apparent that the type and order of features is the same, and the sequence is
identical, while small variations in the structure lead to the lower Z-score. Figures
B.21e–f) shows the influence of non-matching features on the FeatureAAScore cal-
culation: looking at the horizontal line plot of the comparison between the 4MTP:A
sequence and the 4K6M:B sequence, it is clear that the type and order of the features
is the same in the two sequences, with the exception of a non-matching AC Ex-
tendedStrand in 4MTP:A. This pulls the FeatureAAScore down to 0.99, a behaviour
which is desirable and expected. Overall, in the cases of comparisons between very
similar or identical sequences, the FeatureAAScore scoring method performs ade-
quately.
Figure B.20: Correlation
of the FeatureAAScore and
the Z-scores in the 4MTP
dataset. I used the AC Al-
phaHelix_combined and AC
ExtendedStrand landmark
finders, no trig points, and
the HashFraction significance
method with a significance
fraction of 0.01. Matches with a
FeatureAAScore of 0.98 or better
are plotted in red, other matches
in blue.
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(a) (b)
(c) (d)
(e) (f)
Figure B.21: Structure comparisons and horizontal line plots for matches with scores of 0.99
to 1.0. Each row of figures corresponds to one comparison. a–b) Sequence 4MTP:A compared
against itself, FeatureAAScore: 1.0, Z-score: 62.2. c–d) Sequence 4MTP:A compared against
sequence 4MTP:D, FeatureAAScore: 1.0, Z-score: 47.1. e–f) Sequence 4MTP:A (left) com-
pared against sequence 4K6M:B (right), FeatureAAScore: 0.99, Z-score: 49.4. Figures a, c, and
e) show the comparison of the two structures, with 4MTP:A always on the right. Matching features
are shown in red, non-matching features in muddy green. Figures b, d, and f) show the horizontal
line plots for the comparisons in questions, with 4MTP:A always being the top sequence. Only the
best bin is shown.
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B.4.4.2 Investigating scores of matches between dis-similar structures
The second edge case I investigated was how the FeatureAAScore scoring method
performs on sequences that correspond to structures that are not homologous. This
is to get a basic understanding of which light matter scores we may have to expect
for false positive matches. To this end, I compared the 2HLA:A sequence against
all sequences in the Polymerase and HA test datasets, using the ‘PDB AlphaHe-
lix_combined’ and ‘PDB ExtendedStrand’ landmark finders. For a visual impression
of the 2HLA:A structure, as well as an example of a structure from the Polymerase
and HA test dataset, see Fig. B.22. Figures B.23a) and b) show the scores computed
by the FeatureAAScore scoring method resulting from the comparison of 2HLA:A
sequence against all sequences in the Polymerase and HA test datasets plotted against
the BLAST bit scores (Dali is not able to detect any structural similarity, so only the
BLAST bit scores are shown). The bit scores are in a range that can be expected from
non-matching sequences. The light matter scores on the other hand, are surprisingly
high (between 0.3 and 0.6), given that I do not expect any sequences to match be-
tween those test datasets. Looking at Fig. B.22, one could argue that there is some
similarity in the arrangement of the secondary structures between the 2HLA:A and
the HA domain that forms part of the match, but the same argument cannot be made
for the Polymerase, and the light matter scores are similar for both Polymerase and
HA test datasets. Two comparisons with the highest FeatureAAScores, one from
each test dataset, were investigated further. Each row in Fig. B.24 shows the three-
dimensional structures (left) and horizontal line plot (right) of a comparison. The top
row shows the comparison of the 2HLA:A sequence against the 1N35:A sequence
(from the Polymerase test dataset) and the bottom row showing the comparison of the
2HLA:A sequence against the 5HMG:E sequence (from the HA test dataset). When
looking at Figs. B.24a) and c), it becomes apparent that while there are matching
pairs between the two structures (shown in red, connected by white lines), they do not
correspond structurally and it does not indicate that there is structural similarity. The
horizontal line plot in Fig. B.24b indicates that the high score between the 2HLA:A
and 1N35:A sequence is most likely caused by the length normaliser employed in the
FeatureAAScore calculation, which rewards the situation where the matched region
that spans almost the entire length of at least one of the two sequences. Indeed, the
factor for the length normaliser for the match in Fig. B.24b is 0.86. The high score
assigned to the match between 2HLA:A and 5HMG:E sequences seems to be caused
by the algorithm identifying spurious matches between a number of secondary struc-
tures present in both sequences. This suggest that the comparison of sequences based
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on their secondary structures may not be able to accurately differentiate between
structures that are different at the tertiary structure level.
B.4.5 Conclusion
Overall, the scores computed by the three scoring methods of the light matter algo-
rithm correlate with the Dali Z-scores (Fig. B.19). However, neither scoring method
reflects the structural reality for all pairwise comparisons in the test datasets, as some-
times high light matter scores are computed for matches with low (<8) Z-scores, and
low light matter scores for matches with high (>20) Z-scores. While the FeatureAAS-
core scoring method performs adequately for highly similar sequences, it assigns rel-
atively high scores (0.3–0.6) to matches between sequences coding for proteins with
dis-similar structures. This is partly due to the length normalisation performed in
the score calculation, but also suggests that in some cases, the similarity between
secondary structures of two unrelated sequences may lead to false positive matches.
Therefore, care needs to be taken when determining which sequences are actually
considered to match (and are therefore structurally equivalent), and which scores are
indicative of a good match, both of which are areas that require further work.
(a) (b) (c)
Figure B.22: Comparison of the 2HLA:A structure (a)), the 3UQS:A structure from the
Polymerase dataset (b)), and the 5HMG:E structure from the HA dataset (c)). Helices
are shown in red, strands in blue, chains that represent the respective sequence in light green,
and chains not used in the light matter comparison in white. The size of the three structures
is not scaled the same.
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(a) (b)
Figure B.23: Correlation of the bit score and the FeatureAAScore light matter score.
The ‘PDB AlphaHelix_combined’ and ‘PDB ExtendedStrand’ landmark finders were used,
no trig points, and the HashFraction significance method with a significance fraction of 0.01.
a) 2HLA:A against Polymerase test dataset. b) 2HLA:A against HA test dataset. The
lines show the linear regression in green (positive correlation) and red (negative correlation).
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(a) (b)
(c) (d)
Figure B.24: Structure comparisons and horizontal line plots for matches of unrelated
sequences. Each row of figures corresponds to one comparison. a–b) 2HLA:A against
1N35:A (Polymerase test dataset), FeatureAAScore: 0.54, Bit score: 18.5, c–d) 2HLA:A
against 5HMG:E (HA test dataset), FeatureAAScore: 0.58, Bit score: 19.6. Figures a)
and c) show the comparison of the two structures, with 2HLA:A on the right. Matching fea-
tures are shown in red, non-matching helices in light purple, non-matching extended strands
in dark purple. Matching features in the two structures are connected by white lines. Figures
b) and d) show the horizontal line plots for the comparisons in questions, with 2HLA:A being
the top sequence. Only the best bin is shown. No structural similarity as measured by the
Dali Z-score could be detected.
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During the development of the light matter algorithm, I periodically tested it on some
or all of the five test datasets (chapter B.1.2), to better understand the effects of the
functionalities we implemented. This chapter is an extension of the results presented
in chapter 8 of this thesis. In the first section, I show a general overview of the per-
formance of the algorithm under different parameter combinations, using correlations
between light matter scores and Dali Z-scores. The second section aims to improve
our understanding some of the patterns observed in the light matter scoring based on
visualisations of the distribution of features on the three-dimensional protein struc-
tures.
C.1 EVALUATION OF DIFFERENT FINDER AND
PARAMETER COMBINATIONS
Chapter B.2 described the development of the structural features and parameters that
are used by the light matter algorithm. In this chapter, I present an evaluation of
the effects when those finders and parameters are used concurrently. I tested the
following parameter combinations on the five test datasets:
− Performance the light matter algorithm using different combinations of land-
mark finders, and the ‘Peak’, ‘Trough’, and ‘AminoAcids’ trig point finders
(Fig. C.1).
− Performance the light matter algorithm using different combinations of land-
mark finders, and no trig point finders (Fig. C.2).
− Performance the light matter algorithm using different combinations of trig
point finders, and the ‘PDB AlphaHelix’, ‘PDB AlphaHelix_3_10’, ‘PDB Al-
phaHelix_pi’, and ‘PDB ExtendedStrand’ landmark finders (Fig. C.3).
− Performance the light matter algorithm using different values for the Feature-
LengthBase parameter (Fig. C.4).
− Performance the light matter algorithm using different values for the Distance-
Base parameter (Fig. C.5).
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− Performance the light matter algorithm using different values for the MaxDis-
tance parameter (Fig. C.6).
I used the FeatureAAScore scoring method and HashFraction significance method
with a significance fraction of 0.01 throughout. In Figs. C.1–C.6, rows correspond
to different test datasets (top to bottom: 2HLA, 4MTP, HA, 4PH0, Polymerase), and
columns correspond to a different set of parameters under investigation. Each plot
shows the light matter scores computed with the relevant parameters plotted against
the Dali Z-scores of that particular match. Lines indicate the linear regression fitted
to the scores, with its parameters indicated in the title of the subfigure.
Figure C.1 shows the light matter scores inferred with different landmark finders
and the same set of trig point finders (‘Peak’, ‘Trough’, and ‘AminoAcids’), plotted
against the Dali Z-scores. The first column shows the scores calculated using the
‘PDB AlphaHelix’, ‘PDB AlphaHelix_3_10’, ‘PDB AlphaHelix_pi’, and ‘PDB Ex-
tendedStrand’ finders, for reference. Based on the linear regression fitted to the light
matter and Dali Z-scores, neither of the two different combinations of Aho-Corasick
finders in columns two (‘AC AlphaHelix’, ‘AC AlphaHelix_3_10’, ‘AC AlphaHe-
lix_pi’, ‘AC ExtendedStrand’) and three (‘AC AlphaHelix_combined’, ‘AC Extend-
edStrand’) performs consistently better. Furthermore, landmark finders based on the
GOR4 algorithm shown in column four (‘GOR4 AlphaHelix’, ‘GOR4 BetaStrand’,
and ‘GOR4 Coil’) lead to a large number of matches with light matter scores of 0.0.
Therefore, using these finders without any additional landmark finders is not desir-
able. The same is true for the combination of ‘EukaryoticLinearMotif’, ‘AminoAcid-
sLm’ and ‘Prosite’ landmark finders (column seven). This may be explained by
the number of features that each set of landmark finders identifies in the five test
datasets: the GOR4 finders combined identify 27,757 features, ‘EukaryoticLinear-
Motif’, ‘AminoAcidsLm’, and ‘Prosite’ finders combined identify 37,668 features,
while the Aho-Corasick finders identify 56,550 (using ‘AC AlphaHelix_combined’)
or 55,404 (using ‘AC AlphaHelix’, ‘AC AlphaHelix_3_10’, and ‘AC AlphaHelix_pi
separately) features. More features may make it more likely for a match to be iden-
tified as significant, and hence be assigned a score > 0.0. The combination of the
‘AC AlphaHelix_combined’, ‘AC ExtendedStrand’, ‘Prosite’, ‘EukaryoticLinearMo-
tif’, and ‘AminoAcidsLm’ landmark finders in column six performs best, taking into
account the correlation coefficients of the linear regression, as well as the low number
of matches that are assigned a light matter score of 0.0.
Figure C.2 is structured identically as Fig. C.1. It shows the evaluations for the
same combinations of landmark finders as Fig. C.1, but without trig point finders.
Comparing Figs. C.1 and C.2, the evaluations that include trig points in Fig. C.1
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consistently have a better correlation of the light matter score and Dali Z-scores, as
indicated by the linear regression, than when no trig points were used, suggesting
that the ‘Peak’, ‘Trough’, and ‘AminoAcids’ trig points improve the performance of
the light matter algorithm.
Figure C.3 shows the performance of the different trig point finders, while using the
same combination of landmark finders (‘PDB AlphaHelix’, ‘PDB AlphaHelix_3_10’,
‘PDB AlphaHelix_pi’, and ‘PDB ExtendedStrand’). There is very little difference
in the light matter scores computed for different combinations of trig point finders.
When considering the percentage of pairs that are formed between a landmark and
a trig point, as opposed to a landmark and a landmark in the five test dataset, only
16.6% of all pairs consist of a landmark and a trig point. This is because a landmark
is always first paired with other landmarks, and then with any trig points. Based
on the correlation coefficients of the linear regression, using either both ‘Peaks’ and
‘Troughs’, or ‘Peaks’, ‘Troughs’, and ‘AminoAcids’ trig point finders together leads
to the best correlation of light matter scores and Dali Z-scores.
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Figure C.1: Correlation of FeatureAAScore and Z-scores, using different combina-
tions of landmark finders. Each row corresponds to a different test dataset, top to bot-
tom: 1) 2HLA. 2) 4MTP. 3) HA. 4) 4PH0. 5) Polymerase. Each column corresponds to
a different combination of landmark finders, left to right: 1) ‘PDB AlphaHelix’, ‘PDB Al-
phaHelix_3_10’, ‘PDB AlphaHelix_pi’, and ‘PDB ExtendedStrand’. 2) ‘AC AlphaHelix’,
‘AC AlphaHelix_3_10’, ‘AC AlphaHelix_pi’, and ‘AC ExtendedStrand’. 3) ‘AC Alpha-
Helix_combined’, and ‘AC ExtendedStrand’. 4) ‘GOR4 AlphaHelix’, ‘GOR4 BetaStrand’,
and ‘GOR4 Coil’. 5) ‘AC AlphaHelix_combined’, ‘AC ExtendedStrand’, ‘GOR4 AlphaHe-
lix’, ‘GOR4 BetaStrand’, and ‘GOR4 Coil’. 6) ‘AC AlphaHelix_combined’, ‘AC Extended-
Strand’, ‘Prosite’, ‘EukaryoticLinearMotif’, and ‘AminoAcidsLm’. 7) ‘Prosite’, ‘Eukaryoti-
cLinearMotif’, and ‘AminoAcidsLm’. The ‘Peak’, ‘Trough’, and ‘AminoAcids’ trig point
finders, a significance fraction of 0.01, a FeatureLengthBase of 1.01, DistanceBase of 1.1,
DeltaScale of 1.0, and a MaxDistance of 1000 were used throughout. Lines indicate the
linear regression, with coefficients in the title of each subfigure.
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Figure C.2: Correlation of FeatureAAScore and Z-scores, using different combinations
of landmark- and no trig point finders. Rows, top to bottom: 1) 2HLA. 2) 4MTP. 3)
HA. 4) 4PH0. 5) Polymerase. Columns, left to right: 1) ‘PDB AlphaHelix’, ‘PDB Al-
phaHelix_3_10’, ‘PDB AlphaHelix_pi’, and ‘PDB ExtendedStrand’. 2) ‘AC AlphaHelix’,
‘AC AlphaHelix_3_10’, ‘AC AlphaHelix_pi’, and ‘AC ExtendedStrand’. 3) ‘AC Alpha-
Helix_combined’, and ‘AC ExtendedStrand’. 4) ‘GOR4 AlphaHelix’, ‘GOR4 BetaStrand’,
and ‘GOR4 Coil’. 5) ‘AC AlphaHelix_combined’, ‘AC ExtendedStrand’, ‘GOR4 AlphaHe-
lix’, ‘GOR4 BetaStrand’, and ‘GOR4 Coil’. 6) ‘AC AlphaHelix_combined’, ‘AC Extend-
edStrand’, ‘Prosite’, ‘EukaryoticLinearMotif’, and ‘AminoAcidsLm’. 7) ‘Prosite’, ‘Eukary-
oticLinearMotif’, and ‘AminoAcidsLm’. A significance fraction of 0.01, no trig points, a
FeatureLengthBase of 1.01, DistanceBase of 1.1, DeltaScale of 1.0, and a MaxDistance of
1000 were used throughout. Lines indicate the linear regression, with coefficients in the title
of each subfigure.
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Figure C.3: Correlation of FeatureAAScore and the Z-scores, using different com-
binations of trig point finders. Rows, top to bottom: 1) 2HLA. 2) 4MTP. 3) HA.
4) 4PH0. 5) Polymerase. Columns, left to right: 1) no trig points. 2) ‘Peaks’. 3)
‘Troughs’. 4) ‘AminoAcids’. 5) ‘Peaks’, ‘Troughs’. 6) ‘Peaks’, ‘AminoAcids’. 7) ‘Troughs’,
‘AminoAcids’. 8) ‘Peaks’, ‘Troughs’, ‘AminoAcids’. A significance fraction of 0.01, the
‘PDB AlphaHelix’, ‘PDB AlphaHelix_3_10’, ‘PDB AlphaHelix_pi’, and ‘PDB Extended-
Strand’ landmark finders, a FeatureLengthBase of 1.01, DistanceBase of 1.1, DeltaScale of
1.0, and a MaxDistance of 1000 were used throughout. Lines indicate the linear regression,
with coefficients in the title of each subfigure.
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In addition to different combinations of landmark and trig point finders, I also tested
different values for the FeatureLenghtBase, DistanceBase, and MaxDistance param-
eters in the light matter algorithm. The FeatureLenghtBase is the logarithmic scaling
factor applied to the length of the landmarks that are longer than one, the Distance-
Base logarithmically scales the distances between the two features in a pair, and the
MaxDistance is the maximum distance that two features in a pair can be apart in order
to be paired, measured in amino acids.
Figure C.4 shows the effect of different values for the FeatureLenghtBase parameter.
Comparing the regressions, feature length scaling only takes effect when a Feature-
LenghtBase of 1.35 or above is used. This can be explained by the lengths of the
landmark features that I used: the substrings used by the ‘AC AlphaHelix_combined’
finder range in length from 4 to 13 amino acids, with a median of 6, while the ‘AC
ExtendedStrand’ features range from 4 to 9 amino acids, with a median of 5 (Fig.
B.8b). Due to the logarithmic scaling, the scaling of feature lengths only takes effect
when features longer than four amino acids are scaled with a featureLengthBase of
1.35 (Fig. 7.2). Thus, on short features, scaling will not take effect. The median
length of ‘AC AlphaHelix_combined’ and ‘AC ExtendedStrand’ features in the five
test datasets is 5, which could be the reason for the limited effect of the FeatureLengt-
Base parameter. Based on these evaluations, the effect of scaling feature lengths is
negligible.
Figure C.5 shows the performance of different values for the DistanceBase parame-
ter. Based on the results of the linear regression, in our five test datasets, scaling of
the distances between features in pairs only starts having an effect when a parame-
ter value of 1.1 or above is used. Visually comparing the scatter plots of the light
matter and Z-scores shows that higher values for the DistanceBase parameter lead
to higher light matter scores, without shifting their values relative to each other, up
to a DistanceBase of 1.35. The increase in the value of the DistanceBase param-
eter allows more pairs to match, leading to higher values of the numerator in the
MatchedRegionScore in the FeatureAAScore calculation, and hence to the relative
increase of the light matter scores. Based on the correlation coefficients, using a Dis-
tanceBase of 1.35 results in the best correlation between light matter scores and Dali
Z-scores.
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Figure C.4: Correlation of FeatureAAScore and Z-scores, using different values for the
FeatureLengthBase parameter. Rows, top to bottom: 1) 2HLA. 2) 4MTP. 3) HA. 4) 4PH0.
5) Polymerase. Columns, left to right: 1) FeatureLengthBase: 1.0. 2) FeatureLengthBase:
1.1. 3) FeatureLengthBase: 1.2. 4) FeatureLengthBase: 1.35. ‘AC AlphaHelix_combined’,
‘AC ExtendedStrand’, ‘Prosite’, ‘EukaryoticLinearMotif’, and ‘AminoAcidsLm’ landmark
finders and ‘Peak’, ‘Trough’, and ‘AminoAcids’ trig point finders, a significance fraction
of 0.01, a DistanceBase of 1.1, DeltaScale of 1.0, and a MaxDistance of 1000 were used
throughout. Lines indicate the linear regression, with coefficients in the title of each subfig-
ure.
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Figure C.5: Correlation of FeatureAAScore and Z-scores, using different values for
the DistanceBase parameter. Rows, top to bottom: 1) 2HLA. 2) 4MTP. 3) HA. 4) 4PH0.
5) Polymerase. Columns, left to right: 1) DistanceBase: 1.01. 2) DistanceBase: 1.05. 3)
DistanceBase: 1.1. 4) DistanceBase: 1.2. 5) DistanceBase: 1.35. 6) DistanceBase: 1.5.
‘AC AlphaHelix_combined’, ‘AC ExtendedStrand’, ‘Prosite’, ‘EukaryoticLinearMotif’, and
‘AminoAcidsLm’ landmark finders and ‘Peak’, ‘Trough’, and ‘AminoAcids’ trig point find-
ers, a significance fraction of 0.01, a FeatureLengthBase of 1.01, DeltaScale of 1.0, and a
MaxDistance of 1000 were used throughout. Lines indicate the linear regression, with coef-
ficients in the title of each subfigure.
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I tested four different values for the MaxDistance parameter, 10, 100, 500, and 1,000.
The effect of different values for the MaxDistance parameter is minimal based on
changes in the correlation coefficients of the linear regression (Fig. C.6). The light
matter algorithm pairs features starting with the landmark closest to the landmark
from which the pairing starts, and going to the next closest and so on, and subse-
quently from closest to furthest trig point. There is also a limit on the number of
pairs that a landmark can be part of, which I left at 10 throughout, as a higher num-
ber of pairs per landmark negatively impacts the speed of the algorithm (not shown).
Thus, if 10 features are within 100 amino acids of a landmark, we expect to only
detect a difference between a MaxDistance of 10 (column one) and a MaxDistance
of 100 (column two), which is what we see in Fig. C.6. A larger MaxDistance allows
for more distant features to form a pair. In the context of matching short reads, it
makes sense to make the MaxDistance parameter to be at most as long as the length
of the read, hence allowing all features in a short sequence to pair. Should an insertion
have taken place, a bigger MaxDistance parameter would also allow the pairing of
features on both sides of the insertion, and the sequence could then still be compared
to a reference without the insertion.
The analyses of different parameter combinations allows the following conclusions:
landmarks and trig points should be used, with the best combination of features being
the ‘AC AlphaHelix_combined’, ‘AC ExtendedStrand’, ‘Prosite’, ‘EukaryoticLinear-
Motif’, and ‘AminoAcidsLm’ landmarks, and the ‘Peak’, ‘Trough’, and ‘AminoAcids’
trig points. The FeatureLengthBase and MaxDistance parameters have limited effect
on the performance of the light matter algorithm. A DistanceBase of 1.35 results
in the best correlation between light matter scores and Dali Z-scores. The results of
similar analyses presented in chapter 8 have already shown that even when secondary
structures are identified correctly, the matching and scoring as currently implemented
in the light matter algorithm does not achieve acceptable results. This is because there
is often a wide range of light matter scores that are assigned to a narrow range of Z-
scores and vice versa, as well as high light matter scores assigned to matches with
low Z-scores and vice versa. The results in this section also show that even when
using additional finders, and a variety of parameters, these problems persist.
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Figure C.6: Correlation of FeatureAAScore and Z-scores, using different values for
the MaxDistance parameter. Rows, top to bottom: 1) 2HLA. 2) 4MTP. 3) HA. 4) 4PH0.
5) Polymerase. Columns, left to right: 1) MaxDistance: 10. 2) MaxDistance: 100. 3)
MaxDistance: 500. 4) MaxDistance: 1000. ‘AC AlphaHelix_combined’, ‘AC Extend-
edStrand’, ‘Prosite’, ‘EukaryoticLinearMotif’, and ‘AminoAcidsLm’ landmark finders and
‘Peak’, ‘Trough’, and ‘AminoAcids’ trig point finders, and a significance fraction of 0.01, a
FeatureLengthBase of 1.01, DistanceBase of 1.1, and DeltaScale of 1 were used throughout.
Lines indicate the linear regression, with coefficients in the title of each subfigure.
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C.2 INVESTIGATING LIGHT MATTER SCORING
IRREGULARITIES BY EXAMINING THREE-
DIMENSIONAL PROTEIN STRUCTURES
The previous sections have shown that there are inconsistencies in the light matter
scores assigned to matches by the FeatureAAScore scoring method, in comparison to
their associated Z-scores. Namely, similar light matter scores are assigned to matches
with a wide range of Z-scores, matches with similar Z-scores are assigned a range of
light matter scores, and matches with low Z-scores are assigned high light matter
scores. While broad insights can be gained by looking at overall correlations be-
tween light matter scores and Dali Z-scores, it is useful to investigate some matches
in isolation, to better understand why the scores may be higher or lower than ex-
pected. The work presented in this section relies on visualisations of how matching
and non-matching features are distributed on the three-dimensional protein structures,
to understand of how feature identification and distribution influences the light matter
scores computed for a match. Using the 4MTP and Polymerase test datasets, I will
show examples for the following scenarios:
− Matches with similar light matter scores but Z-scores ranging from 2.2 to 25.6.
− Matches that have Z-scores between 32.2 and 33.0, but light matter scores
ranging from 0.2 to 0.6.
− Matches with Z-scores lower than eight, but light matter scores ranging from
0.45 to 0.61.
For the 4MTP dataset, the ‘AC AlphaHelix_combined’, and ‘AC ExtendedStrand’
landmark finders were used, with no trig points. For the Polymerase dataset, the
‘AC AlphaHelix_combined’, ‘AC ExtendedStrand’, and ‘AminoAcidsLm’ landmark
finders were used, with no trig points. The other parameters were:
ScoringMethod=FeatureAAScore,
SignificanceMethod=HashFraction,
SignificanceCutoff=0.01, FeatureLenghtBase=1.0,
MaxDistance=10000, LimitPerLandmark=10,
DistanceBase=1.1, DeltaScale=1.0.
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C.2.1 Matches with similar light matter scores but
Z-scores ranging from 2.2 to 25.6
Figure C.7: Scatter plot of FeatureAAS-
core light matter scores against Dali
Z-scores for the 4MTP test dataset.
Matches with a light matter score between
0.29 and 0.31 are shown in red.
Figure C.7 shows a scatter plot of the FeatureAAScore light matter scores against
the Dali Z-scores computed for the 4MTP test dataset using the parameters described
above. The plot shows a cluster of matches at the bottom to the left of the figure, with
light matter scores between 0.2 and 0.4, and Z-scores between 2.2 and 25.6. This
suggests that the light matter scoring does not adequately separate between proteins
with different structural similarity, as measured by the Z-score. I highlight twelve
matches that have a light matter score between 0.29 and 0.31, and all but one have a
Z-score between 2.2 and 3.8, and an outlier having a Z-score of 25.6 (plotted as red
dots, in Fig. C.7). Examining the structures visually shows that in the comparisons
with low Z-scores, one of the structures being compared has a molecule bound to it,
possibly distorting its shape (an example of which is shown in Fig. C.8), whereas this
is not the case in the match with the high Z-score (Fig. C.9). However, the match with
the high Z-score is assigned a light matter score of 0.3, lower than expected given its
high Z-score. Visually comparing the three-dimensional structures (Fig. C.9), shows
that even though the structures look similar visually, only few features are identified
by the ‘AC AlphaHelix_combined’ and ‘AC ExtendedStrand’ feature finders. Fur-
thermore, the features that are matching do not belong to secondary structures that
are structurally equivalent, meaning that for example, a pair containing an alpha he-
lix matches another pair containing an alpha helix, but the two alpha helices are from
different regions of the structure. The light matter score thus does not adequately
describe the structural similarity between the two structures in Fig. C.9.
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Figure C.8: Structures of 4MTP (right) and 1KLN (left). ‘AC AlphaHe-
lix_combined’ in brown, ‘AC ExtendedStrand’ in green, matching features in red.
White lines show features in matching pairs. FeatureAAScore light matter score:
0.3. Z-score: 2.2.
Figure C.9: Structures of 4MTP (right) and 2CJQ (left). ‘AC AlphaHe-
lix_combined’ in brown, ‘AC ExtendedStrand’ in green, matching features in red.
White lines show features in matching pairs. FeatureAAScore light matter score:
0.3. Z-score: 25.6.
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C.2.2 Matches that have similar Z-scores (32.2 to 33.0) but
light matter scores ranging from 0.21 to 0.55
Figure C.10: Scatter plot of Fea-
tureAAScore light matter scores against
Dali Z-scores for the Polymerase test
dataset. Matches with a Z-score between
32.2 and 33.0 are highlighted in red.
Figure C.10 shows a scatter plot of light matter and Z-scores computed for the Poly-
merase dataset, using the parameters outlined in the introduction to the current sec-
tion. I am focussing on eight matches that have similar Z-scores between 32.2 and
33.0, but variable light matter scores, ranging from 0.21 to 0.55 (plotted as red dots in
Fig. C.10). Visually inspecting the structures for the matches with the highest (0.55,
Fig. C.11) and lowest (0.21, Fig. C.12) light matter score shows that the match that is
assigned a high light matter score has a high number of secondary structures matching
that are structurally equivalent (Fig. C.11). For the match with the worst light matter
score (Fig C.12) on the other hand, matching features are not structurally equivalent.
As in the previous section, the light matter score for the match in Fig. C.12 fails to
reflect the structural similarity, due to inadequate feature identification, and because
the pairs that take part in the score calculation are not structurally equivalent.
Figure C.11: Structures of 3UQS (right) and 2E9Z (left). ‘AC AlphaHe-
lix_combined’ in brown, ‘AC ExtendedStrand’ in green, ‘AminoAcidsLm’ in pink,
matching features in red. White line show features in matching pairs. FeatureAAS-
core light matter score: 0.55. Z-score: 32.2.
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Figure C.12: Structures of 3CDW (right) and 1KHV (left). ‘AC AlphaHe-
lix_combined’ in brown, ‘AC ExtendedStrand’ in green, ‘AminoAcidsLm’ in pink,
matching features in red. White line show features in matching pairs. FeatureAAS-
core light matter score: 0.21. Z-score: 33.0.
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C.2.3 Matches with low Z-scores and high light
matter scores
Figure C.13: Scatter plot of Fea-
tureAAScore light matter scores against
Dali Z-scores for the 4MTP test dataset.
Matches with a light matter score between
0.45 and 0.61 and a Z-score below 8 are
shown in red.
Figure C.13 shows a scatter plot of light matter scores and Z-scores from the 4MTP
dataset. I would like to focus on two out of nine matches with light matter scores
between 0.45 and 0.61 and with Z-scores below 8.0 highlighted in red. Why does the
light matter algorithm assign light matter scores that are seemingly too high? In the
two matches with the highest and the lowest light matter scores, the sequences cod-
ing for these protein structures are of different lengths (634 versus 308 amino acids
for 4MTP and 2G1H, and 634 versus 98 amino acids for 4MTP and 1H6K), and the
resulting structures are dis-similar (Figs. C.14 and C.15). The visual impression thus
agrees with the low Z-scores. The location of the matching features (as indicated
by white lines) also shows that the matching features are not structurally equivalent,
leading to artificially inflated light matter scores. Furthermore, the length discrep-
ancy between the sequences that code for the structures, can also artificially increase
the score, due to the length normalisation that is performed in the FeatureAAScore
calculation, which rewards matches where the matching pairs are distributed across
the entire query and / or subject.
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Figure C.14: Structures of 4MTP (right) and 1H6K (right). ‘AC AlphaHe-
lix_combined’ in brown, ‘AC ExtendedStrand’ in green, ‘AminoAcidsLm’ in pink,
matching features in red. White lines show features in matching pairs. FeatureAAS-
core light matter score: 0.61. Z-score: 3.5.
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Figure C.15: Structures of 4MTP (left) and 2G1H (right). ‘AC AlphaHe-
lix_combined’ in brown, ‘AC ExtendedStrand’ in green, ‘AminoAcidsLm’ in pink,
matching features in red. White lines show features in matching pairs. FeatureAAS-
core light matter score: 0.47. Z-score: 3.0.
C.2.4 Conclusion
I found three reasons for irregularities in the correspondence between light matter
and Z-scores. The first is related to differences in protein structure, caused by ligands,
leading to Z-scores that are lower than expected relative to the light matter score. The
second is that low light matter scores can be caused when the finders do not identify
adequate features. The low light matter scores that are observed from such matches
often stem from matches between features that are not structurally equivalent. And
finally, light matter scores may be artificially inflated, either because a short sequence
is compared to a long one (an artefact of the FeatureAAScore calculation), or again
because of matches between features that are not structurally equivalent. While these
conclusions are based on a very small number of sequence and structure compar-
isons, they nevertheless highlight two areas that need to be improved. The first is the
FeatureAAScore calculation, to improve the scoring of matches between sequences
of different lengths. The second is the feature identification, which needs to ensure
that features are identified correctly and consistently (e.g., an alpha helix is always
identified as an alpha helix), and also that structurally equivalent features match, and
matches between features that are not structurally equivalent do not dominate the
score calculation.
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